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Summary 
In the first phase of this investigation, synthetic approaches to skeletally modified variants 
of 14,17a-ethanoestra-l,3,5(10)-triene-3,17P-diol were examined, with the purpose of 
determining the influence of configurational inversion at C-8, C-9 or C-13 upon the high 
oral estrogenicity associated with introduction of a 14, 17-ethano bridge into the estradiol 
skeleton. 
3-Methoxyestra-1,3,5(10)-trien-17-one was converted conventionally into the 13a-isomer, 
which underwent sequential silyl enol ether formation and dehydrosilylation into 
3-methoxy-13a-estra-1,3,5(10), 15-tetraen-17-one, which failed to undergo conversion into 
the corresponding 3-methoxy-13a-estra-1,3 ,5( 10), 14, 16-pentaen-17-yl acetate required for 
cycloaddition studies. 
Hydrogenation of 3-methoxyestra-1,3,5( 10),8, 14-pentaen-17P-yl acetate afforded 
3-methoxy-8a-estra-1,3 ,5(1 O)-trien-17P-yl acetate, which was converted into 3-methoxy-
8a-estra-1,3 ,5( 10), 14, 16-pentaen-17-yl acetate. Cycloaddition with phenyl vinyl sulfone 
gave a mixture of products, which was converted into the desired 14,17a-ethano-8a-estra-
1,3,5(1 O)-triene-3, 17P-diol, by a hydrogenation, desulfonylation, deprotection reaction 
sequence. The unexpectedly complex result for the cycloaddition reaction was interpreted 
with the assistance of other cycloaddition reactions of the L\14•16-dienyl acetate. 
l 7,17-Ethylenedioxy-3-methoxy-9p-estra-l ,3,5(1 O)-trien-11-one was readily prepared from 
estrone using conventional methodology. Deoxygenation followed by standard functional 
group manipulation afforded 3-methoxy-9p-estra- l ,3 ,5( 1 O)-trien-17-one. As a result of the 
poor overall yield, the optimisation of a number of steps in this reaction sequence was 
investigated. Despite some improvement in the yields, subsequent conversion into the 
target, 14, 1 7 a-ethano-9P-estra- l ,3 ,5(10 )-triene-3, 17 P-diol was not synthetically useful. 
However, dehydrogenation of 14, l 7a-ethanoestra-1,3,5(1 O)-triene-3, l 7P-diol followed by 
standard functional group modification gave 14, 17 a-ethanoestra-1,3 ,5(10),9(11 )-tetraene-
3, l 7P-diyl diacetate, hydrogenation of which afforded 14, l 7a-ethano-9P-estra-l ,3,5(1 O)-
triene-3, l 7P-diol, after conventional deprotection, in moderate yield. 
Preliminary studies directed towards the synthesis of 15,17-bridged estradiol derivatives 
are also described. 3-Methoxyestra-1,3,5(10),15-tetraen-17-one was converted into 
l 7a-allyl-15P-phenylthioestra-l ,3,5(1 O)-triene-I 7P-ol, to allow for generation of a radical 
at C-15 in order to investigate the scope for cyclisation. An oxy-Cope rearrangement of 
17a-allyl-3-methoxyestra-1,3,5(1 O),l 5-tetraen-I 7P-ol afforded l 5a-allyl-3-methoxyestra-
1,3,5(1 O)-trien-17-one. Subsequent modification gave 15a-formylethyl-3-methoxyestra-
l ,3 ,5( 1 O)-trien-17-one for attempted reductive cyclisation. The feasibility of achieving an 
intramolecular aldol condensation was examined on the Wacker oxidation product of 
15a-allyl-3-methoxyestra-1,3,5(1 O)-trien-17-one, 15a-acetonyl-3-methoxyestra-1,3,5(1 O)-
trien-17-one. In addition, the synthesis of 15P, 17P-bridged compounds was investigated 
by similar reductive coupling methodology. 
A molecular modelling study was und1;rtaken to investigate the structure activity 
relationships of skeletally modified estradiol analogues, in order to develop a working 
hypothesis for interpreting and/or predicting their competitive binding affinities towards 
the estradiol receptor. The structures of three compounds, 14, 17a-ethanoestra-1,3,5(1 O)-
triene-3, l 7p-diol, l 4,17a-propanoestra-1,3,5(1 O)-triene-3, 17P-diol and 14P, 17P-propano-
I4P-estra-l ,3,5(1 O)-triene-3, l 7P-diol were determined by the molecular mechanics 
technique of energy minimisation. These conformations were validated by comparison 
with those observed by X-ray crystallographic determination, and energy minimisation was 
shown to be a reliable method for determining molecular structures. 
The minimum energy conformations of several skeletally modified estradiol analogues 
were then compared with estradiol by superimposition, in order to identify key regions 
affecting receptor binding affinity. From this study the steric environment of the ring D 
region of the receptor has been mapped. Steric bulk on the a-face seems to be readily 
accommodated without a loss of binding affinity, and in some cases with enhanced affinity. 
However, steric bulk on the P-face in conjuction with a 17a-hydroxy group significantly 
reduces the binding affinity. With this working hypothesis, predictions were made 
regarding the binding affinities of several synthetic targets. 
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Historically, the process of drug discovery has consisted of screening large quantities of 
test materials in biological assays, and, by a process of separation and further screening, 
identifying the biologically active constituents of the initial sample. Systematic 
modifications of these initial lead molecules then leads to an understanding of the steric 
and electronic requirements of the receptor-ligand interaction. With this information, 
better drugs can then be designed, with greater activity and fewer side-effects. Figure I. I 
summarises the drug discovery process. 
Natural 
Products 







J ~ Refinement 
~ 
~ 
Figure 1.1: Flow-chart summarising the drug discovery process 
The cost of developing a new drug is estimated to be over 200 million German marks, 
requiring the synthesis of I 0,000 to 20,000 new compounds (1992 estimate). 1 This 
enormous expenditure of both time and money, has led to other avenues toward the drug 
discovery process being explored. 
2 
One technique that has been introduced recently is that of combinatorial chemistry 2-5 
which enables large numbers of compounds for screening to be synthesised rapidly and 
economically. At the other end of the drug discovery process, the use of theoretical 
methods to assist in the drug design process (Figure 1.1, refinement stage) has become an 
established technique. 1 
These methods vary from computationally intensive quantum-chemical calculations for 
determining extremely accurate molecular properties 1 to the use of empirical force-fields 
to obtain information regarding the conformation of molecules, drug-protein interactions 
and to perform dynamic simulations of drugs. 1 A number of techniques have been 
developed and applied to establish quantitative relationships between chemical structure 
and biological activity (quantitative structure-activity relationships, QSAR's). 6-13 
These techniques can assist m the drug discovery process by focusing attention on 
molecular features that promote and/or retard the biological property of interest. This will 
enable possible synthetic targets to be ranked according to importance, reducing the burden 
on overtaxed research programs. It could also assist in directing future experiments by 
identifying outliers in QSAR correlations. 1 
Although these techniques are capable of providing useful information regarding structure-
activity relationships, the results must be regarded with a healthy scepticism, due to the 
approximate nature of both the theoretical method and the model simulating the biological 
phenomenon. In addition, the biological tests devised have a different applicability to in 
vivo conditions. It is likely that processes like drug uptake, binding to carrier proteins and 
properties such as bioavailability are influenced differently by a particular structural 
modification. 1 
It is known that the characteristic actions of steroid hormones are contingent on the high-
affinity binding between the steroid and the specific receptor proteins. In the study of the 
binding of a ligand to the steroid hormone receptor, a number of different techniques have 
been identified. 14 The area of interest to this thesis is the study of the steroid-binding site. 
3 
This process has thus far been tackled on two fronts: (i) by analysing the amino acid 
sequences and predicted secondary structures in order to identify possible binding site(s) by 
computer modelling techniques and (ii) by comparing the 3-D structures and relative 
binding affinities of steroids in order to deduce the structural features compatible with 
binding to the receptor and in this way construct an image of the receptor site into which 
the steroid fits. 14 Another interesting approach currently under investigation is the 
crystallisation of the receptor protein in order to identify potential binding sites. 15 
In this thesis, the approach of comparing the 3-D structures and relative binding affinities 
has been investigated for the estradiol receptor. Ultimately, once information regarding the 
nature of the receptor site has been reliably obtained from either X-ray or NMR 
investigations, it should be possible to model receptor-ligand interactions and thus obtain 
structure-activity correlations leading to accurate activity predictions. 
Estrogens are substances which are characterised by their ability to produce estrus in 
females of various mammalian species. The steroidal estrogens are undoubtedly the most 
important group of these hormones. 16 These hormones were first isolated in the early 
1930's in small quantities from the urine of pregnant women and mares. 16 Estradiol 





Figure 1.2: Estra-1,3,5( 1 O)-triene-3, 17P-diol ( estradiol), numbering system indicated 
Estrogens play a vital role in a variety of physiological processes within the body, 17• 18 and 
despite studies linking estrogen use with breast and endometrial cancer remain the only 
way to prevent post menopausal osteoporosis and to successfully palliate the symptoms of 
the perimenopause. 19 The effectiveness of estradiol for this purpose suffers from both the 
4 
poor oral activity of the drug and its short active lifetime. 20 This has been partially 
overcome by the use of novel methods of drug delivery, such as patches and gels. 19 
Synthetic estradiol analogues, possessing both greater activity and higher metabolic 
resistance than estradiol have been the focus of numerous studies. One of the earliest 
synthetic modifications involved the introduction of a 17a-ethynyl group, giving a 
synthetic estradiol analogue ( ethynylestradiol, Figure 1.3) which is 15-20 times more 
orally-active than estradiol (Figure 1.2). 21 
OH 
HO 
Figure 1.3: 17a-ethynylestra-1,3,5(1 O)-triene-3,l 7J3-diol (ethynylestradiol) 
From systematic variations of functional groups around the periphery of the estradiol 
skeleton, the mode of receptor-binding, as well as the nature of the receptor have been 
postulated. In short, the phenolic 3-hydroxy group binds tightly to the receptor through a 
strong hydrogen bond, subsequently, the 17-hydroxy group interacts with the receptor to 
induce the biological response. 22' 23 The greater importance of the 3-hydroxy group for 
binding is evident from the following results: Estra-l,3,5(10)-trien-l 7J3-ol has a 
competition factor (CF) 24 of 59, 25 substantially inferior to estradiol (CF 1 ), while estra-
1,3,5(10)-trien-3-ol has a CF of 7. 25 The relative orientation of the 17-hydroxy group 
appears to be critical, as estra-1,3,5(1 O)-trien-3, 17a-diol (the 17-epimer of estradiol) has a 
CF of 46, once again substantially weaker than estradiol. 25 
An important class of molecules that display affinity towards the estrogen receptor is the 
non-steroidal stilbene class of compounds, exemplified by diethylstilbestrol (Figure 1.4) 
which displays high biological activity. 27 For this class of estradiol analogues, which are 
generally more flexible than steroids, the hydrogen bonding of the phenolic group is 
thought to be more important than the overall conformation of the molecule in receptor 
5 
binding. 22· 26 Although these molecules bear little resemblance to estradiol, they possess 
the basic structure that appears to be necessary for estrogen receptor affinity, namely (i) a 
phenolic hydroxyl group and (ii) two hydroxyl groups separated by a hydrophobic spacer. 
OH 
HO 
Figure 1.4 : Diethylstilbestrol 
The estrogen receptor is generally hydrophobic in nature, as is evidenced by the loss of 
binding affinity on addition of hydroxy groups to the estradiol template. 26 Apart from a 
few areas which will be discussed, there appears to be close contact between the ligand and 
the receptor - the addition of methyl groups in these positions leads to a reduction in 
biological activity. 26 As has been mentioned, the addition of l 7a-substituents does not 
significantly reduce biological activity, and can even increase it (cf l 7a-ethynylestradiol). 
The 11 P- and ?a-positions also appear to be located in the vicinity of a hydrophobic pocket 
in the receptor, as the introduction of a variety of alkyl and ether groups in these positions 
enhances biological activity. 26 Recently, it has been established that the introduction of a 
l 4a-methyl group does not impede receptor binding. 28• 29 
It has been estimated that the free energy of binding to the estradiol receptor is in the region 
of-12.1 kcal mor1 27· 30 with 3-5 kcal mor1 contributed by the hydrogen bonding of the two 
hydroxyl groups. 27 This leaves at least 7 kcal mor1 of the binding energy being 
contributed by hydrophobic interactions between the receptor and the ligand. This should 
provide sufficient energy to enable a flexible molecule to adopt the most favourable 
conformation for binding with the receptor. This argument has been proposed as a possible 
explanation for the high biological activity observed for diethylstilbestrol. 27 
With the discovery that 14, 17a-ethanoestra-1,3,5(10)-3, 17P-diol (Figure 1.5) is an orally-
active estrogen, with biological activity similar or superior to 17a-ethynylestradiol, 31 an 
extensive investigation into structure-activity relationships of other ring D bridged estradiol 
6 
analogues was embarked upon. 3240 The syntheses of a number of these compounds have 
been reported elsewhere, 32-35 and will not be discussed in this thesis, but the implications 
of these modifications towards structure activity relationships will be discussed 
in Chapter 4. 
As a part of this ongoing investigation, the work discussed in this thesis set out to 
investigate the influence of backbone modifications on the biological activity of estradiol 
analogues. Skeletally modified hormone analogues are of interest, 41 as it has been shown 
that they often display promising activity. For example, 9f3, 1 Oa-progesterone 
('retroprogesterone') is approximately 25 times more active than progesterone. 42 As the 
14a, l 7a-ethano bridge is known to enhance biological activity in the natural series, the 
syntheses of skeletally modified versions of 14, l 7a-ethanoestra- l ,3 ,5(1 O)-triene-3, l 7P-diol 
(Figure 1.5) were investigated. 
OH 
HO 
Figure 1.5: 14, l 7a-ethanoestra-l ,3,5(1 O)-triene-3, 17~-diol A 
At present, little has been reported regarding the effect of inversion at C-13 on the 
biological activity of estradiol analogues. 43-46 As can be seen from the perspective 
drawing of the target (Figure 1.6) ring C is forced to adopt a boat-like conformation. Also 
evident from this perspective view is that substantial steric bulk is introduced on the P-face 




Figure 1.6: 14, l 7a-ethano-13a-estra-l ,3,5(1 O)-triene-3, 17P-diol B 
Steroids in other series with this modification are known to display interesting 
pharmacological properties, for example the 13a-gonane derivative ZK 98299 (Figure 1. 7), 
which displays anti-progestational activity. 47 
OH 
Figure 1.7: The anti-progestational steroid, ZK 98299 
Inversion at C-8 results in a dramatic distortion of the planar steroid structure, with rings C 
and D virtually perpendicular to the plane described by rings A and B (Figure 1.8). Despite 
this rather drastic change estradiol analogues with this modification retain biological 
activity, often displaying activities comparable to the natural series. 48-52 For example, 




Figure 1.8: 14,17a-ethano-8a-estra-l,3,5(10)-triene-3,l 7P-diol C 
Inversion at C-9 results in a steroid with the 'folded' conformation indicated (Figure 1.9). 
Estratrienes with this configuration are known, and although most display lower biological 
activity than the corresponding compound in the natural series 53• 54• 28• 29 there are some 
notable exceptions. The 9P-isomer of 17a-ethynylestradiol is reported to have a binding 
affinity comparable to the natural series 53 and even more remarkably, 3-hydroxy-9p-estra-
l ,3,5(10)-trien-l l, l 7-dione has 10 times the estrogenicity of its natural isomer. 54 
OH 
HO 
Figure 1.9: 14, 17a-ethano-9P-estra-1,3,5(1 O)-triene-3, 17P-diol D 
As is evident from the perspective view of the 9p-analogue (Figure 1.9), the structures of 
9P-steroids are rather different to that of the parent hormone, notably in the spatial 
orientation of the two polar functionalities. It has been speculated that these molecules 
9 
may undergo conformational deformation during the receptor binding process, thus leading 
to the observed biological activity. 41 
In an attempt to potentiate steroids towards conformational deformation, Bull et. al have 
synthesised l 4a-methyl-9P-steroids, 28• 29• 41 as the introduction of a further sterically 
impeding group on the already crowded a-face was expected to promote this 
conformational change. This was partially realised in the estratriene series: l 7P-t-
butyloxy-l 4a-methyl-9P-estra-l ,3,5(10)-trien-3-ol was shown to have a ring B boat, ring C 
chair conformation, one ring having inverted. 55• 56 The introduction of an 11 P-hydroxy 
group, which further destabilises the ring C chair conformation through a 1,3-diaxial 
interaction with the 13 P-methyl group, sufficed to induce ring C to adopt a non-chair 
conformation. 55 
Thus, it was anticipated that the 14a,l 7a-ethano bridge would potentiate the 9P-steroid D 
(Figure 1.9) towards conformational deformation resulting in a (relatively) flexible 
estradiol analogue. This conformational mobility might predispose the molecule towards 
an in vivo conformational change enabling the most favourable receptor-ligand interaction 
to occur, leading to higher biological activity. 
A retrosynthetic analysis of the target molecules (14, l 7a-ethano-9P-estra-l ,3,5( I O)-triene-
3, l 7P-diol is used as an example, Scheme I.I) indicates two plausible synthetic routes. In 
the first route, inversion at C-9 affords the known 14,17a-ethanoestra-l,3,5(10)-triene-
3,l 7P-diol, which is readily available from estrone 3-methyl ether. 57 Alternatively, 
removal of the 14, 17 a-ethane bridge affords 3-hydroxy-9p-estra- l ,3 ,5(1 O)-trien-17-one, 











A more detailed synthetic strategy, based upon this retrosynthetic analysis, followed by the 
attempted synthesis will be presented for each series in tum. This will be discussed in the 
next chapter. 
Concurrent with this synthetic work, a detailed computational study of these four 
14, l 7a-ethanoestradiol analogues has been conducted, and will be elaborated upon in 
Chapter 4. In addition, a more general modelling study of ring D bridged estradiol 
analogues has been carried out in order to deduce the structural features that are compatible 
with receptor binding, and hence to construct an image of the receptor cavity in which the 
ligand is bound. This will be discussed in more detail in Chapter 4. 
Scheme 2.1 
Secondly, heating the oxime of a 17-oxo steroid in a mixture of acetic anhydride and 







Thirdly, refluxing the 17-oxime acetate (of a 17-oxo steroid) with nickel powder in a 
mixture of acetic acid and octane affords the l 3a-derivative. 45 
As it has been reported that the first two methods are unsuitable for the large-scale 
preparation of l 3a-estrone 3-methyl ether, 58 the third method was selected for introducing 
the desired unnatural stereocentre. 
Two approaches towards the synthesis of the desired ring D bridged 13a-estradiol analogue 
are conceptually possible, namely introduction of the unnatural stereocentre, followed by 
the addition of the 14, 17-bridge or alternatively, introduction of the 14, 17-bridge followed 
by inversion at the desired stereocentre. In this instance, the latter was not investigated as 
all the available methods for inversion at C-13 require the presence of a 17-ketone, a 
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Scheme 2.3: Planned synthetic route 
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Thus, the planned synthetic route is initial inversion at C-13 of estrone 3-methyl ether a, 
followed by conversion to the derived dienyl acetate c for cycloaddition of an ethylene 
equivalent and subsequent modifications to afford the target B (Scheme 2.3). 
The crucial step of this synthetic sequence was expected to be the formation of the dienyl 
acetate c as it is readily apparent from simple molecular models that the introduction of a 
sp2-hybridised carbon at C-14 of a 13a-steroid forces ring C to adopt a high-energy, 
boat-like conformation. 
Estrone 3-methyl ether 1 was converted into the corresponding 17-oxime acetate 2,59· 60 
which was treated with nickel powder in refluxing acetic acid-hexane to give a readily 
separable mixture of l 3a-estrone 3-methyl ether 3 ( 51 % from 1) and estrone 3-methyl 
ether 1 (8%) (Scheme 2.4). When the reaction was conducted in refluxing acetic acid-
octane as described in the literature, 45 a lower yield (44%) of the desired product, along 
with a comparable amount of estrone 3-methyl ether (7%) was obtained. 
MeO 
1 






Ni powder ... ~ (+ 1) 
3 
The 13a-derivative 3 displayed physical characteristics comparable to the literature values 
thus confirming the structure. As limited NMR data have been published for compounds 
with this unusual 13a-configuration, the full assignment of both the proton nuclear 
magnetic resonance (1H NMR) and carbon-13 nuclear magnetic resonance (13C NMR) 
spectra was conducted to assist with assignments later in the synthetic sequence. Standard 
spectroscopic techniques, for example 1H-1H correlation spectroscopy (COSY) and 13C-1H 
correlation spectroscopy (HETCOR) were used to assist with these assignments. 
Meo 
Figure 2.1: Perspective drawing of 13a 17-ketone 3 
Some interesting features were observed in the 1H NMR spectrum; the signal for 14a-H 
appeared as a doublet of doublets (8 1. 75, J 11 and 6 Hz) in which the large coupling is to 
8P-H and the small coupling to 15a-H. No coupling with 15P-H is observed, owing to a 
near-orthogonal relationship between 14a-H and l SP-H 61 clearly evident from an 
examination of a model. The signals for 8P-H (8 0.92) and 11 P-H (1.0) are both in the 
region of anisotropic shielding of the 17-ketone, 62 clearly indicated from a comparison 
with the comparable shifts for estrone 3-methyl ether: 8P-H (8 1.2) and 11 P-H (8 1.3 ), 63 
15 
confirming the molecular conformation indicated (Figure 2.1 ). Figure 2.2 shows the high-
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Figure 2.2: 1H NMR spectrum of 13a 17-ketone 3 
The introduction of unsaturation into ring D was performed according to a standard 
procedure 64 which has been used successfully in the dehydrogenation of steroidal 
17-ketones. Thus, the 17-ketone 3 was converted via a low-temperature deprotonation-
trapping sequence (LDA, TMSCl) into the corresponding silyl enol ether which was treated 
directly with palladium acetate in refluxing acetonitrile to give a separable mixture of 
starting material 3 (33%) and the desired ~ 15 17-ketone 4 (38%) (Scheme 2.5). This rather 
poor result contrasts with those reported 65 · 66 for 17-oxosteroids in the natural series, and 
may be ascribed to greater steric hindrance towards palladium complexation to the olefinic 
bond in the enol silyl ether. The Ba-methyl group thus inhibits a-face complexation, 
whereas the [3-face is subjected to severe steric hindrance by the elements of ring C, with 
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The ~ 15 1 7-ketone 4 was readily characterised by spectroscopic techniques - an infrared 
absorption (vmax 1701 cm- 1) clearly indicated the presence of a cyclopentenone sub-unit. 
AB Multiplets for 15-H (8 7.76, dd J 5.8 and 2.6 Hz) and 16-H (8 6.18, dd J 5.8 and 1.7 
Hz) were observed confirming the presence of the conjugated olefinic bond. The signal 
for 14a-H (8 2.7, ddd J 11.6, 2.6 and 1.7 Hz) displayed the expected coupling pattern and 
enabled identification of most of the 1H NMR spectrum, and the 13C NMR spectrum with 
the aid of 2D correlation spectroscopy. 
15-H 1-H 4-H 16-H 
8.2 8.0 7 .8 7.6 7 .• 7. 2 7 .0 6.8 6.& PPIII 
I4a-H 
8!3-H 
9a-H 1113-H 713-H 
3.2 3 .0 2.8 2.6 2.• 
Figure 2.3: 1H NMR spectrum of ~ 15 17-ketone 4 
Conversion of the ~ 15 17-ketone 4 into a 14,16-dienyl derivative for cycloaddition studies 
was expected to be problematical. Examination of molecular models clearly indicates that 
the change of hybridisation at C-14 from sp3 to sp2 forces ring C to adopt a boat-like 
conformation (Figure 2.4). This was expected to increase the activation energy of the 
reaction and possibly prevent it from occurring altogether. 
17 
MeO 
Figure 2.4: Perspective view of the desired 14,16-dienyl system 
A review of the literature was undertaken to establish whether or not this structural sub-
class (l 3a-L\ 14 system) has been described, as these compounds would be expected to have 









A reported attempt to introduce a L\ 14-bond into a 13a-methyl steroid by the acid catalysed 
isomerisation of an olefinic bond 67 (HCl, CHCh) indicated that, in contrast with the 
natural series, the L\ 7 -olefin 5 either isomerises to the LI. 8-isomer 6 (R = OH) or to the 
L\ 14Cl 7)_14a-methyl derivative 7 (R = H), with none of the desired L\ 14 13a-methyl 
derivative being formed (Scheme 2.6). The introduction of a Ll. 14-bond has been 
successfully accomplished in related 13a-steroids with a 7a-substituent 68 so this result 
was somewhat unexpected. 
18 
The authors proposed the following explanation (Scheme 2. 7): the collapse of a 
carbocation (incipient or otherwise) at C-14, either by the migration of the 13a-methyl 
group (pathway a) or by the elimination of a 15-proton (pathway b) is determined by the 
7a-substituent (R2). Where this substituent is small (e.g. H) pathway a is favoured. 
However, the presence of a bulkier 7a-substituent (e.g. OH) leads to a 1,3-diaxial 
interaction in the transition state as the l 3a-methyl group migrates to C-14 so that pathway 
b becomes competitive. 67 
Scheme 2.7 
Despite this negative precedent, it was decided to proceed with attempts to synthesise the 
14, 16-dienyl system in the hope that the additional stabilisation provided by conjugation 
would stabilise the system sufficiently to enable isolation of the diene and subsequent 
cycloaddition reactions to proceed smoothly. 
The first method to be investigated for accomplishing this transformation was that 
successfully utilised in the synthesis of 3-methoxyestra-1,3 ,5(10), 14, 16-pentaen- l 7~-yl 
acetate. 57 Refluxing the l\ 15 17-ketone 4 with toluene-p-sulfonic acid in a mixture of 
acetic anhydride and isopropenyl acetate (IPA) afforded a less polar product in poor yield 
(9%) which displayed 1H NMR features consistent with the desired dienyl acetate 8 
(Scheme 2.8), namely two low field signals for 15-H (8 5 .85, m) and 16-H (& 6.17, d, J 2.3 
19 
Hz), and an acetate methyl signal (o 2.23, s) for the 17-0Ac. The expected molecular ion 
(mlz 324) was also observed in the mass spectrum. Further characterisation was rendered 
difficult due to the instability of the material, and in the light of the previous discussion the 
limited data set does not provide conclusive structural proof. As a result of the poor 
conversion, the uncertainty regarding the outcome and the instability of the product this 
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8 R' = Ac 
9 R' = SiMe3 
As an alternative route towards the Ll 14· 16-dienyl system, the synthesis of the derived 
l\.14•16 17-silyl dienol ether 9 was explored. Treatment of the l\. 15 17-ketone 4 with 
trimethylsilyl trifluoromethanesulfonate and triethylamine (TEA) in dichloromethane gave 
a single, less polar, UV active fraction (27%) which 1H NMR analysis indicated to be a 
mixture of products, possibly containing the desired product 9, but the instability of this 
mixture prevented any further investigation. 
The formation of the more stable triisopropylsilyl dienol ether usmg similar reaction 
conditions (triisopropylsilyl trifluoromethanesulfonate, TEA) was also attempted with 
similar results. 
These preliminary experiments confirmed that formation and cycloaddition of 
14,16-dien-17-yl derivatives in the 13a-series would be difficult, and it was decided that 
further work on the problem was beyond the scope of this investigation. 
20 
2.2: Sa-Series 
The availability of 3-methoxyestra-1,3,5(10),8,14-pentaen-17P-yl acetate a 69 as starting 
material suggested two possible approaches to the target system, 14, 17a-ethano-8a-estra-
1,3,5(1 O)-triene-3, l 7P-diol C. In the first approach (Scheme 2.9), conversion of 
17P-acetate a into the corresponding hexaenyl derivative b would provide an intermediate 
for cycloaddition of an ethylene equivalent to the ring D moiety. It was reasoned that the 
presence of the 14a, 17 a-ethano bridge in c would diminish the a-selectivity associated 
with the catalytic hydrogenation of the Li 8 -bond in the unbridged series. 48 Thus, catalytic 
hydrogenation of the olefinic bond in the bridged compound c was expected to furnish the 
desired 14,17a-ethano-8a-estra-l,3,5(10)-triene-3,17P-diol C, almost certainly 
accompanied by the corresponding 9P-isomer D. Such an outcome would, in fact, be 
advantageous since generation of both isomers in practical yields would thus provide 






















The alternative strategy (Scheme 2.10) was to subject the pentaene a to catalytic 
hydrogenation and to convert the resultant 8cx-derivative, 48 into the derived dienyl 
acetate d for cycloaddition of an ethylene equivalent and subsequent modification into the 



















The findings of this investigation into these two synthetic strategies are described in the 
ensuing section. 
22 
2.2.1 Synthesis of 14,17a-ethano-8a-estra-1,3,5(10)-triene-3,17P-diol 
Starting from the 17~-acetate 10, 69 hydrolysis of the ester afforded the 17~-alcohol 11 
(Scheme 2.11 ). 69 Oxidation of this alcohol to the derived 17-ketone 12 proved 
problematical. A wide variety of oxidation methods 70-76 gave complex mixtures of highly 
coloured compounds, from which no 17-ketone 12 could be isolated. The use of tetra-n-
propylammonium perruthenate and N-methylmorpholine N-oxide 77 gave a 20% yield of 












A review of the literature revealed that 3-methoxyestra-1,3,5(10),8, 14-pentaen-17-one 12, 
has been synthesised by a number of different synthetic routes, mostly in racemic 
form. 78-82 In one of these reported syntheses, a (racemic) mixture of the 3-methoxyestra-
1,3,5(10),8, 14-pentaen-171;-ols was oxidised to the 17-ketone (rac. 12) with chromium 
trioxide and Celite in a mixture of dichloromethane and diethyl ether. 82 Utilising these 
reaction conditions on the optically pure 17P-alcohol 11 was unsuccessful, with no reaction 
being observed (TLC). As yet, no explanation has been found to account for the problems 
observed with this oxidation reaction. Due to this problematical reaction this route was 
discontinued. 
The alternative synthetic route (Scheme 2.10) was then investigated. Starting from the 
l 7p-acetoxypentaene 10, catalytic hydrogenation afforded the 8a-estratriene 13. The 
structure of this compound was confirmed by a comparison of physical characteristics 
(m.p. and [a]0 ) with literature values. 
48 Raney nickel was used as the catalyst for this 
23 
reaction as it has been reported 48 that palladium catalysis affords side products, resulting 
from dehydrogenation of ring B. 
Hydrolysis of the 17P-acetate 13, followed by oxidation with Jones' reagent 83 (other 
oxidants worked equally well) gave the desired 17-ketone 14 in 87% overall yield from 10. 
Conclusive 1H NMR evidence for the Sa-configuration could not be obtained, as the 
signals for 8a-, 9a- and 14a-H were all overlapped with other signals, nevertheless the 














In order to help with assignments later in the series, the 1H NMR spectrum of 14 was 
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Figure 2.5: High-field region of the 1H NMR spectrum of 8a 17-ketone 14 
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Introduction of unsaturation into ring D was accomplished by the enol silylation-
dehydrosilylation procedure 64 previously described for the l 3a-series. A low temperature 
deprotonation-trapping sequence (LDA, TMSCl) afforded the corresponding enol silyl 
ether which was treated with palladium acetate in refluxing acetonitrile to give a 
quantitative yield of the L\ 15 17-ketone 15 (Scheme 2.12). All the spectral and analytical 
evidence clearly indicated that the expected c011version had occurred, namely an infrared 
absorption consistent with a cyclopentenone (vmax 1707 cm-1) and the expected AB 
multiplets for both 15-H (8 7.59, ddd, J 6.0, 2.0 and 0.6 Hz) and 16-H (8 6.09, dd, J 6.0 and 
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Figure 2.6: 1H NMR spectrum of L\ 15 17-ketone 15. 
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From the observed signals for 8a-H (8 2.4) and 14a-H (8 2.9) the configuration at C-8 
could be readily assigned. The signal for 8a-H is a broadened doublet of quartets, with 
three small couplings (to 7a-H, 9a-H and 14a-H) and one large coupling (to 7P-H). In the 
case of 14a-H, a signal approximating a quartet is observed, indicating three small 
couplings (to 8a-H, 15-H and 16-H). The identity of the long-range coupling partner to 
15-H could not be determined, even with the assistance of a COSY spectrum. 
The ~ 15 17-ketone 15 was converted to the dienyl acetate 16 following a standard 
procedure which has been used successfully in the natural series. 57 Refluxing the 
~ 15 17-ketone 15 in a mixture of acetic anhydride and IP A with catalytic toluene-p-sulfonic 
acid for 2h gave the desired dienyl acetate 16 (78%) (Scheme 2.13). 
0 
15 





All the spectroscopic and analytical evidence support the assigned structure 
[ Vmax 1748 cm-1, M+ 324, a methyl signal at 8 2.2 for 17P-0Ac, and an AB multiplet for 
15-H (8 5.98, d, J 3 Hz) and 16-H (8 6.08, d, J 3 Hz)]. In this case, the signal for 8a-H (8 
2.94, ddd, J 13.3, 5.4 and 2.6 Hz) provided further spectroscopic evidence for the 
configuration at this centre. The lack of an allylic coupling from 15-H to 8a-H 84 is due to 
the fact that 8a-H is virtually in the plane of the olefinic bond (Figure 2. 7), unlike in the 





Figure 2.7: A, Perspective view of dienyl acetate 16 and 
B, Newman projection along the 8,14-bond 
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C(15) 
Having successfully synthesised this key intermediate, the introduction of the 
14a, 17 a-ethano bridge was investigated. 
Cycloaddition of the dienyl acetate 16 with phenyl vinyl sulfone (PVS) (benzene, 150°C) 
proceeded slowly (140h) to give what appeared on TLC to be a single product, but was 
discovered to be a mixture of three cycloadducts 17, 18 and 19, approximately in a 1: 1 :3 
ratio (Scheme 2.14). The isolation and characterisation of each adduct will be described 
separately, however for comparison purposes, important 1H NMR signals of all three 
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Scheme 2.14 Reagents and conditions: i, H2C=CHS02Ph, PhH, 150°C; 






Table 2.1: 1H NMR signals for the cycloadducts 17, 18 and 19. 
Chemical shift 8/ppm (multiplicity, coupling constant J/Hz) 
Proton(s) OAc OAc OAc 
~-· ~ ~·· ( SO,Ph 0,Ph 
17 18 19 
15 8 6.33 (d, J 6) a: 8 1.72 (dd, J 12.6 p: 8 4.03 (dd, J9.0 and 
and 4.6) 4.8) 
p: 8 2.52 (dd, J 12.6 
and 9.0) 
16 8 6.40 (d, J 6) p: 8 4.05 (dd, J9.0 and p: 8 2.09 (dd, J 12.3 
4.6) and 9.0) 
a: 8 2.63 (dd, J 12.3 
:md 4.8) 
1 ?1 exo: 8 2.14 (dd, J 12.2 8 6.43 (d, J 6) 8 6.37 (d, J 6) 
and 9.4) 
endo: 8 2.57 (dd, J 12.2 
and 4.3) 
1 ?2 exo: 8 4.25 (dd, J9.4 8 5.96 (d, J 6) 8 6.00 (d, J 6) 
and 4.3) 
Chromatography failed to achieve separation and gave a single fraction (79%) comprising a 
mixture of 17, 18 and 19, crystallisation of which gave a single product, 17 (a minor 
product). From the 1H NMR spectrum, the regio- and stereochemistry of the cycloaddition 
was not obvious; the expected doublets for the etheno bridge (8 6.33 and 6.40, J 6 Hz), the 
doublet of doublets for the proton a- to the phenylsulfonyl group (8 4.25, J 9.4 and 4.3 Hz) 
and the corresponding coupling partners (8 2.14, dd, J 12.2 and 9.4 Hz and 8 2.57, dd, J 
12.2 and 4.3 Hz) were all clearly visible, but did not exclude any of the possible 
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Figure 2.8: High-field region of 1H NMR spectrum of 1 iR-phenylsulfonyl 17-acetate 17 
Preliminary structural assignment was made by NOE difference spectroscopy. Irradiation 
of the 13~-methyl group (8 1.03) enhanced both olefinic protons (8 6.33 and 6.40), 
indicating that a,1 a-face cycloaddition had occurred. 
From a NOESY spectrum (a portion of this is shown in Figure 2.10), the structure was 
readily assigned as that of the cycloadduct 17. The key signals used in making this 
assignment were the observed crosspeaks between 1 ?2-Hx and 8a-/9a-H as well as the 
crosspeaks between the 13~-Me and C-15 and C-16 (Figure 2.9). 
Figure 2.9: Perspective view ofl ?2 R-phenylsulfonyl 17-acetate 17 indicating some 
of the observed NOESY crosspeaks 
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Figure 2.10: NOESY spectrum of 1 ?2 R-phenylsulfonyl 17-acetate 17 
As this was a somewhat unexpected result m the light of the extremely selective 
cycloaddition reactions to the corresponding ring D dienyl acetate with the natural 
configuration at C-8, 32· 33· 57 an X-ray crystal structure of the cycloadduct 17 was obtained 
(see Chapter 6 for details), and this provided conclusive proof of the structure 
(Figure 2.11 ). This confirmation of the structure allowed further structural assignments 
from NOE spectroscopy to be made with confidence. 
Figure 2.11: X-ray crystal structure ofl 72 R-phenylsulfonyl 17-acetate 17, 
important carbons are numbered 
31 
c-\lkaline treatment of the cycloaddition mixture 17, 18 and 19 gave two fractions, one of 
which was a single product, less polar than the starting material which absorbed UV light 
(17%). This was assigned as the 14P-(phenylsulfonylethyl) ~ 15 17-one 21, which must 
originate from retrograde cleavage (of the 16,17-bond) of adduct, 18. Both the 1H NMR 
and IR spectra indicated the presence of a cyclopentenone unit [ Ymax 1708 cm-1, doublet for 
16-H (8 6.20, J 5.9 Hz) and a multiplet for 15-H (ca 7.7 - overlapping with other signals)]. 
Although the available data did not provide conclusive proof of the stereochemistry at 
C-14, this was confirmed by the subsequent isolation of 18 from the cycloaddition mixture 
(Scheme 2.15). 
The more polar material, an inseparable mixture of 20 and 22, must originate from 
hydrolysis of the 17P-0Ac of a head-to-tail adduct (Figure 2.14; 17 and 19). A comparison 
of the 1 H NMR spectrum of this mixture with material prepared by alkaline hydrolysis of 
pure l ?2-phenylsulfonyl ~ 15 adduct 17, (product 20) clearly indicates that a mixture of two 
products is indeed present (3: 1 ratio by 1 H NMR), with the minor isomer corresponding to 
product 20. 
32 
Reacetylation of this mixture gave a mixture of the two 17P-acetates 17 and 19 which were 
inseparable on silica gel chromatography. Crystallisation from chloroform-methanol 
afforded the previously identified 172-phenylsulfonyl ~ 15 adduct 17, and evaporation of the 
mother liquor afforded the other head-to-tail adduct, 15a-phenylsulfonyl-14,17a-etheno 
derivative 19. 
As in the case of 17, the 1 H NMR spectrum displayed the expected signals for a 
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Figure 2.12: 1H NMR spectrum of 15a-phenylsulfonyl 17-acetate 19 
The orientation of the 15-phenylsulfonyl group was expected to be a, but in order to 
confirm this, a difference NOE experiment was conducted. Irradiation of the 13P-methyl 
group enhanced the signal for 15P-H (8 4.03, 4.8%) amongst others, thus providing 
conclusive structural proof. 
c~ 
13 V J OAc i 
H 
Figure 2.13: Perspective view of 15a-phenylsulfonyl 17-acetate 19 indicating 
observed NOE enhancements 
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The total cycloaddition fraction 17, 18 and 19 was then hydrogenated as the next step 
towards the target compound. The reaction was performed under forcing conditions (Pd-C, 
H2, 50 bar, 60°C, Sh) in an attempt to ensure complete reaction. In spite of this, some 
starting material remained (18%). The 1H NMR spectrum of this material revealed that it 
was a single product, 16a-phenylsulfonyl 17-acetate 18. Once again, the diagnostic 1H 
NMR signals of a cycloadduct were observed (Table 2.1 ). The other signals in the I H 
NMR spectrum were remarkably well dispersed, enabling most of them to be assigned. 
Figure 2.14 shows the high-field region of the 1H NMR spectrum. 
OAc OAc OAc 
.,,,,S02Ph 
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Scheme 2.15 Reagents and conditions: i, H2, Pd-C, CHC1 3; ii, a) Smlz-HMPA, THF, -20°C; 
b) KOH, MeOH, 25°C OR Na-NH 3, THF, -33°C 
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Figure 2.14: 1H NMR spectrum of 16a-phenylsulfonyl 17-acetate 18 
As before, the structure of this cycloadduct, 18, was ascertained by NOE difference 
spectroscopy. Irradiation of the 13p-methyl group (8 0.95) gave a significant enhancement 
of I6P-H (8 4.05; 7%), confirming that a P-face cycloaddition had occurred (enhancements 
of I5P-H, and 1 IP-H were also observed). Irradiation of 172-H (8 6.0) enhanced the 
signals for 8a-H (8 2.2, 6%) and 9a-H (8 2.9, 7%), as well as the signal for I5a-H (8 1.7, 
1.5%). This, along with the subsequent base treatment of the adduct provided conclusive 
proof for the assigned structure. 
Figure 2.15: Perspective view of the 16a-phenylsulfonyl 17-acetate 18 indicating 
observed NOE enhancements 
Alkaline treatment of this adduct 18, under identical conditions to those used for the 
cycloadduct mixture, gave 14P-(phenylsulfonylethyl) Li 15 17-one 21, identical to that 
35 
isolated previously thus confirming both the regiochemistry of the adduct 18 and the 
stereochemistry of the fragmentation product 21. 
The major product of the hydrogenation reaction was assumed to be a mixture of the 
14, 17-ethano bridged sulfones 23 and 24 (82% ). Recrystallisation afforded what appeared 
to be a single product from the evidence of 1 H NMR analysis. From the recrystallisation 
recovery ( 60% ), this material was assumed to be the l 5a-phenylsulfonyl derivative 24, but 
this was not confirmed. The 1H NMR clearly indicated that the double bond had been 
saturated, with the loss of the AB doublets for 171-H and 172-H, and the presence of a more 
complicated signal for I5P-H (6 3.99, ddd J 11.7, 4.3 and 2.4 Hz), with an additional 
coupling arising from a four-bond 'W-coupling' to 17\-H (Figure 2.16). 85 These data 
once again indicate that the cycloaddition is endo selective, as the exo isomer would not 
display this additional coupling. 
AcO 
Figure 2.16: A perspective drawing of 24 indicating the W-coupling between 
I5P-H and 172x-H 
Thus, from this combination of experimental and spectroscopic evidence it has been shown 
that cycloaddition of PVS to the dienyl acetate 16 gives rise to three adducts (79%) in a 
ratio of approximately 1:1:3 (17:18:19). Possible reasons for this will be discussed later 
(Section 2.2.3). 
Desulfonylation of the mixture of sulfones 23 and 24 was conducted by two different 
methods (Scheme 2.15). Initial desulfonylation with samarium(II) iodide-
hexamethylphosphoramide (HMPA) 86 followed by deacetylation gave 3-methoxy-14,17a-
36 
ethano-8a-estra-1,3,5(1 O)-trien-17P-ol 25 (78% overall yield) or alternatively treatment 
with sodium in ammonia 87' 88 gave the same compound in a somewhat diminished yield 
(53%). The expected absence of definitive downfield signals in the 1H NMR spectrum, 
along with the remainder of the spectroscopic and analytical data confirmed the structure of 
the product. 
Deprotection at the 3-position was performed using standard conditions 89 (Scheme 2.16) 
to give the target estradiol analogue 26 which was subjected to biological evaluation. Due 
to the limited solubility of this material in most organic solvents, full spectroscopic 







Initial microanalyses of 26 gave data consistent with the inclusion of one molecule of 
methanol (the solvent of recrystallisation). A thermal gravimetric analysis (Figure 2.17) 
confirmed this, with a distinct loss of solvent between about 65° and 145°C, the major loss 
occurring between 130°C and 140°C. 
The percentage mass loss (5.646%) corresponds to a loss of about 0.5 molecules of 
methanol, not consistent with the microanalysis, but confirming that solvent has indeed 
been included. After drying the sample at 120°C for 48h under vacuum, a satisfactory 
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Figure 2.17: Thermal gravimetric analysis of 3, 17P-diol 26 
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An alternative approach to the target 14a,17a-ethano analogue of 8a-estradiol 26, 
involving desulfonylation of the cycloadduct mixture 17, 18 and 19, followed by 
hydrogenation of the resultant etheno bridged compounds, was also investigated for two 
reasons. Firstly, in the natural series, this route is higher yielding (see Section 2.3) and 
secondly, it could also provide access to other analogues of 8a-estradiol - the 
corresponding etheno bridged compounds, and derivatives thereof. 57 
A potential side reaction is the capture of the radical generated by the cleavage of the C-S 
bond by the olefinic bond, giving rise to a cyclopropyl compound. This process has been 
well documented in desulfonylation reactions of related steroidal bicyclo[2.2. l ]heptenoid 
systems. 38. 57, 90 
Treatment of the cycloadduct mixture 17, 18 and 19 with sodium in ammonia gave an 
inseparable mixture (36%) of the 14, 1 7-etheno bridged products 29 and 30, and the 
15, 1 ?2-cyclo 27 and the 16, 1 ?1-cyclo 28 compounds (Scheme 2.17). The fate of the 
remainder of the starting material could not be determined. The exact composition of this 
mixture could not be ascertained, but since no evidence excluding any of the possible 
38 
products could be obtained, it was assumed that all four products were present. Clear 
evidence of a mixture was seen in the duplication of signals for the 13P-Me group 
(0.97 and 0.98) and 1-H (8 7.01-7.05). From the two olefinic proton doublets (8 5.75, J 5.9 
Hz and 8 5.90, J 5.9 Hz) which integrated for approximately one proton combined, it was 



























Hydrogenation of this mixture gave a separable mixture of the 14a, 17a-ethano compound 
25 ( 48%) and a chromatographicall y inseparable mixture of the 15, 1 ?2-cyclo and 
39 
16,1 ?1-cyclo compounds 27 and 28 (52%). The structure of the 14a,17a-ethano compound 
25 was assigned by comparison with previously synthesised material, and must originate 
from the two 14, 17-etheno compounds 29 and 30. 
Recrystallisation of the mixture of 27 and 28 afforded a single product which was assigned 
as the 15,172-cyclo compound 27. This assignment was made on the assumption that the 
intramolecular radical trapping reaction by the olefinic bond proceeds with similar facility 
in this series as in the natural series. It has been established that during the desulfonylation 
of the 16a-phenylsulfonyl derivative in the natural series corresponding to 18, the amount 
of 16, 17 1-cyclo compound formed is usually in the region of 5%. 57 
Thus it was assumed that the relatively large amount of cyclo compound formed (52%) is 
due to the radical generated at either C-15 or C-1 ?2 being sterically hindered, hence 
promoting the intramolecular reaction with the olefinic bond. Further confirmation of 
structure was not conducted. No trace of the alternative 16,1 ?1-cyclo compound 28 was 
observed, but it is probably present as a minor, unidentified component of the mother 
liquor material. 
In the I H NMR spectrum of 27 diagnostic signals for the cyclopropyl ring were observed 
(Figure 2.36); 1 ?2-H (8 0. 76, dt, J 5.8 and 2 x 1.5 Hz), 16a-H and 1 ?1 n-H (8 1.44 and 1.48, 
both dd, J9.7 and 1.5 Hz) and 16~-H and lix-H (8 1.81 and 1.90, both dd, J9.7 and 1.5 
Hz) which were assigned by analogy (Figure 2.18). 57 The remainder of the spectroscopic 
and analytical data fully supported this structure. 
5.8 Hz 
9.7 Hz 
Figure 2.18: Perspective view of 15a,1 ?2-cyclo compound 27 indicating some of the 
observed coupling constants (identical values were obtained for the other vicinal and 
geminal coupling constants in this system, but they have not been indicated for clarity) 
40 
This synthetic route does indeed provide access to the target rr~iterial 26, however it is not 
as efficient as that previously described (Scheme 2.15). The desulfonylation step 1s low 
yielding and the relatively large amount of 15, 1 ?1-cyclo compound formed further reduces 
the synthetic utility. This route also failed to provide efficient access to other analogues of 
8a-estradiol. 
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2.2.2 Further cycloaddition reactions of dienyl acetate 16 
The poor regioselectivity and stereoselectivity observed in the cycloaddition of PVS to 
dienyl acetate 16 invited speculation on the influence of structural and steric features in the 
substrate upon the reaction outcome. This is highlighted by the efficient and selective 
cycloaddition of PVS to 3-methoxyestra-1,3,5(10),14,16-pentaen-17-yl acetate, 57 in 
accordance with frontier molecular orbital (FMO) expectations and the well-established 
preference for P-face entry of conventional dienophiles to this and related 14,16-dienyl 
systems in the natural steroid series. 91 
The loss of face selectivity in the reaction of the Sa-isomer 16 is not surprising, in view of 
the change in the steric environment of the 14, 16-dienyl moiety. However, the additional 
manifestation of regioreversal during cyclr ,addition suggests that the skeletal change may 
also influence the FMO status of the Jiene. Furthermore, it may be inferred that the 
reaction outcome could be influenced by the reactivity and steric demand of the dienop!;ile. 
Accordingly, it was considered of interest to conduct cycloadditions of dienyl acetate 16 
with a variety of dienophiles, primarily to seek evidence of a trend in reactivity and 
selectivity, to support a general mechanistic explanation, but also in the hope that 
synthetically useful cycloadducts could be obtained for further transformation into ring D 
modified hormone analogues in the Sa-series. 
In all of the experiments described in the ensuing section, there was evidence of diminished 
reactivity and selectivity, by comparison with the natural series, and the interpretation of 
the results was further complicated by the formation of complex and sometimes 
inseparable mixtures which made certain structural assignments difficult. 
With acrolein, boron trifluoride catalysed cycloaddition to the dienyl acetate 16 (THF, 
25°C, 18h), gave a moderate yield (54%) of l 7p-acetoxy-3-methoxy-14,17a-etheno-8a-
estra-l,3 ,5(1 O)-triene-16a-carbaldehyde 31, along with two other fractions (25% 
combined) comprising inseparable mixtures of products (Scheme 2.1 S). 
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From an examination of the 1 H NMR spectrum of 31, the expected structural features were 
observed, and are summarised in Table 2.2. These, along with the other spectral and 
analytical data provided sufficient evidence that a cycloaddition had taken place. 
Table 2.2: 1H NMR data for cycloadduct 31 
8/ppm Mult. J!Hz Assignment 
1.33 dd 12.4 and 4.1 15a-H 
2.45 dd 12.4 and 9.1 15P-H 
3.15 ddd 9.1, 4.5 and 4.1 16P-H 
6.02 d 6.0 172-H 
6.36 d 6.0 li-H 
9.47 d 4.5 l6a-CHO 
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The structure of the cycloadduct 31 was assigned from NOE difference spectroscopy and 
subsequent reactions. Irradiation of the 13P-methyl group enhanced the signals for 16P-H 
(8 3.15; 7.5%) and 15P-H (8 2.45; 2%), amongst others (Figure 2.19). The regiochemistry 
of the cycloaddition was assigned on the basis of the ready conversion of the adduct 31 into 
the 14P-allyl ~ 15 17-ketone 32 following the reaction sequence developed in the natural 
series (Scheme 2.18). 33 Reduction of the cycloadduct afforded the 16a-hydroxymethyl 
17P-alcohol which was tosylated and subjected to a Wharton fragmentation 92 to give the 
14P-allyl ~ 15 17-ketone 32 (58%). 
Figure 2.19: Perspective view of 16a-formyl 17-acetate 31 indicating 
observed NOE enhancements 
The 14P-allyl ~ 15 17-ketone 32 was readily identified from a comparison of spectral data 
with the corresponding compound in the natural series. 33 The IR spectrum displayed an 
absorption band at Ymax 1703 cm-', and the 1H NMR spectrum, characteristic AB doublets 
for 16-H (8 6.15, d, J 5.8 Hz) and 15-H (8 7.50, d, J 5.8 Hz), confirming the presence of 
the cyclopentenone sub-unit. The presence of the 14P-allyl group was indicated by the 
distinctive 1H NMR signals (8 5.08-5.14, 2H, m and 8 5.7-5.8, lH, m). 
The corresponding 14P-allyl ~ 15 17-ketone in the natural series 33 is a key intermediate in 
the synthesis of a number of estradiol analogues. 33 · 37 Thus it is envisaged that this 
compound 32 could be used to synthesise the corresponding Sa-analogues. 
The cycloaddition reactions of two other monosubstituted dienophiles (methyl acrylate and 
nitroethylene; benzene, 100°C) both gave complex, inseparable mixtures which were not 
characterised. 
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The cycloaddition of methyl propiolate with dienyl acetate 16 (benzene, 100°C, 120h) gave 
two fractions (TLC). The minor fraction (10%) was a mixture of products and was not 
investigated further. The major fraction (66%) was a single product, identified as methyl 
17P-acetoxy-3-methoxy-14, 17a-etheno-8a-estra-1,3,5(10), 15-tetraene-16-carboxylate 33 
(Scheme 2.19). Important signals observed in the 1H NMR spectrum of 33 are tabulated 














Table 2.3: 1H NMR data for cycloadduct 33 
8/ppm Mult. J!Hz Assignment 
3.72 s I6-C02Me 
6.40 d 5.1 li-H 
7.05 d 5.1 17 1-H 







An useful feature of the 13C NMR spectrum of this compound, 33, is that the signal for 
C-13 (8 87.4) is significantly downfield, enabling ready identification. A similar 
deshielding has been observed in the corresponding cycloadduct in the natural series. 
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As before, the structure of the cycloadduct, 33 was ascertained by NOE difference 
experiments (Figure 2.20). 
Figure 2.20: Perspective view of 16-methyl carboxylate 33 indicating the 
observed NOE enhancements 
Irradiation of the BP-methyl group (8 1.25) enhanced the signal for 15-H (8 7.5; 1%), 
amongst others, confirming that a P-face reaction had occurred, while irradiation of 15-H 
enhanced the signal for 8a-H (8 2.4; 3%) and 7-H2 (8 1.7-1.8; 6%), indicating the 
regiochemistry of the product. 
Chemoselective reduction of the conjugated olefinic bond of the methyl propiolate 
cycloadduct 33 with sodium borohydride 93 gave two products, assigned as the methyl 
16P-carboxylate 35 ( 4 7%) and the methyl 16a-carboxylate 34 (22% ). Examination of the 
spectra of the two products clearly indicates that the ~ 15 bond has been selectively 
saturated, and the remainder of the spectroscopic and analytical data are consistent with the 
proposed structures. 
The only question to be resolved is the stereochemistry at C-16 of each isomer. It is known 
that reactions of 7, 7-disubstituted bicyclo(2.2.1 ]heptanoid systems occur preferentially 
from the a-face. 94· 95 On this basis, the intermediate enolate 36 (Scheme 2.20) would 
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preferentially be protonated from the a-face (pathway b) giving methyl 16P-carboxylate 35 
as the major product. 








Experimental confirmation of the regiochemistry of the cycloadduct 33 was obtained in a 
similar manner as for the acrolein cycloadduct 31. The methyl 16P-carboxylate 35 was 
subjected to the reduction-tosylation-fragmentation sequence to give the 14P-allyl 
i:1 15 17-ketone 32 (46%), identical to that described previously. 
Cycloaddition with 2-acetoxyacrylonitrile (benzene, 150°C, 288h) gave two fractions, 
along with some starting material (13%) despite the regular addition of further dienophile 
during the course of the reaction (Scheme 2.21 ). The major fraction (65%) was a single 
product 37 and was readily separated from the minor fraction (4%), which was an 
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The major product 37 was readily identified as a cycloadduct from the 1H NMR data, 
supported by the analytical results. For clarity, key signals in the 1H NMR spectrum have 
been tabulated (Table 2.4). However, the stereo- and regiochemistry of the product could 
not be determined from this information. 
Table 2.4: 1 H NMR data for cycloadduct 37 
8/ppm Mult. J!Hz Assignment 
1.62 d 14 15a-H 
2.07 and 2.20 both s 16a-0Ac and 17P-0Ac 
3.12 d 14 15P-H 
6.02 d 6 li-H 
6.36 d 6 li-H 
The assignment of both regio- and stereochemistry was made by NOE difference 
experiments (Figure 2.21). Irradiation of the 13p-methyl group (8 1.3) enhanced the signal 
for 15P-H (8 3.1; 3.5%) amongst others, clearly showing that the cycloaddition had 
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occurred from the P-face. Irradiation at 15P-H (8 3.1) enhanced 7a-H (8 1.8; 6%), 
indicating that a head-to-head cycloaddition had occurred. Additionally, irradiating the 
signal for 1 ?2-H (8 6.0) enhanced the signals for 9a-H (8 2.8; 6%), 8a-H (8 2.1; 6%) and 
15a-H (8 1.6; 1 %), further supporting both assignments. The final structural detail, the 
relative orientation of the 16-cyano and -acetoxy groups was assigned by analogy to the 
natural series. 32 
Figure 2.21: Perspective view of 16P-cyano 16a, 17P-diacetate 37 indicating the 
observed NOE enhancements 
Conversion of the cycloadduct to the derived l 7p-hydroxy 16-ketone 38 and 
16P, l 7p-diol 39, following the procedures used in the natural series, 32 proceeded 
uneventfully. Both compounds were readily identified from their spectral characteristics; 
key 1H NMR data are summarised in Table 2.5. 
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Table 2.5: Key 1 H NMR data for compounds 38-40 
Chemical shift 8/ppm (multiplicity, coupling constant J/Hz, assignment) 
38 
8 1.98 and 2.44 (both d, J 
16.8, 15a-H and 15P-H), 
5.83 and 6.22 (both d, J 5.9, 
1 ?2 -H and 1 ?1 -H) 
39 
8 3.90 (dd, J7.7 and 2.4, 
16a-H), 5.76 and 5.89 (both 
d,J5.9, 172-Hand 17'-H) 
40 
8 2.15 (dd, J 16.6 and 1.1, 
141-H), 3.17 (dd, J 16.6 and 
2.3, 141-H), 6.17 and 7.80 
(both d, J 6.0, I 7'-H and 
Ii-H) and 9.80 (dd,J2.3 
a11J I.I, 141-CHO) 
The configuration at C-16 of the 16P, l 7P-diol 39 was assigned by analogy with the natural 
series where reduction of the corresponding cycloadduct gave the 16P, 17P-diol as the 
major product. 32 Some support for this assignment was obtained from the 1 H NMR 
spectrum. The chemical shift of the 13P-Me (8 1.17) in the 16P,17P-diol 39 is deshielded 
relative to the 14a, 17a-ethano-8a-17P-alcohol 25 (8 1.00). The 14, 17a-etheno compound 
was not available for comparison, but in the natural series the chemical shift of the angular 
methyl is not affected by hydrogenation of the olefinic bond, 57 so this appears to be a 
reasonable comparison. This deshielding is indicative of a l 6P-hydroxy group. The signal 
for 16a-H (8 3.90, dd J 7.7 and 2.4 Hz), with a large endo-endo coupling (to 15a-H) 
and a smaller endo-exo coupling (to 15P-H), does not exclude the alternative configuration 
at C-16. 32 
Oxidative cleavage of the 16P,17P-diol 39 afforded the 14P-formylmethyl ~ 15 17-ketone 
40, thus confirming the assigned regiochemistry, and hence that of the cycloadduct 37. The 
structure of this compound, 40, was confirmed by characteristic spectroscopic data, but it 
was rather labile, precluding complete characterisation. 
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Interestingly, compounds 38 and 39 appear to form inclusion compounds with methanol 
(the solvent of crystallisation), as in the 1H NMR spectra peaks attributable to this solvent 
were clearly observed (approximately 1: 1 ratio of host : guest). Thorough drying (80°C, 
48h, high vacuum) enabled acceptable microanalytical data to be obtained. 
The results obtained for the cycloaddition reactions of both methyl propiolate and 
2-acetoxyacrylonitrile to the dienyl acetate 16 can be explained on steric grounds. For the 
methyl propiolate cycloaddition, an examination of molecular models clearly indicates that 
the formation of a P-face and head-to-tail adduct is disfavoured due to steric interactions 
between the dienophile and the 7,8-bond (Figure 2.22; R = C02Me, R' = H). a-Face 
cycloaddition is also disfavoured as the reagent must approach from the concave face of the 
diene. On this basis the P-face and head-to-head adduct would be expected to be the major 
product, and this is indeed what is observed. 
OMe 
Figure 2.22: Methyl propiolate P-face approach to the dienyl acetate 16 
A similar argument can be used to explain the outcome of the 2-acetoxyacrylonitrile 
cycloaddition. As can be seen from Figure 2.23, a P-face and head-to-tail approach of the 
dienophile suffers from severe steric hindrance (R, R' = OAc, CN). a-Face cycloaddition 
is again disfavoured as the dienophile is required to approach from the more hindered, 
concave face, so one would expect the P-face and head-to-head adduct to predominate, as 
is indeed observed. 
OMe 
Figure 2.23: 2-Acetoxyacrylonitrile P-face and head-to-tail approach 
to the dienyl acetate 16 
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The monosubstituted dienophiles (PVS, nitroethylene and methyl acrylate) all display a 
similar pattern of multiple cycloadducts. As the results for both nitroethylene and methyl 
acrylate could not be quantified the result for PVS will be used for the purpose of this 
discussion. 
An examination of molecular models reveals no major steric impediment to a P-face and 
head-to-tail cycloaddition reaction (Figure 2.23; R = H, R' = S02Ph). The a-face remains 
sterically disfavoured, but with a monosubstituted dienophile, the steric effects will be 
minimised. Thus, P-face addition should be favoured on these grounds, but there are no 
obvious steric factors influencing the regiochemistry. 
From an FMO perspective, the regiochemistry of the reaction is dependent on the nature of 
the groups at C-14 and C-17. 96 If it is assumed that the influence of these groups in the 
Sa-series is similar to that observed in the natural series, where the effect of the electron 
donating 1 ?-acetate 97 predominates over that of the electron-donating C-14 substituent ( on 
the basis of experimental results, Figure 2.24), 98 then the selective formation of head-to-
head adducts is predicted. From the results, P-face selectivity (4:1) is indeed observed, but 
the predicted regioselectivity is incorrect, as head-to-tail adducts are favoured over head-to-
head adducts ( 4: 1). 
H 
OAc 
' ' ' ' ' , , , , --er SO,Pti 
----- bond fonning 
Figure 2.24: Cycloaddition of PVS to 3-methoxyestra-1,3,5(10), 14, 16-pentaen-17-yl 
acetate, indicating the HOMOdiene·LUMOdienophile interaction assumed to be 
responsible for the regioselectivity observed 
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It therefore appears as though inversion at C-8 in the dienyl acetate moiety increases the 
electron donating ability of the C-14 group, overriding the effect of the 1 7-acetate on the 
frontier orbitals (Figure 2.25). This would lead to the preferential formation of head-to-tail 
adducts, as observed. However, as the orbital coefficients of either diene have not been 
calculated, this hypothesis cannot be verified. 
OAc 
' ' - ',0 
-----~ 
S02Al 
----- bond forming 
Figure 2.25: Cycloaddition of PVS to dienyl acetate 16, indicating the HOMOdiene· 
LUMOdienophiie interaction assumed to be responsible for the regioselectivity observed 
The addition of a Lewis acid to a 'normal' cycloaddition reaction is known to polarise the 
LUMO of the dienophile, thus enhancing the selectivity inherent in the uncatalysed 
reaction. 99 However, this does not account for the reversal of regioselectivity observed for 
the Lewis acid catalysed cycloaddition of acrolein to the dienyl acetate 16, where the head-
to-head adduct 31 is the major product. Further work is required to explain this 
observation. 
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From these results, some conclusions can be drawn about cycloaddition reactions of the 
dienyl acetate 16. Sterically hindered dienophiles display a similar reaction pattern to that 
observed in the natural series, with somewhat diminished yield. A combination of subtle 
steric and stereo-electronic factors results in a loss of regio- and stereoselectivity for 
monosubstituted dienophiles. Further work is warranted to explore the role of Lewis acid 




Two possible synthetic routes towards the target, 14, 17a-ethano-9P-estra-1,3,5(10)-triene-
3, 17P-diol D, were investigated. The first approach involved inversion at C-9 of estrone, 
followed by incorporation of the ethano bridge using methodology similar to that described 
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d C D 
Scheme 2.22: Planned synthetic route 
In this regard, the first key intermediate is the ~9(1 ll_compound b which is readily available 
from estrone a. ioo-ios Configurational inversion at C-9 can then be achieved by one of two 
alternate methods, viz. (i) hydroboration followed by oxidation to give the I I-ketone d 100· 
105 which is readily equilibrated to the 9PH-11-ketone c 100· 106 or (ii) epoxidation followed 
by a Lewis acid catalysed 1,2-hydride shift to give the 9PH-1 l-ketone c. 100 
Deoxygenation of the 9PH-11-ketone c should then provide the desired 9P-derivative e, 
further modification of which, along similar lines to the Sa-series (Section 2.2), namely 
cycloaddition of an ethylene equivalent to the derived dienyl acetate followed by 




The alternative approach explored was inversion at C-9 of 14, 17a-ethanoestra-1,3,5(1 O)-
triene-3,l 7j)-diol A (or a suitable derivative) (Scheme 2.23). The first key intermediate is 
the .'\9(lt)_derivative g, which should be available from the 14,17a-ethanoestratriene f 
utilising similar reaction conditions to those envisaged for the unbridged series. The 
hydroboration-oxidation sequence described for the unbridged series (Scheme 2.22) should 
provide the I I-ketone i, however equilibration (i-h) is unlikely to lead to the desired 
9PH-11-ketone h. 
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Scheme 2.23: Planned synthetic route 
As indicated in Scheme 2.22, the equilibration of d favours the 9j)H-11-ketone e. 
Replacing the 14a-H of d with a 14a-methyl group has been shown both by calculations 
and experimental findings to distort this equilibrium in favour of the 9aH-11-ketone. 55 
The 14, 17a-ethano bridge is expected to be at least as sterically demanding as a 
14a-methyl group, so it is unlikely therefore that equilibration of the 9aH-11-ketone i 
would provide any 9j)H-1 l-ketone h. 
The epoxidation-hydride shift reaction sequence could provide access to the 
9PH-l l-ketone h, but the 14a, 17a-ethano bridge is expected to influence the a-selective 
OH 
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epoxidation observed in the natural series, resulting in a diminished yield of the desired 
product h accompanied by the isomeric 9aH- l l-ketone i. With the 9PH-l l-ketone h in 
hand, subsequent deoxygenation and further modification would provide the target 
material D. 
An alternative, more direct, approach to the unnatural stereocentre is via hydrogenation of 
the ~ 90ll_olefin gin the expectation that the 14a,17a-ethano bridge would diminish the 
a-face selectivity observed in the natural series, 101-109 thus providing the target molecule 
D. A similar reduction of a-face selectivity has been observed in the hydrogenation of 
other l 4a-substituted ~ 9(! l)_olefins , 
methylestra-1,3,5(10),9(11 )-tetraene 29 
for example l 7P-t-butoxy-3-methoxy-14a-
and 14, l 7a-ethylidenedioxy-3-methoxy-l 9-
norpregna-1,3,5(10),9(11 )-tetraen-20-one. 110 
The results of these two investigations will be presented in the next section. 
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2.3.1 Synthesis of 3-methoxy-9p-estra-1,3,5(10)-trien-17-one 
17, 17-Ethylenedioxy-3-methoxy-9p-estra-1,3,5( 1 O)-trien-11-one 42 was synthesised from 
estrone 41 according to the procedure of Collins and Sjovall 1°0 (15% overall yield, Scheme 




11 l-olefin. Both oxygen functionalities were then protected (3-0-methylation followed 
by 17-ketalisation). Stereoselective epoxidation gave the 9a, 11 a-epoxide, which after 






Scheme 2.24 Reagents and conditions: i, DDQ, MeOH, 25°C; ii, Me2S04, K2C03, acetone, 25°C; 
iii, (CH20H)z, p-TsOH, PhH, ii; iv, m-cpba, NaHC03, CH2Clz-H20, 25°C; v, LiCI04, PhH, ii 
Attempts at direct deoxygenation of the 11-ketone 42 ( dithioketalisation-desulfurisation, 111 
or Wolff-Kishner) 112 were unsuccessful with complex mixtures of products being isolated. 
Thus the use of an indirect method for accomplishing this transformation was investigated. 
Reduction of the I I-ketone 42 with sodium borohydride in aqueous THF gave exclusively 
the 11 a-alcohol 43 (Scheme 2.25). Similar selectivity has been observed in the reduction 
of other 17, 17-ethylenedioxy-9p-estra-l ,3,5(1 O)-trien-11-ones. 113 A comparison of the 
1H NMR spectrum of 43 with that previously reported 100 provided conclusive structural 
proof. The signal for 1-H (8 7. 77, d, J 8 .5 Hz) is diagnostic for the configuration at C-11, 
as in both the natural and 9P-series the I la-hydroxy group is in close proximity with 1-H, 
causing a significant deshielding (ca. 0.5 ppm) of the signal for 1-H relative to the 
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Scheme 2.25 
Conversion of the 11 a-alcohol 43 into the 11 a-xanthate 44 for Barton-McCombie 
deoxygenation 114 was accomplished utilising standard methodology (74%). 114 Some loss 
of the 17-ketal, to give the 17-ketone 45, was observed on storage. Alternatively, this 
deprotection could readily be accomplished by stirring the 17-ketal 44 with 
toluene-p-sulfonic acid in aqueous acetone giving the 17-ketone 45 (85%). The important 
1 H NMR signals and coupling constants used to identify these compounds are summarised 
in Table 2.6. 
Table 2.6: Table of important 1H NMR features of9p-estratrienes 43-45. 
Chemical shift o/ppm (multiplicity, coupling constant J/Hz) 
Proton 
43 
9P-H o 3.13 (br m) 
11 P-H cS 4.45 (dt, J 7.5 
and 2 x 4.6) 
1-H cS 7.77 (d, J 8.5) 
MeO 
44 
cS 3.50 (t, J 4.3) 
cS 6.30 (dt, J 10.9 
and 2 x 4.3) 
cS 7. 6 1 ( d, J 8. 5) 
MeO 
45 
cS 3.50 (t, J 4.7) 
cS 6.31 ( dt, J 8.3 
and 2 X 4.6) 
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ii) DMP, CH2C'2 
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Refluxing the 17, 17-ethylenedioxy-11 a-xanthate 44 with tributylstannane and 
a,a'-azobis(isobutyronitrile) (AIBN) in toluene, 114 followed by deprotection at C-17 gave 
the desired 3-methoxy-9p-estra-1,3,5(10)-triene-17-one 46 (28%). Alternatively, 
deoxygenation of the 17-oxo-lla-xanthate 45 followed by reoxidation at C-17 [with the 
Dess-Martin periodinane (DMP)] 72 gave the same product 46 (14%). This compound is 
known, 115 but the only information available was an optical rotation, which was 
comparable to that measured. Thus, a detailed NMR analysis of the 9P 17-ketone 46 was 
conducted; all data were consistent with the structure. Table 2.7 shows extensive 
assignments of the 1H NMR spectrum. Figure 2.27 shows a perspective 





2 .a 2.6 2. 4 
12a-H 
SP-H 
2 .2 2 .o 1 8 1 6 1 4 ppm 
Figure 2.26: High field region of 1H NMR spectrum of the 9P 17-ketone 46. 
Table 2.7: 1H NMR assignments of the 9p 17-ketone 46 
& I i,pm Int. Mult. J/Hz Assignment 
0.97 3H s 13P-Me 
1.24 lH td (obsc.) 2 X 12.8 and 3.8 12a-H 
1.54-1.61 2H m (obsc.) 12P-H and 14a-H 
1.86-2.04 6H m (obsc.) 7-H2, 11-H, 15-H2 and 16-H 
2.20 lH m (obsc.) 8P-H 
2.34-2.42 2H m (obsc.) 11-H and 16-H 
2.70 lH dt 16.8 and 2 x 4.6 6P-H 
2.80 lH td 2 x 16.8 and 8.8 6a-H 
3.01 lH brm W'I, 10 Hz 9P-H 
3.77 3H s 3-0Me 
6.62 lH d 2.7 4-H 
6.72 lH dd 8.6 and 2.7 2-H 




Figure 2.27: Perspective view of the 9P 17-ketone 46 
Diagnostic features in the I H NMR spectrum of the 9p 17-ketone 46 are the broad, 
unresolved signal for 9P-H (8 3.01) and the separation of the signals for the two hydrogens 
on C-6, which generally appear as an unresolved two proton multiplet in the natural series. 
Although this reaction sequence provided access to the desired 3-methoxy-9p-estra-
1,3,5(1 O)-trien-17-one 46, the overall yield from estrone 41 was ca. 2%; thus it is not a 
synthetically viable route for the large-scale preparation of this material. In order to 
improve the overall conversion from estrone 41, the optimisation of some of the low-
yielding steps was attempted. 
The first step to be investigated was the introduction of the ~9CI I)_bond. Although the DDQ 
oxidation affords a reasonable yield (ca. 80%) of the desired product, the reaction is 




1 !)_compound is difficult, so it has to be carried through the synthetic sequence, until it 
can be readily separated from the 9PH-1 l-ketone 42. 
A number of other methods have been reported for the introduction of a ti9C1 I)_bond into the 
estratriene skeleton. 101 -104 Of these, the only one which could be reproduced was the 
dimethyldioxirane (DMD) 9a-hydroxylation-dehydration reaction sequence 


















Estrone 41 was acetylated, giving estrone 3-acetate 47, which was treated with DMD 
generated in situ 116 ( ox one ® and acetone in a pH 7 buffered water-dichloromethane 
mixture) to give of the desired 9a-alcohol 48 (30%), along with starting material 47 (52%). 
Dehydration of the 9a-alcohol 48 with toluene-p-sulfonic acid in benzene afforded the 
,19<I I)_compound 49 (65%). Alternatively, treatment of the 3-acetate 47 with an isolated 
solution of DMD in acetone 101 (prepared by the method of Adam et al) 117 followed by 
dehydration gave the desired L\9(1 1)-compound 49 (35% overall yield). Both yields were 
substantially inferior to that obtained in the DDQ reaction, and despite all attempts, the 
reported yields (80%) 101 • 116 for this transformation could not be reproduced. Thus, the 
attempted optimisation of this stage of the synthesis was discontinued. 
The next step of the synthetic sequence to be investigated was the epoxidation-
rearrangement of the L\9(1 1)-olefin to the 9~H-11-ketone 42. The instability of the 
intermediate 9,1 la-epoxy-17,17-ethylenedioxy-3-methoxyestra-l,3,5(10)-triene to acidic 
conditions, led to a significant amount of decomposition, despite the buffered medium in 
which the reaction was conducted. 100 
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In an attempt to overcome this problem, the protecting group at C-3 was changed from a 
methyl ether to an acetate, as this is reported to increase the stability of the resultant 
9a,l la-epoxide. 100 The extremely mild epoxidising reagent, DMD 118• 119 was used 
instead of a peracid in order to keep the reaction at neutral pH. This necessitated a change 
of protecting group at C-17, as DMD is known to convert ketals to ketones. 120 
Thus, DDQ oxidation of estrone 41 100 followed by sodium borohydride reduction of the 
A9<11 l 17-ketone and acetylation of the resultant A9Clll 3, l 7P-diol, gave the 
A9(lll 3, l 7p-diacetate 50 (90%) (Scheme 2.28). A comparison of the physical properties 
with those reported 103• 121 and careful examination of the 1H NMR spectrum of this 
material indicated the presence of a small amount (ca. 10%) of estra-1,3,5(10)-triene-
3, l 7P-diyl diacetate. This was confirmed by subsequent reactions. 
Treatment of the A9(J J) 3,17P-diacetate 50 with DMD in acetone led to a rapid conversion 
into the 9a, l la-epoxide, which was not isolated, but was treated directly with lithium 
perchlorate in refluxing benzene 100 to give the 9PH-l l-ketone 51 (50%). The 
configuration at C-9 was assigned from a comparison of the 1H NMR signal for 9P-H 
(8 3.62, d, J 5.2 Hz), with literature values. 100• 106 It has been established that for simple 
11-oxoestra-1,3,5(10)-trienes, the signal for 9a-H displays a coupling constant of ca 12Hz 
and the signal for 9P-H displays a coupling constant of ca 5Hz. 100· 106 The remainder of 
the spectroscopic data supported the assigned structure. Also isolated from this reaction 











i) DDQ, MeOH 
ii) NaBl-4, MeOH-THF .. 
AcO 
i) NaBl-4, THF-HiO 
.... 







i) DMD, acetone-Cl+.!C12 




Reduction of the I I-ketone 51 with sodium borohydride, followed by 3-0-methylation 
gave a separable mixture of the isomeric I I-alcohols 52 (28%) and 53 ( 46% ). This result 
contrasts with the reduction of the 17, 1 7-ethylenedioxy 9PH-11-ketone 42 which provides 
exclusively the I la-hydroxy derivative 43. A satisfactory explanation for this loss of 
stereoselectivity has not been found. 
The I I -alcohols 52 and 53 were readily separated and identified from a comparison of 
1 H NMR data with those reported for the 17, l 7-ethylenedioxy-3-methoxy-9p-
estratriene-1 l s-ols. 100 The signal for 1-H in the 11 a-alcohol 53 was significantly 
deshielded relative to the equivalent signal in the 11 P-alcohol 52 (Table 2.8). Also 
apparent was the deshielding of the 13 P-methyl group of the 11 P-alcohol 52 under the 
known influence of the 1,3-diaxial relationship between I IP-OH and 13P-Me. 






Chemical shift cS/ppm (multiplicity, coupling constant J/Hz) 
52 
cS 1.05 (s) 
cS 2.40 (br d, J 10.6) 
a-H, cS 4.6-4.7 (m) 
cS 7.16 (d,J8.6) 
53 
cS 0.91 (s) 
cS 3 .11 (t, J 4.5) 
P-H, cS 4.38 ( dt, J 8.1 and 2 x 4.5) 
cS 7.86 (d, J 8.6) 
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Using this modified reaction sequence, the overall conversion from estrone 41 to an 
11-alcohol (52 and 53) is 33%, significantly better than the previous yield of ca. 15%. 
However, the need to perform further reactions on either a mixture of compounds 52 and 
53, or on the two derivatives separately complicates the reaction sequence, thus it was 
discontinued. 
In conclusion, a synthetic route to 3-methoxy-9p-estra-l,3,5(10)-trien-17-one 46 has been 
developed. The poor overall conversion from estrone ( ca. 2%) led to an investigation into 
the optimisation of several of the steps in this route. The yield for the dehydrogenation 
step was not improved by the alternative methods investigated. The epoxidation-
rearrangement sequence was improved, with the overall yield of 9PH-l l-ketone (from 
estrone 41) increasing from 15% to 45%. The subsequent conversion of the 
9PH-l l-ketone into an I I-alcohol did not occur as selectively as in the initial sequence, 
due to the different protecting groups employed in order to improve the yield of the 
synthesis. This is a significant disadvantage and led to this, otherwise promising, route 
being discontinued. 
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2.3.2 Synthesis of 14,17a-ethano-9f3-estra-1,3,5(10)-trien-17f3-ol 
As the attempted synthesis of the target molecule D via inversion at C-9 followed by 
introduction of the 14,17-bridge was rendered impractical by the low conversion of 
estrone 41 into 9f3-estrone 3-methyl ether 46, the alternative approach of inversion at C-9 
of 14,17a-ethanoestra-l,3,5(10)-triene-3,17p-diol (or a suitably protected derivative) was 
investigated. 
The starting material utilised in this study was 3-methoxy-14,17a-ethanoestra-l,3,5(10)-






















iO Separation from 58 
Scheme 2.29: Preparation of 3-methoxy-14, l 7a-ethanoestra-l ,3,5(1 O)-trien-l 7P-ol 59 
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Cycloaddition of the dienyl acetate 54 with PVS proceeded to give the adduct 55, as 
reported. 57 Two approaches towards the desired product 59 are possible, either via 
hydrogenation followed by desulfonylation, or via the reverse sequence. In the latter route, 
the desulfonylation reaction is known to afford a small quantity (ca. 5%) of the 
16a, I 7'-cyclo compound 58 57 making an additional separation step essential. 
Large-scale (> 1 g) hydrogenation of the cycloadduct 55, using the reported conditions 
(Pd-C, I atm. H2, ethyl acetate, 25°C), 57 was found to be impractical, with mixtures of the 
cycloadduct 55 and the dihydro compound 56 being formed, possibly due to catalyst 
deactivation. The insolubility of the cycloadduct 55 in ethyl acetate necessitated the use of 
a large solvent volume, a further complicating factor. However, this was overcome by 
performing the reaction under more forcing conditions, and changing the solvent (Pd-C, 50 
bar H2, chloroform, 75°C). Some loss of the l 7P-acetoxy group was observed under these 
conditions, however reacetylation of the crude reacticn mixture gave the dihydro 
compound 56. Desulfonylation 87• 88 of the dihydro compound 56 gave the desired product 
59 in 70% overall yield from the cycloadduct 55. 
Alternatively, desulfonylation of the cycloadduct 55 followed by hydrogenation gave the 
desired product 59 in 77% yield, which was separated from the 16a, 171-cyclo 
compound 58 (9%) by a combination ofrecrystallisation and chromatography. 
Although the latter route affords a slightly higher yield of the desired product 59, the need 
to separate it from the 16a, 17'-cyclo compound 58 makes this route less attractive; thus the 
former is the method of choice for this conversion. 
The first key intermediate is the ~9(l I)_compound (Scheme 2.23, g). The synthesis of this 
material was explored, using the procedures established for the unbridged series (Section 
2.3. I). Treatment of the 3, l 7p-diol 60 (synthesised by deprotection 57• 89 of the 3-methyl 
ether 59) with DDQ, followed by acetylation gave a ca 2: I mixture of the ~9(1 l)_olefin 62 
and the saturated diacetate 61 (a 1H NMR estimate from the signals for 1-H, at 8 7.30 for 
61 and 8 7.66 for 62 respectively) which was inseparable by either silica gel 
chromatography or selective crystallisation (from either methanol or acetone-hexane) 
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(Scheme 2.30). The use of protecting groups for the two hydroxy functionalities was 
necessitated by the extreme insolubility of the 3, 17P-diol 60, (and the resultant 
~
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Alternatively, DDQ oxidation of 3-methoxy-14, 1 7a-ethanoestra-1,3 ,5(1 O)-trien-17P-ol 59 
gave an inseparable mixture of the starting material 59 and the ~9(1 I) derivative 63 (ca 1: 1 
by 1H NMR; judged by the signals for 1-H - cS 7.2 for 59 and cS 7.6 for 63) (Scheme 2.31). 










Allowing the reaction to proceed for longer periods (18h) did not increase the amount of 
~
9(l ll_product 63 in the reaction mixture, and from an examination of the 1H NMR 
spectrum of this mixture, signals attributable to 3-methoxy-14, 17a-ethanoestra-
l ,3,5(10),6,8-pentaene-I 7p-ol 65 ( subsequently synthesised, see Scheme 2.32) were 
observed. 
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Attempts at separating these two compounds (59 + 63) by derivatisation were unsuccessful; 
neither the derived 17P-acetates nor the 17P-t-butyldimethylsilyl ethers were separable on 
silica gel chromatography or by crystallisation. 
In an attempt to improve this reaction, the use of an acid catalyst was investigated. The use 
of acid to modify the reactivity of DDQ is well-documented, 122 for example steroidal 
A4-3-ketones are dehydrogenated to A1,4-3-ketones by DDQ, but in the presence of strong 
acid, dehydrogenation affords the A 4•6-3-ketones. 122 In the event, treatment of 3-methoxy-
14, 17a-ethanoestra-1,3,5(1 O)-trien-17P-ol 59 with DDQ and toluene-p-sulfonic acid in 








Scheme 2.32 Reagents and conditions: i, DDQ, p-TsOH, MeOH, 25°C, 18h; 11, 2h; 
ii, H2, Pd-C, 25°C 
OH 
Selective hydrogenation of the A 11 -bond of the hexaene 64 gave the pentaene 65. The 
hexaene 64 and the pentaene 65 were readily identified from their 1H NMR spectra, with 
the low field signals characteristic for ring B aromatic compounds clearly evident. 29 
Table 2.9 summarises the important low field 1H NMR data. These assignments were 
corroborated by the remaining spectral information and the analytical data. 
Table 2.9: Selected 1H NMR data for hexaene 64 and pentaene 65 








<5 8.60 (d, J9.3) 
<5 7 .18 ( dd, J 9 .3 and 2. 7) 
<5 7 .12 ( d, J 2. 7) 
<5 7.64 (d,J8.3) 
<5 7.21 (d,J8.3) 
11-H <57.15(d,J9.8) 
12-H <5 6.65 (d,J9.8) 
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<5 7. 92 ( d, J 9 .1) 
<5 7.18 (dd,J9.l and2.4) 
<5 7.12 (d, J2.4) 
<5 7.57 (d, J8.5) 
<5 7.20 (d, J 8.5) 
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The corresponding 3-hydroxy derivatives of the hexaene 64 and pentaene 65 (Scheme 2.32, 
3-0H), previously synthesised by another route, 123 have been found to be biologically 
active. 124 While this reaction is of no use in the current synthesis, it does provide an 
alternative, more direct route to these compounds. 
The introduction of the ~9(I Il_bond via the DMD C-9a-hydroxylation-dehydration reaction 
sequence IOL 102• 116 [ successfully used in the unbridged series (Scheme 2.27)] was also 
investigated. DMD treatment of the 3, l 7P-diacetate 61 gave a complex mixture of 
products from which only 6-oxo-14, l 7a-ethano-3, l 7P-diacetate 66 could be isolated 
(16%). The molecular ion (mlz 396) indicated the addition of oxygen into the molecule, 
and the signal for 4-H in the 1H NMR spectrum (<5 7.75, d, J2.6 Hz) was diagnostic for the 
position of the new carbonyl group, as it is significantly deshielded by the 6-oxo 
functionality. 125 The remainder of the spectroscopic and analytical data were compatible 







Presumably, the steric hindrance imposed by the 14a,17a-ethano bridge hinders reaction at 
the more reactive tertiary and benzylic C-9, allowing reaction at the less reactive secondary 
and benzylic C-6 to become a competitive process. 118• 119 It is assumed that the initially 
formed 6-hydroxy derivative is rapidly oxidised to the 6-ke'>,me by DMD. 118 
Despite the foregoing success in introducing the desired ~9(l l)_bond into the 14, 17-bridged 
system, it was recognised that the incomplete reaction and the resulting inseparable mixture 
of saturated and unsaturated compounds would necessitate subsequent reactions being 
conducted on this mixture. 
Attempted catalytic hydrogenation (Pd-C, H2) of the mixture of 3-methyl ethers 59 and 63, 
gave an intractable mixture of products. 1H NMR examination of this mixture indicated 
that there were at least three products present, thus rendering this reaction synthetically 
useless. 
In contrast, catalytic hydrogenation of the mixture of 3, 17P-diacetates 61 and 62 
(H2, Raney nickel) gave a separable mixture of 14,17a-ethanoestra-1,3,5(10)-triene-
3,17P-diyl diacetate 61 (52%) and 14,17a-ethano-9p-estra-1,3,5(10)-triene-3,17P-diyl 
diacetate 67 (19%) (Scheme 2.34). If the 14a,17a-ethano 3,17P-diacetate 61 already 
present in the starting material (33%) is excluded, this ratio changes to 23:19 (instead of 
52: 19). Thus, the expectation that the 14a, 17a-ethano bridge would affect the 
stereochemical course of the hydrogenation reaction was fulfilled with hydrogenation 
72 
occurring with approximately equal facility from either face of the molecule, providing 















Ionic hydrogenation was also attempted, in the hope that protonation of the intermediate 
carbocation 107 would occur selectively from the P-face, leading to an improved selectivity 
for the 9P-compound 67. however, it is known that ionic hydrogenation tends to give 
products with the more stable, natural trans-anti-trans configuration in unsubstituted 
estratetraenes 107 and this could also occur in the present series, thereby reducing the 
amount of 9P-product being formed. 
The reaction proceeded extremely slowly (7 days) to give the same two products in an 5: I 
ratio. If the 14a, 17a-ethano 3, 17P-diacetate 61 already present in the starting material 
(33%) is excluded, as before, this ratio changes to 2:1. Thus this reaction appears to be 
more a-face selective than normal hydrogenation, indicating that the preference for 
forming the thermodynamically more stable product dominates over steric considerations. 
14,17a-Ethanoestra-l,3,5(10)-triene-3,17P-diyl diacetate 61 was identified by comparison 
with authentic material made previously. Although it was considered unlikely that any 
other product could have resulted from this reaction sequence, the other isomer, 
14, l 7a-ethano-9P-estra-l J,5(10)-triene-3, I 7p-diyl diacetate 67 was thoroughly examined 
by spectroscopic techniques in order to ensure that the assigned structure was correct, and 
to obtain information about the conformation of the molecule in solution. Figure 2.28 
shows the high-field region of the 1H NMR spectrum of 67 in deuteriobenzene (C6D6) and 
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deuteriochloroform (CDCh). Some of the assignments have been tabulated (Table 2.10). 
Figure 2.29 shows a portion of the COSY spectrum of 67 (C6D6). 
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Figure 2.28: 1 H NMR spectrum of 14, l 7a-ethano-9p-estra-l ,3,5( I0)-trien-
3, l 7P-diyl diacetate 67 (a) CDCh and (b) C6D6 
Table 2.10: Selected proton signals for 14, 17a-ethano-9P-estra-l ,3,5(1 O)-trien-
3, 17P-diyl diacetate 67 in deuteriochlorofonn and deuteriobenzene 
Chemical shift 8/ppm (multiplicity, coupling constant J/Hz) 
Proton CDCh C6D6 
1-H 8 7.31 (d, J 8.5) 8 7.07 (d,J8.3) 
2-H 8 6.89 (dd, J 8.5 and 2.5) 8 6.93 (dd, J8.3 and 2.3) 
4-H 8 6.82 (d, J2.5) 8 6.88 (d, J2.3) 
6a-H 8 2.55 (ddd, J 15, 11 and 5.6) 8 2.20 (m, obsc.) 
6P-H 0 2.66 (dt, J 15 and 2 X 5.2) 8 2.35 (m, obsc.) 
7-H2 8 1.30, 2.00 (both m, obsc.) 8 1.00 (m), 1.58 (m, obsc.) 
8P-H 8 2.22 (m, obsc.) 8 1.72 (m, obsc.) 
9P-H 8 2.84 (br t, J 6.2) 8 2.44 (br t, J 6.7) 
1 la-H 8 2.44 (br dq, J 15) 8 2.18 (m, obsc.) 
l lp-H 8 2.00 (m, obsc.) 8 1.72 (m, obsc.) 
12a-H 8 1.30 (m, obsc.) 8 1.66 (m, obsc.) 
12P-H 8 1.70 (m, obsc.) 8 1.28 (dt, J 12.6 and 2 x 4.1, obsc.) 
1 J2 x-H 0 1.16 (dt, J 13 and 2 X 3.5) 8 1.15 (m, obsc.) 
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Figure 2.29: High field region of COSY spectrum of 
14, 17a-ethano-9P-estra-1,3,5(1 O)-trien-3, 17P-diyl diacetate 67 
Support for the assigned stereochemistry at C-9 was obtained from a NOE difference 
experiment (Figure 2.30). Figure 2.31 shows the observed NOE enhancements. The 
9p-configuration was indicated by the enhancement of the signal for 12a-H (8 1.64-1.68; 
ca 2%) observed on irradiation of 1-H (8 7.07) (Figure 2.31). Also observed was an 
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enhancement of the signal for 1 la-H (o 2.2; 7%). Irradiation of the BP-methyl group 
enhanced the signals for llP-H and 12P-H, confirming the identity of 1 la-Hand 12a-H 
from the observed crosspeaks in the COSY spectrum (Figure 2.29) 
l la-H 
Figure 2.30: NOE difference spectrum of 14,17a-ethano-9P-estra-1,3,5(10)-




Figure 2.31: Perspective view of 14,17a-ethano-9P-estra-1,3,5(10)-trien-
3, 17P-diyl diacetate 67, indicating observed NOE enhancements 
Further support for this 'folded' conformation was obtained from the signals for I ?2-H2, 
which both appear to be quite significantly shielded by the aromatic ring. In the 
corresponding compound in the natural series, the corresponding signals, although not 
conclusively identified, resonate between o 1.2 and o 2.0. This shift showed a significant 
solvent dependence, with a different shielding being observed in deuteriobenzene than 
deuteriochloroform, in CDCl3 : I7
2
x (o 1.16, dt, J 13 and 2 x 3.5 Hz), 17\ (0.94, ddd, J 13, 
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9.8 and 5.2 Hz), in C6D6: 17\ (8 1.15, m, obsc.), 17
2
n (0.68, ddd, J 12.6, 9.9 and 5.1 Hz), 
this is possibly due to the molecule adopting slightly different conformations in the two 
solvents. A similar shielding of a 14a-substituent by the aromatic ring of a 9P-steroid has 
been observed in 3-methoxy-14a-methyl-9P-estra- l ,3 ,5( 10)-trienes. 29 
Alkaline hydrolysis of the 3, 17P-diacetate 67 afforded 14, 17a-ethano-9p-estra-1,3,5(1 O)-






In conjunction with this successful synthesis of 14, 17a-ethano-9p-estra-1,3,5(1 O)-triene-
3, 17P-diol 68, other possible routes to this target, as mentioned in the introduction to this 
section (Scheme 2.23), were explored and the results of this investigation will be presented 
in the next section. 
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2.3.3 Further reactions of 14a,17a-ethano L'.l9<11>-derivatives 61 and 63 
The two other possible routes towards the 9P-series of compounds previously discussed 
(Scheme 2.23, p. 55) are the epoxidation-rearrangement sequence (g to h or i) successfully 
utilised in the unbridged series (Section 2.3 .1) and the hydroboration-oxidation-
equilibration sequence (g to h to i). The first route is dependent on achieving an 
a-selective epoxidation, which appears unlikely in the bridged series, in the light of the 
hydrogenation experiment described previously. Similarly, the hydroboration-oxidation 
reaction sequence was not expected to provide a synthetically useful access to the 
9P-series, for the reasons mentioned in the introduction (p. 55). Despite this, it was 
decided to explore these reaction sequences, both to investigate the possibility of 
synthesising 9P-compounds by these routes, albeit in small amounts, and to obtain access 
to 11-functionalised estradiol derivatives. The latter are of interest as several such 
compounds display enhanced hormonal activities. 54· 126 
The results obtained for the epoxidation-rearrangement reaction sequence will be presented 
first. The choice of protecting groups (acetate) and reagents (DMD, LiC104) for 
accomplishing this transformation was influenced by the experience gained from the 
unbridged series (Scheme 2.28). Although a mixture of products 61 + 62 was used for this 
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Epoxidation of the mixture of 3,17P-diacetates 61 + 62 with DMD followed by a lithium 
perchlorate catalysed 1,2-hydride shift (as in the unbridged series) gave the 3,17P-diacetate 
61 (33%) and a mixture of the epimeric 11-ketones 69 and 70 (46%) (Scheme 2.36). 
Recrystallisation afforded pure 3, 1 7P-diacetoxy-14, 17 a-ethanoestra-1,3 ,5( 1 O)-
trien-11-one 69. The 11-ketone 69 was characterised by a strong absorption in the infrared 
spectrum at Vmax 1732 cm·1, along with the expected molecular ion and microanalytical 
data. The configuration at C-9 was assigned from the I H NMR in which the signal for 
9a-H (8 3.89, d, J 12.8 Hz) indicates a 9a-configuration. This was confirmed by 
subsequent experiments. 
In order to conserve material, the crude mixture of 11-ketones 69 and 70 was treated with 
sodium borohydride in methanol, followed by chemoselective 3-0-methylation to afford a 
separable mixture of 11 P-hydroxy-3-methoxy-14, 17a-ethanoestra-1,3,5(1 O)-triene-17P-yl 
acetate 71 (56%) and 1 la-hydroxy-3-methoxy-14,17a-ethano-9P-estra-1,3,5(10)-triene-
17P-yl acetate 72 (11 %). 
The maJor product, 11 P-hydroxy-3-methoxy-14, 17a-ethanoestra-1,3,5(10)-triene-l 7p-yl 
acetate 71 was readily identified from spectral data. The signal for the 13P-Me group 
(8 1.19) is deshielded by the 1,3-diaxial relationship with 11 P-OH. The signal for 9a-H (8 
2.8) is unfortunately masked by the signal for 6-H2, but that of 1 la-H (8 4.75, q, J 3 x 3.2 
Hz) clearly indicated the equatorial orientation of this proton. A small-scale deacetylation 
reaction (KOH, MeOH) gave the 11 p, 17P-diol 73 which displayed similar spectral 
characteristics to the precursor 17P-acetate 71. For this derivative it proved possible to 
unravel the signal for 9a-H (8 2.89, dd, J 12 and 3.3 Hz), providing further confirmation of 
the stereochemistry at C-9 and C-11. 
The mmor isomer, 11 a-hydroxy-3-methoxy-14, 17a-ethano-9P-estra-1,3,5(1 O)-triene-
17p-yi acetate 72 was readily identified as an 1 la-hydroxylated product by 1H NMR 
spectroscopy, from the deshielding of 1-H (8 7.67, d, J 8.3 Hz). The configuration at C-9 




Figure 2.32: Perspective drawing of 1 la-hydroxy-3-methoxy-14,17a-ethano-9P-estra-
1,3,5(1 O)-triene-l 7p-yl acetate 72, indicating the folded conformation 
Further support for the assigned stereochemistry at C-9 was obtained from the high-field 
region of the 1H NMR spectrum, where a one proton multiplet (8 0.94, m) was observed 
(for 17\-H), unlike in the natural series. This shielding of a 14a-substituent appears to be 
characteristic of 9P-estratrienes in the folded conformation depicted (Figure 2.32). 29 
This assignment was subsequently confirmed by the synthesis of 3-methoxy-14, 17a-
ethanoestra-1,3,5(1 O)-trien-11 a, 17P-diol 76 (p. 84 ), which displayed substantially different 
coupling constants in the 1 H NMR spectrum, excluding the possibility that reduction of the 
9aH-11-ketone 69 could have afforded a 9aH-11 a-hydroxy compound as a minor product. 
The important 1H NMR signals of selected 11-hydroxylated derivatives have been 
tabulated for comparison purposes (Table 2.12, p. 86). 
As the 11a-hydroxy-14,17a-ethano-9P-I7p-acetate 72 was not crystalline, the 
corresponding lla,I7P-diacetate 74 was synthesised (74%) in an attempt to obtain a 
suitable derivative for characterisation purposes. This material was also non-crystalline, 
and was characterised by spectra and an accurate mass determination, which fully 
supported the assigned structure. 
In order to exclude the possibility that the I I-ketone 69 could undergo epimerisation at C-9 
prior to reduction, the 9aH-11-ketone 69 was stirred with hydrochloric acid in methanol 54 
for 24h. No evidence of equilibration was observed, indicating that the I la-alcohol 72 
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originates from reduction of the 9PH- l l-ketone 70. Base-mediated equilibration was not 
feasible on this substrate due to the extremely base-sensitive 3-acetoxy group. 
Oxidation of the I IP-alcohol 71 (DMP, CH2Ch) 72 gave the I I-ketone 75 (68%). 
Reduction of a portion of the crude product prior to any purification gave the starting 
11 p-alcohol 71, with no other products either observed (TLC) or isolated. This confirms 
that epimerisation at C-9 prior to reduction of the I I-ketone does not occur. Hence the 
source of the 11 a-alcohol 72 must be the corresponding 9PH-1 l-ketone 70, present as an 
unidentified minor product of the epoxidation-rearrangement sequence (Scheme 2.36). 
The I I-ketone, 75, displayed all the expected analytical and spectral characteristics, similar 
to the previously synthesised l l-oxo-3,l 7P-diacetate 69. Figure 2.33 shows the high-field 
region of the I H NMR spectrum, and some of the assignments are tabulated (Table 2.11 ). 
The signal for 9a-H (8 3.88, d, J 12.2 Hz) had a similar coupling constaPt to that 
previously observed, and was taken as evidence of the 9a-configuration. In order to 
confirm this assignment, and those made previously, a NOE difference experiment was 
conducted (Figure 2.34). 
9a-H 
3 8 3 .6 
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Figure 2.33: 1H NMR spectrum of 3-methoxy-l l-oxo-14,l 7a-ethanoestra-
l,3,5(1 O)-trien-l 7p-yl acetate 75 
ppm 
Table 2.11: Key signals in the 1H NMR spectrum of 3-methoxy-l l-oxo-14,l 7a-
ethanoestra-1,3,5(1 O)-trien-l 7P-yl acetate 75 
8/ppm Int. Mult. J/Hz Assignment 
2.22 lH d 12.0 12P-H 
2.36 lH tt 2 X 12. 7 and 2 X 3. 7 172x-H 
2.76 lH dd 12 and 0.8 12a-H 
3.88 lH d 12.2 9a-H 
2 ' 
Figure 2.34: NOE difference spectrum of 14a,17a-ethano 11-ketone 75 
(irradiation of 9a-H, 8 3.88) 
-
MeO 
Figure 2.35: Perspective view of 14a, 17a-ethano 11-ketone 75 indicating 
observed NOE enhancements 
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Irradiating the signal for 9a-H (8 3.88) enhanced the signals for 7a-H (8 1.52, ca 2%), 
1 ?2 x-H (8 2.36, 13%) and 12a-H (8 2. 76, 4%), thus confirming this assignment, and hence 
also the remainder of the assignments (Figure 2.35). 
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Thus, conclusive proof of the 9a-configuration of the I I-ketone 75 has been obtained, 
confirming previous assignments. Additionally, from the assignment of 1 ?2 x-H from NOE 
difference spectroscopy, it was possible to assign the 13C NMR signals of the two ethano 
bridges ( C-15, C-16 and C-17', C-1 72). These have been used to help assign the carbon 
resonances of all the 14a, 17 a-ethano bridged compounds reported in this thesis, as in most 
cases it is impossible to differentiate between these signals. 
In conclusion, it has been demonstrated that the presence of the 14a,17a-ethano bridge 
significantly diminishes the a-face stereoselectivity of epoxidation of the ~9(1 l)_bond, thus 
reducing the synthetic utility of this approach to 9P-derivati ves of 14, 17 a-ethanoestra-
l ,3 ,5( 10)-triene-3, 17p-diol. However, it does provide efficient access to the 11-ketones 69 
and 7\ which are versatile precursors to 11-functionalised derivatives. 105• 127 
Hydroboration-oxidation of the ~9(l I)_bond was also investigate.i. For this reaction 
sequence the base-labile 3-acetate was inappropriate, so the mixture of 3-methyl ethers 59 
and 63 was used. Although this route was not expected to provide a synthetically useful 
entry into the 9P-series, it was hoped that the I4a,17a-ethano bridge would influence the 
stereoselectivity of the hydroboration reaction, similarly to the hydrogenation and 
epoxidation reactions previously described. Once again, for convenience, only the 
~
9
(! l)_olefin constituent, 63, of the starting material has been displayed. 
Hydroboration-oxidation of the ~901 >-compound 63 (contaminated with the saturated 
analogue 59) gave compound 59 (35%) followed by the I la-alcohol 76 (31 %) 
(Scheme 2.37). From both the 1H NMR data and TLC, no evidence of any isomer was 
observed. This result is similar to that obtained for the hydroboration/oxidation of 
l 7P-t-butyloxy-14a-methyl-3-methoxyestra-1,3,5(10),9(11 )-tetraene. 55 Evidently, the 
presence of a 14a-substituent does not significantly affect the selectivity of hydroboration-
oxidation, unlike hydrogenation and epoxidation reactions. 
MeO 
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The configuration at both C-9 and C-11 was assigned by comparison with the previously 
synthesised I I-alcohols, 71 and 72 (Table 2.12). The presence of an 11 a-hydroxy group 
was indicated by the deshielding of the signal for 1-H (8 7.88, d, J 8.7 Hz), while the signal 
for 9a-H (8 2.48, t, J 2 x 10 Hz), with two large couplings, indicative of two anti-
periplanar relationships (with 8P-H and 11 P-H) confirmed this. 
As the 11 a, 1 7P-diol 76 was not crystalline, it was characterised as the 11 a, 17P-diacetate 
77 (74% yield for the conversion). The 1 la,17P-diacetate 77 displayed similar 
characteristics to the precursor 76. In the case of the 11 a, 17P-diacetate 77, it proved 
impossible to obtain the molecular ion (m/z 412) in the mass spectrum. A primary 
fragmentation ion (m/z 352) corresponding to the loss of acetic acid was clearly evident. 
For comparison, key 1H NMR signals for representative members of all the I I-oxygenated 
I4a,17a-ethanoestratriene derivatives synthesised have been tabulated (Table 2.12). 
Table 2.12: 1H NMR data for selected 11,;-hydroxy 14a,17a-ethano bridged 
compounds 71, 72 and 76 




13P-Me 8 1.19 (s) 
9-H a: 8 2.77 (m) 
11-H a, 8 4.75 (q, J3 x 3.2) 
1-H 87.23(d,J8.5) 
72 
8 1.09 (s) 
p: 8 3 .11 ( dd, J 7. 3 and 
5.3) 
p, 8 4.57 (dt, J 8.8 and 
2 X 5.3) 
8 7.67 (d, J8.3) 
76 
8 0.89 (s) 
a: 8 2.48 (t, J2 X 10) 
p, 8 4.20 (td, J2 X 10 
and 5.8) 
8 7.88 (d, J 8.7) 
86 
Demethylation, 128 followed by deacetylation of the 3-methoxy-11 a, l 7p-diacetate 77 
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Swem oxidation 70 of the I la-alcohol 76 afforded the I I-ketone 79 (58%) (Scheme 2.39). 
The structure was readily assigned from a comparison of the 1 H NMR spectrum with that 





76 79 73 
Scheme 2.39 Reagents and conditions: i, a) (COCl)2, DMSO, CH2Cl2, - 78°C; 
b) Et3N, -78°C725°C; ii, LAH, THF, 25°C 
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OH 
Reduction of the 11-ketone 79 (LAH, THF) gave the 11 P-alcohol 73 which was identical to 
that synthesised previously, providing conclusive proof for the assigned stereochemistry at 
C-9 and C- I l. As expected, the I I -ketone 79 was recovered unchanged after acid-
mediated equilibration. 54 However, attempted base-medhted equilibration 54• 100 gave an 
intractable mixture of products which could not be ider.tlfied. Refinement of the reaction 
conditions might provide a more interpretable result, but in the light of the acid-mediated 
equilibration reaction this was not investigated. 
In conclusion, a number of interesting ring C oxygenated 14,I 7a-ethano bridged estradiol 
derivatives have been synthesised. Although access to the desired 9P-series is achieved by 
the methods described, this is not a synthetically viable route. The I I-ketones 69, 75 and 
79 are potential precursors to I I-alkylated 14,I 7a-ethanoestradiol derivatives following the 
procedure established for the unbridged series 127 (Grignard or alkyllithium addition to the 
I I-ketone followed by ionic hydrogenation of the resulting tertiary alcohol). 
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2.3.4 Other methods of ring C functionalisation 
An alternative method of introducing ring C functionality to be investigated was 
cerium(IV) ammonium nitrate ( eerie ammonium nitrate, CAN) oxidation, as it has been 
reported that CAN treatment of estrone 3-acetate gives the corresponding 9a, 11 P-diol 
11-nitrate ester. 129 This intermediate has been used in the preparation of a number of 
estradiol analogues with 'remarkable' biological activity. 130 
Of more interest to this work was the reported conversion of the 9a, 11 P-diol I I-nitrate 
ester into the 9a,1 la-epoxide. 131 As has been demonstrated, this epoxide can be 
converted into the 9PH-11-ketone. 100 As direct epoxidation-rearrangement of the 
14a, 17a-ethano d 9( 11 l-compound 62 did not provide efficient access to the desired 
9PH-11-ketone 70, this indirect approach was investigated. 
CAN oxidation of the 3, 17P-diacetate 61 unexpectedly gave 1 l-oxo-14, 17a-ethanoestra-
1,3,5(10),6,8-pentaene-3, 17P-diyl diacetate 80 instead of the anticipated 9a, 11 P-diol 
I I-nitrate ester (Scheme 2.40). Subsequently, independent confirmation of this result was 









i) KOH, MeOH C 80, R, R' = Ac 
ii) MeiS04, K2C03 
acetone 81, R = Me, R' = H 
Scheme 2.40 
The I H NMR spectrum of 80 showed all the expected signals for the aromatic system, and 
these are summarised in Table 2.13 along with the I H NMR signals for other, related 
compounds. The significant deshielding observed for 1-H is due to the planarity of the 
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I I-ketone and the aromatic system forcing this proton into the deshielding region of the 
I I-ketone, and has been observed for other 11-oxo equilenin derivatives. 132 
It has been reported 132-134 that Birch reduction of 11-oxoequilenin systems gives the 
corresponding 11-oxoestra-1,3,5(10),8-tetraenes. Further reduction has been reported to 
give either a poor yield of the 11 a-hydroxy-8p,9a-estratriene 132 or the 11-oxo-8p,9a-
triene. 135 
For the purpose of performing a comparable reduction on the current system, the 3-acetoxy 
group of 80 was replaced by a 3-methyl ether using standard methodology, affording 81. 
The 1H and 13C NMR spectra of this compound, 81, were assigned with by standard 
2-D NMR spectroscopic techniques. Treatment of the 1 I-ketone 81 under Birch reduction 
conditions (sodium, ammonia, t-BuOH) gave the !J.8 11-ketone 82 in variable yields (68% 
at best) (Scheme 2.4 I). This reaction remained capricious despite all attempts at 
optimisation, with .he yield fluctuatir:g substantially. The /J. 8 I I-ketone 82 was readily 
identified from spectral information, with the loss of the signals for 6-H and 7-H from the 
aromatic region of the I H NMR spectrum clearly indicating that saturation of the olefinic 













Table 2.13: Selected 1H NMR signals for 11-oxo-14,17a-ethano derivatives 80, 81 and 82 
Chemical shift 8/ppm (multiplicity, coupling constant J/Hz) 
Proton OAc OH OH 
~ ~ ~ AcO MeO MeO 
80 81 82 
1-H 8 9.40 (d, J9.5) 8 9.30 (d, J9.6) 8 7.97 (d, J8.6) 
2-H 8 7.36 (dd, J9.5 and 2.5) 8 7.29 (dd, J 9.6 and 2.9) 8 6.78 (dd, J 8.6 and 2.7) 
4-H 8 7.55 (d, J2.5) 8 7.12 (d, J2.9) 8 6.70 (d, J2.7) 
6-H 8 7.95 (d, J 8.5) 8 7.90 (d, J 8.3) 
7-H 8 7.32 (d,J8.5) 8 7.26 (d, J 8.3 Hz) 
12a-H 8 3.20 (dd, J 18 and 1.2) 8 2.98 (dd, J 18 and 1.2) 8 2.74 (dd, J 17 and 1.2) 
12P-H 8 2.61 (d, J 18) 82.55 (d,J18) 8 2.40 (d, J 17) 
Further reduction of the ~ 8 11-ketone 82 (lithium/ammonia or hydrogenation) failed to 
provide any synthetically useful products, and this approach was discontinued. 
In an attempt to explore the general applicability of this unusual oxidation reaction, two 
other 14-functionalised analogues were prepared. 14, 17a-Ethano-8a-estra-1,3,5(1 O)-
triene-3, 17P-diyl diacetate 83 was readily synthesised from the 3,17P-diol 26. CAN 
oxidation of the 3,17P-diacetate 83 afforded a complex mixture of products (Scheme 2.42). 
Interestingly, DMD treatment of the 3,17P-diacetate 83 afforded a moderate yield (50%) of 
the 6-ketone 84, readily identified from 1H NMR and 13C NMR data; key signals were 
those for 4-H (8 7.69, d J 2.5 Hz) and C-6 (8 197.4). This result is comparable with that 
observed in the natural series (seep. 70); however, the yield is substantially better. 
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OH OAc 








3-Acetoxy-14P-ethylestra-l,3,5(10)-trien-l 7-one 86 was synthesised from 14P-ethyl-3-
methoxyestra-1,3,5(1 O)-triene-17-one 85. 136 Demethylation with trimethylsilyl chloride-
sodium iodide 128 followed by acid-catalysed acetylation gave the desired product in good 
overall yield (70%) (Scheme 2.43). CAN oxidation of this material once again failed to 
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CAN ,.,. Complex 
AcOH-H20 mixture 
Thus, the only conclusion drawn from this preliminary study is that the presence of an alkyl 
substituent at C-14 prevents the reaction from proceeding as in 14-unsubstituted 
compounds, possibly due to steric hindrance. 
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2.4 Conclusions 
In conclusion, the pnmary objectives of this section of the project, the synthesis of 
skeletally modified 14, 17a-ethanoestradiol analogues have been largely met. Both 
14, 17a-ethano-8a-estra-1,3,5(10)-triene-3, 17P-diol 26 and 14, 17a-ethano-9P-estra-
1,3,5(1 O)-triene-3, 17P-diol 68 have been successfully synthesised. The inability to induce 
diene formation in the 13a-series prevented further work towards the synthesis of 14, 17a-
ethano-13a-estra-1,3,5(10)-triene-3, 17P-diol being performed. Figure 2.36 summarises all 
the estradiol analogues synthesised in this section along with their competitive binding 
affinities for the estradiol receptor, expressed as a competition factor (see Appendix 1 
for details). 24 
OH OH 
HO HO 





78, CF 273 
Figure 2.36: Estradiol analogues synthesised, along with their competition factors 
Thus, the Sa-derivative displayed significant receptor binding affinity, while inversion at 
C-9 led to a fairly substantial reduction in competitive binding affinity. This will be 
discussed in more detail in Chapter 4. The introduction of an 11 a-hydroxy group led to a 
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complete loss of binding affinity, as has been observed in the unbridged senes, 26 
confirming the hydrophobic nature of the receptor in that region. 
The route developed for the synthesis of Sa-analogue 26 allows for the preparation of a 
number of other analogues of 8a-estradiol, and some of the precursors to these compounds 
have been synthesised. 
Although the route developed for the synthesis of the 9P-analogue 68 is less amenable 
towards the preparation of a large variety of analogues of 9P-estradiol it can be applied to 
any I4a-functionalised estradiol analogue. Efficient access to C-11 functionalised 
I4a,17a-ethanoestradiol analogues has also been achieved. 
Future work directed towards the synthesis of 9P-steroids should be focused on developing 
a total synthesis route towards a 9p-estrone derivative for further modification. The 
inversion methodology developed in both the 14,17-bridged as well as in the unbridged 
series is rather laborious and low yielding. 
Two potential precursors identified in this context are l 4p-hydroxy-3-methoxy-9p-estra-
1,3,5(1 O)-trien-17-one, available from the hydrogenation of I 4p-hydroxy-3-methoxyestra-
1,3,5( 10),8-tetraen-17-one 137 and 17P-t-butyloxy-3-methoxy-9p-estra-1,3,5(10),6, 11-
hexaene, available from the Heck coupling of (Z)-(2-bromoethenyl)bromobenzene and a 
hexahydro-IH-indene derivative. 138 
More work on the CAN oxidation reaction, incorporating other estrone derivatives, such as 
17-oxo-14a-methyl-estra-1,3,5(1 O)-trien-3-yl acetate, is also warranted in order to ascertain 
the mechanism of this interesting transformation. 
Chapter 3 
Approaches to the Synthesis of 15,17-Bridged Analogues of Estradiol 
A number of ring D modified estradiol analogues have been synthesised since the original 
discovery that 14,17a-ethanoestra-1,3,5(10)-triene-3,17P-diol 60 is an orally active 
estrogen. 31 These include analogues with bridging between C-14 and C-17, 35 between 
C-14 and C-16, 32 and C-14, C-15 fused ring systems 40 (Figure 3 .1 ). 
OH OH OH 
~ 
Figure 3.1: Some examples of ring D modified estradiol analogues 
As yet, few examples of 15, 17-bridged systems have been synthesised, one example is 
3-methoxy-15P, 17P-ethano-14P-estra-1,3,5(10),8-tetraen-17a-ol, which is one of a number 
of products resulting from the acid-catalysed rearrangement of 3-methoxy-14, 17a-
ethenoestra-1,3,5( I0)-trien-17P-ol (Figure 3 .2). 90 
OH OH 
Meo Meo 
40% (+ other products: 
Figure 3.2: Acid-catalysed rearrangement of 3-methoxy-14, l 7a-ethenoestra-
l ,3,5( 10)-trien-1 7P-ol 
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As part of the molecular modelling study (Chapter 4), some 15, 17-bridged systems were 
examined and the preliminary evidence indicated that they could well be biologically 
active. In the light of these predictions, some precursors to 15, 17-bridged systems were 
prepared in order to examine the facility with which a bridge between these two positions 
can be constructed. 
In this investigation, the synthesis of 15a, I ?a-bridges was studied primarily, as it was 
recognised that steric hindrance between the 13 P-methyl group and the elements of a 
15 p, l 7P-bridge could pose a significant impediment to the formation of 15P, l 7P-bridges. 
As an example, a retrosynthetic analysis of 15a, 17a-propanoestra-l ,3,5(1 O)-triene-
3, l 7P-diol A, identified four synthons (Figure 3.3). Of these, synthons band c, requiring 
the introduction of functionalised 17a- and 15a-alkyl residues, were not considered in this 
investigation. Further elaboration of synthons a and d as well as the coupling reactions 
attempted will be presented in the ensuing section. 
A 
U\ 
* H 0 
~··· 
---. \ 
a b C d * 
Figure 3.3: Retrosynthetic analysis 
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3.1 Synthesis and attempted coupling reactions of C-17a and C-15 
functionalised derivatives 
Synthon a requires the introduction of a functionalised l 7a-propyl chain, as well as an 
activating group at C-15. As there is ample precedent for the stereoselective a-face 
addition of nucleophiles to 17-ketones 139 the introduction of a l 7a-propyl moiety was not 
expected to present any synthetic problems. The introduction of an activating group at 
C-15 via conjugate addition to the ~ 15 17-ketone should also be feasible. 66 Thus, the 
following synthetic route was envisaged (Scheme 3.1): conjugate addition of thiophenol to 
the ~ 15 17-ketone B followed by addition of a l 7a-allyl group would provide a precursor 
for radical cyclisation C, to provide either the 15a, l 7a-ethano compound D or the 






















The well-documented preference for cyclisation reactions of 5-hexenyl radicals to proceed 
via the 5-exo trig pathway 140 should lead to the preferential formation of the 
15a, l 7a-ethano product D. The steric constraints imposed upon this reaction pathway 
might allow the less strained 6-endo trig process (leading to A) to become an effective 
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competing reaction, but it is more likely that quenching of the radical prior to cyclisation, 
to give the 17a-allyl compound E will be the major alternative reaction pathway. 140 
The conjugate addition ofthiophenol to ~ 15-estrone 3-methyl ether 87 has been reported to 
give the desired 15P-phenylthio 17-ketone 88. 86 However, no experimental conditions for 
the reaction, or any characterisation of the product were reported. Accordingly, the 
~
15 17-ketone 87 141 was treated with thiophenol and ethyldiisopropylamine for 3h at 25°C 
to give a high yield (93%) of a single product, which was readily identified as the desired 
15P-phenylthio 17-ketone 88 from spectroscopic and analytical information (Scheme 3.2). 




CHrCHCH:irv"gCI .. .. 
THF 
I SPh 
87 88 89 
Scheme 3.2 
The configuration of the 15 P-phenylthio group was assigned from the 1 H NMR spectrum, 
specifically the signals for 14a-H (8 1.42, dd, J 11.2 and 7.0 Hz) and 15a-H (8 3.49, ddd, J 
8.0, 7.0 and 1.6 Hz). The small coupling constant between 14a-H and 15a-H indicates the 
synclinal relationship between the two protons, and hence the configuration at C-15. This 
information, along with the well established precedent for conjugate addition to 
~
15 17-ketones to give rise to ISP-substituted products 66 was considered sufficient proof of 
the structure. 
Allylation of the l 5p-phenylthio 17-ketone 88 proceeded smoothly to give the desired 
17a-allyl 15P-phenylthio 17P-alcohol 89 (83%). The product was identified from the 
1 H NMR spectrum, in which signals for both the 15 P-phenylthio (8 7 .18-7.40) and the 
17a-allyl (8 5.20, m, 2H; 5.88-6.20, m, 1 H) groups were clearly visible. The remainder of 
the spectroscopic and analytical data fully supported the assigned structure. 
Refluxing the 17a-allyl 15P-phenylthio 17P-alcohol 89 with tributylstannane and the 
radical initiator, AIBN, gave an inseparable mixture of 17a-allyl estradiol 90 and the 
corresponding ~ 14-derivative 91 (ca 7:3 by 1H NMR) (52%) as well as some starting 
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material (20%) (Scheme 3.3). From the 1H NMR spectrum of the product mixture, both 
the presence of the 17a-allyl group and the absence of the 15f3-phenylthio group were 
observed. The major product, 90, was identified by comparison with authentic material 
prepared independently (see next reaction), and the minor product was identified from the 
doublet of doublets (o 5.68, J 6.0 and 3.2 Hz) for 15-H, characteristic of a t114-bond. 142-144 
Thus, formation of a 15a,17a-ethano bridge by a 5-exo-trig cyclisation appears to be 
sterically disfavoured, 6-endo-trig cyclisation does not occur, and radical quenching is the 
only reaction pathway observed. 












o~ ...... r 
91 
The 17a-allyl-15f3-phenylthio 17f3-alcohol 89 was also treated with sodium in ammonia 145 
in the hope that cyclisation of the intermediate radical would occur. However, simple 
desulfurisation was expected to be the major reaction pathway. In the event, the only 
product isolated from this reaction was the 17a-allyl 17f3-alcohol 90 in low yield (28%). 
This product was readily identified by a comparison of its physical properties with 
literature values 146 and from the 1H NMR spectrum, which clearly showed the loss of the 
15 f3-phenylthio group, and the presence of the 17 a-ally I group. This confirmed the identity 
of the major product of the previous reaction (tributylstannane - AIBN). 
It was recognised that extension of the 17a-alkenyl side-chain, might enable the cyclisation 
process to proceed via a favourable 6-exo-trig cyclisation and a less strained transition 
state, but this was not investigated for the following reason: As the rate of 6-heptenyl 
cyclisation is significantly slower than that of 5-hexenyl cyclisation 147 radical quenching 
becomes a significant reaction pathway. 147 Since no cyclisation was observed in the 
5-hexenyl system, with radical quenching being the only reaction pathway, it was 
considered unlikely that a 6-heptenyl cyclisation would proceed in this system. Thus, this 
approach was discontinued. 
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The disconnection to synthon d (Figure 3.3) appeared to offer the most scope for further 
retrosynthetic analysis, provided a stereoselective method for introducing a three-carbon 
fragment at C-15a could be developed. However, achieving the desired cyclisation with 
C-17 is likely to be demanding due to the distance between the reacting centres. 
Regioselective functionalisation of the I Sa-alkyl moiety would enable intramolecular 
coupling of the three carbon fragment with the 17-carbonyl group. Thus, the 15a-acetonyl 
17-ketone F, the 15a-formylethyl 17-ketone G and the terminally functionalised ( e.g. X = 
halide) 15a-propyl 17-ketone H were identified as real intermediates of synthon d. It is 
evident that all of these share a common precursor, the 15a-allyl 17-ketone I. This in turn 
should be available from the Li 15 17-ketone B, by an oxy-Cope rearrangement of the 
17a-allyl 17P-alcohol J. The overall retrosynthetic plan is depicted in Figure 3.4. 





d F G H 
0 OH 0 
~ ... ! :> :> :> 
~ J B 
Figure 3.4: Retrosynthesis based upon synthon d 
Treatment of the Li15 17-ketone 87 with allylmagnesium bromide gave the 17a-allyl 
17P-alcohol 92 in high yield (97%) (Scheme 3.4). In the 1H NMR spectrum, signals for the 
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17a-allyl group (8 5.20, m, 2H; 8 5.82-6.00, m, IH) and the ti15-bond (8 5.67, dd, J 6.0 and 
3.2 Hz, 15-H; 8 5.99, dd, J 6.0 and 1.6 Hz, 16-H) were observed, confirming that the 













An anion-assisted oxy-Cope rearrangement 148• 149 proceeded sluggishly in THF 
(incomplete reaction after refluxing for 18h), but on changing the solvent to refluxing 
1,4-dioxane, a rapid conversion (lh) resulted in the expected 15a-allyl 17-ketone 93 
(94%). An attempted thermal oxy-Cope rearrangement of the 17a-allyl ti15 17P-alcohol 92 
failed to give any conversion, with the starting material isolated unchanged after 18h at 
reflux in mesitylene. 
Compound 93 displayed all the expected spectroscopic and analytical properties, with the 
diagnostic features being an IR absorption at Vmax 1728 cm-1 , the signals for 14a-H (8 
1.33, t, J 2 x 10.8 Hz) and the 15a-allyl group (8 4.95, m, 2H; 5.52-5.63, m, IH). The 
stereochemistry at C-15 was confirmed by the signal for 14a-H , as only two anti-
periplanar coupling partners would give rise to the observed coupling constants. 
In order to further explore the scope of this reaction, the corresponding 17a-methallyl 
17P-alcohol 94 was prepared (72%) and subjected to similar reaction conditions resulting 
in a smooth conversion to the 15a-methallyl 17-ketone 95 (75%) (Scheme 3.5). These two 
compounds, the 17a-methallyl 17P-alcohol 94 and the 15a-methallyl 17-ketone 95, were 
readily identified from the expected 1H NMR signals for the methallyl group (8 1.7-1.8, 
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Tv10 possible transition states for this oxy-Cope rearrangement are envisaged (Figure 3.5); 
:iamely chair-like, A, md boat-like, B. 148 An examination of these two possibilities 
indicates that for the 17a-methallyl 17P-alco.r0l 94 (R = Me), th~ chair-like transition state 
is likely to be disfavoured due to steric interaction between the 1 I2-methyl group and 
14a-H. Thus it appears as if the boat-like transition state would be favoured in this case. 
As this reaction proceeds efficiently under similar reaction conditions to those used for the 
17a-allyl 17P-alcohol 92, it appears as though the transition state adopted does not 
significantly affect the reaction outcome. 
A B 
Figure 3.5: The two transition states for the oxy-Cope rearrangement 
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In addition to the synthesis of the 15a-allyl 17-ketone 93, the synthesis of the epimeric 
15P-allyl 17-ketone 96 was explored in order to examine the feasibility of constructing 
15P, 17P-bridged compounds. 
The first conjugate allylation method to be investigated was the Sakurai reaction. 150 
Treatment of the ~ 15 17-ketone 87 with titanium tetrachloride and allyltrimethylsilane in 
dichloromethane at -78°C afforded a low yield (32%) of the desired product (Scheme 3.6). 
The structure of the 15P-allyl 17-ketone 96 was confirmed by the expected infrared 
absorption band at Ymax 1725 cm-1 for the 17-oxo group and 1H NMR signals at 8 5.04 (2H, 




* LA = TiCl4, SnC'4, BAIC!i 
Scheme 3.6 
Owing to the low yield obtained for this conversion, a number of different catalysts for this 
reaction were investigated. Tetra-n-butylammonium fluoride, which has been reported to 
be a superior catalyst for the Sakurai reaction, 151 led to decomposition of the starting 
material without any conjugate addition product being formed. The use of milder Lewis 
acids than titanium tetrachloride gave better results, with both ethylaluminium dichloride 
and tin tetrachloride providing approximately 50% yields of the desired 15P-allyl 
17-ketone 96. However, these improved yields were still unsatisfactory, so alternative 
methods of introducing the desired 15 ~-allyl moiety were investigated. 
It has been reported that the conjugate allylation of a,f3-unsaturated ketones with 
allylcuprates, in contrast to the conjugate addition reactions of other cuprates, is extremely 
unreliable. 152· 153 In a recent paper, Lipschutz and co-workers 153 ascribed this to the 
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instability of allylcopper, but added that the addition of chlorotrimethylsilane to the 
reaction mixture results in a reproducible conjugate allylation procedure. Treatment of the 
~ 15 17-ketone 87 with a solution of an allyl copper species (stabilised with 
chlorotrimethylsilane) in THF at -78°C 153 afforded starting material (26%) and the 
~
14 
17-ketone 97 (22%); none of the desired product was observed (Scheme 3.7). 
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Scheme 3.7 
Attempts at using the more stable allylcyanocuprate 154 for the introduction of the desired 
1 SP-allyl group were also unsuccessful; however some interesting observations were made 
regarding the preparation of the reagent. Treatment of the ~ 15 17-ketone 87 with 
allylcyanocuprate, prepared by the addition of allyltributylstannane to the methyl lithium 
derived cyanocuprate, 153 in THF at -78°C afforded the 1,2-allylation product 92 ( 67% ), 
which was identified by comparison with authentic material, and an inseparable mixture of 
1,4-allylation products 93 (8%) and 96 (25%). From the signal for the angular methyl 
group [viz. 15P-allyl 17-ketone 96; 13P-Me (8 1.05) and 15a-allyl 17-ketone 93; 13P-Me 
(8 0.97)) it was possible to estimate the ratio of the two conjugate addition products in this 
mixture (3: 1) (Scheme 3. 7). This result is in agreement with literature findings in which 
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1,2-allylation has been reported to predominate in conjugate addition reactions of 
allylcyanocuprates to a,P-unsaturated ketones. 153 The loss of P-face selectivity observed 
for the conjugate addition process appears to be unprecedented. 66· 155 The 15a-allyl 
17-ketone 93 might arise from oxy-Cope rearrangement of the I 7a-allyl I 7P-alcohol 92, 
but this has not been investigated. 
Interestingly, when allyltriphenylstannane was substituted for allyltributylstannane in the 
preparation of allylcyanocuprate, a single product, formulated as the ISP-phenyl 
17-ketone 98 was isolated (77%). From the analytical data, it was apparent that the 
addition of a phenyl ligand had occurred, and this was supported by the I H NMR spectrum. 
The stereochemistry at C-15 was assigned by literature precedent. 66 Some support for this 
assignment was obtained from the signal for 15a-H (8 3.90, m Wy, 8 Hz), as the signal for 
l 5a-H in other I SP-substituted 17-ketones (for e:xarnple, l 5P-phenylthio 17-ketone 88) has 
approximately the same width, and a l 5P-H would be expected to have a larger signal 
width than that observed. 
Both allyltributyltin and allyltriphenyltin have been used as a source of ally! ligand in the 
preparation of allyllithium. 153· 156 However, allyltriphenyltin is clearly not a suitable 
precursor for the preparation of allylcyanocuprate, possibly due to the phenyl ligand 
competing with the ally! ligand in the transmetalation reaction, 152 in contrast to butyl 
ligand transfer. As this result was not useful for the purpose at hand, further investigation 
was not conducted. 
Subsequent and independently to this work, a short communication was published 157 
describing the use of the oxy-Cope rearrangement to synthesise the l 5a-allyl 17-ketone 93, 
and the Lipschutz method 153 for the synthesis of the l 5P-allyl 17-ketone 96. The 
assignment of stereochemistry in these two products was made in a similar fashion to that 
discussed in this thesis, and was confirmed by NOE difference spectroscopy. 
With the 15a-allyl 17-ketone 93 in hand, a number of different cyclisation pathways to 
15a, I 7a-propano compound were investigated. Wacker oxidation 158 of the l 5a-allyl 
I 7-ketone 93 should provide the I 5a-acetonyl 17-ketone for an intramolecular aldol 
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reaction, while hydroboration followed by oxidation should give the 15a-formylethyl 
17-ketone for an intramolecular reductive coupling reaction. 159-164 Subsequent 
modifications of either of these products would provide the target material. As a result of 
the poor yield for the conversion of the ~ 15 17-ketone 87 into the 15 P-allyl 17-ketone 96 a 
similar sequence of reactions on the 15P-allyl 17-ketone 96 was not investigated. 
However, one cyclisation precursor, the 15P-formylethyl 17-ketone was synthesised by an 
alternative route, (seep. I 08). 
Treatment of the 15a-allyl 17-ketone 93 with palladium(II) chloride-copper(!) chloride in a 
mixture of dimethylformamide (DMF) and water under an oxygen atmosphere (Wacker 
oxidation) 158 afforded the 15a-acetonyl 17-ketone 99 in high yield (87%) (Scheme 3.8). 
From the analytical data, it was evident that the addition of oxygen had occurred, and the 
presence of an acetyl methyl singlet (3 2.17, 153-H3) in the 
1H NMR spectrum provided 















It was hoped that base treatment of the l 5a-acteonyl 17-ketone 99 would give rise to a 
15a, l 7a-propano derivative (Scheme 3.8) as the other possible cyclisation reactions all 
lead to systems containing strained three or four membered rings. However, as the aldol 
reaction is reversible, it was recognised that the product (if formed) could readily revert 
back to the starting material. It was also recognised that a reductive coupling of the 
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15a-acetonyl 17-ketone 99 could provide a 15a,17a-ethano bridged derivative suitable for 
further modification. 
In the event, subjecting the 15a-acetonyl 17-ketone 99 to a range of reaction conditions, 
including attempts at inducing selective deprotonation at C-173 with lithium 
diisopropylamide or lithium hexamethyldisilazide at -78°C as well as simple equilibration 
processes (for example, potassium hydroxide in methanol at 25°C) failed to induce any 
cyclisation (Scheme 3.9). Treatment of the 15a-acetonyl 17-ketone 99 with samarium(II) 
iodide in refluxing THF 161· 162 failed to induce any coupling reaction, instead a complex 
mixture of 152, 17-diols 100 was obtained. Oxidation of this mixture (DMP, CH2Ch) 72 
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Hydroboration of the 15a-allyl 17-ketone 93 with borane-dimethyl sulfide gave an 
inseparable mixture of the desired 15a-hydroxypropyl 17~-diols 101 and 102 in low yield 
(39%, ca. 1: 1 ratio from 1H NMR) (Scheme 3.10). The use of a hindered hydroborating 
reagent, dicyclohexylborane 165 gave a more satisfactory result, with a single product, 
formulated as the 15a-hydroxypropyl 17P-alcohol 101 (59%) being obtained. The identity 
of the product was confirmed by the standard spectroscopic and analytical techniques. The 
stereochemistry at C-17 was assigned on the basis of dicyclohexylborane hydroboration of 
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15a-allyl 17J3-alcohol 103 (obtained from LAH reduction of the 15a-allyl 17-ketone 93), 
which afforded the same product, l 5a-hydroxypropyl l 7J3-alcohol 101 (57%). 





















Oxidation of the 15a-hydroxypropyl 17J3-alcohol 101 (DMP, CH2Cli) 
72 gave 
15a-formylethyl 17-ketone 104 (98%), as an unstable oil, thus rendering complete 
characterisation difficult (Scheme 3 .11 ). However the data set collected supported the 
assigned structure. Attempted reductive coupling 161 • 162 failed to give any 
15a, 17a-bridged compound. In one reaction, the 15a-hydroxypropyl l 7J3-alcohol 101 
(25%) was the sole isolable product and in a separate experiment a small quantity of the 
15a-hydroxypropyl 17-ketone 105 (5%) was isolated. 
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Scheme 3.11 
This result is in contrast with the successful pinacol coupling of 14-(formylethyl)-3-
methoxy-14p-estra-1,3,5(10)-trien-17-one 106 35 and is attributed to the inability of the 
I Sa-side-chain to fold under the a-face of the steroid, due to steric hindrance. From a 
comparison of the two systems (Figure 3.6), it is clear that in the case of the 
14P-formylethyl 17-ketone 106, the formyl group does not encounter any major steric 
hindrance in adopting a conformation appropriate for the reaction to occur. In the case of 
15a-formylethyl 17-ketone 104, the formyl ketyl radical is required to fold under ring D, 
into a sterically crowded environment, so as to react with the ketyl radical generated at 
C-17. A large energy barrier needs to be overcome in order to adopt this transition state, 
thus the desired coupling reaction fails and only reduction is observed. 
~o 
106 104 
Figure 3.6: A comparison of 14~-formylethyl 17-ketone 106 and 
15a-formylethyl 17-ketone 104 
In a final attempt to induce the formation of a 15a,17a-bridge, the 15a-allyl 17-ketone 93 
was refluxed with samarium(II) iodide and t-butyl alcohol in THF in the hope that an 
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intramolecular ketyl-olefin coupling 166 would result. After 40h, a mixture of the 15a-allyl 
17a-alcohol 107 (26%) and the 17P-epimer 103 (47%) was obtained, along with some 
starting material (15%) (Scheme 3 .12). The major product was identified through a 
comparison with authentic material prepared previously (Scheme 3 .10), and the minor 
product was identified from the 1 H NMR spectrum which clearly showed the presence of 
the 15a-allyl group (8 5.02, m, 2H; 5.8, m, lH) and 17P-H (8 3.70, d, J 5.3 Hz). 
0 OH OH 
Smli, t-BuOH .. + 
THF, t. 
93 ~ 107 ~ 103 ~ 
Scheme 3.12 
In conjunction with this ~tudy some attempts at constructing 15P, 17P-bridged analogues 
were also investigated. The first of these was the reductive coupling of the 
15P-formylethyl 17-ketone 109. The poor yield obtained for the synthesis of the l 5P-allyl 
17-ketone 96 from the Ll 15 17-ketone 87 resulted in an alternative approach (in comparison 
with the 15a-series) towards the 15P-formylethyl 17-ketone 109 being investigated. 
Conjugate butenylation of the Ll 15 17-ketone 87 was accomplished with a modified copper 
catalysed Grignard reaction to give the I5P-butenyl 17-ketone 108 (80%) (Scheme 3.13). 
The structure of 108 was confirmed by the expected infrared absorption band at Vmax 
1725 cm·1 for the 17-oxo group, and 1H NMR signals for the I5P-butenyl group (8 4.95-
5.10, 2H, m; 8 5.70-5.92, IH, m). 
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Treatment of the 15P-butenyl 17-ketone 108 with osmium tetroxide followed by oxidative 
cleavage of the resultant mixture of diols gave the desired 15P-formylethyl 17-ketone 109 
(72% overall yield) (Scheme 3.14). The structure of this product was evident from the 
infrared absorption at Vmax 1725 cm·1 for the two carbonyl groups and the low-field singlet 
for 153-H (8 9.8). Treatment of the 15P-formylethyl 17-ketone 109 with a titanium(III) 
chloride-dimethoxyethane complex [nominally TiCh(DME)15] 
159 and a zinc-copper 
couple in dimethoxyethane (McMurray coupling) 159' 160 initially at 0°C (for 30 min), and 
subsequently at 25°C for 18h failed to induce any reaction (TLC). On refluxing for 4h, a 
complex mixture, from which no steroidal products could be isolated, was formed. This 
negative result, coupled with the failure to induce any cyclisation in the 15a-formylethyl 
1 7-ketone 104 led to this approach being discontinued. 
0 
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The final method for the synthesis of a I5P,17P-bridge to be examined was the recently 
reported samarium(II) iodide induced Barbier-type intramolecular coupling of iodoalkyl 
side-chains with cyclic ketones to form bicyclo[m.n. l ]alkan-1-ols. 167 In particular, the 
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reported cyclisation of 3-(iodomethyl)cyclopentan-l-one to give 
bicyclo[2. l. l ]hexan-1-ol 167 led to the synthesis and coupling of the corresponding 
15P-iodomethyl 17-ketone 111 being investigated. 
Following a literature procedure, 168 conjugate methylenation of the ~ 15 17-ketone 87 with 
a mixture of trimethylsulfoxonium iodide and sodium hydride in DMF 169 gave 
15PJ6P-methylene-3-methoxyestra-l,3,5(10)-trien-17-one 110 168 in quantitative yield 
(Scheme 3 .15). 
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Treatment of the 15 p, 16P-cyclopropyl 1 7-ketone 110 with chlorotrimethylsilane and 
sodium iodide in acetonitrile 170 afforded the desired 15P-iodomethyl 17-ketone 111 in 
reasonable yield (60%). From the analytical data, it was clear that addition of iodine had 
occurred, and the spectroscopic data confirmed this. The assignments of 15 1-Hpro-R (8 3.24, 
dd, J 12.8 and 2.9 Hz) and 15 1-Hpro-s (8 3.50, dd, J 12.8 and 9.7 Hz) in the 1H NMR 
spectrum were made on the assumption that the C 15-C 15 1 bond was locked as a single 
rotamer, due to steric hindrance between the 13P-Me and the l 5P-iodomethyl groups. This 
would lead to the two protons on C-15 1 being non-equivalent, readily accounting for the 
observed coupling constants (Figure 3.7). 
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12.8 Hz Hpro-R 
C(14) C(16) 
9.7 Hz 
Figure 3.7: Newman projection along the 15 1, 15-bond of the 15P-iodomethyl 17-ketone 
111, with the observed coupling constants indicated 
On refluxing the l 5p-iodomethyl 17-ketone 111 with samarium(II) iodide and catalytic 
tris-(dibenzoylmethido)iron(III) 167 [Fe(DBM)3] in THF a slow reaction, yielding 
15P-methyl 17-ketone 112 (38%) as the sole product, resulted. From both the 1H NMR 
and infrared spectra, it was evident that no cyclisation had occurred, and the product was 
identified by comparison with authentic material. 171 Thus, it appears as though the 
additional steric constraints imposed by the steroid prevents this cyclisation from occurring 
unlike the simple 3-(iodomethyl)-cyclopentan-1-one. 167 As this is probably the most 
strained example of a 15,17-bridged analogue that can be envisaged, the failure to achieve 
this cyclisation, while disappointing, does not mean that this approach will not succeed. 
Once a method for synthesising other chain-extended 15-iodoalkyl derivatives has been 
developed the applicability of this methodology can be re-evaluated. 
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3.2 Conclusions 
Although the primary objectives of this study, namely the synthesis of 15,17-bridged 
estradiol analogues have not been accomplished, several aspects of the reactivity of the 
precursors has been documented. In addition, from this brief investigation, it is has been 
demonstrated that the formation of 15, 17-bridged estradiol analogues by coupling a 
15-functionalised alkyl chain with C-17 does not appear to be feasible. 
The failure of the 17a-allyl group to couple with a radical at C-15 was somewhat 
surprising in the light of the successful oxy-Cope rearrangement, which clearly indicates 
that a 17a-allyl functionality is capable of 'reaching' to C-15. Possible extension of this 
side-chain might enable this reaction to proceed successfully. 
Future work in this area should rather cor,centrate on attempting to couple functionalised 
alkyl fragments attached to C-15 and C-17 (Scheme 3.3; synthoas band c) as this should 
facilitate a more ready cyclisation. 
Chapter 4 
Molecular Modelling Study of Ring D Modified Estradiol Analogues 
Two broad objectives were envisaged for this work: firstly to find an explanation for the 
biological activities observed in ring D bridged estradiol analogues and then to develop a 
basis for predicting the activity of potential synthetic targets. 
A number of theoretical methods exist for determining the conformations of molecules. A 
firmly established method is that of molecular mechanics. A basic outline of this 
procedure and some of the limitations thereof will be presented. 
From a molecular mechanics perspective, molecules are considered to be a collection of 
masses that interact with one another via (almost) harmonic forces. Potential energy 
functions 174 are used to describe the interactions between the nuclei. These interactions; 
namely bond stretching, (Es), angle bending (Eb), van der Waals interactions (Evdw), 
torsional interactions (Etor) and electrostatic interactions (Ee1ec), all contribute to the total 
energy (Etota1) of the molecule, leading to an equation describing the system [1]. 
Etotal = Es + Eb + Evdw + Etor + Ee1ec [ 1] 
A more refined molecular mechanics model will take cross term interactions, such as 
stretch-bend, into account as well, but these terms are usually small and are often 
neglected. 173 
Any deviations from the 'ideal' molecular geometry will result in an increase in energy. 173 
Through a process of energy minimisation using these potential energy functions, a 
minimum energy conformation of the molecule can be obtained. A number of different 
methods for performing this process of energy minimisation exist, 174 but will not be 
discussed here. 
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The major problem associated with the energy minimisation process is that the minimum 
energy conformation obtained is largely dependent on the initial geometry of the molecule. 
Most minimisation algorithms can only go in a 'downhill' direction and are unable to 
surmount energy barriers in order to locate a lower energy conformation elsewhere on the 
potential energy surface. 175 For example, if a cyclohexane molecule was placed in a boat-
like conformation and minimised, the structure would minimise to the boat conformation 
and the process would stop. The chair conformation, which has a lower energy would not 
be found by this procedure. 
A large number of methods have been developed to search the conformational space of a 
molecule, in order to determine the minimum energy conformations. These range from 
systematically rotating every single bond in the molecule and determining the energy of 
each possibility, to randomly changing the 'current' structure to give a new structure which 
is then minimised, repeating this latter process a large number of times. The systematic 
method rapidly becomes impossible to implement as the number of rotatable bonds 
increases. The random method suffers from a lack of certainty that the entire 
conformational space has been covered and that all energy minima, including the global 
minimum, have been located. 175 
A further limitation of molecular mechanics, and molecular modelling in general, is that 
the effects of solvent are often not included as this renders the calculation extremely time 
intensive. The energy minima determined are, in effect, in vacuum, and may have limited 
applicability to the solution state, where most biological processes occur. Attempts have 
been made to incorporate solvent effects in the calculation 175 but these are still 
imperfect. 175 For the purposes of this thesis, solvent effects were excluded, as it was 
considered unlikely that they would have a substantial effect on the conformations 
obtained. 
What makes the molecular mechanics method so attractive though, is that through careful 
parameterisation of the force-field (the potential energy functions used to describe the 
system) these calculations are capable of reproducing experimentally determined 
geometries within experimental error, without being too computationally intensive. 173 For 
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these reasons, the molecular mechanics method was chosen over the more sophisticated ab 
initio and semi-empirical methods. 
The first stage of this computational study was to establish the structure of the compound 
under investigation. It is known that the conformation observed in the solid state of most 
uncharged organic molecules, such as steroids, is at or near a local energy minimum. 23 
Additionally, if the global minimum structure is significantly lower in energy than other 
local minimum energy conformations it is highly probable that a crystal incorporating this 
conformation will be formed preferentially. 23 Thus a combination of X-ray 
crystallography and molecular mechanics was envisaged as being suitable for establishing 
the structure of the molecule under investigation. 
Since steroids, and especially estra-1,3,5(10)-trienes are fairly rigid molecules the number 
of possible conformations is limited, and in most cases the minimum energy structure is 
likely to have the ring B half chair, ring C chair conformation. 176 Most of the 
conformational flexibility of these molecules is located in the B ring region, where the 
7a,8P-half chair conformation is generally favoured, but structures with the alternative 
SP-envelope conformation have also been observed. 176 Ring D is another source of 
flexibility, as a result of pseudorotation, 176 however, for most of the molecules studied in 
this thesis, there is a conformational restraint placed upon ring D, removing this flexibility. 
For all the molecules studied in this thesis, the simple procedure of manually distorting 
each of ring B and C into the respective boat, chair and/or half-chair conformations 
followed by energy minimisation was employed. Apart from the skeletally modified 
analogues, which will be discussed in a separate section, the lowest energy structure was 
invariably the ring B half-chair (8H7), ring C chair (
8C12) conformation. In many cases it 
proved impossible to minimise the molecule in any other conformation. No flexibility in 
ring D was observed, even in cases where this might be expected. This could be due to 
inaccurate parameterisation of the force-field. All comparisons, unless otherwise stated, 
were performed on the minimum energy conformer. 
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Once the minimum energy structure ( or structures if they are close in energy) has been 
determined, the next stage is to somehow compare them with the natural hormone 
template, estradiol. A comparison of this type allows the features which lead to enhanced 
binding affinity, as well as those which lead to decreased affinity to be identified. It is 
assumed that estradiol binds to the receptor in a conformation approximating that of the 
global minimum energy structure, 6• 22• 173• 177 hence it is reasonable to assume that the test 
molecule will adopt a conformation that allows for the best possible overlap with estradiol. 
A number of different protocols for this type of comparison can be envisaged, ranging from 
a purely manual superimposition of the molecules to the computationally intensive 
methods which have been developed precisely for this purpose, for example comparative 
molecular field analysis (CoMF A). 6"13• 177 As this project was merely an initial foray into 
this area, these latter methods were not investigated. 
The comparison was performed by superimposing the two oxygen and ring A atoms of the 
test material with the corresponding atoms of estradiol using a simple root-mean-square 
fitting procedure (Figure 4.1). It was reasoned that by superimposing the minimised 
conformations of both the test material and estradiol, systematic inaccuracies in the 
molecular geometry would cancel one another out, thus enabling a reasonable comparison 




















Figure 4.1: A schematic depiction of the superimposition process indicating the 
paired atoms 
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These selections of atom pairs for the superimposition were based upon the postulated 
method of estradiol binding to the receptor. The phenolic A ring initially binds strongly to 
the receptor through the 3-hydroxy group, followed by the 17P-hydroxy group interacting 
with another part of the receptor to induce the desired biological response. As both 
functional groups are essential for biological activity, it was decided to include both in the 
superimposition. This choice could introduce some bias into the derived model, a criticism 
which could equally well be applied to any other selection of atoms. Alternative models 
which were considered but not investigated were that of superimposing only the atoms of 
ring A and superimposing all the atoms of rings A, B and C, C-17 and 0-17. 
In addition to the superimposition studies, several molecular dynamics simulations were 
performed in order to assess the conformational flexibility of these ring D modified 
estradiol analogues. The molecular dynamics process aims to reproduce the time-
dependent motional behaviour of a molecule. 175 The molecule is provided with energy 
( determined by the temperature at which the simulation is run) and the atoms are allowed 
to move freely, restrained only by the force-field. In this way, it is possible to analyse the 
dynamic behaviour of a molecule at the desired temperature. 175 
In most cases, the molecule under investigation was observed to adopt just one other 
conformation and this for a brief period only. In these instances, the initial ground state is 
obviously far more stable, and thus is the only conformation used for the superimposition 
studies. 
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4.1 Comparison of calculated and experimental structures 
In order to assess the validity of the calculated minimum energy structures that will be used 
in the superimposition studies, crystal structures of three ring D bridged estradiol analogues 
were determined and compared to the calculated minimum energy conformations (Figure 
4.2). Two of these determinations were conducted as a part of this thesis (seep. 214 for 
details), the third was conducted in a separate investigation. 37 
The three compounds investigated were 14,17a-ethanoestra-1,3,5(10)-triene-3,17f3-diol 60, 
14,17a-propanoestra-l ,3,5(1 O)-triene-3,l 7f3-diol 114 and 14,17f3-propano-14f3-estra-
l,3,5(10)-triene-3,17a-diol 116, (Figure 4.2) as they form the 'core' set of ring D modified 
estradiol analogues upon which much of this work has been based. 
OR' OR' OR' 
RO RO RO 
60 R = R' = H 114R=R'=H 116R=R'=H 
113 R = Me, R' = Ac 115 R = Me, R' = Ac 117 R = Me, R' = H 
Figure 4.2: Structures used for X-ray crystallographic determinations 
The crystal structure determinations were by necessity carried out on protected forms of the 
analogues (Figure 4.2, 113, 115 and 117), as no crystals suitable for X-ray diffraction could 
be obtained for the diols 60, 114 and 116 (Figure 4.2). This was not anticipated to have a 
significant effect on the observed conformations. 176 However, the presence of the 
protecting groups will affect intermolecular contacts in the unit cell and this in turn could 
influence the observed conformations. 
3-Methoxy-14,17a-ethanoestra-1,3,5(10)-trien-17f3-yl acetate, 113 57 was found to possess 
two crystallographically independent molecules in the unit cell, both of which exhibit a 
conformation similar to the calculated minimum energy form of 60, with some deviation 
observed in ring B. This similarity is evident from a comparison of the puckering 
parameters 178• 179 (also see Appendix 2) for these two rings (Table 4.1). 
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Table 4.1: Puckering parameters for the experimental and calculated structures of the 
14a,17a-ethano derivatives 60 and 113 
RingB RingC 
Structure Conf. Q/A e1° ~/0 Conf. Q/A 81° ~/0 
113 (X-ray) sE sH ' 7 0.524 127.3 10.8 
8
C12 0.546 4.6 232.1 
113 (X-ray) 8H1 0.521 129.4 18.7 8C12 0.521 4.0 233.3 
60 (calc.) 8H1 0.488 134.5 26.4 8C12 0.547 4.8 283.1 
3-Methoxy-14,17a-propanoestra-1,3,5(10)-trien-17P-yl acetate 115 also had two 
crystallographically independent molecules in the unit cell. As was observed for the 
14,17a-ethano bridged compound 113, both of the crystallographically independent 
molecules ~isplayed a conformation similar to the calculated minimum energy 
conformation, with some deviation in ring B. Table 4.2 shows the puckering parameters 
for rings B and C. In both the calculated and the experimentally determined structures, the 
14a,l 7a-bridging ring was in a slightly distorted chair conformation. 
Table 4.2: Puckering parameters for the experimental and calculated structures of the 
14a,l 7a-propano derivatives 114 and 115 
RingB RingC 
Structure Conf. Q/A e;o ~/0 Conf. Q/A e;o ~/0 
115 (X-ray) 8H1 0.518 130.0 19.3 8C12 0.528 6.4 285.2 
115 (X-ray) 8H1 0.544 128.0 16.8 8C12 0.502 11.2 274.2 
114 (calc.) 8H1 0.492 134.2 25.9 8C12 0.568 13.5 278.7 
In the case of 3-methoxy-14,l 7p-propano-14P-estra-1,3,5(10)-trien-17a-ol 117, 37 four 
crystallographically independent molecules were present in the asymmetric unit, each 
possessing a different conformation. The main source of this deviation was in ring B 
which was found to adopt a different conformation in each structure. The calculated 
minimum energy structure of 116 has ring B in the expected half-chair (8H7) conformation, 
while the experimentally determined structures have ring B in a variety of conformations 









Puckering parameters for the experimental and calculated structures of the 
14J3,17J3-propano derivatives 116 and 117 
RingB RingC 
Conf. QIA 9;0 ~/0 Conf. Q!A 8/0 ~/o 
5Tg 0.597 104.3 317.4 8C12 0.539 6.9 192.7 
5T9 0.535 109.5 321.9 
8 C12 0.540 4.2 151.8 
BE 0.510 129.9 353.0 8 C12 0.542 8.4 176.9 
8
S9 0.534 115.5 330.3 
8 
C12 0.539 6.3 171.7 
8H1 0.495 133.1 31.0 
8
C12 0.539 4.7 88.5 
Upon energy minimisation, two of these conformations adopted the calculated minimum 
energy structure, while the other two converged upon a slightly higher energy structure 
with ring B in a boat-lie conformation. This discrepancy between the calculated and 
observed structures is unlikely to be due to the presence of the protecting group, as this has 
not significantly affected the previous determinations. 
The space group of 117, Pl, has a natural number of one. In 117, however, the number of 
molecules in the asymmetric unit is four. In addition to this unusual observation, there 
exists a hydrogen bonding network between the four molecules and a water molecule. The 
presence of hydrogen bonds is obviously not accounted for in the calculation, and may be 
responsible for the molecules adopting higher energy conformations in the crystal lattice. 
Although this is a small comparison set, if all three crystal structure determinations are 
taken into consideration, the molecular conformations obtained by calculation appear to be 
reasonable structures for subsequent superimposition studies. However, the force-field 
does not accurately reproduce the observed ring B geometry, and appears to be insensitive 
to possible conformational transmission effects. The use of these structures for the 
superimposition studies is further justified by the fact that they possess the most 'estradiol-
like' conformation. The lowest energy conformations of all the natural backbone estradiol 
analogues were then confidently used for superimposition purposes. Each of these will be 
discussed in turn. An explanation for the observed biological activities based solely upon 
the experimentally observed structures is presented in Section 4.4. 
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4.2 Analysis of ring D modified estradiol analogues 
The first three structures to be considered in this study were the 'core' molecules, the 
14a, 17a-ethano 60, 57 14a, 17a-propano 114 34 and 14P, I 7p-propano 116 35' 37 analogues 
of estradiol. These structures are indicated in Figure 4.3, along with their observed binding 
affinity, expressed as a competition factor (CF). 24 This measurement is explained in more 
detail in Appendix 1, but to summarise, the smaller the CF, the higher the activity. Any 
molecule with a CF of less than one is a more effective at binding to the estradiol receptor 
than estradiol itself. 
OH OH OH 
HO HO 
60 (CF 0.6) 114 (CF 1.5) 116 (CF 69) 
Figure 4.3: 14,17-Bridged estradiol analogues 60, 114 and 116 
In order to assess the relative flexibility of ring D modified estradiol analogues, the 
14, l 7a-ethano compound 60 was subjected to a molecular dynamics simulation. It was 
assumed that other ring D modified estradiol analogues in the natural series would display 
similar conformational flexibility. It is recognised that this is a major assumption to make, 
as the conformational transmission effects of the different bridging ring sizes on the 
conformations of both ring B and ring C will differ. 180-182 However, as a first 
approximation it was considered reasonable. 
During the simulation, two torsion angles which provide an indication of the conformations 
of ring B and ring C were measured, $6,7.8.9 (~1) and $8,9.ll.12 ($2). In the ground state 
conformation, $1 = -60.2° and $2 = 48.6°. If ring B were to invert into the boat 
conformation, $1 would change to approximately 0° and if ring C were to adopt the boat 
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Figure 4.4: Results of the molecular dynamics simulation of 14a,17a-ethano derivative 
60. <j>1 (<!>6,7,8,9) Indicates the relative flexibility of ring B, and <!>2 (<!>s,9,11 ,12) that ofring C. 
From the results of this simulation (Figure 4.4), it is evident that some inversion of ring B 
occurs. The resulting conformation appears to be an unfavourable, high energy structure as 
it rapidly reverts to the more stable conformer (resembling the ground state conformation). 
Ring C does not undergo any inversion and remains in the chair conformation. Hence, as 
expected, the only source of flexibility is in ring B, and inversion of this ring results in a 
less favourable conformation. 
The additional steric bulk introduced by the ring D bridge is clearly displayed by 
superimposing 60 with estradiol. Apart for the ring D environment, there is a remarkably 
close correspondence between the two molecules (Figure 4.5). 
Figure 4.5: Superimposition of 14a,17a-ethano analogue 60 with estradiol 
The major differences are obviously the 14a,17a-ethano bridge, and the conformation of 
ring D, which is forced to adopt a 13E conformation by the bridge. The introduction of a 
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hydrophobic substituent to the l 7a-position is known to either enhance receptor binding 
(l 7a-ethynyl) or moderately decrease it (l 7a-methyl), 26 thus the 14a,l 7a-ethano bridge 
appears to have an effect similar to that of the l 7a-ethynyl substituent, enhancing binding. 
The slightly modified ring D conformation does not appear to inhibit binding in any way. 
Increasing the size of the 14a,l 7a-bridge, to give the 14a,l 7a-propano analogue 114, 
appears to have very little effect on receptor binding. As can be seen from the 
superimposition of the 14a,l 7a-propano compound 114 with estradiol (Figure 4.6), the 
molecules are remarkably similar. 
Figure 4.6: Superimposition of 14a,17a-propano derivative 114 with estradiol 
As is the case for the 14a,17a-ethano compound 60 the major difference is the additional 
steric bulk introduced on the a-face of ring D, which appears to be readily accommodated 
by the receptor. However, the slight increase in steric bulk does appear to reduce the 
binding affinity, indicating that the receptor pocket is relatively small. Very little ring D 
deviation is observed. This molecule (114) possesses a more 'estradiol-like' conformation 
than the 14a, l 7a-ethano compound 60, but this is not expected to influence the activity. 
In contrast, increasing the size of the 14P,17P-bridge to give the 14P,17P-propano 
derivative 116 results in major inhibition of binding affinity. The superimposition with 




Figure 4.7: Superimposition of the 1413,1713-propano analogue 116 with estradiol 
It can be seen that the overall superimposition with estradiol is poorer in this case than in 
the previous two. The observed loss of binding affinity might be ascribed to two factors; 
either steric interactions between the receptor and the 14j3,17l3-propano bridge (specifically 
C-1 ?1 and C-172) destabilises the receptor-ligand interaction or the 17a-hydroxy group is 
protruding into a hydrophobic region of the receptor. 
The observed difference in binding affinity between the 14a,17a-propano compound 114 
and the 1413, 1713-propano compound 116 is increased upon the introduction of unsaturation 
into the bridging ring. Thus, the 14a,17a-propeno compound 118 34 (Figure 4.8) has an 
extremely high receptor affinity while the corresponding 1413, 1713-propeno compound 
119 37 (Figure 4.8) is completely inactive. 
OH OH 
HO HO 
118 (CF 0.4) 119 (CF 470) 
Figure 4.8: Ring D bridged estradiol analogues 118 and 119 
Similarly to the previously described 14a,l 7a-bridged compounds (60 and 114), the 
14a,17a-propeno compound 118 displays a close correspondence to estradiol with respect 
to the conformation of rings B, C and D (Figure 4.9). The additional steric bulk on the 
a-face appears to be readily accommodated by the receptor, as is the case for 60 and 114. 
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The introduction of unsaturation flattens the bridging ring, and this appears to enhance the 
binding affinity. 
Figure 4.9: Superimposition of 14a,17a-propeno compound 118 with estradiol 
In the case of the 14P,17P-propeno bridged compound 119 the introduction of unsaturation 
also flattens the bridging ring. A possible explanation for the dramatic loss of binding 
affinity (relative to 116) is that the slightly altered orientation of C-172 places it in an 
extremely unfavourable position, which results in a destabilisation of the receptor-ligand 
interaction (Figure 4.10). 
Figure 4.10: Superimposition of 14P,l 7p-propeno derivative 119 with estradiol 
From this brief examination of structures, it has been concluded that the estradiol receptor 
is able to accommodate 'linear' steric bulk on the a-face of ring D. This corresponds with 
the results discussed in the introduction related to the methylation of estradiol, where 
substitution at the 17a- position was not detrimental to binding. The complete loss of 
activity for the 14P,l 7P-propano and 14P,l 7p-propeno bridged compounds (116 and 119) 
could be due to a number of factors. The first possibility is the poor alignment of the 
I ?a-hydroxy relative to estradiol, with this group possibly protruding into a hydrophobic 
region of the receptor; alternatively it could be that the extra steric bulk introduced on the 
P-face of the molecule prevents binding due to close contacts with an inflexible portion of 
the receptor. 
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In an attempt to explain the difference in binding affinity between the 14a.,17a.-bridged 
compounds and the 14P,17P-bridged compounds, estradiol, 14a.,17a.-ethano 3,l 7P-diol 60, 
14a.,17a.-propano 3,17P-diol 114 and 14P,l 7p-propano 3,l 7a.-diol 116 were 
superimposed. Then the van der Waals volume occupied by the active analogues 
(estradiol, 60 and 114) was subtracted from the volume occupied by the inactive analogue 
116. The volume remaining must therefore be the portion of 116 responsible for the loss of 
binding affinity. Three different views of this volume superimposed on the structure of 
116 are displayed in Figure 4.11. 
172 
.-- 17-0H 
Figure 4.11: Three views of the additional steric bulk associated with the 
14P, l 7P-propano derivative 116 
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As can be seen from Figure 4.11, this extra steric bulk is largely located on the P-face of 
ring D. The main areas of difference are the orientation of the 17-hydroxy group, the 
1 i-carbon and the 1 i-carbon. This leads to the preliminary conclusion that the observed 
loss of binding affinity is probably due to a combination of the misaligned 17-hydroxy 
group and the additional steric hindrance imposed by the 14P, l 7p-propano bridge. 
The next senes of compounds to be investigated were the 14, 16-bridged estradiol 
analogues 120-125. [14,16P-ethano-14P-estra-1,3,5(10)-triene-3,17P-diol 120 and 14,16P-
ethano-14P-estra-1,3,5(1 O)-triene-3, 17a-diol 123, 90 14, 16a-ethanoestra-1,3,5(1 O)-triene-
3, 17P-diol 121 and 14,16a-ethanoestra-l,3,5(10)-triene-3,17a-diol 124, 32 14,17a-ethano-
17a-homoestra-l,3,5(1 O)-triene-3, l 7P-diol 122 and 14, l 7a-ethano-l 7a-homoestra-
l ,3,5(1 O)-triene-3,l 7a-diol 125] 34 The structures of these cc ,npounds along with their 
binding affinity are displayed in Figure 4.12. For simplicity, only the ring D porti0n of 
each compound has been shown. 
OH OH OH 
120 (CF 1.1) 121 (CF 1) 122 (CF 3) 
OH OH OH 
123 (CF n.d.) 124 (CF 0.8) 125 (CF 210) 
Figure 4.12: 14,16-Bridged estradiol analogues 120-125 (n.d. = not determined) 
These analogues can be divided into a l 7P-series (120-122) and a 17a-series (123-125). In 
the case of 122 and 125 the correct nomenclature is actually 17ap and I7aa, but for the 
purpose of this discussion they will be classified as 17P and 17a compounds respectively. 
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Considering the 17P-series first, it is evident from the superimpositions with estradiol 
(Figure 4.13) that all three have structures very similar to that of estradiol. 
a b 
~ l 6a.-region ' 
C 
Figure 4.13: (a) Superimposition of 14P,16P-ethano compound 120 with estradiol, (b) 
superimposition of 14a., 16a.-ethano derivative 121 with estradiol, ( c) superimposition of 
14a.,17a.-ethano 17a-homo analogue 122 with estradiol 
From the observed binding affinities, it appears as though the receptor is able to 
accommodate the 14a.,16a.-bridge readily, and apart from this, the two 14,16-ethano 
bridged compounds, 120 and 121, do not introduce any other significant steric bulk. On 
the other hand, the 14a.,17a.-ethano 17a-homo derivative, 122 does introduce some steric 
bulk in the 16a.-region (indicated on Figure 4.13, c). This could be the reason for the slight 
loss of activity observed in this case. 
In the 17a.-series, all of the molecules have the 17-hydroxy group in the 17a.-orientation, 
which is expected to be deactivating towards receptor binding. While this holds true for 
the 14a.,17a.-ethano 17a-homo compound 125, it is clearly not the case for the 
14a., 16a.-ethano compound 124. The corresponding 14P, 16P-ethano compound 123 has 
not been synthesised as yet, and so cannot be included in this comparison. 
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From the superimpositions with estradiol (Figure 4.14), it is evident that none of these 
compounds fit the template ( estradiol) very well. In order to accommodate the misaligned 
1 7-hydroxy group, a significant distortion of the backbone is required. The 





Figure 4.14: (a) Superimposition of 14P,16P-ethano derivative 123 with estradiol, (b) 
superimposition of 14a, 16a-ethano compound 124 with estradiol, ( c) superimposition of 
14a,17a-ethano 17a-homo derivative 125 with estradiol 
Considering the 14a, 16a-ethano compound 124, from the superimposition with estradiol 
(Figure 4.14, b) it would appear as though the receptor is capable of recognising structures 
with a 17a-hydroxy group. Possibly the lack of steric bulk on the P-face (unlike the 
14P,17P-propano compound 116) and the presence of steric bulk on the a-face of the 
molecule (unlike estra-l,3,5(10)-triene-3,17a-diol) 25 prevents this group from deactivating 
the molecule towards receptor binding. 
The 17a-homo compound, 125 has a low binding affinity, which can be explained as being 
due to a combination of the misaligned 17-hydroxy group and the steric bulk introduced on 
the P-face, similar to the explanation for the 14P,l 7P-propano compound 116. Thus it 
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would appear as though both an incorrectly oriented 17-hydroxy group and steric bulk on 
the P-face are required for the loss of binding affinity. On this basis, the 14P, l 6P-ethano 
analogue 123 is an extremely interesting synthetic target, as it has the incorrectly oriented 
17-hydroxy group, along with steric bulk on the P-face, and provides an excellent 
candidate to test the validity of this hypothesis. 
Further support for this proposal is obtained from another series of compounds, the 
14P,15p-cycloalka analogues 126-131 (Figure 4.15). {cyclobuta[l4,15]-14p-estra-
1,3,5(1 O)-triene-3, l 7p-diol 126 and cyclobuta[l 4, 15]-l 4P-estra-l ,3,5(1 O)-triene-
3, 17a-diol 129, 36 cyclopenta[l4,15]-14P-estra-1,3,5(10)-triene-3,17P-diol 127 and 
cyclopenta[l 4, l 5]-14P-estra-1,3,5(1 O)-triene-3, 17a-diol 130, 37 perhydrobenzo-14P-estra-
1,3,5(1 O)-triene-3, 17P-diol 128 and perhydrobenzo-l 4P-estra-l ,3,5(1 O)-triene-
3, l 7a-diol 131} 40 
OH OH OH 
126 (CF n.d.) 127 (CF 1.3) 128 (CF 1.5) 
OH OH OH 
129 (CF 2) 130 (CF 7.4) 131 (CF 14) 
Figure 4.15: 14P, 15P-Cycloalka analogues of estradiol 126-131 
Once again, these compounds can be grouped into a l 7a- and a l 7rJ-series. In the 
17P-series binding affinities have been determined only for the cyclopenta[14P,15P] 127 
132 
and the perhydrobenzo-14P 128 analogues. Both of these analogues display a fairly 
significant deviation relative to estradiol upon superimposition (Figure 4.16). 
a b 
C 
Figure 4.16: (a) Superimposition of cyclobuta[14P,15P] analogue 126 with estradiol, (b) 
superimposition of cyclopenta[14P,15P] compound 127 with estradiol, (c) superimposition 
of perhydrobenzo-14P analogue 128 with estradiol 
From the observed high binding affinities for the cyclopenta[14P,15P] 127 and 
perhydrobenzo-14P 128 analogues it can be concluded that the receptor is capable of 
accommodating steric bulk on the a.-face, in the 14a., l 5a.-region (relative to estradiol). 
This agrees with the previous findings that steric bulk on the a.-face (relative to ring D of 
estradiol) is not detrimental towards receptor binding. On this basis, it is anticipated that 
the cyclobuta[14P,15P] analogue 126 will display significant binding affinity. 
The corresponding 17a.-series displays a similar pattern of poor superimpositions with 
estradiol (Figure 4.17). Although the cyclobuta[14P,15P] analogue 129 has a 17a.-hydroxy 
group, the presence of steric bulk in the a.-face region of ring D (relative to estradiol, as 
indicated on Figure 4.17, a) appears to reduce the negative impact of this misaligned 
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functional group. This explanation is similar to that proposed for the 14a, 16a.-ethano 
compound 124, and the molecule displays significant binding affinity . 
. I b 
a-face 
C 
Figure 4.17: (a) Superimposition of cyclobuta[14P,15P] analogue 129 with estradiol, (b) 
superimposition of cyclopenta[14P,15P] compound 130 with estradiol, (c) superimposition 
of perhydrobenzo 14P-analogue 131 with estradiol 
As the size of the 14P,15P-ring increases, the binding affinity decreases. As is evident 
from the superimpositions of the cyclopenta[14P,15P] 130 and the perhydrobenzo 14P 131 
compounds, increasing the size of this ring has little effect on the remainder of the 
molecule. Thus, the reduction in binding affinity must be due to the increased steric bulk 
destabilising the receptor-ligand interaction. 
Another important class of compounds to be studied are the 15, 15-dialkyl analogues 
132-137 (Figure 4.18). 66 Apart from the 14P-analogue 137, all of these compounds have 
very similar conformations, however for those possessing longer alkyl chains ( ethyl, 
isopropyl) the possibility of rotamers exists. As the energy barrier between these forms is 
likely to be small (i.e. relatively free rotation), only the lowest energy form of each 
compound has been considered in the superimpositional study. 
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135 (CF 82) 136 (CF 50) 137 (CF 1.0) 
Figure 4.18: 15,15-Dialkyl estradiol analogues 132-137 
Immediately evident from the biological results is that the introduction of the 
15,15-dimethyl groups does not significantly impede binding. This is a surprising 
observation in the light of the reported poor binding affinity displayed by the corresponding 
15P-methyl and 15a-methyl analogues. 26 Modelling indicates that the steric demand of 
the 15,15-dimethyl analogue is simply the sum of the 15P-methyl and 15a-methyl 
analogues; hence the combination of methyl groups must impart some additional stability 
to the receptor-ligand complex. From the superimposition of the 15, 15-dimethyl analogue 
132 with estradiol (Figure 4.19), it is evident that the only substantial difference between 
the two molecules is the two methyl groups at C-15. Hence it can be concluded that the 
receptor is capable of accommodating this steric bulk in a 17P-derivative. 
Figure 4.19: Superimposition of the 15,15-dimethyl analogue 132 with estradiol 
135 
If the alkyl chains at either C-1 Sa or C-15 p are extended, then binding affinity decreases 
sharply. In the superimpositions of the four chain extended analogues, 133-136, with 
estradiol (Figure 4.20) no significant deviations relative to estradiol are observed, so this 
loss of binding affinity must be due to the increased steric bulk in either the 15a- or 
ISP-regions (or both). 
a b 
C d 
Figure 4.20: (a) Superimposition of 15P-ethyl-15a-methyl derivative 133 with estradiol, 
(b) superimposition of 15a-ethyl-15P-methyl analogue 134 with estradiol, 
(c) superimposition of 15,15-diethyl compound 135 with estradiol, 
(d) superimposition of 15a-iso-propyl-I5P-methyl analogue 136 with estradiol 
The binding results appear to indicate that the receptor is better able to accommodate steric 
bulk on the a-face than on the P-face, as the loss of activity on extension of the 15 P-alkyl 
chain is more pronounced. 
The 15,15-dimethyl 14P analogue 137 can be classified as a member of the I ?a-series, and 
displays similar characteristics to other compounds in this series mentioned previously. 
Despite the poor overlap with estradiol displayed in the superimposition (Figure 4.21 ), and 
the incorrectly oriented 17-hydroxy group, this molecule retains binding affinity. This can 
once again be ascribed to the fact that there is steric bulk on the a-face of the molecule 
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(relative to the estradiol template), and no steric bulk on the P-face. Thus this molecule fits 
in with the previously identified pattern of binding for 17a-analogues. 
Figure 4.21: Superimposition of the 15, 15-dimethyl 14P-analogue 137 with estradiol 
From this brief investigation of ring D modified estradiol analogues, it appears as though 
the selected mode of superimposition is a reasonable first method with which to evaluate 
estradiol analogues. On this basis, a picture has begun to emerge regarding the nature of 
the steric environment surrounding the ring D region. It appears as though there is a pocket 
located on the a-face (relative to estradiol) which is able to accommodate small groups 
without a loss of binding affinity, and in some cases with enhanced affinity. 
Surprisingly, the orientation of the 17-hydroxy group is not as critical as originally 
supposed. It appears as though the presence of steric bulk on the a-face (relative to 
estradiol) reduces the negative impact that a I ?a-hydroxy group otherwise introduces. 
However, the combination of a I ?a-hydroxy group and steric bulk on the P-face (relative 
to estradiol) leads to a complete loss of binding affinity. 
The synthetic targets investigated in this thesis were then examined using this preliminary 
hypothesis as the basis for making qualitative predictions of activity. The skeletally 
modified analogues will be considered first, followed by the 15,17-bridged compounds. 
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4.3 Predictive modelling studies 
4.3.1 Skeletally modified analogues of 14,17a-ethanoestra-1,3,5(10)-triene-3,17P-diol 
Unlike all the previously discussed estradiol analogues, the skeletally modified estradiol 
analogues (138, 26 and 68, Figure 4.22) are incapable of adopting the ring B half-chair 
(
8H7), ring C chair (
8C12) conformation that is invariably the lowest energy conformation in 
the natural series. Furthermore, the conformational flexibility of 14, 17a-ethanoestra-
1,3,5(1 O)-triene-3, 17P-diol 60 (as determined by the molecular dynamics simulation) is not 
in any way representative of the flexibility of these molecules. Thus, a conformational 
search was conducted on each of these skeletally modified 14a,17a-ethanoestradiol 
analogues to determine the global minimum energy structure. Molecular dynamics 
simulations were then performed in order to ascertain the relative flexibility of these 
analogues. Table 4.4 summarises the results of the conformational search, the results for 
60 have been included for comparison purposes. In the case of the 9P-analogue 68, four 
conformations were identified, and these have all been included, in order of steric energy. 
OH 
HO 
138 (CF n.d.) 26 (CF 2.2) 68 (CF 7.9) 
Figure 4.22: Skeletally modified 14a,17a-ethano estradiol analogues 138, 26 and 68 
138 
Table 4.26: Selected torsion angles, interatomic distances and puckering 
parameters 178· 179 for the low energy conformations of 14,17a-ethano-
8~,9~, 13~-estra-1,3,5( 1 O)-trien-17P-ols. Minimum energy conformations 
are indicated in bold type. 
RingB Ring C 
Cpd. E/kcal Conf. <!>10 .. Q/A q>o 90 Conf. <!>20 ... Q/A q>o 
mor1 • 
60 87.8 8H1 -60.2 0.488 26.4 134.5 8C12 48.6 0.547 283.1 
138 107.1 SE -60.1 0.518 4.9 133.9 t4T9 54.2 0.665 78.5 
26 99.9 7Hs 56.5 0.458 207.7 44.7 8C12 49.4 0.522 205.7 
68a 93.0 7Hs 54.4 0.439 200.8 44.8 8C12 54.4 0.542 259.4 
68b 93.9 6,9B -4.7 0.601 116.1 90.4 8C12 45.4 0.528 246.2 
68c 98.2 E1 -50.8 0.434 57.2 130.0 9 T14 -53.5 0.680 267.6 
68d 99.8 7Sr. 30.5 0.504 275.7 73.4 9T14 -46.5 0.640 274.4 
• Steric energy as determined by CVFF 183 
•• <j> 1 = torsion angle defined by C6-C7-C8-C9 (<!>6,7,S,9) 









The conformational search performed on the 14a,17a-ethano Ba-derivative 138 indicated 
that the 8E (envelope) ring B, 14T9 (twist) ring C conformation has the lowest energy. The 
molecular dynamics simulation, performed as before, with the same two angles monitored 
throughout the simulation [q>6,1,s,9 (<!>1) and <l>s,9,11,12 (<!>2)] (Figure 4.23) clearly showed the 
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Figure 4.23: Results of the molecular dynamics simulation of the 14a,17a-ethano 
13a analogue 138. ~1 (~6.7,8,9) Indicates the relative flexibility of ring B, 
and ~2 (~s,9,11,12) that ofring C. 
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Analysis of the results shows that ~1 varies from -60° to 0°, indicating that ring B is 
inverting from the 8E to the B6,9 conformation. However, the transient nature of this 
configuration is evident from the rapid reversion to the more stable ground state 
conformation. The flexibility of ring C is indicated by the variation of ~2 which fluctuates 
between 60° and 10°, indicating that ring C is capable of undergoing interconversion from 
the 14T9 (ground state) to other boat and twist conformations which cannot be identified 
from this parameter alone. However, the greater stability of the ground state conformation 
is again indicated by the transient nature of these other structures, which rapidly revert to 
the more stable form. 
From the superimposition with estradiol (Figure 4.24), using the hypothesis developed, it is 
predicted that this analogue would be inactive. Firstly, the 17-hydroxy group is slightly 
misaligned, and secondly there is steric bulk on the P-face (relative to estradiol); the two 
factors that appear to cause a loss of binding affinity. However, the steric bulk on the 
P-face is in a different region to that identified as being detrimental to binding. In addition, 
the role of the 13a-methyl group has not been included in this prediction, and this could 
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introduce other factors influencing the receptor affinity. As this molecule has yet to be 
synthesised, this prediction cannot be verified. 
Figure 4.24: Superimposition of the 14a,17a-ethano 13a analogue 138 with estradiol 
The minimum energy structure determined for the 8a-analogue 26, has the ring B half-
chair (H8) , ring C chair (
8C1 2) conformation. Although there is a cis fusion between rings 
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Figure 4.25: Results of the molecular dynamics simulation of the 14a,17a-ethano 
8a derivative 26. ~1 ( ~6,7,s,9) Indicates the relative flexibility of ring B, and 
~2 (~s,9,11 ,12) that ofring C. 
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As can be seen from Figure 4.25, ~1 varies from 60° to 0°, indicating that ring B undergoes 
inversion from the 7Hs to the 6·9B conformation. However, the molecule rapidly reverts to 
the lower energy 'ground state' conformation. Ring C does not undergo any inversion, as 
~2 remains at about 45°, indicative of the 
8C12 configuration. 
141 
Superimposition with estradiol (Figure 4.26) indicates that a reasonable overlap is achieved 
at the two polar ends of the molecule (3 and 17) and the extra steric bulk of ring D is 
situated on the a -face relative to estradiol. Thus, as there appear to be no obvious steric 
factors ( of the nature discussed previously) impeding binding, it was anticipated that this 
analogue would display binding affinity. 
Figure 4.26: Superimposition of the 14a,17a-ethano 8a analogue 26 with estradiol 
This expectation was borne out by the observed binding affinity (CF 2.2). The loss of 
affinity in comparison to the corresponding analogue in the natural series, 60, is probably 
due to the poor alignment of rings B and C relative to estradiol. This slight loss of affinity 
on inversion at C-8 has also been observed in other estradiol analogues. 48· 49· 52 
Unlike the previous conformational searches, four conformations were identified for the 
9P-analogue 68. The relative steric energies of two of these are extremely close, so it is not 
possible to predict the favoured conformer. Both of these structures have ring C in the 8C12 
conformation, but they differ in ring B, which is either in the 7Hs or the 6·9B configuration. 
The other two structures, which are slightly higher in energy, have ring C in the 9T1 4 form, 
and again differ in ring B, which is in either the E1 or the 7S6 conformation. Perspective 
views of all four conformers are shown in Figure 4.27. 
68a (HC) 68b (BC) 
68c (ET) 68d (ST) 
Figure 4.27: Perspective views of the four low energy conformations of the 
9P-analogue 68 
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The molecular dynamics simulation (performed on conformer 68a) results (Figure 4.28) 
make the flexibility of ring B immediately apparent. Ring C, fairly rigid in all the previous 
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Figure 4.28: Results of the molecular dynamics simulation of the 9P-derivative 68a. 
~1 (~6,7,8,9) Indicates the relative flexibility of ring B, and ~ 2 (~s,9,11 ,12) that ofring C. 
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Analysis of the results indicates that ~1 fluctuates from about 55° to -55° indicating that 
ring B varies from the starting 7Hs conformation to the 6•9B and other boat-like 
conformations. These other conformers appear to be fairly stable, as the molecule remains 
in these configurations for a significant time period before reverting to the alternative form. 
Ring C is more rigid, largely remaining in the 8C12 conformation, as indicated by ~2 which 
remains at about 55° for most of the simulation. Inversion of this ring is observed, 
however, for a significant percentage of the simulation, indicating that the higher energy 
conformers are accessible at 298K. Thus, as a significant amount of energy is released 
during the binding process (estimated to be -12.1 kcal mor1) 27, the possibility exists that 
ring C might invert during binding, therefore these conformations must also be considered 
in the superimposition study. 
All four conformations were superimposed with estradiol (Figure 4.29). It is apparent that 
the two lower energy conformers, with ring C in the chair conformation (68a and 68b), are 
unlikely to possess significant affinity, as it is impossible to overlap ring A and the 
17~-hydroxy group with the corresponding features of estradiol. Inversion of ring C, to 
produce conformers 68c and 68d improves the correlation, with conformer 68c displaying a 
reasonable overlap with estradiol. 
68a(HC) 68b (BC) 
68c (ET) 68d (ST) 
Figure 4.29: Superimpositions of the four low energy conformations of the 
14a, 17 a-ethano 9~ analogue 68a-d with estradiol 
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In all previous cases, it has been assumed, based on the molecular dynamics simulations, 
that the minimum energy conformation is responsible for the observed binding affinity. In 
the case of this relatively flexible molecule, more than one structure could invoke a 
response. Hence, since conformer 68c has the best overlap with estradiol, the predicted 
affinity will be based upon this superimposition. The 17-hydroxy group is in 
approximately the correct orientation and there is some steric bulk on the a.-face. The 
presence of steric bulk on the ~-face as well as the poor overlap of rings A, B and C is 
likely to counter this. On this basis, the 9~-analogue 68 is expected to display binding 
affinity, but it will probably be less active than the corresponding 'natural' analogue 60. 
This expectation is borne out by the binding affinity (CF 7.9) substantially lower than the 
'natural' analogue 60. 
4.3.2 Other estradiol analogues 
The other synthetic targets to be investigated in this thesis were 15,17-bridged estradiol 
analogues. A small selection of these structures, indicated in Figure 4.30, will be presented 
in order to indicate their possible binding affinities. For simplicity only the ring D portion 
of the molecule is displayed. 
OH OH OH 
~J ::::> ~ 
139 140 141 
Figure 4.30: 15,17-bridged estradiol analogues 139-141 
It is apparent from their superimpositions with estradiol (Figure 4.31), that the 
15a.,17a.-bridged analogues 139 and 140 display an extremely close correspondence to the 
template. The additional steric bulk introduced on the a.-face should be readily 
accommodated by the receptor, thus it is anticipated that these two analogues will display 
high binding affinity. The 15~,17~-ethano analogue 141 possesses the two features 
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identified as having a negative impact on receptor binding, namely a 17a-hydroxy group 
and steric bulk on the P-face. Therefore, this analogue is not expected to be biologically 
active. As none of these targets has been synthesised as yet, these predictions can 
unfortunately not be verified. 
a b 
C 
Figure 4.31: (a) Superimposition of 15a,17a-ethano analogue 139 with estradiol, (b) 
superimposition of 15a,17a-propano compound 140 with estradiol, (c) superimposition of 
15f3,17f3-ethano analogue 141 with estradiol 
Some other possible synthetic targets identified are the 14a,17aa-propano-17a-homo 
derivative 142 and the 14a,15a-cycloalka compounds 143-146 (Figure 4.32). The 
synthesis of these analogues has not been attempted in this thesis, but it was considered to 
be of interest to evaluate their binding affinities, based upon the model developed. 
OH 
~ 
OH OH OH OH 
H H H 
142 143 144 145 146 
Figure 4.32: Other possible synthetic targets 
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On the basis of their superimpositions with estradiol, the 14a, 15a-cycloalka compounds 
are all expected to display high binding affinity. Considering the I 7p-compounds (143 and 
144) first; the steric bulk on the a-face should be readily accommodated by the receptor, 
similarly to other derivatives discussed previously, and not impede receptor binding. As an 
example, Figure 4.33 shows the superimposition between the cyclopenta[14a,I5a] 
compound 143 and estradiol. The I ?a-compounds (145 and 146), have an unfavourably 
oriented 17-hydroxy group. However, they possess steric bulk on the a-face, which 
appears to reduce the negative impact of the I ?a-hydroxy group, and hence these two 
derivatives are also expected to display high receptor affinity. 
Figure 4.33: Superimposition of the cyclopenta[I4a,15a] compound 143 with estradiol 
The other compound, I4a,17aa-propano 17a-homo analogue 142 is an extremely 
interesting synthetic target. As can be seen from the superimposition with estradiol 
(Figure 4.34) the I ?a-hydroxy group does not appear to be protruding into an unfavourable 
region of the receptor. However, 142 does possess sterie bulk on the P-face (as indicated), 
which is linked with reduced binding affinity (in combination with a I ?a-hydroxy group). 
These factors render it difficult to make a confident prediction regarding the affinity of this 
compound. This makes it an extremely appealing synthetic target. 
Figure 4.34: Superimposition of the I4a,17aa-propano 17a-homo compound 142 
with estradiol 
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4.4 Receptor binding model based upon the observed structures 
From an examination of the three X-ray crystal structure determinations conducted in this 
thesis, an alternative explanation based solely upon these data has also been developed. By 
superimposing the observed conformations upon that of estradiol (as observed in the 
estradiol-water crystal structure, 184 as this appears to be the most representative of the 
three crystal structures of estradiol that have been determined. For further details of this 
structure, see Appendix 5) using the same fitting procedure described previously (p. 117), 
the differences between the test molecules and the estradiol template can be readily 
ascertained. Any contradictions would necessitate a re-examination of the molecular 
modelling study and the conclusions drawn. 
In the case of the 14a,l 7a-ethano compound 113, two conformations were observed in the 
unit cell. From the superimpositions of each of these with estradiol (Figure 4.35), it is 
readily apparent that the only major difference is the presence of the 14a, 17a-ethano 
bridge and the conformation of ring D, which is forced to adopt a highly puckered 13E 
conformation in the 14a, 1 7 a-ethano compound. 
a b 
Figure 4.35: Superimposition of the 14a,17a-ethano compound 113 with estradiol. (a) 
Conformer A and (b) conformer B 
Similarly, in the case of the 14a,17a-propano compound 115, the two conformations are 
fairly similar to estradiol (Figure 4.36), with one conformation having a somewhat poorer 
fit than the other. This is possibly due to the slight difference in the configuration of ring B 
and ring C, and serves to illustrate how slight differences in conformation of individual 
rings can result in rather different overall steric profiles. 
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a b 
Figure 4.36: Superimposition of the 14a.,17a.-propano compound 115 with estradiol. (a) 
Conformer A and (b) conformer B 
In the case of the 14P, 17P-propano compound 117, none of the observed conformations 
displays any significant overlap with estradiol (Figure 4.37). This is largely due to the 
different ring B conformation adopted by the estradiol analogue in the crystal structure 
(boat-like instead of the half-chair observed in estradiol). 
a b 
C d 
Figure 4.37: Superimposition of the 14P,17p-propano compound 117 with estradiol. (a) 
Conformer A, (b) conformer B, (c) conformer C and (d) conformer D 
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From these superimpositions it appears as though the estradiol receptor is capable of 
accommodating steric bulk on the a-face of ring D, as has been concluded from the 
modelling study. However, in the case of the 14P,l 7P-propano compound 117, the 
observed low binding affinity would appear to be due to the poor fit with estradiol. 
The conclusions drawn from this crystallographic study are that a-face substitution on ring 
D, as well as a good fit with estradiol results in either enhanced or only slightly reduced 
receptor affinity. However, a poor fit with estradiol results in low receptor affinity. These 
do not in any way contradict the conclusions drawn from the modelling study and only 




In the introduction to this chapter, two broad objectives were outlined, namely to explain 
the observed binding affinities and secondly to develop a basis for predicting the affinity of 
potential synthetic targets. 
This investigation has succeeded in establishing a working hypothesis for interpreting the 
observed binding affinities. The method of superimposing the test molecule and estradiol 
appears to be a reasonable basis for comparison, and does provide a way of explaining the 
results obtained. However, this is largely an a posteriori interpretation, as it is not possible 
to quantify the effect that a novel structural modification will have on receptor binding 
affinity. Until the structure of the receptor before, during and after binding to the ligand 
can be determined, this will continue to be the case. 
In an attempt to address the second objective, a large number of potential synthetic targets 
have been superimposed with estradiol and their activities predicted using the previously 
determined positive and negative structural features. While this approach has enabled the 
identification of possible synthetic targets, these predictions have, of necessity, been rather 
simple statements. It is not possible to predict actual binding affinities using this type of 
approach. Furthermore, as many of these targets have not yet been synthesised, correlation 
of predicted and observed activities is not possible. Thus, the second objective has been 
partially addressed, but there is scope for significant refinement of this approach. 
Experimental 
Melting points were measured using a Reichert-Jung Thermovar hot-stage microscope and 
are uncorrected. Optical rotations were measured on a Perkin-Elmer 141 polarimeter using 
chloroform solutions unless otherwise specified, and are recorded in units of 
10·1 deg cm2 g·1• Infrared spectra were recorded in chloroform solutions using a Perkin-
Elmer 983 infrared spectrometer or a Perkin-Elmer Paragon 1000 FT-IR spectrometer, over 
the range 4000-800 cm·1• Microanalyses were determined using a Fisons EA 1108 
CHNS-0 instrument. Mass spectra were recorded on a VG micromass 16F spectrometer 
operating at 70 eV with an accelerating voltage of 4 kV and a variable source temperature 
( depending on the nature of the compound). Accurate masses were determined on a 
VG-70E spectrometer at the Cape Technikon. All 1H-NMR spectra were recorded, unless 
otherwise specified, as deuteriochloroform solutions using tetramethylsilane as an internal 
standard on a Varian VXR-200 (200 MHz) or a Varian Unity Spectrometer (400 MHz). 
13C-NMR spectra were recorded on the same instruments at 50 or 100 MHz (using 
tetramethylsilane as an internal standard). 
Thin layer chromatography was performed on aluminium backed silica gel 60 F2s4 plates in 
a variety of solvent systems using the ascending technique. The plates were visualised by 
spraying with cerium(IV) ammonium sulfate in 8 mol dm·3 sulfuric acid and baking at 
200°C. Column chromatography was conducted with Merck Kieselgel 60: 70-230 mesh 
for gravity and 230-400 mesh for flash chromatography. 
All solvents used were dried by the appropriate technique 185 and unless otherwise 
specified, all reactions were carried out under a nitrogen or argon atmosphere with 
exclusion of water and oxygen. 
A list of abbreviations can be found in Appendix 3. 
Computational results were obtained usmg software programs from Molecular 
Simulations 186 - dynamics calculations were done with the Discover ® program (version 
2.9.8) using the CVFF forcefield. 
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Molecules were minimised using the Discover® program (version 2.9.8) using the CVFF 
forcefield using a combination of steepest descents, conjugate gradient and modified 
Newton-Raphson minimisation techniques as implemented within the software. 
Superimpositions were performed using the superimpose command as implemented within 
the software. 
Molecular dynamics simulations were performed usmg a constant volume, constant 
temperature (NVT) ensemble at 298K with the Verlet leapfrog integrator and a 1 fs 
timestep. An initial 10 ps equilibration period was followed by a 100 ps data collection 
period in which structures were sampled every 50 fs. 
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3-Methoxy-13a-estra-1,3,5(10)-trien-17-one 3 
A solution of estrone 3-methyl ether 1 (13.5 g, 48 rnrnol), hydroxylarnine hydrochloride 
(8.4 g, 120 rnrnol) and 1,4-diazabicyclo[2.2.2]octane (DABCO) (3 g, 43 rnrnol) was 
refluxed in methanol (300 cm3) for 2h. The methanol was removed under reduced pressure 
and the residue was dissolved in chloroform, washed [water, aq. HCl (1 mol dm-3), satd. 
aq. NaHC03, water], dried (MgS04), and the solvent was removed under reduced pressure 
to give a solid residue (16.7 g) which was dissolved in a mixture of pyridine (50 cm3) and 
acetic anhydride (30 cm3) and stirred at 25°C for 2 h. Water and solid sodium hydrogen 
carbonate were added until effervescence ceased. The precipitate was filtered off under 
suction, thoroughly washed with water and dried to give the crude oxime acetate 2 as a pale 
yellow solid (18 g) (m/z 341). 
A solution of the oxime acetate 2 (2 g) was refluxed with nickel powder (2.5 g) in a 
mixture of acetic acid (50 cm3) and hexane (50 cm3) for 24 h. Water and solid sodium 
hydrogen carbonate were added to the cooled solution until effervescence ceased and the 
resulting mixture was extracted with ethyl acetate. This extract was washed (satd. aq. 
NaHC03, water, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue (1.19 g). One recrystallisation from methanol afforded pure 3-methoxy-13a-estra-
1,3,5(10)-trien-17-one 3 (562 mg, 34%), m.p. 128-I30°C; [a]0 -30° (c 0.8) (lit., 
43· 44 
130-133°C; [a]o -27.5°) (Found: C, 80.3; H, 8.65; M\ 284. C19H2402 requires C, 80.2; H, 
8.5; M, 284); Vmaxlcm-1 1728; 8H (400 MHz) 0.92 (IH, qd, J3 x 11 and 2.8 Hz, 8P-H), 0.98 
(IH, m, 1 IP-H), 1.06 (3H, s, I3a-Me), 1.75 (IH, dd, J 11 and 6.1 Hz, 14a-H), 1.95 (IH, 
td, J2 x 11.6 and 5.5 Hz, 15P-H), 2.83 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 6.61 (IH, d, J 
2.9 Hz, 4-H), 6.71 (IH, dd, J 8.6 and 2.9 Hz, 2-H) and 7.18 (IH, d, J 8.6 Hz, 1-H); 8c (100 
MHz) 21.0 (C-15), 25.l (13a-Me), 28.2 (C-11), 28.3 (C-7), 30.3 (C-6), 32.0 (C-12), 33.4 
(C-16), 41.4 (C-9), 41.5 (C-8), 49.3 (C-14), 50.1 (C-13), 55.1 (3-0Me), 111.7 (C-2), 113.5 
(C-4), 126.8 (C-1), 131.9 (C-10), 138.0 (C-5), 157.5 (C-3) and 210.0 (C-17). The mother 
liquor residue was adsorbed on silica gel (50 g) and eluted with ethyl acetate-hexane (I :9) 




A solution of the 17-ketone 3 (1.03 g, 3.6 mmol) in tetrahydrofuran (THF) (20 cm3) was 
added to a solution of lithium diisopropylamide [prepared by adding n-butyllithium (2.5 
mol dm·3 in hexanes; 6 cm3; 15 mmol) to a solution of diisopropylamine (2 cm3; 15.3 
mmol) in THF (10 cm3) at -10°C and stirring the mixture at this temperature for 15 min 
and then cooling the mixture to -78°C] at -78°C and the mixture was stirred at this 
temperature for lh. Chlorotrimethylsilane (1.9 cm3; 15 mmol) was added and the mixture 
was allowed to warm up to 25°C. Water was added and the resulting mixture was 
extracted into diethyl ether. The extract was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a crude residue (1.3 g) which was refluxed in 
acetonitrile (70 cm3) with palladium acetate (820 mg, 3.65 mmol) for 5h. The cooled 
mixture was filtered through Celite, and, after removal of the solvent, the residue (1.24 g) 
was flash chromatographed on silica gel (85 g) with ethyl acetate-hexane (I :9) as eluent to 
give the 17-ketone 3 (345 mg, 33%) followed by the~ 15 l 7-ketone 4 (387 mg, 38%), m.p. 
66-68°C (from diisopropyl ether); [a]0 -81 ° (c 0.8) (Found: C, 80.7; H, 7.9%; ~' 282. 
C19H220 2 requires C, 80.8; H, 7.9%; M, 282); Ymaxlcm·
1 1701; 8H (400 MHz) 1.20 (3H, s, 
13a-Me), 1.73 (lH, qd, J 3 x 11.6 and 2.8 Hz, 8P-H), 2.16 (IH, ddd, J 13.9, 9.3 and 7 Hz, 
I2a-H), 2.61 (IH, dtd, J 12.7, 2 x 3.8 and 2.8 Hz, 7P-H), 2.71 (lH, ddd, J 11.6, 2.6 and 1.6 
Hz, 14a-H), 2.82-2.91 (IH, m, 1 lP-H), 3.01-3.09 (lH, m, 9a-H), 3.21 (2H, m, 6-H2), 3.76 
(3H, s, 3-0Me), 6.17 (lH, dd,J5.8 and 1.6 Hz, 16-H), 6.58 (IH, d,J2.8 Hz, 4-H), 6.73 
(lH, dd, J 8.6 and 2.8 Hz, 2-H), 7.13 (lH, dd, J 8.6 and 0.6 Hz, 1-H) and 7.76 (IH, dd, J 
5.8 and 2.6 Hz, 15-H); 8c (100 MHz) 24.2 (13a-Me), 27.0 (C-11), 28.2 (C-7), 29.2 (C-12), 
29.9 (C-6), 38.4 (C-9), 41.2 (C-8), 46.5 (C-13), 55.2 (3-0Me), 56.7 (C-14), 112.3 (C-2), 
113.3 (C-4), 128.0 (C-1), 131.3 (C-16), 132.8 (C-10), 137.2 (C-5), 157.4 (C-3), 164.0 
(C-15) and 214.2 (C-17). 
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3-Methoxy-13a-estra-l ,3,5(10),14,16-pentaen-17P-yl acetate 8 
A solution of the ~ 15 17-ketone 4 (100 mg, 0.35 mmol) and toluene-p-sulfonic acid (20 
mg) was refluxed in a mixture of acetic anhydride (5 cm3) and isopropenyl acetate (5 cm3) 
for 18h. The cooled solution was poured into saturated aqueous sodium hydrogen 
carbonate and extracted with diethyl ether. The combined organic phase was washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a crude 
residue (650 mg) which was flash chromatographed on silica gel (20 g) with ethyl acetate-
hexane (1 :9) as eluent to give 3-methoxy-13a-estra-1,3,5(10),14, 16-pentaen-l 7p-yl acetate 
8 (10 mg; 9%) as an oil, mlz 324; SH (200 MHz) 1.11 (3H, s, 13a-Me), 2.23 (3H, s, 
17-0C(O)CH3), 3.79 (3H, s, 3-0Me), 5.85 (IH, m, 15-H), 6.17 (lH, d, J 2.3 Hz, 16-H), 
6.68 (lH, d, J2.5 Hz, 4-H), 6.74 (lH, dd, J 8.5 and 2.5 Hz, 2-H) and 7.22 (IH, d, J 8.5 Hz, 
1-H), followed by starting material 4 (80 mg; 80%). 
Attempted formation of 17-trimethylsilyl-14,16-dienyl ether 9 
Trimethylsilyltrifluoromethanesulfonate (1 cm3, 5.2 mmol) was added to a solution of 
triethylamine (TEA) (0.8 cm3, 5.7 mmol) in diethyl ether (2 cm3) at 25°C and the mixture 
was stirred for 5 min. A solution of the ~ 15 17-ketooe 4 (100 mg, 0.35 mmol) in diethyl 
ether ( 4 cm3) was added and the resulting mixture was stirred at 25°C for 4h. Ice-water 
was then added and the resulting mixture was extracted into diethyl ether. The combined 
organic phase was washed (water, brine), dried (MgS04) and evaporated under reduced 
pressure to give an oily residue (70 mg) which was flash chromatographed on silica gel 
(20 g) with ethyl acetate-hexane (1 :99) as eluent to give an oily residue (33 mg), which 
1 H NMR analysis indicated was a complex mixture. 
3-Methoxyestra-1,3,5(10),8,14-pentaen-17P-ol ll 
A solution of the 3-methoxyestra-1,3,5(10),8,14-pentaene-17P-yl acetate 10 (660 mg, 
2 mmol) in a mixture of THF (3 cm3) and methanolic potassium hydroxide (I%; 20 cm3) 
was stirred at 25°C for 90 min. Saturated aqueous ammonium chloride (25 cm3) was 
added and the mixture was extracted into ethyl acetate. The combined organic phase was 
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washed (water, brine), dried (MgS04) and concentrated under reduced pressure to give the 
l 7P-alcohol 11 (540 mg, 94%), m.p. 106-109°C (from ethanol) (lit., 69 l 10-l 12°C), 
Vma,/cm·1 3609 (OH); mlz 282; 8H (200 MHz) 0.96 (3H, s, I3P-Me), 1.70, (lH, s, D20 
exch, l 7P-OH), 3.80 (3H, s, 3-0Me), 4.10 (lH, dd, J9.1 and 7.7 Hz, l 7a-H), 5.50 (IH, t, J 
2x2.9 Hz, 15-H), 6.70-6.79 (2H, m, 2- and 4-H) and 7.22 (lH, d, J8.8 Hz, 1-H). 
3-Methoxyestra-1,3,5(10),8,14-pentaen-17-one 12 
A solution of the l 7P-alcohol 11 (850 mg, 3.0 mmol), N-methylmorpholine (0.4 g) and 
crushed molecular sieves (4A) in dry dichloromethane (15 cm3) was stirred for 10 min at 
25°C, then tetra-n-propylarnmonium perruthenate (TPAP) (35 mg, 0.1 mmol) was added 
and the mixture was stirred for lh at 25°C. Dichloromethane (30 cm3) was added and the 
resulting mixture was washed (satd. aq. Na2S03, brine, satd. aq. CuS04), dried (MgS04) 
and evaporated to give a residue (1 g) which was adsorbed onto silica gel (80 g) and eluted 
with ethyl acetate-toluene (1:19) to give the 17-ketone 12 (169 mg, 20%), m.p. I36-142°C 
(lit., 79 143°C); Uma:/cm·I 1741 (C=O); m/z 280. Despite all attempts at purification, a 
persistent purple impurity remained in this material. 
3-Methoxy-8a-estra-1,3,5(10)-trien-17-one 14 
A solution of3-methoxyestra-l,3,5(10),8,14-pentaen-17p-yl acetate 10 (8.6 g, 27 mmol) in 
ethanol (40 cm3) was stirred with Raney nickel (Aldrich W-2; 5 cm3) under a hydrogen 
atmosphere (50 bar) at 60°C for 48h. The mixture was filtered through Celite, and the 
catalyst was thoroughly washed with ethanol, ethyl acetate and chloroform. The filtrate 
was evaporated under reduced pressure to give a solid residue (10 g) [a portion of which 
was chromatographed on silica gel ( 10 g) with ethyl acetate-toluene (1 : 19) to give 
3-methoxy-8a-estra-l,3,5(10)-trien-l 7P-yl acetate 13, m.p. 97-99°C (from ethanol); 
[a]0 -10° (c 1.1) (lit., 
48 99°C; [a]o -8.9°); m/z 328; Vmaxlcm·1 1720; 8tt (200 MHz) 0.92 
(3H, s, I3p-Me), 2.05 (3H, s, l 7P-OC(O)CH3), 2.54-2.86 (3H, m, 6-H2 and 9a-H), 3.77 
(3H, s, 3-0Me), 4.63 (IH, dd, J 9.1 and 8.2 Hz, 17a-H), 6.61 (IH, d, J 2.7 Hz, 4-H), 6.72 
(IH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.6 (lH, d, J 8.5 Hz, 1-H)]. 
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The solid residue (9.9 g) was dissolved in a mixture of methanolic potassium hydroxide 
(1 %, 60 cm3) and THF (30 cm\ and the mixture was stirred at 25°C for 18h. Water was 
added and the resulting mixture was extracted into ethyl acetate. The organic phase was 
washed (water), dried (MgS04) and evaporated under reduced pressure to afford a residue 
(7 g), which was dissolved in acetone ( 40 cm\ cooled to 0°C and stirred vigorously while 
a solution of chromic acid (8 mol ctm·3, 10 cm3, 27 mmol) was added. After stirring for 
30 min at 0°C, water was added and the solution was extracted with ethyl acetate and 
chloroform. The combined organic extract was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a crude residue (7.17 g) which was flash 
chromatographed on silica gel ( 45 g), eluting with ethyl acetate-toluene (1: 19) to afford 
3-methoxy-8a-estra-1,3,5(10)-trien-17-one 14 (6.6 g, 87% from 10), m.p. 89-90°C (from 
methanol); [a]o +91 ° (c 2.9) (lit., 48 93-94°C, [a]o + 100°); mlz 284; vmaxlcm·1 1729; 88 
(400 MHz) 1.00 (3H, s, 13P-Me), 1.42 (lH, td, J 2 x 14.1 and 4.6 Hz, 12a-H), 2.48 (lH, 
ddd, J 19.0, 8.5 and 1.3 Hz, I6P-H), 2.62-2.74 (2H, m, 6a-H and 9a-H), 2.82 (lH, ddd, J 
16.6, 4.9 and 2.0 Hz, 6P-H), 3.77 (3H, s, 3-0Me), 6.61 (lH, d, J 2.7 Hz, 4-H), 6.72 (lH, 
dd, J 8.6 and 2.7 Hz, 2-H) and 7.05 (lH, d, J 8.6 Hz, 1-H); 8c (100 MHz) 16.2 (13P-Me), 
21.4 (C-15), 21.6 (C-11), 28.5 (C-7), 31.4 (C-6), 32.3 (C-12), 35.7 (C-16), 38.7 (C-8), 41.2 
(C-9), 47.1 (C-13), 48.7 (C-14), 55.2 (3-0Me), 112.2 (C-2), 113.3 (C-4), 130.2 (C-1), 
133.3 (C-10), 137.5 (C-5), 157.4 (C-3) and 220.6 (C-17). 
3-Methoxy-8a-estra-1,3,5(10),15-tetraen-17-one 15 
A solution of the 17-ketone 14 (800 mg, 2.8 mmol) in THF (20 cm3) was added to a 
solution of lithium diisopropylamide [prepared from n-butyllithium (2.5 mol dm·3 in 
hexanes, 6 cm3, 15 mmol) and diisopropylamine (2 cm3, 15.3 mmol) in THF (10 cm3)] at 
-78°C and the mixture was stirred for 30 min. Chlorotrimethylsilane (1.9 cm3, 15 mmol) 
was added and the mixture was stirred for 10 min and then allowed to warm up to 25°C. 
Saturated aqueous ammonium chloride was added and the resultant mixture was extracted 
into ethyl acetate. The combined organic phase was washed (water), dried (MgS04) and 
concentrated under reduced pressure to give a residue (1.2 g) which was refluxed with 
palladium acetate (670 mg, 3 mmol) in acetonitrile (70 cm3) for lh. The solids were 
filtered off, and the filtrate was evaporated under reduced pressure to give a solid residue 
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(1.01 g) which was flash chromatographed on silica gel (75 g) with toluene as eluent to 
afford the ~ 15 17-ketone 15 (795 mg, 100%), m.p. ll 5-l l 6°C (from diisopropyl ether); 
[a]o -39° (c 0.2) (Found: C, 81.0; H, 8.0%; M\ 282. C19H2202 requires C, 80.8; H, 7.9%; 
M, 282); Ymai/cm·1 1707 (C=O); Ott (400 MHz) 1.24 (3H, s, 13P-Me), 2.41 (lH, m, 8a-H), 
2.66-2.85 (3H, m, 6-H2 and 9a-H), 2.97 (lH, m, Wv2 8Hz, 14a-H), 3.77 (3H, s, 3-0Me), 
6.09 (IH, dd, J 6.0 and 3.4 Hz, 16-H), 6.61 (IH, d, J 2.7 Hz, 4-H), 6.73 (lH, dd, J 8.4 and 
2.7 Hz, 2-H), 7.08 (IH, d, J 8.4 Hz, 1-H) and 7.59 (lH, ddd, J 6.0, 2.0 and 0.6 Hz, 15-H); 
oc (100 MHz) 22.8 (C-7), 23.3 (13P-Me), 28.5 (C-11), 30.3 (C-12), 31.6 (C-6), 37.8 (C-8), 
40.8 (C-9), 52.0 (C-13), 54.0 (C-14), 55.2 (3-0Me), 112.3 (C-2), 113.5 (C-4), 130.1 (C-1), 
131.9 (C-16), 132.9 (C-10), 137.4 (C-5), 157.5 (C-3), 160.4 (C-15) and 212.8 (C-17) 
3-Methoxy-8a-estra-1,3,5(1 O),l 4,16-pentaen-17P-yl acetate 16 
A solution of the ~ 15 17-ketone 15 (1.4 g, 4.9 mmol) and toluene-p-sulfonic acid (200 mg) 
in a mixture of isopropenyl acetate ( 15 cm3) and acetic anhydride (15 cm3) was heated 
under reflux for 2 h. The mixture was then poured into ice-water and stirred for 1.5 h, with 
the regular addition of solid sodium hydrogen carbonate until effervescence ceased. The 
resulting mixture was extracted into diethyl ether, the extract was washed (satd. aq. 
NaHC03, water), dried (MgS04) and evaporated under reduced pressure to give a residue 
(1.5 g) which was flash chromatographed on silica gel (50 g), eluting with toluene-hexane 
(1:1), to give the dienyl acetate 16 (1.25 g, 78%), m.p. 107-l 10°C (from methanol); [a]0 
+ 108° (c 0.3) (Found: C, 77.9; H, 7.7%; ~. 324. C21H2403 requires C, 77.7; H, 7.5%; 
M, 324); Ymai/cm·1 1748 (C=O); Ott (400 MHz) 1.21 (3H, s, 13P-Me), 1.94 (lH, dt, J 12.8 
and 2 x 3.1 Hz, 12P-H), 2.21 (3H, s, 17-0Ac), 2.61 (IH, dt, J 11.6 and 2 x 5.5 Hz, 9a-H), 
2.79 (2H, m, 6-H2), 2.94 (IH, ddd, J 13.3, 5.4 and 2.6 Hz, 8a-H), 3.77 (3H, s, 3-0Me), 
5.98 (IH, d, J3.0 Hz, 15-H), 6.08 (IH, d, J3.0 Hz, 16-H), 6.62 (lH, d, J2.6 Hz, 4-H), 6.71 
(lH, dd, J 8.4 and 2.6 Hz, 2-H) and 7.02 (IH, d, J 8.4 Hz, 1-H). 
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Cycloaddition of dienyl acetate 16 with phenyl vinyl sulfone (PVS) 
A mixture of the dienyl acetate 16 (400 mg, 1.23 mmol) and PVS (1 g, 5.95 mmol) in 
anhydrous benzene (10 cm3) was heated at 150°C for 140h in a sealed tube. The cooled 
solution was adsorbed on silica gel (50 g) and eluted with ethyl acetate-toluene (1: 19) to 
give unidentified products ( 144 mg), followed by an inseparable mixture of cycloadducts 
17, 18 and 19 (476 mg, 79%). Recrystallisation from chloroform-methanol afforded 
3-methoxy-172R-phenylsulfonyl-l 4, 17a.-ethano-8a.-estra-l ,3,5(10), 15-tetraen-17P-yl 
acetate 17, m.p. 286-287°C; [a.]0 +92° (c 0.4) (Found: C, 70.4; H, 6.6; S, 6.4%; M\ 492. 
C29H3205S requires C, 70.7; H, 6.5; S, 6.5%; M, 492); Ymaxlcm·
1 1739 (C=O) 1318, 1147 
(S02Ph); 88 (400 MHz) 1.03 (3H, s, 13p-Me), 2.05 (3H, s, 17P-0Ac), 2.14 (lH, dd, J 12.2 
and 9.4 Hz, 1 ix-H), 2.57 (IH, dd, J 12.2 and 4.3 Hz, 1 ?1 0-H), 2.79 (2H, m, 6-H2), 3.09 
(2H, m, 8a.-H and 9a.-H), 3.78 (3H, s, 3-0Me), 4.25 (lH, dd, J 9.4 and 4.3 Hz, 17\-H), 
6.33 (lH, d, J 6.0 Hz, 15-H), 6.40 (IH, d, J 6.0 Hz, 16-H), 6.62 (IH, d, J2.8 Hz, 4-H), 6.72 
(IH, dd, J8.4 and 2.8 Hz, 2-H), 7.04 (lH, d, J8.4 Hz, 1-H), 7.50 (2H, m, m-H of PhS02), 
7.58 (IH, m, p-H of PhS02) and 7.80 (2H, m, o-H of PhS02); 8c (100 MHz) 16.9 
(13P-Me), 21.3 (17-0C(O)CI-h), 22.6 (C-11), 27.2 (C-7), 28.1 (C-12), 31.1 (C-1?1), 31.3 
(C-6), 34.6 (C-8), 35.4 (C-9), 55.2 (3-0Me), 60.3 (C-13), 61.1 (C-14), 66.3 (C-172), 92.4 
(C-17), 112.4 (C-2), 113.2 (C-4), 128.1 (C-2'and C-6'), 129.2 (C-3' and C-5'), 130.4 (C-1), 
132.5 (C-15), 132.7 (C-10), 133.3 (C-4'), 135.5 (C-16), 137.6 (C-5), 141.3 (C-1'), 157.6 
(C-3) and 170.4 (17-0C(O)CH3). 
Base hydrolysis of cycloaddition mixture 17, 18 and 19 
A solution of the mixture of cycloadducts 17, 18 and 19 (55 mg, 0.11 mmol) in methanolic 
potassium hydroxide (1%; 5 cm3) was stirred for 18h at 25°C. The mixture was poured 
into saturated aqueous sodium hydrogen carbonate (10 cm3) and extracted into ethyl 
acetate. The combined organic phase was washed (water), dried (MgS04) and evaporated 
under reduced pressure to give a crude residue (39 mg) which was chromatographed on 
silica gel ( 4.5 g) with ethyl acetate-toluene (1 :9) as eluent to give 3-methoxy-14-
phenylsulfonylethyl-8a., 14p-estra-1,3,5(10), 15-tetraen-17-one 21 (9 mg, 17%), as an oil, 
[a.]o +14° (c 0.8) (Found: M\ 450.185. C21H3004S requires M, 450.186); Ymaxlcm·' 1708 
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(C=O), 1307, 1152 (S02Ph); oH (200 MHz) 1.08 (3H, s, 13p-Me), 3.76 (3H, s, 3-0Me), 
6.20 (lH, d, J 5.9 Hz, 16-H), 6.60 (lH, d, J 2.8 Hz, 4-H), 6.70 (lH, dd, J 8.4 and 2.8 Hz, 
2-H), 6.92 (lH, d, J 8.4 Hz, 1-H) and 7.14-7.90 (6H, m, PhS02 and 15-H) followed by an 
inseparable mixture of 3-methoxy-172 R-phenylsulfonyl-14, 17a-ethanoestra-1,3,5(10), 15-
tetraen-17P-ol 20 and 3-methoxy-15a-phenylsulfonyl-14,17a-ethenoestra-1,3,5(10)-trien-
17P-ol 22 (33 mg, 66%), as an oil; mlz 450; Vmai/cm·1 3599, 3412 (OH), 1307, 1148 
(S02Ph), oH (400 MHz) for 22 (ca 70%) 0.95 (3H, s, 13p-Me), 3.76 (3H, s, 3-0Me), 4.00 
(lH, dd, J 8.7 and 4.7 Hz, 15P-H), 5.96 (lH, d, J 5.9 Hz, 172-H), 6.06 (lH, d, J 5.9 Hz, 
1 i-H), 6.57 (lH, d, J 2.6 Hz, 4-H), 6.66-6.74 (lH, m, 2-H), 6.98 (lH, d, J 8.4 Hz, 1-H), 
7.48-7.88 (SH, m, 15a-S02Ph); oH (400 MHz) for 20 (ca 30%) 1.00 (lH, s, 13P-Me), 3.77 
(3H, s, 3-0Me), 4.17 (lH, dd, J7.8 and 5.4 Hz, 172x-H), 6.06 (lH, d, J 5.9 Hz, 15-H), 6.31 
(lH, d, J 5.9 Hz, 16-H), 6.61 (lH, d, J2.8 Hz, 4-H), 6.66-6.74 (lH, m, 2-H), 7.02 (lH, d, J 
8.4 Hz, 1-H), 7.48-7.88 (SH, m, 17\-S02Ph). 
3-Methoxy-172R-phenylsulfonyl-14,17a-ethano-8a-estra-1,3,5(10),15-
tetraen-17P-ol 20 
A solution of the 17P-acetate 17 (20 mg, 0.05 mmol) in methanolic potassium hydroxide 
(1%, 2 cm3) was stirred for 18h at 25°C. Work-up, as in the previous experiment, gave a 
crude residue (17 mg) which was chromatographed on silica gel (1.5 g) with ethyl acetate-
hexane (1:1) as eluent to give the 17P-alcohol 20 (13 mg, 73%), as an oil, 
(Found: M+, 450.185. C21H3004S requires M, 450.186); Vmaxlcm·1 3599, 3412 (OH), 1307, 
1148 (S02Ph); OH (400 MHz) 1.00 (3H, s, 13P-Me), 1.90 (lH, br. s, 17P-OH), 3.77 (3H, s, 
3-0Me), 4.17 (lH, dd, J7.8 and 5.4 Hz, lix-H), 6.06 (lH, d, J5.9 Hz, 15-H), 6.31 (lH, d, 
J 5.9 Hz, 16-H), 6.61 (lH, d, J 2.8 Hz, 4-H), 6.71 (lH, dd, J 8.6 and 2.8 Hz, 2-H), 7.02 
(lH, d,J8.6 Hz, 1-H), 7.48-7.80 (SH, m, 17\-S02Ph). 
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Acetylation of the mixture of alcohols 20 and 22 
A solution of the two alcohols 20 and 22 (26 mg, 0.05 mmol) and 4-(dimethylamino)-
pyridine (DMAP) (5 mg) in pyridine (2 cm3) was stirred for 4h at 25°C. Saturated aqueous 
ammonium chloride was added and the resultant mixture was extracted into ethyl acetate. 
The combined organic phase was washed [aq. HCI (1 mol dm·3), satd. aq. NaHC03, water, 
brine], dried (MgS04) and evaporated under reduced pressure to give a residue (30 mg) 
which was chromatographed on silica gel (2 g) with ethyl acetate-toluene (1: 19) as eluent 
to give a mixture of the 17P-acetates 17 and 19 (25 mg; 88%). Recrystallisation from 
chloroform-methanol afforded 17P-acetate 17, m.p. 285-287°C. Evaporation of the mother 
liquor afforded 3-methoxy-15a.-phenylsulfonyl-14, 17a.-ethenoestra-1,3,5(1 O)-trien-l 7p-yl 
acetate 19 as an oil, [a.]o -1° (c 1.4) (Found: M\ 492. C29H320sS requires M, 492); 
Vmaxlcm·1 1739 (C=O), 1319, 1149 (S02Ph); DH (400 MHz) 1.00 (3H, s, 13P-Me), 2.05 
(3H, s, 17P-0Ac), 2.09 (lH, dd, J 12.3 and 9.0 Hz, 16P-H), 2.63 (lH, dd, J 12.3 and 4.8 
Hz, 16a.-H), 3.77 (3H, s, 3-0Me), 4.03 (lH, dd, J 9.0 and 4.8 Hz, 15P-H), 6.00 (lH, d, J 
6.0 Hz, 172-H), 6.37 (lH, d, J6.0 Hz, li-H), 6.59 (lH, d, J2.7 Hz, 4-H), 6.70 (lH, dd, J 
8.4 and 2.7 Hz, 2-H), 7.00 (lH, d, J 8.4 Hz, 1-H), 7.55 (2H, m, m-H of PhS02), 7.63 (lH, 
m,p-H of PhS02) and 7.88 (2H, m, o-H of PhS02). 
Hydrogenation of the mixture of cycloadducts 17, 18 and 19 
A solution of the mixture of cycloadducts 17, 18 and 19 ( 460 mg, 0.9 mmol) was stirred 
with palladium on carbon (10%, 100 mg) in chloroform (10 cm3) under hydrogen (50 bar) 
at 60°C for 5 h. The solution was filtered through Celite and the filtrate was evaporated 
under reduced pressure to give a solid residue ( 483 mg) which was adsorbed onto silica gel 
(50 g). Elution with ethyl acetate-toluene (1: 19) gave an inseparable mixture of 
3-methoxy-1 i R-phenylsulfonyl-14, 17a.-ethano-8a.-estra-1,3,5(1 O)-trien-17P-yl acetate 23 
and 3-methoxy-15a.-phenylsulfonyl-14, 17a.-ethano-8a.-estra-1,3,5( 1 O)-trien-17P-yl acetate 
24 (375 mg, 82%). Recrystallisation from chloroform-methanol afforded 24, m.p. 312-
3130C; [a.]o +7° (c 0.3) (Found: C 70.0; H, 6.9; S, 6.3%; M\ 494. C29H340sS requires C, 
70.4; H, 6.9; S, 6.5%; M, 494); Vmaxlcm·1 1734 (C=O), 1306, 1147 (S02Ph); DH (200 MHz) 
1.01 (3H, s, 13P-Me), 2.00 (3H, s, 17P-0Ac), 3.79 (3H, s, 3-0Me), 3.99 (lH, ddd, J 11.7, 
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4.3 and 2.4 Hz, 15P-H or 172x-H), 6.62 (lH, d, J 2.7 Hz, 4-H), 6.74 (lH, dd, J 8.5 and 2.7 
Hz, 2-H), 7.06 (lH, d, 18.5 Hz, 1-H), 7.58 (3H, m, m- andp-H of PhS02) and 7.88 (2H, m, 
o-H of PhS02) followed by 3-methoxy-16a-phenylsulfonyl-14, 17a-etheno-8a-estra-
l,3,5(10)-trien-17P-yl acetate 18 (82 mg, 18%), m.p. 218-220°C (from chloroform-
methanol); [a]o +22° (c 0.2) (Found: C, 70.8; H, 6.7; S, 6.3%; M\ 492. C29H320 5S 
requires C, 70. 7; H, 6.5; S, 6.5%; M, 492); Vmaxlcm·1 1746 (C=O), 1320, 1152 (S02Ph); 8H 
(400 MHz) 0.91 (lH, dt, J 13.8 and 2 x 3.2 Hz, 12P-H), 0.95 (3H, s, 13P-Me), 1.44 (lH, 
qd, J 3 x 13.8 and 3.8 Hz, 1 lP-H), 1.63 (3H, s, 17P-0Ac), 1.72 (lH, dd, J 12.6 and 4.6 Hz, 
15a-H), 2.18 (lH, ddd,113.5, 4.6 and 2.4 Hz, 8a-H), 2.31 (lH, tdd,J 13.8, 2 x 4.2 and 0.8 
Hz, 12a-H), 2.52 (lH, dd, J 12.6 and 9.0 Hz, 15P-H), 2.74 (2H, m, 6-H2), 2.85 (lH, dt, J 
12.6 and 2 x 4.2 Hz, 9a-H), 3.76 (3H, s, 3-0Me), 4.05 (lH, dd, J 9.0 and 4.6 Hz, 16P-H), 
5.96 (lH, d, J 6 Hz, 1 ?2-H), 6.43 (lH, d, J 6 Hz, 17'-H), 6.60 (lH, d, J 2.6 Hz, 4-H), 6.70 
(lH, dd, J 8.6 and 2.6 Hz, 2-H), 7.00 (lH, d, J 8.6 Hz, 1-H), 7.62 (3H, m, m- and p-H of 
PhS02) and 7.91 (2H, m, o-H of PhS02); 8c (100 MHz) 16.5 (13p-Me), 20.1 (C-7), 20.9 
(l 7-0C(O)CH3), 28.2 (C-11), 28.9 (C-15), 29.2 (C-12), 30.5 (C-6), 37.8 (C-8), 38.2 (C-9), 
55.2 (3-0Me), 54.4 (C-13), 61.2 (C-14), 67.2 (C-16), 95.l (C-17), 112.3 (C-2), 113.2 
(C-4), 128.5 (C-2' and C-6'), 129.l (C-3' and C-5'), 129.2 (C-17'), 130.4 (C-1), 133.3 
(C-4'), 133.4 (C-10), 136.3 (C-172), 136.9 (C-5), 140.9 (C-1 '), 157.6 (C-3) and 168.9 
(l 7-0C(O)CH3). 
3-Methoxy-14,17a-ethano-8a-estra-1,3,5(10)-trien-17P-ol 25 
a) A solution of 1,2-diiodoethane (1.9 g, 6.8 mmol) in THF (68 cm3) was added slowly to 
samarium ( 1.1 g, 7 .6 mmol) and the mixture was allowed to stir at 25°C until a deep blue 
solution was formed (ca 90 min). Hexamethylphosphoramide (HMPA) (5.5 cm3) was 
added and the mixture was stirred for lh at 25°C to give a dark purple solution which was 
cooled to -20°C. A solution of the mixture of sulfones 23 and 24 (366 mg, 0.7 mmol) in 
THF (35 cm3) was added and the mixture was stirred at -20°C for 4h. Saturated aqueous 
ammonium chloride was added and the mixture was extracted into ethyl acetate. The 
combined organic phase was washed (water, satd. aq. Na2S203, brine), dried (MgS04) and 
evaporated under reduced pressure to give a residue (382 mg) which was chromatographed 
on silica gel ( 40 g) with ethyl acetate-toluene (1: 19) as eluent to give starting material 
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(5 mg), preceded by a crude product (206 mg) which was stirred in a methanolic potassium 
hydroxide solution (1%, 10 cm3) for 18h. The mixture was poured into water and extracted 
into ethyl acetate. The combined organic phase was washed (water, brine), dried (MgS04) 
and evaporated under reduced pressure to give a solid residue ( 181 mg) which was 
chromatographed on silica gel (20 g) with ethyl acetate-toluene (1: 19) as eluent to give 
3-methoxy-l4,l 7a-ethano-8a-estra-l,3,5(10)-trien-l 7P-ol 25 (180 mg, 78%), m.p. 146-
1480C (from methanol); [a]o -34° (c 0.3) (Found: C, 80.5; H, 9.1 %; M\ 312. C21 H280 2 
requires C, 80.7; H, 9.0%; M, 312); Vma,/cm·1 3601, 3438 br. (OH); 8H (200 MHz) 1.00 
(3H, s, 13P-Me), 2.6-3.2 (3H, m, 6-H2 and 9a-H), 3.78 (3H, s, 3-0Me), 6.62 (IH, d, J 2.8 
Hz, 4-H), 6.74 (lH, dd, J 8.4 and 2.8 Hz, 2-H) and 7.08 (IH, d, J 8.4 Hz, 1-H). 
b) A solution of the sulfones 23 and 24 (320 mg, 0.65 mmol) in THF (10 cm3) was added 
to a solution of sodium (700 mg, 30 mmol) in a mixture of ammonia (40 cm3, freshly 
distilled from sodium) and THF (5 cm3) at -33°C. The resulting solution was stirred for 2h 
at -33°C. Solid ammonium chloride was added and the ammonia was allowed to 
evaporate. Water was added and the resulting mixture was extracted into ethyl acetate. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give a solid residue (133 mg) which was chromatographed on 
silica gel (13 g) eluting with ethyl acetate-toluene (1: 19) to give 3-methoxy-14,17a-ethano-
8a-estra-1,3,5(10)-trien-l 7P-ol 25 (108 mg, 53%), identical in all respects (m.p., and [a]o) 
to that synthesised previously. 
14,17a-ethano-8a-estra-1,3,5(10)-triene-3,17P-diol 26 
A solution of boron tribromide (1.0 mol dm"3 in dichloromethane, 3 cm3, 3 mmol) was 
added to a solution of the 3-methyl ether 25 (206 mg, 0.7 mmol) in dichloromethane (20 
cm3) at 0°C and the mixture was stirred at 0°C for 90 min. The mixture was poured into 
water and extracted with ethyl acetate. The combined organic phase was washed (water, 
brine), dried (MgS04) and concentrated under reduced pressure to give a residue (186 mg) 
which was adsorbed onto silica gel ( 18 g) and eluted with methanol-chloroform ( 1: 9) to 
give the 3,17P-diol 26 (160 mg, 81%), m.p. 248-249°C (from methanol); [a]0 -34° (c 0.8 
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in THF) (Found: C, 80.5; H, 8.9%; M\ 298. C20H2602 requires C, 80.5; H, 8.8%; M, 298); 
Yma,/cm·1 (in THF) 3442, 3320 br. (OH). 
Desulfonylation of the mixture of phenyl vinyl sulfone cycloadducts 17, 18 and 19 
A solution of the phenyl vinyl sulfone cycloadducts 17, 18 and 19 (700 mg, 1.4 mmol) in 
THF (20 cm3) was added to a solution of sodium (700 mg, 30 mmol) in a mixture of 
ammonia (40 cm3; freshly distilled from sodium) and THF (5 cm3) at -33°C. The resulting 
mixture was stirred for 2h at -33°C. Solid ammonium chloride was added, and the 
ammonia was allowed to evaporate. Water was added and the resulting mixture was 
extracted into ethyl acetate. The combined organic phase was washed (water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (616 mg). 
Chromatography on silica gel ( 60 g) with ethyl acetate-toluene ( 1: 19) gave two unidentified 
mixtures of products (50 mg and 12 mg), followed by an inseparable mixture of products 
27, 28, 29 and 30 (157 mg, 36%), m.p. 83-85°C (from methanol) (Found: C, 81.1; H, 
8.7%; M\ 310. C21H2602 requires C, 81.3; H, 8.4%; M, 310); Ymru/cm·1 3598 (OH); OH 
(200 MHz) 0.97 and 0.98 (3H, both s, 13P-Me), 3.77 (3H, s, 3-0Me), 5.75 (0.5H, d, J 5.9 
Hz), 5.90 (0.5H, d, J 5.9Hz), 6.60 (lH, m, 4-H), 6.70 (lH, m, 2-H) and 7.01-7.05 
(IH, m, 1-H). 
Hydrogenation of the desulfonylation mixture 27, 28, 29 and 30 
A solution of the mixture of products 27, 28, 29 and 30 (33 mg, 0.1 mmol) in ethyl acetate 
(2 cm3) was stirred with palladium on carbon (10%, 3 mg) under hydrogen at 25°C for 3h. 
After filtration of the catalyst (Celite ), evaporation of the filtrate gave a residue (34 mg) 
which was chromatographed on silica gel ( 5 g) with ethyl acetate-toluene ( 1 : 19) to give a 
mixture of the two cyclopropyl compounds 27 and 28 (17 mg, 52%). Recrystallisation 
from methanol afforded 3-methoxy-15,1 i-cyclo-14,17a-ethano-8a-estra-1,3,5(1 O)-trien-
17P-yl acetate 27, m.p. 77-80°C; [a]o +2° (c 0.5) (Found: C, 81.1; H, 8.6%; M\ 310. 
C21H2602 requires C, 81.3; H, 8.4%; M, 310); Vmaxfcm·1 3596 (OH); OH (400 MHz) 0.76 
(lH, dt, J 5.8 and 2 x 1.5 Hz, 172-H), 0.98 (3H, s, 13P-Me), 1.44 and 1.48 (each lH, dd, J 
9.7 and 1.5 Hz, 16a-H and 1 in-H), 1.81 and 1.90 (each lH, dt, J 9.7 and 2 x 1.6 Hz, 
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16P-H and 17\-H), 3.77 (3H, s, 3-0Me), 6.60 (IH, d, J 2.7 Hz, 4-H), 6.72 (lH, dd, J 8.4 
and 2.7 Hz, 2-H), 7.06 (lH, d, J 8.4 Hz, 1-H). Further elution with the same solvent 
afforded 3-methoxy-14a,17a-ethano-8a-estra-l,3,5(10)-trien-17P-ol 25 (16 mg, 47%), 
m.p. 145-147°C (from methanol). 
Further cycloaddition reactions of 3-methoxy-8a-estra-1,3,5(10),14,16-pentaen-
17-yl acetate 16 
a) With acrolein: boron trifluoride-diethyl etherate (0.1 cm3, 0.8 mmol) was added to a 
cooled (0°C) solution of the dienyl acetate 16 (200 mg, 0.6 mmol) and acrolein (0.3 cm3, 
4.5 mmol) in THF (10 cm3) and the resulting mixture was stirred at 25°C for 18h. The 
mixture was poured into a saturated aqueous sodium hydrogen carbonate solution, 
extracted into ethyl acetate (3x) and the combined organic extracts were dried (MgS04) 
and evaporated under reduced pressure to give a crude residue (318 mg). This was 
chromatographed on silica gel (20 g) eluting with ethyl acetate-hexane (1 :4) to give two 
fractions (16 and 43 mg respectively) which were mixtures of products, followed by 
17P-acetoxy-3-methoxy-14, 17a-etheno-8a-estra-l ,3,5(1 O)-triene-16a-carbaldehyde 31 
(127 mg, 54%), m.p. 141-143°C (from chloroform-diisopropyl ether); [a.]0 -12° (c 0.2) 
(Found: C, 75.4; H, 7.5%; ~. 380. C24H2s04 requires C, 75.8; H, 7.4%; M, 380); 
Yma,/cm·1 1734, 1710 (C=O); 8H (400 MHz) 1.06 (3H, d, J0.8 Hz, 13P-Me), 1.12 (lH, dt, J 
13.2 and 2 x 3.4 Hz, 12P-H), 1.33 (lH, dd, J 12.4 and 4.1 Hz, 15a-H), 2.11 (3H, s, 
17P-0Ac), 2.45 (lH, dd, J 12.4 and 9.1 Hz, 15P-H), 2.7-2.90 (3H, m, 6-H2 and 9a-H), 
3.15 (lH, ddd, J 9.1, 4.5 and 4.1 Hz, 16P-H), 3.77 (3H, s, 3-0Me), 6.02 (lH, d, J 6 Hz, 
1 i-H), 6.36 (lH, d, J 6 Hz, 171-H), 6.61 (lH, d, J2.6 Hz, 4-H), 6.72 (lH, dd, J 8.4 and 2.6 
Hz, 2-H), 7.02 (lH, d, J 8.4 Hz, 1-H) and 9.47 (lH, d, J 4.5 Hz, 16-CHO); 8c (100 MHz) 
16.4 (13P-Me), 20.1 (C-7), 21.3 (l 7-0C(O)CH3), 28.1 (C-11), 28.3 (C-15), 30.6 (C-6), 
30.9 (C-12), 38.0 (C-8), 38.6 (C-9), 54.4 (C-14), 55.2 (C-16), 55.2 (3-0Me), 59.3 (C-13), 
95.5 (C-17), 112.3 (C-2), 113.2 (C-4), 129.8 (C-17'), 130.4 (C-1), 133.5 (C-10), 137.1 
(C-5), 140.2 (C-172), 157.6 (C-3), 171.2(17-0C(O)CH3) and 201.9 (16-CHO). 
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b) With methyl propiolate: a solution of the dienyl acetate 16 (430 mg, 1.3 mmol) and 
methyl propiolate (0.6 cm3, 6.7 mmol) in benzene (6 cm3) was heated in a sealed tube at 
100°C for 72h. The cooled solution was adsorbed onto silica gel ( 40 g) and eluted with 
ethyl acetate-toluene (1: 19) to give an unidentified mixture of products (54 mg), followed 
by methyl 17P-acetoxy-3-methoxy-14, 17a-etheno-8a-estra-1,3,5(10), 15-tetraene 
16-carboxylate 33 (361 mg, 66%), m.p. 177-178°C (from benzene-hexane); [a]0 -50° 
(c 0.4) (Found: C, 73.7; H, 7.0%; Nt, 408. C2sH2sOs requires C, 73.5; H, 6.9%; M, 408); 
Ymaxlcm·1 1742, 1711 (C=O); DH (400 MHz) 1.25 (3H, d, J0.8 Hz, 13P-Me), 1.36 (lH, dt, J 
12.7 and 2 x 3.2 Hz, 12P-H), 1.54 (lH, qd, J 3x13.8 and 3.8 Hz, 1 lP-H), 1.66 (lH, dq, J 
13.8 and 3 x 3.8 Hz, 1 la-H), 1.74-1.88 (2H, m, 7-H2), 2.18 (3H, s, 17P-0Ac), 2.40-2.50 
(2H, m, 8a-H and 12a-H), 2.74-2.90 (3H, m, 6-H2 and 9a-H), 3.72 (3H, s, l6-C02Me), 
3.77 (3H, s, 3-0Me), 6.40 (lH, d, J 5.1 Hz, 1 ?2-H), 6.62 (lH, d, J 2.8 Hz, 4-H), 6.72 (lH, 
dd,J8.4 and 2.8 Hz, 2-H), 7.04 (IH, d,J8.4 Hz, 1-H), 7.05 (lH, d,J5.l Hz, li-H) and 
7.50 (lH, s, 15-H); De (100 MHz) 18.6 (13P-Me), 21.4 (17-0C(O)CH3), 21.6 (C-7), 27.4 
(C-11), 30.4 (C-12), 30.8 (C-6), 36.1 (C-8), 37.4 (C-9), 51.3 (16-C02Me), 55.2 (3-0Me), 
64.8 (C-14), 87.4 (C-13), 98.7 (C-17), 112.3 (C-2), 113.3 (C-4), 130.4 (C-1), 133.2 (C-10), 
136.9 (C-5), 140.0 (C-1 ?1), 143.5 (C-172), 146.8 (C-16), 152.8 (C-15), 157.6 (C-3), 164.7 
(l6-C02Me) and 170.7 (17-0C(O)CH3). 
c) With 2-acetoxyacrylonitrile: a solution of the dienyl acetate 16 (200 mg, 0.6 mmol), 
hydroquinone (50 mg) and 2-acetoxyacrylonitrile (0.1 cm3, 0.9 mmol) in benzene (3 cm3) 
was heated in a sealed tube at 150°C for 288h. Further aliquots of dienophile (0.1 cm3) 
were added after 40, 96, 140, 188 and 236h. The cooled mixture was adsorbed onto silica 
gel (20 g) and eluted with ethyl acetate-toluene ( 1: 19) to give starting material (27 mg, 
13%) followed by 16a,17P-diacetoxy-3-methoxy-14,17a-etheno-8a-estra-l,3,5(10)-triene-
16P-carbonitrile 37 (174 mg, 65%), m.p. 177-179°C (from dichloromethane-methanol); 
[a]0 +92° (c 0.4) (Found: C, 71.8; H, 6.8; N, 3.1 %; M\ 435. C26H29NOs requires C, 71.7, 
H 6.7; N, 3.2%; M, 435); Ymaxlcm·1 2238 (CN), 1745 (C=O); DH (400 MHz) 1.12 (lH, dt, J 
13.4 and 2 x 3.2 Hz, 12P-H), 1.29 (3H, d, J 0.8 Hz, 13P-Me), 1.54 (lH, qd, J 3 x 13.6 and 
3.9 Hz, 1 lP-H), 1.62 (lH, d, J 14 Hz, 15a-H), 2.07 (3H, s, 16a-OC(O)CH3), 2.11 (lH, 
ddd, J 13.3, 4.9 and 13.3 Hz, 8a-H), 2.20 (3H, s, 17P-0Ac), 2.36 (lH, tdd, J2 x 13.6, 4.8 
and 0.8 Hz, 12a-H), 2.7 (lH, m, 6-H), 2.84 (2H, m, 6-H2 and 9a-H), 3.12 (lH, d, J 14 Hz, 
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15P-H), 3.76 (3H, s, 3-0Me), 6.02 (IH, d,J6 Hz, 1?2-H), 6.36 (lH, d,J6 Hz, 171-H), 6.60 
(lH, d, J 2.6 Hz, 4-H), 6.71 (IH, dd, J 8.4 and 2.6 Hz, 2-H) and 7.00 (lH, d, J 8.4 Hz, 
1-H); 8c (100 MHz) 17.7 (13P-Me), 19.8 (C-7), 20.9 (l6-0C(O)CH3), 21.3 
(17-0C(O)CH3), 27.7 (C-11), 30.2 (C-12), 30.4 (C-6), 37.5 (C-8), 37.8 (C-9), 42.3 (C-15), 
54.8 (C-14), 55.1 (3-0Me), 59.7 (C-13), 79.0 (C-16), 97.7 (C-17), 112.3 (C-2), 113.l 
(C-4), 117.1 (16-CN), 130.2 (C-1), 130.6 (C-17'), 132.9 (C-10), 136.8 (C-5), 139.5 
(C-1 ?2), 157.6 (C-3), 169.0 and 169.2 [l6-0C(O)CH3 and 17-0C(O)CH3]. Further elution 
with the same solvent gave an unidentified mixture of products (10 mg). 
Sodium borohydride reduction of methyl propiolate adduct 33 
A solution of the methyl propiolate cycloadduct 33 (277 mg, 0.7 mmol) in a mixture of 
THF (21 cm3) and methanol (3 cm3) was stirred at 25°C while sodium borohydride (100 
mg, 2.6 mmol) was added portionwise. The mixture was stirred for 15 min at 25°C, 
poured into water (25 cm3) and extracted with ethyl acetate. The combined organic 
extracts were washed with water, dried (MgS04) and evaporated under reduced pressure to 
give a crude residue (281 mg) which was chromatographed on silica gel (30 g) with ethyl 
acetate-hexane (1 :4) as eluent to give methyl l 7p-acetoxy-3-methoxy-l4, 17a-etheno-8a-
estra-l ,3,5(l O)-triene l6P-carboxylate 35 (130 mg, 47%), m.p. 128-130°C (from 
methanol); [a]o +34° (c 1.6) (Found: C, 73.2; H, 7.5%; M\ 410. C2sH300s requires C, 
73.1; H, 7.4%; M, 410); Ymaxlcm-1 1732 (C=O); 8H (400 MHz) 0.97 (3H, d, J 0.4 Hz, 
13P-Me), 1.18 (lH, dt, J 13 and 2 x 3.2 Hz, 12P-H), 2.15 (3H, s, 17P-0Ac), 2.65 (lH, dd, 
J 12.4 and 4.6 Hz, 15P-H), 3.25 (lH, dd, J 9.6 and 4.6 Hz, 16a-H), 3.69 (3H, s, 
l6P-C02Me), 3.77 (3H, s, 3-0Me), 5.90 (lH, d, J 5.7 Hz, 17
2-H), 6.40 (lH, d, J 5.7 Hz, 
17'-H), 6.62 (lH, d, J2.6 Hz, 4-H), 6.72 (lH, dd, J8.6 and 2.6 Hz, 2-H) and 7.02 (lH, d, J 
8.6 Hz, 1-H); 8c (50 MHz) 16.1 (13P-Me), 20.2 (17-0C(O)CH3), 21.5 (C-7), 28.3 (C-11), 
28.7 (C-15), 30.7 (C-12), 31.6 (C-6), 38.0 (C-8), 38.2 (C-9), 44.9 (C-16), 51.7 
(l6P-C02Me), 53.2 (C-14), 55.2 (3-0Me), 57.4 (C-13), 94.7 (C-17), 112.2 (C-2), 113.2 
(C-4), 130.4 (C-1), 133.7 (C-10), 134.3 (C-17'), 137.2 (C-5), 141.0 (C-172). 157.5 (C-3), 
171.6 (l 7-0C(O)CH3) and 173.0 (16P-C02Me), followed by mixed fractions (43 mg, 
15%), and methyl l 7P-acetoxy-3-methoxy-l4, l 7a-etheno-8a-estra-l,3,5(l 0)-triene 
l6a-carboxylate 34 (61 mg, 22%) as a glass, [a]o +17° (c 5.0) (Found: C, 72.5; H, 7.5%; 
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M\ 410. C25H300 5 requires C, 73.1; H, 7.4%; M, 410); Ymaxlcm-
1 1740 (C=O); DH (200 
MHz) 1.03 (3H, s, 13P-Me), 2.10 (3H, s, 17P-0Ac), 2.40 (lH, dd, J 12 and 9 Hz, 15P-H), 
3.25 (lH, dd, J9 and 4.2 Hz, 16P-H), 3.64 (3H, s, l6a-C02Me), 3.76 (3H, s, 3-0Me), 5.90 
(lH, d, J 6.1 Hz, 1 i-H), 6.33 (lH, d, J 6.1 Hz, 171-H), 6.61 (lH, d, J 2.5 Hz, 4-H), 6.71 
(lH, dd, J 8.5 and 2.5 Hz, 2-H) and 7.01 (lH, d, J 8.5 Hz, 1-H), De (50 MHz) 16.6 
(13P-Me), 20.1 (17-0C(O)CH3), 21.4 (C-7), 28.4 (C-11), 29.0 (C-15), 30.6 (C-12), 31.2 
(C-6), 38.0 (C-8), 38.4 (C-9), 46.6 (C-16), 51.6 (l6a-C02Me), 54.1 (C-14), 55.1 (3-0Me), 
59.6 (C-13), 95.9 (C-17), 112.2 (C-2), 113.1 (C-4), 130.2 (C-17 1), 130.3 (C-1), 133.7 
(C-10), 137.0 (C-5), 137.8 (C-1 i), 157.5 (C-3), 170.0 (17-0C(O)CH3) and 173.9 
(l6a-C02Me). 
14-Allyl-3-methoxy-8a,14P-estra-1,3,5(10),15-tetraen-17-one 32 
a) A solution of the 16P-methyl carboxylate 35 (130 mg, 0.3 mmol) in THF (20 cm3) was 
stirred with LAH (100 mg, 2.6 mmol) for 18h at 25°C. Ethyl acetate (2 cm3) was added 
and the reaction mixture was poured into a saturated aqueous sodium hydrogen carbonate 
solution. The resulting mixture was extracted into ethyl acetate. The combined organic 
phase was washed (water, brine), dried (MgS04) and evaporated under reduced pressure to 
give a residue (104 mg) which was chromatographed on silica gel (8 g) with ethyl acetate-
toluene (2:3) to give a solid residue (87 mg). This was stirred with toluene-p-sulfonyl 
chloride (100 mg, 0.5 mmol) in pyridine (2 cm3) for 2h. Saturated aqueous sodium 
hydrogen carbonate was added and the mixture was extracted with ethyl acetate. The 
combined organic extracts were washed [satd. aq. NaHC03, aq. HCl (1 mol dm-3), water, 
brine], dried (MgS04) and evaporated under reduced pressure to give a residue (90 mg). 
The was refluxed with methanolic potassium hydroxide ( 1 %, 25 cm3) for 90 min. 
Saturated aqueous ammonium chloride was added to the cooled solution and it was 
extracted into ethyl acetate. The combined organic phase was washed (water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (70 mg) which was 
filtered through silica gel ( 10 g) with ethyl acetate-toluene (1: 19) as eluent to give the 
14P-allyl Ll 15 17-ketone 32 (37 mg, 46% from 35), m.p. 118-121 °C (from diisopropyl 
ether); [a]o +68° (c 0.6) (Found: C, 82.0; H, 8.3%; M\ 322. C22H260 2 requires C, 81.9; H, 
8.1%; M, 322); Ymaxlcm-1 1703 (C=O); DH (400 MHz) 1.18 (3H, s, 13P-Me), 2.18 (lH, ddd, 
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J 13.0, 4.5 and 2.6 Hz, 8a-H), 2.61 (lH, m, 141-H), 3.77 (3H, s, 3-0Me), 5.08-5.14 (2H, 
m, 143-H2), 5.7-5.8 (IH, m, 142-H), 6.15 (lH, d, J 5.8 Hz, 16-H), 6.60 (lH, d, J 2.6 Hz, 
4-H), 6.69 (lH, dd, J 8.3 and 2.6 Hz, 2-H), 6.94 (IH, d, J 8.3 Hz, 1-H) and 7.50 (IH, d, J 
5.8 Hz, 15-H); 8c (50 MHz) 17.1 (13P-Me), 20.0 (C-7), 28.4 (C-11), 30.3 (C-12), 35.4 
(C-6), 37.5 (C-9), 39.3 (C-141), 44.6 (C-8), 51.3 (C-14), 53.6 (C-13), 55.2 (3-0Me), 112.3 
(C-2), 113.0 (C-4), 118.7 (C-143), 129.8 (C-1), 130.0 (C-142), 133.8 (C-10), 136.5 (C-5), 
157.6 (C-3), 170.7 (C-15) and 213.9 (C-17). 
b) A solution of the acrolein cycloadduct 31 (55 mg, 0.1 mmol) in THF (5 cm3) was stirred 
while LAH (50 mg, 1 mmol) was added and the mixture was stirred for 10 min, ethyl 
acetate (2 cm3) was added and the mixture was poured into saturated aqueous sodium 
hydrogen carbonate (20 cm3). The combined organic phase was washed (water, brine), 
dried (MgS04) and evaporated under reduced pressure to give a residue (60 mg) which 
stirred with toluene-p-sulfonyl chloride (100 mg, 0.5 mmol) in pyridine (2 cm3) at 25°C for 
15 min and then stored at 7°C for 48h. Saturated aqueous sodium hydrogen carbonate was 
added and the mixture was extracted into ethyl acetate. The combined organic phase was 
washed [aq. HCl (1 mol dm-3), water, brine], dried (MgS04) and evaporated under reduced 
pressure to give a solid residue (60 mg) which was refluxed in methanolic potassium 
hydroxide (1 %, 10 cm3) for 30 min. Saturated aqueous ammonium chloride was added to 
the cooled solution and work-up [as in (a)] gave a solid residue (36 mg) which was 
chromatographed on silica gel (5 g) with ethyl acetate-toluene (1: 19) as eluent to give the 
14P-allyl-~15 17-ketone 32 [26 mg, 58% from 31] which was identical in all respects 
(m.p., mixed m.p., [a]0 , and 
1H NMR) with that synthesised in the previous experiment. 
17P-Hydroxy-3-methoxy-14,17 a-etheno-Sa-estra-1,3,5(1 O)-trien-16-one 38 
Aqueous potassium hydroxide (2 mol dm-3, 5 cm3) was added to a solution of the 
2-acetoxyacrylonitrile cycloadduct 37 (70 mg, 0.2 mmol) in a mixture of dimethylsulfoxide 
(DMSO) (2 cm3) and THF (2 cm3) and the resulting mixture was stirred for 5h at 25°C. 
Saturated aqueous ammonium chloride was added and the mixture was extracted into ethyl 
acetate. The extract was washed (water, brine), dried (MgS04) and evaporated under 
reduced pressure to give a residue ( 66 mg) which was chromatographed on silica gel (10 g) 
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with ethyl acetate-toluene (1 :9) as eluent to give the 17p-hydroxy 16-ketone 38 (32 mg, 
62%), m.p. 170-172°C (from chloroform-methanol); [a]o +387° (c 0.2) (Found: C, 77.7; 
H, 7.7%; M+, 324. C21H2403 requires C, 77.7; H, 7.5%; M, 324); Ymaxlcm-1 3523, 3402 
(OH), 1746 (C=O); 8H (200 MHz) 1.00 (3H, s, 13p-Me), 1.98 (IH, d, J 16.8 Hz, 15P-H), 
2.44 (lH, d,. J 16.8 Hz, 15a-H), 3.78 (3H, s, 3-0Me), 5.83 (lH, d, J 5.9 Hz, 1 ?2-H), 6.22 
(lH, d, J 5.9 Hz, 17'-H), 6.62 (lH, d, J2.6 Hz, 4-H), 6.74 (IH, dd, J 8.5 and 2.6 Hz, 2-H) 
and 7.06 (lH, d, J 8.5 Hz, 1-H). 
3-Methoxy-14,17 a-etheno-8a-estra-1,3,5(1 O)-triene-16P ,17P-diol 39 
a) Sodium borohydride (60 mg, 1.6 mmol) was added to a solution of the 
2-acetoxyacrylonitrile cycloadduct 37 (60 mg, 0.1 mmol) in methanol (5 cm3) and the 
mixture was stirred at 25°C for 20h. Water was added, and the mixture was extracted into 
ethyl acetate. The combined organic phase was washed (water, brine), dried (MgS04) and 
evaporated under reduced pressure to give a residue (50 mg) which was adsorbed onto 
silica gel (5 g) and eluted with ethyl acetate-toluene (1 :4) to give an unidentified impurity 
(3 mg) followed by the 16P,17P-dio/ 39 (26 mg, 57%), m.p. 135-136 °C (from methanol); 
[a]0 +29° (c 0.3) (Found: C, 77.1; H, 8.2%; M\ 326. C21H2603 requires C, 77.3; H, 8.0%; 
M, 326); Ymaxlcm-1 3690, 3611, 3566 (OH); 8H (200 MHz) 1.17 (3H, s, 13p-Me), 2.22 and 
2.62 (each IH, br. s, 16P- and 17P-OH), 3.77 (3H, s, 3-0Me), 3.90 (IH, dd, J 7.7 and 2.4 
Hz, 16a-H), 5.76 (IH, d, J 5.9 Hz, 172-H), 5.89 (IH, d, J 5.9 Hz, 17'-H), 6.62 (IH, d, J2.6 
Hz, 4-H), 6.72 (lH, dd, J 8.3 and 2.6 Hz, 2-H) and 7.04 (lH, d, J 8.3 Hz, 1-H). 
b) Lithium aluminium hydride (60 mg, 1.6 mmol) was added to a solution of the 
17P-hydroxy 16-ketone 38 (30 mg, 0.1 mmol) in THF (5 cm3) and the mixture was stirred 
for 30 min. Work-up, as in (a) followed by recrystallisation from methanol afforded the 
16p,11p-diol 39 (25 mg, 83%) m.p. 134-135°c. 
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14-Formylmethyl-3-methoxy-8a,14P-estra-1,3,5(10),15-tetraen-17-one 40 
A solution of the 16P, 17P-diol 39 (10 mg, 0.03 mmol) in ethanol (2 cm3) was stirred at 
25°C while aqueous sodium periodate (6%, 2 cm3) was added and the resulting mixture 
was stirred for 10 min. Ethylene glycol and water were added, and the product was 
isolated by extraction with chloroform. Flash chromatography on silica gel ( 1 g) with ethyl 
acetate-toluene (1 :9) as eluent gave the product 40 (6 mg, 62%), as an oil (Found: M\ 324. 
C21H2403 requires M, 324); Ymaxlcm-1 1710 (C=O); cSH (400 MHz) 1.14 (3H, s, 13P-Me), 
2.15 (lH, dd, J 16.6 and 1.1 Hz, 141-H), 3.17 (lH, dd, J 16.6 and 2.3 Hz, 141-H), 3.75 (3H, 
s, 3-0Me), 6.17 (lH, d, J 6.0 Hz, 1 ?1-H), 6.58 (lH, d, J 2.6 Hz, 4-H), 6.68 (lH, dd, J 8.4 
and 2.6 Hz, 2-H), 6.92 (lH, d, J 8.3 Hz, 1-H), 7.80 (lH, d, J 6.0 Hz, 1 ?2-H) and 9.80 (lH, 
dd, J 2.3 and 1.1 Hz, 141-CHO). The !ability of the product precluded further 
characterisation. 
17 ,17-Ethylenedioxy-3-methoxy-9P-estra-1,3,5(10)-trien-1 la-yl 11-methyl xanthate 44 
Sodium borohydride (500 mg, 12.5 mmol) was added to a solution of 17,l 7-ethylenedioxy-
3-methoxy-9p-estra-1,3,5(10)-trien-11-one 42 100 ( 465 mg, 1.4 mmol) in a mixture of THF 
(10 cm3) and water (1 cm3) and the mixture was stirred for 2h. Water was added and the 
mixture was extracted into ethyl acetate. The combined organic phase was washed (water, 
brine), dried (MgS04) and evaporated under reduced pressure to give crude I la-alcohol 43 
(438 mg), cSH (200 MHz) 1.02 (3H, s, 13P-Me), 3.50 (lH, br. m, 9P-H), 3.77-3.85 (4H, m, 
17, 17-0CH2CH20), 3.77 (3H, s, 3-0Me), 4,45 (lH, dt, J 7.5 and 2 x 4.6 Hz, 11 P-H), 6.63 
(lH, d, J 2.7 Hz, 4-H), 6.71 (lH, dd, J 8.8 and 2.7 Hz, 2-H) and 7.77 (lH, d, J 8.8 Hz, 
1-H). The 1 la-alcohol 43 (430 mg, 1.3 mmol), sodium hydride (0.5 g of a 60% suspension 
in mineral oil, 12.5 mmol) and imidazole (10 mg) were refluxed in THF (20ml) for 90 min. 
Carbon disulfide (0.2 cm3, 3 mmol) was added and the mixture was refluxed for 30 min, 
then methyl iodide (0.2 cm3, 3 mmol) was added. The resulting mixture was refluxed for 
30 min. Acetic acid (2 cm3) was added to the cooled solution and the mixture was 
extracted into ethyl acetate. The combined organic phase was washed (water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (826 mg) which was 
chromatographed on silica gel (50 g) with ethyl acetate-hexane (1 :9) as eluent to give the 
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1 la-xanthate 44 (402 mg, 74%), as an oil, [a]o +50° (c 0.3) (Found: M+, 434. C23H3o04S2 
requires M, 434); Vmaxlcm·' 1235, 1120, 1052 (C=S); <'.>tt (200 MHz) 1.09 (3H, s, 13P-Me), 
2.56 (3H, s, l la-OCS2Me), 3.50 (lH, t, J 2 x 4.3 Hz, 9P-H), 3.75-3.9 (4H, m, 
17,17-0CH2CH20), 3.78 (3H, s, 3-0Me), 6.30 (IH, dt, J 10.9 and 2 x 4.3 Hz, 1 lP-H), 6.63 
(lH, d, J 2.7 Hz, 4-H), 6.73 (IH, dd, J 8.8 and 2.7 Hz, 2-H) and 7.61 (lH, d, J 8.8 Hz, 
1-H). 
3-Methoxy-17-oxo-9p-estra-1,3,5(10)-trien-lla-yl 11-methyl xanthate 45 
A solution of the 17-ketal 44 (87 mg, 0.2 mmol) and toluene-p-sulfonic acid (30 mg) in a 
mixture of acetone and water (7: 1; 16 cm3) was stirred for 22h at 25°C. The residue after 
evaporation of the solvent under reduced pressure was dissolved in ethyl acetate. The 
resulting solution was washed (satd. aq. NaHC03, water), dried (MgS04) and evaporated 
under reduced pressure to give a solid residue which was chromatographed on silica gel 
(5 g) with ethyl acetate-toluene (1 :19) as eluent to give the l 7-ketone 45 (66 mg, 85%), 
m.p. 152-154°C (from acetone-hexane); [a]0 + 161 ° (c 0.4) (Found: C, 64.9; H, 6.9; S, 
16.4%; M\ 390. C21H2603S2 requires C, 64.6; H, 6.7; S, 16.4%; M, 390); Vmaxlcm·' 1734 
(C=O), 1239, 1150, 1055 (C=S); 8tt (200 MHz) 1.11 (3H, s, I3P-Me), 2.53 (3H, s, 
l la-OCS2Me), 3.50 (lH, t, J 2 x 4.7 Hz, 9P-H), 3.77 (3H, s, 3-0Me), 6.31 (lH, dt, J 8.3 
and 2 x 4.6 Hz, llP-H), 6.64 (IH, d, J2.6 Hz, 4-H), 6.72 (lH, dd, J8.5 and 2.6 Hz, 2-H) 
and 7.51 (lH, d, J 8.5 Hz, 1-H). 
3-Methoxy-9 P-estra-1,3,5(1 O)-trien-17-one 46 
a) A solution of the 17,17-ethylenedioxy-lla-xanthate 45 (100 mg, 0.2 mmol), 
tributylstannane (1 g, 3.4 mmol) and a,a'-azobis(isobutyronitrile) (AIBN) (30 mg) in 
toluene (5ml) was refluxed for 3h. The cooled mixture was adsorbed onto silica gel (20 g) 
and eluted with toluene (to remove the tin residues) followed by ethyl acetate-toluene 
( 1: 19) to give an oily residue (36 mg, 0.1 mmol) which was dissolved in a mixture of 
acetone and water (7: 1; 10 cm3) and stirred with toluene-p-sulfonic acid (IO mg) for 18h. 
The acetone was removed under reduced pressure and the resulting solution was extracted 
with ethyl acetate. The combined organic phase was washed (satd. aq. NaHC03, water, 
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brine), dried (MgS04) and evaporated under reduced pressure to give a residue (25 mg) 
which was filtered through silica gel (0.5 g) with ethyl acetate-toluene (1: 19) to give 
3-methoxy-9(3-estra-1,3,5(10)-trien-17-one 46 (18 mg, 28%) as an oil, [a.]o +40° (c 0.2) 
(lit., 115 [a.]o +43°) (Found: M+, 284. C19H2402 requires M, 284); Vmru/cm·1 1728 (C=O); 
8H (400 MHz) 0.97 (3H, s, 13(3-Me), 1.24 (lH, td, J2 x 12.8 and 3.8 Hz, 12a.-H), 2.20 (lH, 
m, 8(3-H), 2.70 (IH, dt, J 16.8 and 2 x 4.6 Hz, 6(3-H), 2.80 (IH, td, J2 x 16.8 and 8.8 Hz, 
6a.-H), 3.01 (IH, br. s, Wy, 10 Hz, 9(3-H), 3.77 (3H, s, 3-0Me), 6.62 (IH, d, J2.7 Hz, 4-H), 
6.72 (IH, dd, J 8.6 and 2.7 Hz, 2-H) and 7.22 (lH, d, J 8.6 Hz, 1-H); 8c (100 MHz) 13.4 
(13f3-Me), 21.8 (C-15), 24.2 (C-11), 24.8 (C-7), 26.0 (C-6), 27.4 (C-12), 33.8 (C-8), 35.4 
(C-16), 37.3 (C-9), 42.3 (C-14), 47.9 (C-13), 55.2 (3-0Me), 112.0 (C-2), 113.9 (C-4), 
127.4 (C-1), 129.6 (C-10), 138.4 (C-5), 157.5 (C-3) and 220.8 (C-17). 
b) A solution of the 17-oxo lla.-xanthate 45 (90 mg, 0.2 mmol) and AIBN (30 mg) in 
toluene (10 cm3) was added to tributylstannane (1 g) and the mixture was refluxed for 48h. 
Further tributylstannane (1 g) and AIBN ( 40 mg) were added after 24h. The cooled 
mixture was adsorbed onto silica gel (20 g) and eluted with toluene (to remove the tin 
residues) followed by ethyl acetate-toluene (2:3) to give an oily residue (342 mg) which 
was dissolved in dichloromethane (5 cm3). Dess-Martin periodinane 72 (200 mg, 0.5 
mmol) was added and the mixture was stirred for 3h, poured into a solution of sodium 
thiosulfate (500 mg) in saturated aqueous sodium hydrogen carbonate (20 cm3) and 
extracted into diethyl ether. The combined organic phase was washed (water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (350 mg) which was 
chromatographed on silica gel (30 g) with ethyl acetate-toluene (1 :9) to give 3-methoxy-
9f3-estra-1,3,5(10)-trien-17-one 46 (9 mg, 14%), identical with that described in the 
previous experiment. 
174 
17-0xoestra-1,3,5(10)-trien-3-yl acetate 47 
A solution of estrone 41 (1.63 g, 6 rnmol) and toluene-p-sulfonic acid (100 mg) in acetic 
anhydride (20 cm3) was stirred at 25°C under nitrogen for 18h. Ice and solid sodium 
hydrogen carbonate were added and the solution was extracted into ethyl acetate (3x). 
After removal of the solvent, crystallisation of the residue from ethanol afforded the 
3-acetate 47 (l.69 g, 90%), m.p. 123-126°C (lit., 187 125-127°C). 
17-0xoestra-1,3,5(10),9(11)-tetraen-3-yl acetate 49 
a) To a solution of estrone 3-acetate 47 (174 mg, 0.6 rnmol) in dichloromethane was added 
tetrabutylammonium hydrogen sulfate (100 mg), acetone (10 cm3) and phosphate buffer 188 
(pH 7.5, 25 cm3). The mixture was cooled in an ice bath and the pH adjusted to 7.5 (5 mol 
dm"3 aq. potassium hydroxide). A solution of oxone® (9 g) and disodium 
ethylenediaminetetraacetate (200 mg) in distilled water (60 cm3) was added dropwise over 
7h, while maintaining the temperature and pH at 0-5°C and 7.5 respectively. The mixture 
was stirred for a further 1 7h at 4 °C. The dichloromethane solution was separated, dried 
(MgS04) and evaporated under reduced pressure to give a residue (218 mg) which was 
adsorbed onto silica gel (20 g) and flash chromatographed with ethyl acetate-toluene (1 :9) 
to give starting material 47 (90 mg, 52%) followed by 9a-hydroxy-17-oxoestra-1,3,5(10)-
trien-3-yl acetate 48 (55 mg, 30%), m.p. 152-155°C (from ethanol) (lit., IOI, 116 165-166°C, 
162-164°C); Ymai/cm·1 3682, 3598 (OH), 1733 cm·1 (C=O); 8H (200 MHz) 0.88 (3H, s, 
13P-Me), 2.28 (3H, s, 3-0Ac), 6.86 (lH, d, J 2.5 Hz, 4-H), 6.92 (IH, dd, J 8.5 and 2.5 Hz, 
2-H) and 7.54 (lH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 12.9 (13P-Me), 20.0 (3-0C(O)CH3), 
21.1 (C-7), 21.4 (C-15), 27.7 (C-12), 29.4 (C-6), 32.2 (C-11), 35.9 (C-16), 41.1 (C-8), 43.l 
(C-14), 47.6 (C-13), 70.0 (C-9), 119.6 (C-2), 122.3 (C-4), 126.5 (C-1), 138.4 (C-5), 139.2 
(C-10), 150.0 (C-3), 169.6 (3-0C(O)CH3) and 220.4 (C-17). 
Toluene-p-sulfonic acid (I 00 mg) was added to a stirred solution of the 9a-alcohol 48 
(81 mg, 0.3 mmol) in dry benzene (10 cm3) and the mixture stirred at 25°C for 7h. Solid 
sodium hydrogen carbonate and water were added and the mixture was extracted into 
toluene (3x). The combined organic phase was washed (water), dried (MgS04) and 
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evaporated under reduced pressure to give a residue (73 mg) which was adsorbed onto 
silica gel (7 g) and eluted with ethyl acetate-toluene (1 :9) to give 17-oxoestra-
1,3,5(10),9(11 )-tetraen-3-yl acetate 49 (50 mg, 65%), m.p. 122-125°C (from methanol) 
(lit., 101 124-127°C); mlz 310; cSH (200 MHz) 0.92 (3H, s, 13f3-Me), 2.27 (3H, s, 3-0Ac), 
6.22 (IH, m, 11-H), 6.80-6.90 (2H, m, 2- and 4-H) and 7.58 (IH, d, J 8.5 Hz, 1-H) 
followed by unidentified coloured material (20 mg). 
b) To a solution of estrone 3-acetate 47 (100 mg, 0.3 mmol) in acetone (2 cm3) was added 
a freshly prepared solution of dimethyldioxirane in acetone 117 (ca. 0.1 mol dm-3, 8.5 cm3, 
0.85 mmol). The mixture was allowed to stir for 48h at 25°C. The acetone was removed 
under reduced pressure to give a residue (100 mg) which was dissolved in benzene 
(10 cm3) and stirred with toluene-p-sulfonic acid (100 mg) at 25°C for 18h. Solid sodium 
hydrogen carbonate and water were added and the mixture was extracted into toluene (3x). 
The combined organic phase was washed with water (Ix), dried (MgS04) and evaporated 
under reduced pressure to give a residue (100 mg) which was absorbed onto silica gel 
( 10 g) and eluted with ethyl acetate-toluene (1 :9) to give the ,19(I I) 3-acetate 49 (36 mg, 
35% from 47). 
Estra-1,3,5(10),9(11)-tetraen-3,17f3-diyl diacetate 50 
A solution of estrone 41 (5 g, 18.5 mmol) in dry methanol (800 cm3) was stirred at 25°C 
while a solution of 2,3-dichloro-5,6-dicyano-l ,4-benzoquinone (DDQ) ( 4.3 g, 18.9 mmol) 
in methanol (30 cm3) was added over 2 min. The resulting dark purple solution was stirred 
for 100 min at 25°C. The methanol was evaporated under reduced pressure and the 
resulting brown solid was triturated with chloroform (500 cm3) and allowed to stand for 
18h. Activated charcoal was then added and the mixture was stirred for 5 min and then 
filtered through Celite to give a pale yellow solution. Removal of the chloroform gave a 
yellow-brown crystalline residue (7.4 g) which was dissolved in a mixture of THF 
(120 cm3) and methanol (20 cm3). Sodium borohydride (1.5 g, 39.5 mmol) was added and 
the mixture was stirred for 30 min at 25°C. Water was added and the resulting mixture 
was extracted into chloroform. The combined organic phase was washed (water), dried 
(MgS04) and evaporated under reduced pressure to give a residue ( 6.1 g) which was 
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dissolved in a mixture of THF ( 15 cm3) and acetic anhydride ( 5 cm3). Toluene-p-sulfonic 
acid (200 mg) was added and the mixture was stirred for 18 h at 25°C. Water and solid 
sodium hydrogen carbonate were added until effervescence ceased. The resulting mixture 
was extracted into ethyl acetate. The combined organic phase was washed (water, brine), 
dried (MgS04) and evaporated under reduced pressure to give a residue (7 .2 g) which was 
recrystallised from methanol to give impure estra-1,3,5(10),9(11)-tetraen-3,17P-diyl 
diacetate 50 (3.63 g, 55%), m.p. 140-142°C (lit., lOJ 134-135°C, 121 149°C); 8H (200 MHz) 
(ca. 90%) 0.82 (3H, s, 13p-Me), 2.06 (3H, s, I 7p-oAc), 2.26 (3H, s, 3-0Ac), 2.85 (2H, m, 
6-H2), 4.75 (lH, dd, J 8.9 and 7.2 Hz, 17a-H), 6.20 (IH, dt, J 5.5 and 2 x 2.3 Hz, 11-H), 
6.60 (IH, d, J2.8 Hz, 4-H), 6.66 (IH, dd, J 8.6 and 2.8 Hz, 2-H) and 7.56 (IH, d, J 8.6 Hz, 
1-H); 8H (200 MHz) (ca. 10%) 0.80 (3H, s, 13P-Me), 2.04 (3H, s, 17P-0Ac), 2.27 (3H, s, 
3-0Ac), 4.75 (IH, dd, J 8.9 and 7.2 Hz, 17a-H), 6.60 (IH, d, J2.8 Hz, 4-H), 6.66 (IH, dd, 
J 8.6 and 2.8 Hz, 2-H) and 7.25 (IH, d, J 8.6 Hz, 1-H). The mother liquor material was 
flash chromatographed on silica gel (165 g) with toluene (for 3 column volumes) followed 
by ethyl acetate-toluene (1 :9) to give further impure ~9<11> 3,17P diacetate 50 (2.27 g, 35%). 
l l-Oxo-9P-estra-1,3,5(10)-triene-3,17P-diyl diacetate 51 
A solution of dimethyldioxirane in acetone (ca. 0.1 mol dm·3, 75 cm3, 7.5 mmol) was 
added to the ~9<11> 3,17P-diacetate 50 (2.42 g, 6.8 mmol) and the mixture was stirred for 2h 
at 25°C. The acetone was evaporated under reduced pressure and the residue was 
dissolved in benzene (60 cm3). Lithium perchlorate (200 mg) was added and the mixture 
was refluxed for lh. The cooled solution was washed with water and evaporated under 
reduced pressure to give a residue (2.35 g) which was flash chromatographed on silica gel 
(165 g) with ethyl acetate-hexane (1 :4) as eluent to give estra-1,3,5(10)-triene-3, 17P-diyl 
diacetate (312 mg, 13%), m.p. 95-97°C (from methanol) '(lit., 189 97-98°C); mlz 356, 
followed by the I I-ketone 51 (1.27 g, 50%), as a foam, [a.] 0 + 133° (c 0.3) (Found: C, 70.8; 
H, 7.2%; M\ 370. C22H2605 requires C, 71.3; H, 7.1 %; M, 370); Ymaxlcm·
1 1726 (C=O); 
OH (400 MHz) 0.84 (3H, s, 13P-Me), 2.00 (3H, s, 17P-0Ac), 2.27 (3H, s, 3-0Ac), 2.68-
2.92 (2H, m, 6-H2), 3.62 (lH, d, J 5.2 Hz, 9P-H), 4.70 (IH, dd, J 8.9 and 8.3 Hz, 17a-H), 
6.82 (lH, dd, J 8.5 and 2.5 Hz, 2-H), 6.87 (IH, d, J 2.5 Hz, 4-H) and 7.30 (IH, dd, J 8.5 
and 1.0 Hz, 1-H); 8c (100 MHz) 12.9 (13P-Me), 20.9 (17-0C(O)CH3), 21.1 
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(3-0C(O)C1-h), 22.5 (C-15), 23.5 (C-7), 24.5 (C-6), 27.5 (C-16), 33.4 (C-8), 40.9 (C-14), 
46.4 (C-13), 50.7 (C-12), 53.7 (C-9), 80.2 (C-17), 119.8 (C-2), 122.6 (C-4), 128.7 (C-1), 
128.8 (C-10), 137.1 (C-5), 148.3 (C-3), 169.5 (3-0C(O)CH3), 170.7 (17-0C(O)CH3) and 
211.6 (C-11). 
Sodium borohydride reduction of 11-ketone 51 
To a stirred solution of the I I-ketone 51 (310 mg, 0.9 mmol) in a mixture of THF (5 cm3) 
and water (0.5 cm3) was added sodium borohydride (200 mg, 5.3 mmol) and the mixture 
was stirred for 48h at 25°C. Water was added and the resulting mixture was extracted with 
chloroform. The combined organic phase was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a residue (200 mg) which was dissolved in dry 
acetone (5 cm3). Potassium carbonate (1 g) and dimethyl sulfate (0.5 cm3) were added and 
the mixture was stirred for 18h at 25°C. Aqueous ammonia (1 cm3) was added and the 
mixture was stirred for 30 min and then was extracted into ethyl acetate. The extract was 
washed (water), dried (MgS04) and evaporated under reduced pressure to give a mixture of 
products (244 mg) which was adsorbed onto silica gel (25 g) and eluted with ethyl acetate-
toluene (1 :9) to give I 7p-acetoxy-3-methoxy-9p-estra-1,3,5(1 O)-triene-11 P-ol 52 (84 mg, 
28%), as an oil, (Found: M\ 344. C21H2s04 requires M, 344); Vmaxlcm-1 3571 (OH), 1716 
(C=O); DH (200 MHz) 1.05 (3H, s, 13P-Me), 2.03 (3H, s, 17P-0Ac), 2.40 (IH, br. d, J 10.6 
Hz, 9P-H), 2.8 (2H, m, 6-H2), 3.75 (3H, s, 3-0Me), 4.6-4.7 (2H, m, 1 la- and 17a-H), 6.64 
(IH, d, J 2.8 Hz, 4-H), 6.74 (IH, dd, J 8.6 and 2.8 Hz, 2-H) and 7.16 (IH, d, J 8.6 Hz, 
1-H), followed by 17P-acetoxy-3-methoxy-9p-estra-1,3,5(1 O)-triene-11 a-ol 53 
(136 mg, 46%), as an oil, (Found: M\ 344. C21H2s04 requires M, 344); Vmaxlcm-1 3604 
(OH), 1723 (C=O); DH (200 MHz) 0.91 (3H, s, 13p-Me), 2.00 (3H, s, 17P-0Ac), 2.65 (2H, 
m, 6-H2), 3.11 (IH, t, J2 x 4.5 Hz, 9P-H), 3.74 (3H, s, 3-0Me), 4.38 (lH, dt, J 8.1 and 4.5 
Hz, 1 la-H), 4.55 (IH, dd, J 8.9 and 7.2 Hz, 17a-H), 6.60 (lH, d, J2.8 Hz, 4-H), 6.66 (IH, 
dd,J8.6 and 2.8 Hz, 2-H) and 7.86 (IH, d,J8.6 Hz, 1-H). 
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3-Methoxy-16a-phenylsulfonyl-14,17a-ethanoestra-1,3,5(10)-trien-17P-yl acetate 56 
A solution of 3-methoxy- l 6a-phenylsulfonyl-14, 17 a-ethenoestra-1,3 ,5( 1 O)-trien-17P-yl 
acetate 55 57 (100 mg, 0.2 mmol) in ethyl acetate (6 cm3) was shaken in the presence of 
palladium on charcoal (10%, 10 mg) under a hydrogen atmosphere (414 kPa) for 3h at 
25°C. The catalyst was removed by filtration (Celite) and washed thoroughly with 
chloroform. The combined organic phase was concentrated under reduced pressure to 
afford the dihydro compound 56 (95 mg, 96%), m.p. 195-197°C (from benzene-hexane) 
(lit., 57 199-200°C) (Found: M\ 494. C29H3405S requires M, 494); 8H (200 MHz) 0.91 
(3H, s, 13P-Me), 1.67 (3H, s, l 7p-0Ac), 3.76 (3H, s, 3-0Me), 4.38 (lH, ddd, J 11.8, 4.9 
and 2.6 Hz, I6P-H), 6.60 (lH, d, J2.8 Hz, 4-H), 6.70 (lH, dd, J 8.5 and 2.8 Hz, 2-H), 7.17 
(IH, d,J8.5 Hz, 1-H) and 7.5-8.0 (5H, m, 16a-S02Ph). 
3-Methoxy-14,l 7a-ethanoestra-l,3,5(1 O)-trien-l 7P-ol 59 
a) A solution of 3-methoxy-16a-phenylsulfonyl-14,l 7a-ethenoestra-l,3,5(10)-trien-17P-yl 
acetate 55 (7.6 g, 15.5 mmol) in chloroform (20 cm3) was stirred with palladium on carbon 
(10%, 1 g) at 75°C under a hydrogen atmosphere (50 bar) for 72h. The cooled solution 
was filtered through Celite and evaporated to give a residue (8.2 g) which was dissolved in 
a mixture of acetic anhydride (10 cm3) and THF (20 cm3) and stirred with toluene-p-
sulfonic acid (1 g) for 4h. Water and solid sodium hydrogen carbonate were added until 
effervescence ceased. The resulting mixture was extracted into ethyl acetate. The 
combined organic phase was washed (satd. aq. NaHC03, water, brine), dried (MgS04) and 
evaporated under reduced pressure to give crude 3-methoxy-l 6a-phenylsulfonyl-14, 17a-
ethanoestra-1,3,5(10)-trien-17P-yl acetate 56 (8.4 g). This was dissolved in THF (150 cm3) 
and was added to a solution of sodium (6 g, 260 mmol) in a mixture of liquid ammonia 
(800 cm3; freshly distilled from sodium) and THF (50 cm3) and the resulting mixture was 
stirred at -33°C for 2h. Solid ammonium chloride was added and the ammonia was 
removed by evaporation. The resultant mixture was diluted with water and extracted with 
chloroform. The combined organic phase was washed (water, brine), dried (MgS04) and 
evaporated under reduced pressure to give a residue (4.47 g). This was flash 
chromatographed on silica gel (120 g) with ethyl acetate-toluene (1 :4) as eluent to give 
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3-methoxy-14, 17a-ethanoestra-1,3,5(1 O)-trien-17-ol 59 (3.4 g, 70%), m.p. 119-121 °C 
(from methanol) (lit., 57 120.5-121 °C) (Found: M+, 312. C21H2s02 requires M, 312); bH 
(200 MHz) 0.88 (3H, s, 13P-Me), 3.76 (3H, s, 3-0Me), 6.60 (lH, d, J 2.8 Hz, 4-H), 6.70 
(lH, dd, J8.5 and 2.8 Hz, 2-H) and 7.20 (lH, d, J8.5 Hz, 1-H). 
b) A solution of 3-methoxy-16a-phenylsulfonyl-14,17a-ethenoestra-1,3,5(10)-trien-17P-yl 
acetate 55 (3.49 g, 7.1 mmol) in dry tetrahydrofuran (20 cm3) was added slowly to a 
solution of sodium (1.8 g, 78 mmol) in liquid ammonia (freshly distilled from sodium; 400 
cm3) and dry tetrahydrofuran (50 cm3). The solution was stirred at -33°C for 2h, then solid 
ammonium chloride (200 g) was added and the ammonia allowed to evaporate. The 
resulting mixture was extracted into chloroform, the combined organic phase was washed 
(brine), dried (MgS04) and evaporated under reduced pressure to afford 
3-methoxy-14,l 7a-ethenoestra-1,3,5(10)-trien-17P-ol 57 (1.9 g, 87%), contaminated with 
3-methoxy-14, 17a-ethano-16a, 1 ?1-cycloestra-1,3,5(1 O)-trien-17P-ol 58. 
A solution of the 14,17a-etheno compound 57 [(1.8 g, 5.8 mmol), containing 58] in ethyl 
acetate (6 cm3) was shaken under a hydrogen atmosphere (414 kPa) in the presence of 
palladium on charcoal catalyst (10%, 180 mg) for Sh at 25°C. The catalyst was removed 
by filtration through Celite and then washed with ethyl acetate. The combined organic 
phase was evaporated under reduced pressure to afford a residue (1.8 g). This was 
combined with a residue from a similar experiment (1.65 g) and recrystallised from 
methanol to give the 14, 17a-ethano compound 59 (2. 7 g, 78% ). The mother liquor 
material was adsorbed onto silica gel (80 g) and eluted with ethyl acetate-toluene (1 :9) to 
afford the 16a,1 ?1-cyclo compound 58 (300 mg, 9%) followed by another portion of the 
14,17a-ethano compound 59 (394 mg, 11 %). 
14,17a-Ethanoestra-l ,3,5(1 O)-triene-3,17P-diol 60 
a) A solution of boron tribromide (1 mol dm"3 in dichloromethane, 5 cm3, 5 mmol) was 
added to a solution of the 3-methyl ether 59 (500 mg, 1.6 mmol) in dichloromethane 
(10 cm3) and the mixture was stirred at 25°C for 30 min. Water (50 cm3) was added and 
the mixture was stirred for a further 10 min, poured into water (20 cm3) and extracted with 
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ethyl acetate. The combined organic phase was washed (water, brine), dried (MgS04) and 
removed under reduced pressure to give a solid residue (485 mg). This was adsorbed onto 
silica gel ( 40 g) and eluted with methanol-chloroform (1 :99) to give impure product 
(117mg) followed by 14,17a-ethanoestra-l,3,5(10)-triene-3,17P-diol 60 (389 mg, 82%), 
m.p. 232-234°C (lit., 57 240-241 °C) (Found: M\ 298; C20H2602 requires M, 298). 
b) Diisobutylaluminium hydride (DIBAH) (1.5 mol dm-3 in toluene, 2.7 cm3, 4 mmol) was 
added to solution of the 3-methyl ether 59 (298 mg, 0.96 mrnol) in dry toluene (15 cm3) 
and the mixture was refluxed for 24h. Hydrochloric acid (10%, 10 cm3) was added to the 
cooled mixture and the product extracted into ethyl acetate. Chromatography of the residue 
after evaporation of the solvent (308 mg) on silica gel (30 g) with methanol-chloroform 
(1: 19) afforded starting material 59 (19 mg) followed by the 3, 17P-diol 60 (285 mg). 
14,17a-Ethanoestra-1,3,5(10)-triene-3,17P-diyl diacetate 61 
A solution of 3,17P-diol 60 (1.62 g) in a mixture of THF (20 cm3) and acetic anhydride 
(2.5 cm3, 23 mrnol) was stirred with toluene-p-sulfonic acid (100 mg) for 18h at 25°C. 
Water and solid sodium hydrogen carbonate were added and once effervescence ceased the 
mixture was extracted into ethyl acetate. The combined organic phase was washed (satd. 
aq. NaHC03, water, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue (1.8 g). Flash chromatography on silica gel (50 g) with toluene afforded a mixture 
of the 3,17P-diacetate 61 and less polar impurities (404 mg, 22%) followed by the 
3,17P-diacetate 61 (1.29 g, 70%), m.p. 137-141°C (from acetone-hexane); [a]0 +32° 
(c 0.8) (Found: C, 75.1; H, 8.0%; M\ 382. C24H3004 requires C, 75.4; H, 7.9%; M, 382); 
Vma,/cm-1 1727 (C=O); 8H (400 MHz) 0.93 (3H, s, 13P-Me), 2.02 (3H, s, 17P-0Ac), 2.28 
(3H, s, 3-0Ac), 2.65 (lH, td, J2 x 11.5 and 4.2 Hz, 9a-H), 2.85 (2H, m, 6-H2), 6.78 (lH, 
d, J 2.5 Hz, 4-H), 6.84 (lH, dd, J 8.4 and 2.5 Hz, 2-H) and 7.30 (lH, d, J 8.4 Hz, 1-H); 
8c (100 MHz) 14.0 (13P-Me), 21.1 (3-0C(O)CH3), 21.6 (17P-OC(O)CI-IJ), 23.6 (C-7), 
26.0 (C-11), 27.2 (C-172), 27.7 (C-12), 29.2 (C-1 i), 29.9 (C-6), 32.0 (C-15), 32.8 (C-16), 
37.9 (C-8), 40.0 (C-9), 45.1 (C-14), 48.2 (C-13), 89.6 (C-17), 118.6 (C-2), 121.5 (C-4), 
126.6 (C-1), 138.2 (C-10), 138.6 (C-5), 148.4 (C-3), 169.9 (17-0C(O)CH3) and 171.0 
(3-0C(O)CH3). 
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14,17a-Ethanoestra-1,3,5(10),9(11 )-tetraene-3,17P-diyl diacetate 62 
A solution of the 3,l 7P-diol 60 (390 mg, 1.3 mmol) in dry methanol (60 cm3) was stirred at 
25°C while a solution of DDQ (320 mg, 1.4 mmol) in dry methanol was added over 2 min. 
The dark red solution was stirred at 40°C for 3h, during which time the colour faded to a 
light orange. The methanol was evaporated under reduced pressure and the residue was 
dissolved in ethyl acetate (50 cm\ This solution was washed [aq. K2C03 (1 mol dm·3), 
aq. Na2S03 (2 mol dm·3), aq. K2C03 (1 mol dm·3), water, brine]. The combined washings 
were extracted with ethyl acetate, and these extracts were combined with the original 
solution, and the resulting mixture was washed (water, brine), dried (MgS04) and 
evaporated under reduced pressure to give a residue ( 428 mg). This was dissolved in a 
mixture of pyridine (5 cm3) and acetic anhydride (5 cm3) and stirred with DMAP (20 mg) 
at 25°C for 24h. Water and solid sodium hydrogen carbonate were added, and once 
effervescence ceased the mixture was extracted with ethyl acetate. The combined organic 
phase was washed [satd. aq. NaHC03, aq. HCl (1 mol dm·3), water, brine], dried (MgS04) 
and evaporated under reduced pressure to give a residue (515 mg) which was adsorbed 
onto silica gel (50 g) and eluted with ethyl acetate-hexane (1 :9) to give an inseparable 
mixture of 14, 17a-ethanoestra-1,3,5(1 O)-triene-3, 17P-diyl diacetate 61 and 
14,17a-ethanoestra-l,3,5(10),9(11)-tetraene-3,17P-diyl diacetate 62 (324 mg, ca. 65%), 
mlz 382 and 380; Vmax /cm·' 1729 (C=O); Dtt (400 MHz) (62, ca. 65%) 0.93 (3H, s, 
13P-Me), 2.03 (3H, s, 17P-OC(O)CH3), 2.28 (3H, s, 3-0C(O)CH3), 6.29 (lH, dt, J 5.4 and 
2 x 2.7 Hz, 11-H), 6.80 (lH, d, J 2.5 Hz, 4-H), 6.85 (lH, dd, J 8.7 and 2.5 Hz, 2-H) and 
7.66 (lH, d, J 8.7 Hz, 1-H); 8tt (400 MHz) (61, ca. 35%) 0.93 (3H, s, 13P-Me), 2.03 (3H, s, 
17P-OC(O)CH3), 2.28 (3H, s, 3-0C(O)CH3), 6.78 (lH, d, J 2.5 Hz, 4-H), 6.84 (1-H, dd, J 
8.5 and 2.5 Hz, 2-H) and 7.30 (lH, d, J 8.5 Hz, 1-H). 
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Dehydrogenation of 3-methoxy-14,17a.-ethanoestra-1,3,5(10)-trien-17P-ol 59 
To a stirred solution of3-methoxy-14,17a.-ethanoestra-l,3,5(10)-trien-17P-ol 59 (2.7 g, 8.7 
mmol) in dry methanol ( 430 cm3) at 25°C was added DDQ (2 g, 8.8 mmol) in methanol 
(25 cm3) over a period of 2 min. After stirring for 1 h, during which time the solution 
faded from a deep red to a pale orange, the methanol was evaporated under reduced 
pressure and the residue was triturated with hot chloroform (50 cm3) and then allowed to 
stand at 4 °C for 16h. After stirring with activated charcoal for 5 min the solution was 
filtered through Celite to give a pale yellow solution which was concentrated under 
reduced pressure to give a residue (3.74 g) which was adsorbed onto alumina (activity III, 
100 g) and eluted with ethyl acetate-toluene (3: 17) to give an inseparable mixture of 
starting material 59 and 3-methoxy-14, 17 a.-ethanoestra-1,3 ,5( 10),9( 11 )-tetraen- l 7p-ol 63 
(2. 7 g), mlz 312 and 310; OH (200 MHz) (59 ca. 50%) 0.89 (3H, s, 13 P-Me ), 3. 76 (3H, s, 
3-0Me), 6.6-6.8 (2H, m, 2- and 4-H) and 7.20 (lH, d, J 8.5 Hz, 1-H); oH (200 MHz) (63 
ca. 50%) 0.89 (3H, s, 13P-Me), 3.76 (3H, s, 3-0Me), 6.20 (lH, m, 11-H), 6.6-6.8 (2H, m, 
2- and 4-H) and 7.60 (lH, d, J8.8 Hz, 1-H). 
3-Methoxy-14a.,17a.-ethanoestra-1,3,5(10),6,8,11-hexaen-17P-ol 64 
A solution of 3-methoxy-14a.,17a.-ethanoestra-l,3,5(10)-trien-17P-ol 59 (270 mg, 
0.9 mmol) and toluene-p-sulfonic acid (300 mg, 1.74 mmol) in dry methanol (50 cm3) was 
stirred at 25°C while a solution of DDQ (400 mg, 1.76 mmol) in dry methanol (5 cm3) was 
added in a dropwise fashion. The reaction was stirred for 18h at 25°C followed by 2h at 
reflux. The solvent was removed under reduced pressure and the residue was dissolved in 
chloroform (20 cm\ This solution was washed (satd. aq. NaHC03), dried (MgS04) and 
evaporated to give a residue (220 mg). Chromatography on silica gel (25 g) with ethyl 
acetate-toluene (1:9) as eluent gave the hexaene 64 (154 mg, 58%), m.p. 198-200°C (from 
methanol); [a.]0 -31 ° (c 0.2) (Found: C, 82.4; H, 7.5; M+, 306. C21H2202 requires C, 82.3; 
H, 7.2; M, 306), Vmax /cm-1 3609, 3464 (OH); OH (200 MHz) 0.85 (3H, s, 13P-Me), 1.70 
(lH, s, D20 exch., 17P-OH), 3.92 (3H, s, 3-0Me), 6.65 (lH, d, J 9.8 Hz, 12-H), 7.12 (lH, 
d, J2.7 Hz, 4-H), 7.15 (lH, d, J9.8 Hz, 11-H), 7.18 (lH, dd, J9.3 and 2.7 Hz, 2-H), 7.21 
(lH, d, J8.3 Hz, 7-H), 7.64 (lH, d, J8.3 Hz, 6-H) and 8.60 (lH, d, J9.3 Hz, 1-H). 
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3-Methoxy-14,17 a-ethanoestra-1,3,5(10),6,8-pentaen-17P-ol 65 
A solution of the hexaene 64 (140 mg, 0.5 mmol) in ethyl acetate (5 cm3) was stirred with 
palladium on carbon (10%, 10 mg) under hydrogen at 25°C for 4h. The catalyst was 
filtered off (Celite) and the residue after evaporation of the solvent (137 mg) was 
chromatographed on silica gel (12 g) with ethyl acetate-toluene (1 :9) to give a non-steroidal 
impurity (35 mg) followed by the pentaene 65 (53 mg, 37%), m.p. 130-131°C (from 
methanol); [a]o +29° (c 0.1) (Found: C, 81.8; H, 7.9; M\ 308. C21H2402 requires C, 81.8; 
H, 7.8; M, 308); Ymax /cm-1 3600, 3425 (OH); DH (200 MHz) 0.92 (3H, s, 13P-Me), 1.65 
(lH, s, D20 exch., 17P-OH), 3.92 (3H, s, 3-0Me), 7.12 (lH, d, J2.4 Hz, 4-H), 7.18 (IH, 
dd, J 9.1 and 2.4 Hz, 2-H), 7.20 (lH, d, J 8.5 Hz, 7-H), 7.57 (IH, d, J 8.5 Hz, 6-H) and 
7.92 (IH, d, J9.l Hz, 1-H). 
Reaction of 14,17a-Ethanoestra-1,3,5(10)-triene-3,17P-diyl diacetate 61 with 
dimethyldioxirane 
A solution of the 3,17P-diacetate 61 (104 mg, 0.3 mmol) in freshly prepared DMD 
(0.1 mol dm"3 in acetone, 8 cm3, 0.8 mmol) was stirred for 48h at 25°C. The acetone was 
removed under reduced pressure to give a residue (100 mg) which was adsorbed onto silica 
gel (10 g) and eluted with ethyl acetate toluene (1 :9) to give starting material 61 (20 mg, 
20%), an impure product (40 mg) and a complex mixture of polar products (ca 40 mg). 
The impure product was rechromatographed on silica gel (5 g) with ethyl acetate-toluene 
(1: 19) as eluent to give 6-oxo-14,17a-ethanoestra-l ,3,5(1 O)-triene-3,l 7P-diyl diacetate 66 
(18 mg, 16%), m.p. 169-172°C (from methanol); [a]o -17° (c 0.5) (Found: M+, 396.195 
C24H2sOs requires M, 396.194); Ymaxlcm·1 1728, 1681 (C=O); DH (200 MHz) 0.95 (3H, s, 
13P-Me), 2.03, (3H, s, 17P-0Ac), 2.31 (3H, s, 3-0Ac), 7.27 (lH, dd, J 8.5 and 2.6 Hz, 
2-H), 7.48 (lH, d, J 8.5 Hz, 1-H) and 7.75 (lH, d, J 2.6 Hz, 4-H); 8c (50 MHz) 13.7 
(13P-Me), 21.0 (3-0C(O)CH3), 21.5 (l 7p-OC(O)CH3), 25.3 (C-7), 27.2 (C-11), 27.6 
(C-12), 29.2 (C-172), 31.8 (C-li), 32.3 (C-15), 37.7 (C-16), 40.3 (C-8), 41.4 (C-9), 44.7 
(C-14), 48.0 (C-13), 89.2 (C-17), 120.0 (C-2), 126.9 (C-1 and C-4), 133.5 (C-10), 145.0 
(C-5), 149.2 (C-3), 169.4 (l 7p-OC(O)CH3), 170.8 (3-0C(O)CH3) and 197.1 (C-6). 
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14,17a-Ethano-9l3-estra-1,3,5(10)-triene-3,17l3-diyl diacetate 67 
a) A solution of 14,17a-Ethanoestra-l,3,5(10),9(11)-tetraene-3,17l3-diyl diacetate 62 
(contaminated with 61) (324 mg, 0.9 mmol) in THF (10 cm3) and ethanol (10 cm3) was 
stirred with Raney nickel (Aldrich W-2, 10 cm3) at 50°C under a hydrogen atmosphere (50 
bar) for 48h. The cooled solution was filtered through Celite, the catalyst was washed 
thoroughly with ethyl acetate and chloroform. The residue after evaporation of the solvent 
(272 mg) was adsorbed onto silica gel (35g) and eluted with ethyl acetate-toluene (1 :99) to 
give 14,17a-ethanoestra-l,3,5(10)-triene-3,17l3-diyl diacetate 61 (121 mg, 37%), m.p. 138-
1400C (from acetone-hexane), mixed fractions (109 mg), and 14,17a-ethano-9l3-estra-
I,3,5(10)-triene-3,17l3-diyl diacetate 67 (27 mg, 9%), m.p. 106-109°C (from isopropanol); 
[a]o +46° (c 0.4) (Found: C, 75.2; H, 8.0; M\ 382. C24H3004 requires C, 75.4; H, 7.9; 
M, 382); Vmw/cm-1 1750, 1727 (C=O); Ott (400 MHz) 0.94 (IH, ddd, J 13, 9.8 and 5.2 Hz, 
17\-H), 1.03 (3H, s, 13!3-Me), 1.16 (lH, dt, J 13 and 2 x 3.5 Hz, 1?2x-H), 1.99 (3H, s, 
17!3-0Ac), 2.27 (3H, s, 3-0Ac), 2.44 (lH, br. d, J 15 Hz, 1 la-H), 2.55 (IH, ddd, J 15, 11 
and 5.6 Hz, 6a-H), 2.66 (lH, dt, J 15 and 2 x 5.2 Hz, 6!3-H), 2.84 (IH, br. t, J2 x 6.2 Hz, 
9!3-H), 6.82 (lH, d, J2.5 Hz, 4-H), 6.89 (lH, dd, J8.5 and 2.5 Hz, 2-H) and 7.31 (lH, d, J 
8.5 Hz, 1-H); cc (100 MHz) 14.2 (13!3-Me), 21.2 (3-0C(O)CH3), 21.6 (17l3-0C(O)CH3), 
21.8 (C-11), 23.2 (C-7), 24.5 (C-12), 28.4 (C-6), 28.8 (C-172), 29.1 (C-171), 31.8 (C-16), 
33.8 (C-15), 34.3 (C-9), 35.3 (C-8), 45.2 (C-14), 48.7 (C-13), 89.8 (C-17), 118.8 (C-2), 
120.3 (C-4), 124.5 (C-1), 139.3 (C-10), 141.2 (C-5), 148.1 (C-3), 169.7 (l 7l3-0C(O)CH3) 
and 170.9 (3-0C(O)CH3); Ott (400 MHz, C6D6) 0.68 (lH, ddd, J 12.6, 9.9 and 5.1 Hz, 
17\-H), 0.92 (3H, s, 13!3-Me), 1.00 (lH, m, 713-H), 1.28 (lH, dt, J 12.6 and 2 x 4.1 Hz, 
1213-H), 1.46 (lH, m, 171n-H), 1.65 (3H, s, 17!3-0Ac), 1.76 (3H, s, 3-0Ac), 2.44 (lH, br. t, 
J2 x 6.7 Hz, 913-H), 6.88 (lH, d, J2.3 Hz, 4-H), 6.93 (lH, dd, J 8.3 and 2.3 Hz, 2-H) and 
7.07 (lH, d, J 8.3 Hz, 1-H); cc (100 MHz, C6D6) 14.4 (13!3-Me), 20.6 (3-0C(O)CH3), 21.1 
(17l3-0C(O)CH3), 22.0 (C-11), 23.4 (C-7), 25.0 (C-12), 28.6 (C-6), 28.9 (C-172), 29.4 
(C-171), 32.3 (C-16), 33.9 (C-15), 34.4 (C-9), 35.4 (C-8), 45.4 (C-14), 48.9 (C-13), 89.7 
(C-17), 119.4 (C-2), 120.8 (C-4), 124.5 (C-1), 139.2 (C-10), 141.2 (C-5), 149.1 (C-3), 
168.6 (l 7l3-0C(O)CH3) and 169.8 (3-0C(O)CH3). The mixed fractions were 
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rechromatographed on silica gel (15 g) eluting with ethyl acetate-toluene (1 :99) to give 
further 61 (50 mg, 15%) and 67 (33 mg, 10%). 
b) To a solution of the ~9(ll) 3,17P-diacetate 62 (contaminated with 61) (37 mg, 0.1 mmol) 
in dichloromethane (5 cm3) at 25°C was added triethylsilane (0.5 cm3) followed by 
trifluoroacetic acid (2 cm\ The mixture was stirred at 25°C for 168h, with further 
triethylsilane (0.5 cm3) and trifluoroacetic acid (2ml) being added after 72h. The solution 
was then poured into saturated aqueous sodium hydrogen carbonate (50 cm3) and extracted 
into ethyl acetate. The combined organic phase was washed (satd. aq. NaHC03, water, 
brine), dried (MgS04) and evaporated under reduced pressure to give a residue (56 mg). 
Chromatography on silica gel (5 g) with ethyl acetate-toluene (1 :99) gave 
14,17a.-ethanoestra-l,3,5(1 O)-triene-3,17P-diyl diacetate 61 (19 mg, 50%) followed by 
14,17a.-ethano-9P-estra-l ,3,5(10)-triene-3,l 7P-diyl diacetate 67 (4 mg, 10%). 
14a.,17a.-Ethano-9P-estra-1,3,5(10)-triene-3,17P-diol 68 
A solution of the 3, 17P-diacetate 67 ( 46 mg, 0.1 mmol) in methanolic potassium hydroxide 
(1 %, 10 cm3) was stirred for 24h at 25°C. Water was added and the mixture was extracted 
into ethyl acetate. The combined organic phase was washed (water, brine), dried (MgS04) 
and evaporated under reduced pressure to give a residue ( 40 mg) which was 
chromatographed on silica gel (5 g) with ethyl acetate-toluene (1 :4) as eluent to give the 
3,17P-diol 68 (33 mg, 91%), m.p. 208-209°C (from chloroform); [a.]o +48° (c 0.5) (Found: 
M+, 298.192. C20H2602 requires M, 298.193); Vmaxfcm·1 3692, 3599, 3352 br. (OH). 
Epoxidation-rearrangement 
3,17P-diyl diacetate 62 
of 14,17a.-Ethanoestra-1,3,5(10),9(11 )-tetraene-
A solution of the ~9(Il) 3,17P-diacetate 62 (contaminated with 61) (450 mg, 0.8 mmol) in 
dichloromethane (5 cm3) was stirred at 25°C while a solution of dimethyldioxirane (ca 
0.1 mol dm·3 in acetone, 25 cm3, 2.5 mmol) was added, and the resulting mixture was 
stirred for 75 min at 25°C. The solvent was removed under reduced pressure to give a 
residue (500 mg) which was dissolved in benzene (15 cm3) and refluxed with lithium 
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perchlorate (100 mg) for lh. The cooled solution was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a residue ( 456 mg). Flash chromatography on 
silica gel (50 g) with ethyl acetate-hexane (1 :4) as eluent gave 14,17a-ethanoestra-
l,3,5(10)-triene-3,17l3-diyl diacetate (149 mg, 33%) followed by a mixture of 11-ketones 
69 and 70 (220 mg, 46% ). Recrystallisation of a portion of this mixture from acetone-
hexane afforded 11-oxo-14a,17a-ethanoestra-1,3,5(10)-triene-3,17l3-diyl diacetate 69, 
m.p. 157-160°C; [a]o +220° (c 0.1) (Found: C, 72.3; H, 7.2%; M\ 396. C24H2sOs requires 
C, 72.7; H, 7.1 %; M, 396); Vmaxlcm·1 1732 (C=O); 8H (400 MHz) 1.03 (3H, d, J 0.8 Hz, 
13!3-Me), 1.53 (lH, qd,J3 x 12.8 and 5.8 Hz, 7a-H), 1.84 (lH, m, 713-H), 1.98 (lH, td,J2 
x 12.8 and 2.2 Hz, 8!3-H), 2.02 (3H, s, 17!3-0Ac), 2.23 (lH, d, J 12.8 Hz, 1213-H), 2.27 
(3H, s, 3-0Ac), 2.77 (lH, dd, J 12.8 and 0.8 Hz, 12a-H), 2.84 (2H, m, 6-H2), 3.89 (lH, d, J 
12.8 Hz, 9a-H), 6.81 (lH, d, J2.4 Hz, 4-H), 6.89 (lH, dd, J 8.7 and 2.4 Hz, 2-H) and 7.40 
(lH, d, J 8.7 Hz, 1-H); 8c (100 MHz) 14.6 (13!3-Me), 21.1 (3-0C(O)CH3), 21.4 (17l3-
0C(O)CH3), 24.3 (C-7), 27.7 (C-172), 29.5 (C-li), 30.1 (C-6), 31.8 (C-15), 32.2 (C-16), 
42.5 (C-8), 45.4 (C-14), 47.1 (C-12), 50.1 (C-9), 54.3 (C-13), 88.1 (C-17), 118.6 (C-2), 
121.6 (C-4), 129.2 (C-10), 131.6 (C-1), 138.4 (C-5), 148.9 (C-3), 169.6 (l 7l3-0C(O)CH3), 
170.9 (3-0C(O)CH3) and 209.2 (C-11). 
Sodium borohydride reduction of 11-ketones 69 and 70 
Sodium borohydride (200 mg, 5 mmol) was added to a solution of the total product mixture 
obtained from the previous experiment (69 and 70) (200 mg, 0.5 mmol) in a mixture of 
THF (2 cm3) and methanol (2 cm3) and the mixture was stirred for 18h at 25°C. Water was 
added and the resulting mixture was extracted with ethyl acetate followed by chloroform. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give a residue (188 mg) which was dissolved in dry acetone and 
stirred with potassium carbonate (1 g) and dimethyl sulfate (1 cm3) for 18h at 25°C. 
Ammonia (25%, 3ml) was added and the mixture was stirred for 30 min. Water was added 
and the mixture was extracted into ethyl acetate. The combined organic phase was washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a residue 
(170 mg) which was chromatographed on silica gel (20 g) with ethyl acetate-toluene (I :9) 
as eluent to give 17l3-acetoxy-3-methoxy-14a, 17a-ethanoestra-1,3,5(1 O)-trien- l l l3-ol 71 
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(106 mg, 56%), m.p. 193-194°C (from methanol); [a]o +92° (c 0.5) (Found: C, 74.5; H, 
8.3%; M\ 370. C23H3004 requires C, 74.6; H, 8.2%; M, 370); Ymai/cm-1 3573 (OH), 1728 
(C=O); oH (400 MHz) 1.19 (3H, s, 13P-Me), 1.56 (lH, s, D20 exch., 1 lP-OH), 2.02 (3H, s, 
17P-0Ac), 2.77-2.96 (3H, m, 6-H2 and 9a-H), 4.75 (lH, q J 3.2 Hz, 1 la-H), 6.67 (lH, d, J 
2.6 Hz, 4-H), 6.77 (lH, dd, J8.5 and 2.6 Hz, 2-H) and 7.23 (lH, d, J8.5 Hz, 1-H) followed 
by 17P-acetoxy-3-methoxy-14a,17a-ethano-9P-estra-1,3,5(10)-trien-l la-ol 72 (21 mg, 
11%), as an oil, (Found: M\ 370. C23H3004 requires M, 370); Ymai/cm-1 3691, 3600 (OH), 
1727 (C=O); OH (400 MHz) 0.94 (lH, m, 17\-H), 1.09 (3H, s, 13P-Me), 2.54 (lH, td, J2 x 
13.2 and 5.1 Hz, 6a-H), 2.65 (lH, ddd, J 13.2, 4.7 and 2.9 Hz, 6P-H), 3.11 (lH, dd, J 7.3 
and 5.3 Hz, 9P-H), 3.78 (3H, s, 3-0Me), 4.57 (lH, dt, J 8.8 and 2 x 5.3 Hz, 1 lP-H), 6.68 
(lH, d, J 2.6 Hz, 4-H), 6.72 (lH, dd, J 8.3 and 2.6 Hz, 2-H) and 7.67 (lH, d, J 
8.3 Hz, 1-H). 
3-Methoxy-14,17a-ethanoestra-1,3,5(1 O)-triene-11 P,17P-diol 73 
A solution of the 17P-acetate 71 (11 mg, 0.03 mmol) in a mixture of methanolic potassium 
hydroxide (1 %, 1 cm3) and THF (0.5 cm3) was stirred at 25°C for 22h. Water was added 
and the mixture was extracted with ethyl acetate. The combined organic phase was washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a residue 
(10 mg) which was recrystallised from methanol to give the 11P,17P-dio/ 73, m.p. 193-
1940C; [a]o +105° (c 1.2) (Found: C, 77.0; H, 8.5%; M+, 328. C2 1H2s03 requires C, 76.8; 
H, 8.6%; M, 328); Ymax /cm-1 3685, 3598 (OH); OH (400 MHz) 1.16 (3H, s, 13P-Me), 1.33 
(lH, qd, J3 x 12 and 5.6 Hz, 7a-H), 1.51-1.54 (2H, 2 x s, D20 exch, 1 lP-, 17P-OH), 1.88 
(lH, td, J 2 x 12 and 2.3Hz, 8P-H), 2.82 (2H, m, 6-H2), 2.89 (lH, dd, J 12 and 3.3 Hz, 
9a-H), 3.78 (3H, s, 3-0Me), 4.75 (lH, q, J 3.3 Hz, 1 la-H), 6.66 (lH, d, J 2.7 Hz, 4-H), 
6.76 (lH, dd, J 8.6 and 2.7 Hz, 2-H) and 7.22 (lH, d, J 2.7 Hz, 1-H); oc (100 MHz) 16.3 
(13P-Me), 23.4 (C-7), 26.3 (C-172), 30.4 (C-6), 32.2 (C-15), 33.3 (C-1 ?1), 35.5 (C-16), 
33.0 (C-12), 35.2 (C-8), 43.4 (C-9), 46.4 (C-13), 47.7 (C-14), 55.2 (3-0Me), 67.3 (C-11), 
84.3 (C-17), 112.4 (C-2), 114.7 (C-4), 126.3 (C-1), 128.2 (C-10), 139.9 (C-5) and 
157.7 (C-3). 
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3-Methoxy-14,17a-ethano-9P-estra-1,3,5(10)-triene-lla,17P-diyl diacetate 74 
A solution of the 11 a-alcohol 72 (20 mg, 0.05 mmol) in a mixture of pyridine (1 cm3) and 
acetic anhydride (1 cm3) was stirred with catalytic DMAP for 30 min at 25°C. Saturated 
aqueous sodium hydrogen carbonate was added and once the effervescence ceased the 
mixture was extracted into ethyl acetate. The combined organic phase was washed [ satd. 
aq. NaHC03, aq. HCl (1 mol dm-3), water, brine], dried (MgS04) and evaporated under 
reduced pressure to give a residue (28 mg) which was chromatographed on silica gel (5 g) 
with ethyl acetate-toluene (1:9) as eluent to give the lla,17P-diacetate 74 (15 mg, 74%), 
as an oil, [a]0 +57° (c 1.5) (Found: M+, 412.256. C2sH320s requires M, 412.255); 
Ymai/cm-1 1724 (C=O); OH (400 MHz) 0.86 (lH, m, 1 ?20-H), 1.13 (3H, s, 13P-Me), 1.70 
(lH, dd, J 12.3 and 4.2 Hz, 12P-H), 2.49 (lH, td, J 2 x 13.3 and 5.2 Hz, 6a-H), 2.58 (lH, 
ddd, J 13.3, 4.8 and 2.8 Hz, 6P-H), 3.21 (lH, t, J 2 x 6.3 Hz, 9P-H), 3.78 (3H, s, 3-0Me), 
5.58 (lH, ddd, J 12.1, 5.6 and 4.8 Hz, 1 lP-H), 6.69 (lH, d, J2.8 Hz, 4-H), 6.71 (lH, dd, J 
8.5 and 2.8 Hz, 2-H) and 7.61 (lH, d, J8.5 Hz, 1-H). 
3-Methoxy-11-oxo-14,17a-ethanoestra-1,3,5(1 O)-trien-17P-yl acetate 75 
To a solution of 17P-acetoxy-3-methoxy-14a, 17 a-ethanoestra-1,3 ,5( 10)-trien-11 P-ol 71 
(94 mg, 0.3 mmol) in dichloromethane (5 cm3) was added Dess-Martin periodinane 72 (120 
mg, 0.33 mmol) and the mixture was stirred for 60 min. Diethyl ether (20 cm3) was added, 
and the resulting mixture was poured into a saturated aqueous sodium hydrogen carbonate 
solution (30 cm3) with sodium thiosulfate (2 g) dissolved in it and the resulting mixture 
was extracted into diethyl ether. The combined organic phase was washed (satd. aq. 
NaHC03, water, brine), dried (MgS04) and evaporated under reduced pressure to gave a 
residue (95 mg). A portion of this (75 mg) was chromatographed on silica gel (1 g) with 
diethyl ether-hexane (3:7) as eluent to. give the I I-ketone 75 (59 mg, 68%), m.p. 135-
1380C (from diisopropyl ether); [a]0 +239° (c 0.4) (Found: C, 75.0; H, 7.8%; M+, 368. 
C23H2s04 requires C, 75.0; H, 7.7%; M, 368); Ymai/cm- 1 1729, 1711 (C=O); 88 (400 MHz) 
0.90 (3H, d, J 0.8 Hz, 13p-Me), 1.52 (lH, qd, J 3 x 12.2 and 5.6 Hz, 7a-H), 1.98 (lH, td, J 
2 x 12.2 and 2.0 Hz, 8P-H), 2.01 (3H, s, 17P-0Ac), 2.22 (lH, d, J 12.0 Hz, 12P-H), 2.36 
(IH, tt, J 2 x 12.7 and 2 x 3.7 Hz, 1 ix-H), 2.76 (lH, dd, J 12.0 and 0.8 Hz, 12a-H), 2.80 
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(2H, m, 6-H2), 3.88 (lH, d, J 12.2 Hz, 9a-H), 3.76 (3H, s, 3-0Me), 6.61 (lH, d, J 2.9 Hz, 
4-H), 6.75 (lH, dd, J 8.8 and 2.9 Hz, 2-H) and 7.30 (lH, d, J 8.8 Hz, 1-H); oc (100 MHz) 
14.7 (13P-Me), 21.4 (17p-OC(O)CH3), 24.7 (C-7), 27.8 (C-1?2), 29.6 (C-171), 30.4 (C-6), 
31.8 (C-15), 32.2 (C-16), 42.8 (C-8), 45.4 (C-14), 47.0 (C-12), 50.0 (C-9), 54.4 (C-13), 
55.2 (3-0Me), 88.1 (C-17), 111.6 (C-2), 113.8 (C-4), 123.8 (C-10), 131.5 (C-1), 138.2 
(C-5), 157.9 (C-3), 170.7 (17P-OC(O)CH3) and 209.7 (C-11). The remainder of the crude 
product (20 mg) was treated with sodium borohydride (200 mg) in a mixture of THF 
(2 cm3) and methanol (2 cm3) for 30 min at 25°C. Water was added and the mixture was 
extracted into ethyl acetate. The combined organic phase was washed (water), dried 
(MgS04) and evaporated under reduced pressure to give a residue (17 mg) which was 
recrystallised from methanol to give l 7p-acetoxy-3-methoxy-14,17a-ethanoestra-
l,3,5(10)-trien-11P-ol 71, m.p. 190-192°C (from methanol); [a]o +90° (c 0.5). 
3-Methoxy-14,17a-ethanoestra-1,3,5(1 O)-triene-11 a,17P-diol 76 
Borane-dimethyl sulfide complex (10 mol dm·3, 10 cm3, 100 mmol) was added slowly to a 
stirred solution of 3-methoxy-14, l 7a-ethanoestra-l,3,5(10),9(11)-tetraen-17P-ol 63 
(contaminated with 59) (2.7 g, ca. 8.7 mmol) in dry tetrahydrofuran (150 cm3) at 25°C. 
The mixture was refluxed for 72h, with a further aliquot of borane being added after 24h. 
After cooling to 0°C, hydrogen peroxide (100 vol, 20 cm3) and aqueous sodium hydroxide 
( 4 mol dm"3, 20 cm3) were added cautiously and the mixture was stirred for 18h at 25°C. 
Water (80 cm3) was added and the mixture was extracted into ethyl acetate. The combined 
organic phase was washed with brine, dried (MgS04) and evaporated to give a residue 
(ca 3 g) which was adsorbed onto silica gel (150 g) and eluted with ethyl acetate-toluene 
(1 :9) to give 3-methoxy-14,17a-ethanoestra-1,3,5(10)-trien-17P-ol 59 (958 mg, 35%), 
followed by an unidentified, non-steroidal product (400 mg). Further elution with ethyl 
acetate-toluene (3:2) afforded the lla,I7P-diol 76 (888 mg, 31%), as an oil, (Found: 
M\ 328. C21H2s03 requires M, 328); Ymaxlcm·1 3597, 3457 br. (OH); OH (200 MHz) 0.89 
(3H, s, BP-Me), 2.48 (lH, t, J2 x 10 Hz, 9a-H), 2.76 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 
4.20 (lH, td, J2 x 10 and 5.8 Hz, 1 lP-H), 6.64 (lH, d, J2.8 Hz, 4-H), 6.74 (lH, dd, J 8.7 
and 2.8 Hz, 2-H) and 7.88 (lH, d, J 8.7 Hz, 1-H); oc (50 MHz) 14.4 (13P-Me), 23.0 (C-7), 
27.0 (C-172), 29.1 (C-6), 32.1 (C-15), 32.9 (C-1?1), 35.3 (C-16), 38.0 (C-8), 39.5 (C-12), 
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45.4 (C-9), 46.8 (C-13), 48.1 (C-14), 55.2 (3-0Me), 71.2 (C-11), 83.8 (C-17), 111.1 (C-2), 
113.7 (C-4), 127.5 (C-1), 132.9 (C-10), 139.1 (C-5) and 157.7 (C-3). 
3-Methoxy-14,17a-ethanoestra-1,3,5(10)-triene-l la,17P-diyl diacetate 77 
To a solution of the 1 la,17P-diol 76 (160 mg, 0.5 mmol) in pyridine (5 cm3) at 25°C was 
added acetic anhydride (0.2 cm3, 2.2 mmol) and DMAP (10 mg). The mixture was stirred 
for 16h at 25°C, water was then added and the solution was extracted with ethyl acetate. 
The combined organic phase was washed [aq. HCl (3 mol dm-3), satd. aq. NaHC03, brine], 
dried (MgS04) and evaporated under reduced pressure to give a residue (196 mg) which 
was adsorbed onto silica gel (20 g) and eluted with ethyl acetate-toluene (1 :9) to give the 
1 la,l 7P-diacetate 77 (150 mg, 74%), m.p. 156-157 °C (from methanol); [a]o -101 ° (c 0.9) 
[Found: C, 72.8; H, 7.7%; ~. 352 (M-HOAc). C2sH320s requires C, 72.8; H, 7.8%; 
M, 412]; Ymaxlcm-1 1724 (C=O); 8H (200 MHz) 0.92 (3H, s, 13P-Me), 1.93 and 2.03 (both 
3H, s, 1 la-OAc and l 7p-0Ac), 2.70 (3H, m, 9a-H, 6-H2), 3.70 (3H, s, 3-0Me), 5.30 (lH, 
td, J2 x 10.5 and 5.6 Hz, llP-H), 6.62 (2H, m, 2-H and 4-H) and 6.95 (lH, d, J9.4 Hz, 
1-H); 8c (50 MHz) 14.5 (13P-Me), 21.4 and 21.7 (Ila-, 17P-OC(O)CH3), 22.8 (C-7), 27.8 
(C-172), 28.7 (C-171), 29.2 (C-6), 32.0 (C-15), 32.4 (C-16), 33.5 (C-12), 39.0 (C-8), 41.2 
(C-9), 44.7 (C-13), 49.2 (C-14), 55.1 (3-0Me), 74.1 (C-11), 89.1 (C-17), 111.1 (C-2), 
113.8 (C-4), 125.3 (C-1), 132.2 (C-10), 139.3 (C-5), 157.8 (C-3), 170.7 and 170.8 
(I la-, 17P-OC(O)CH3). 
14,17a-Ethanoestra-1,3,5(10)-triene-3,l la,17P-triol 78 
A solution of the 1 la,I 7p-diacetate 77 (150 mg, 0.4 mmol), chlorotrimethylsilane (0.05 
cm3; 0.4 mmol) and sodium iodide (60 mg, 0.4 mmol) in dry acetonitrile (5 cm3) was 
stirred for 18h at 25°C, followed by 8h at reflux. Water (l O cm3) was added and the 
mixture was extracted into ethyl acetate. The combined organic phase was washed (satd. 
aq. Na2S203, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue ( 150 mg) which was dissolved in methanolic potassium hydroxide (1 %, 20 cm3) 
and was stirred for 50h at 25°C. Saturated aqueous ammonium chloride was added and the 
mixture was extracted into ethyl acetate. The combined organic phase was washed (brine), 
191 
dried (MgS04) and evaporated under reduced pressure to give a residue (120 mg) which 
was adsorbed onto silica gel (12 g) and eluted with methanol-chloroform (1 :9) to give the 
3,l la,17P-trio/ 78 (74 mg, 65%), m.p. 257-260°C (from ethyl acetate); [a]o -65° (c 0.8 in 
THF) (Found: M\ 314.188. C20H2603 requiresM, 314.188). 
l 7p-Hydroxy-3-methoxy-14,17a-ethanoestra-1,3,5(1 O)-trien-11-one 79 
A solution of DMSO (0.7 cm3, 9 mmol) in dry dichloromethane (5 cm3) was added to a 
solution of oxalyl chloride (2 mol dm"3 in dichloromethane, 1.5 cm3, 3 mmol) at -78°C. 
After stirring for 5 min at -78°C, 3-methoxy-14,17a-ethanoestra-1,3,5(10)-
triene-lla,17P-diol 76 (780 mg, 2.4 mmol) in dry dichloromethane (10 cm3) was added 
and the mixture stirred for 20 min at -78°C. Triethylamine (1.7 cm3, 12 mmol) was added 
and the mixture allowed to warm to 25°C. Water (20 cm3) was added and the mixture 
extracted with dichloromethane. The combined organic phase was washed [aq. HCl (3 mol 
dm·3), water, satd. aq. Na2C03, water), dried (MgS04) and evaporated to give a residue 
(600 mg) which was adsorbed onto silica gel (80 g) and eluted with ethyl acetate-toluene 
(1 :4) under pressure to give the I I-ketone 79 (450 mg, 58%), as an oil (Found: M\ 326. 
C21H2603 requires M, 326); Vmai/cm·1 1709 (C=O); DH (200 MHz) 0.79 (3H, s, 13P-Me), 
3.70 (3H, s, 3-0Me), 3.80 (IH, d, J 12 Hz, 9a-H), 6.55 (IH, d, J 2.6 Hz, 4-H), 6.69 (lH, 
dd, J 8.5 and 2.6 Hz, 2-H) and 7.22 (lH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 14.2 (13p-Me), 
24.2 (C-7), 27.1 (C-172), 30.3 (C-6), 31.4 (C-15), 33.1 (C-171), 35.5 (C-16), 43.4 (C-8), 
46.5 (C-12), 47.3 (C-13), 50.0 (C-9), 53.4 (C-14), 55.2 (3-0Me), 82.9 (C-17), 111.5 (C-2), 
113.8 (C-4), 123.9, 131.5 (C-1, C-10), 138.2 (C-5), 157.9 (C-3) and 210.3 (C-11). 
Treatment of the I I-ketone 79 with hydrochloric acid (10 mol dm-3, 0.2 cm3) in methanol 
(5 cm3) at reflux for 15 min 54 afforded unchanged material 79. 
Treatment of the I I-ketone 79 with piperidine at reflux for 15 min, 54 or with methanolic 
potassium hydroxide (1 %) at reflux for lh 100 afforded a complex mixture of products. 
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3-Methoxy-14,17a-ethanoestra-1,3,5(10)-triene-11 P, 17P-diol 73 
LAH (1 g, 26 mmol) was added to a solution of the II-ketone 79 (513 mg, 1.6 mmol) in 
THF (20 cm3) and the mixture was stirred for lh at 25°C. Ethyl acetate (20 cm3) was 
added and once effervescence ceased (10 min) the mixture was extracted with ethyl acetate. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give a residue (424 mg) which was flash chromatographed on 
silica gel (50 g) with ethyl acetate-toluene (1 :4) affording an unidentified product (72 mg) 
followed by the 11 p, l 7p-diol 73 (280 mg, 54%), identical in all respects with that 
synthesised previously. 
l l-Oxo-14,17a-ethanoestra-1,3,5(10),6,8-pentaene-3,17P-diyl diacetate 80 
To a solution of 14,17a-ethanoestra-1,3,5(10)-triene-3,17P-diyl diacetate 61 (1.29 g, 3.3 
mmol) in a mixture of acetic acid (90 cm3) and water (10 cm3) was added eerie ammonium 
nitrate (16.3 g, 29.7 mmol) and the mixture was stirred for 1 h at 25°C. Ice and solid 
sodium hydrogen carbonate were added, and once effervescence ceased the mixture was 
extracted into diethyl ether. The combined organic phase was washed (satd. aq. NaHC03, 
water, brine), dried (MgS04) and evaporated under reduced pressure to give a crude residue 
(1.18 g) which was adsorbed onto silica gel (100 g) and eluted with ethyl acetate-toluene 
(1:19) to give the 11-ketone 80 (740 mg, 57%), m.p. 157-160 °C (from methanol); 
[a]o -46° (c 0.5) (lit., 123 m.p. 169-170°C [a]o -48°) (Found: M\ 392. C24H2405 requires 
M, 392); Vmaxlcm·1 1755, 1731 (C=O); DH (200 MHz) 0.99 (3H, d, J l.2 Hz, 13P-Me), 2.06 
(3H, s, 17P-0Ac), 2.34 (3H, s, 3-0Ac), 2.61 (lH, d, J 18 Hz, 12P-H), 3.20 (lH, dd, J 18 
and 1.2 Hz, 12a-H), 7.32 (lH, d, J 8.5 Hz, 7-H), 7.36 (lH, dd, J 9.5 and 2.5 Hz, 2-H), 7.55 
(IH, d, J 2.5 Hz, 4-H), 7.95 (lH, d, J 8.5 Hz, 6-H) and 9.41 (IH, d, J 9.5 Hz, 1-H); 8c 
(50 MHz) 16.1 (13P-Me), 21.2 (3-0C(O)CH3), 21.4 (17P-OC(O)CH3), 31.2 (C-172), 31.7 
(C-171), 32.3 (C-15), 39.9 (C-16), 45.6 (C-12), 46.0 (C-13), 51.0 (C-14), 88.8 (C-17), 
118.9 (C-4), 123.8 (C-2), 124.7 (C-7), 128.4 (C-1), 134.5 (C-6), 148.2 (C-3), 125.1 (C-9), 




A solution of the 3, l 7p-diacetate 80 (756 mg, 1.9 mmol) in methanolic potassium 
hydroxide (3%, 30 cm3) was stirred at 25°C for 2 h. Saturated aqueous ammonium 
chloride (20 cm3) was added and the mixture was extracted into ethyl acetate (3x). The 
combined organic phase was washed (water, brine), dried (MgS04) and evaporated under 
reduced pressure to afford a residue (649 mg) which was dissolved in acetone (20 cm3) and 
stirred with dimethyl sulfate (0.5 cm3, 5.3 mmol) and anhydrous potassium carbonate (1 g) 
for 18 h. Aqueous ammonia (25%, 1 cm3) was added and the mixture was stirred for 1 h, 
poured into water (30 cm3) and extracted with ethyl acetate. The combined organic phase 
was washed (water, brine), dried (MgS04) and evaporated under reduced pressure to afford 
a residue (1.2 g). This was chromatographed on silica gel (75 g) with ethyl acetate-toluene 
(1 :4) as eluent to afford the 3-methyl ether 81 (353 mg, 56%), m.p. 138-140°C (from 
acetone-hexane); [a]o -59° (c 0.6) (Found: C, 78.0; H, 7.0%; M\ 322. C21 H2203 requires 
C, 78.2; H, 6.9%; M, 322); Vmaxlcm·1 1658 (C=O); 8H (200 MHz) 0.98 (3H, d, J 1.2 Hz, 
BP-Me), 1.75 (lH, br. s, D20 exch., 17P-OH), 2.55 (lH, d, J 18 Hz, 12P-H), 2.98 (lH, dd, 
J 18 and 1.2 Hz, 12a-H), 3.92 (3H, s, 3-0Me), 7.12 (lH, d, J 2.9 Hz, 4-H), 7.26 (lH, d, J 
8.3 Hz, 7-H), 7.29 (lH, dd, J 9.6 and 2.9 Hz, 2-H), 7.90 (lH, d, J 8.3 Hz, 6-H) and 9.30 
(lH, d, J 9.6 Hz, 1-H); 8c (50 MHz) 15.7 (13p-Me), 31.3 (C-172), 34.6 (C-1 ?1), 35.8 
(C-15), 39.3 (C-16), 45.2 (C-12), 47.9 (C-14), 49.9 (C-13), 55.2 (3-0Me), 83.9 (C-17), 
106.6 (C-4), 121.0 (C-2), 124.1 (C-7), 125.2 (C-9), 126.9 (C-10), 128.2 (C-1), 133.6 (C-6), 
134.4 (C-5), 146.5 (C-8), 157.2 (C-3) and 200.7 (C-11); 8H (400MHz, C6D6) 0.84 (3H, d, J 
1.2 Hz, 13P-Me), 2.00 (lH, br. s, 17P-OH), 2.63 (lH, d, J 17.6 Hz, 12P-H), 2.88 (lH, dd, J 
17.6 and 1.2 Hz, 12a-H), 3.39 (3H, s, 3-0Me), 6.95 (lH, d, J 2.9 Hz, 4-H), 7.04 (lH, d, J 
8.3 Hz, 7-H), 7.39 (lH, dd, J 9.6 and 2.9 Hz, 2-H), 7.65 (lH, d, J 8.3 Hz, 6-H) and 9.93 
(lH, d, J9.6 Hz, 1-H); 8c (100 MHz, C6D6) 15.7 (13P-Me), 31.5 (C-1?2), 34.7 (C-171), 
36.0 (C-15), 39.4 (C-16), 45.8 (C-12), 47.9 (C-14), 50.2 (C-13), 54.7 (3-0Me), 83.6 
(C-17), 107.0 (C-4), 121.4 (C-2), 124.4 (C-7), 125.7 (C-9), 126.9 (C-10), 129.1 (C-1), 
133.7 (C-6), 135.0 (C-5), 146.8 (C-8), 157.8 (C-3) and 200.4 (C-11). 
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3-Methoxy-11-oxo-14,17a-ethanoestra-1,3,5(10),8-tetraen-17P-ol 82 
To a stirred solution of sodium (1 g, 43.5 mmol) in ammonia (20 cm3, freshly distilled 
from sodium) was added the 11-oxo pentaene 81 (137 mg, 0.4 mmol) in dry THF (10 cm\ 
After stirring for 15 min at -33°C, t-butyl alcohol (5 cm3) was added dropwise over a 
period of 120 min with stirring at -33°C. The mixture was stirred until the blue colour 
faded (60 min). Water (20 cm3) was added and the ammonia allowed to evaporate. The 
resulting mixture was extracted with ethyl acetate, the combined organic phase was washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a crude 
residue (144 mg). This was chromatographed on silica gel (25 g) with ethyl acetate-toluene 
(1 :4) as eluent to give starting material 81 (31 mg, 23%), followed by the tetraene 82 
(95 mg, 68%), m.p. 171-173°C (from acetone-hexane); [a]o -32° (c 0.5) (Found: C, 77.6; 
H, 7.5%; M\ 324. C21H2403 requires C, 77.7; H, 7.5%; M, 324); Vmru/cm-1 1654 (C=O); 
DH (400 MHz) 1.00 (3H, d, J 1.2 Hz, 13P-Me), 2.40 (lH, d, J 17 Hz, 12P-H), 2.74 (IH, dd, 
J 17 and 1.2 Hz, 12a-H), 3.79 (3H, s, 3-0Me), 6.70 (lH, d, J 2.7 Hz, 4-H), 6.78 (lH, dd, J 
8.6 and 2.7 Hz, 2-H) and 7.97 (IH, d, J 8.6 Hz, 1-H); De (100 MHz) 15.4 (13P-Me), 25.6 
(C-7), 28.0 (C-172) 29.7 (C-1?1) 34.1 (C-15), 35.5 (C-16), 37.4 (C-6), 44.0 (C-12), 48.8 
(C-13), 49.9 (C-14), 55.3 (3-0Me), 83.6 (C-17), 111.0 (C-2), 113.3 (C-4), 124.0 (C-10), 
128.3 (C-1), 137.6 (C-5), 156.1 (C-9), 157.3 (C-3), 167.0 (C-8) and 200.3 (C-11). 
14,17a-ethano-8a-estra-1,3,5(10)-triene-3,17P-diyl diacetate 83 
14, 17a-Ethano-8a-estra-l ,3,5(10)-triene-3, 17P-diol 26 ( 40 mg, 0.1 mmol) and toluene-p-
sulfonic acid ( 10 mg) were dissolved in a mixture of acetic anhydride (2 cm3) and THF 
(2 cm3) and the mixture was stirred for 18h. Saturated aqueous sodium hydrogen carbonate 
was added and once effervescence ceased the mixture was extracted into ethyl acetate. The 
combined organic phase was washed [satd. aq. NaHC03, aq. HCl (1 mol dm·3), water, 
brine], dried (MgS04) and evaporated under reduced pressure to give a residue (110 mg) 
which was chromatographed on silica gel (5 g) with ethyl acetate-toluene ( 1: 19) as eluent 
to give the 3,17P-diacetate 83 (46 mg, 90%), m.p. 187-189°C (from methanol); [a]o-42° 
(c 0.2) (Found: C, 75.1; H, 8.1%; M\ 382. C24H3004 requires C, 75.4; H, 7.9%; M, 382); 
Ymaxlcm-1 1731 (C=O); DH (200 MHz) 1.02 (3H, s, 13P-Me), 2.01 (3H, s, 17P-OC(O)CH3), 
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2.28 (3H, s, 3-0C(O)CH3), 6.78 (lH, d, J 2.3 Hz, 4-H), 6.84 (lH, dd, J 8.3 and 2.3 Hz, 
2-H) and 7.16 (lH, d, J 8.3 Hz, 1-H); 8c (50 MHz) 15.8 (13P-Me), 20.5 (3-0C(O)CH3), 
21.1 (l 7p-OC(O)CH3), 21.6 (C-7), 28.1 (C-11), 28.5 (C-15), 29.5 (C-12), 30.7 (C-6), 30.9 
(C-172), 31.6 (C-16), 32.9 (C-171), 36.5 (C-8), 38.3 (C-9), 45.0 (C-14), 46.7 (C-13), 90.0 
(C-17), 118.7 (C-2), 121.1 (C-4), 130.6 (C-1), 137.8 (C-10), 139.1 (C-5), 148.2 (C-3), 
169.8 (17-0C(O)CH3) and 170.9 (3-0C(O)CH3). 
6-0xo-14a,17a-ethano-8a-estra-1,3,5(1 O)-trien-3,17P-diyl diacetate 84 
The 3,17P-diacetate 83 (90 mg, 0.2 mmol) was dissolved in a solution of DMD 
(0.1 mol dm"3 in acetone, 20 cm3, 2 mmol) and was stirred for 120h at 25°C. The solution 
was evaporated under reduced pressure to give a crude residue (95 mg) which was filtered 
through silica gel (10 g) with ethyl acetate-hexane (1 :9) to give the 6-ketone 84 ( 44 mg, 
47%), m.p. 178-180°C (from methanol); [a]o +5° (c 0.3) (Found: C 73.1; H, 7.3%; 
M\ 396. C24H2sOs requires C 72.7; H, 7.1 %; M, 396); Yma·Jcm·1 1731 (C=O); 8H (200 
MHz) 1.08 (3H, s, 13P-Me), 2.02 (3H, s, 17P-OC(O)CH3), 2.30 (3H, s, 3-0C(O)CH3), 
7.25 (lH, dd, J8.5 and 2.5 Hz, 2-H), 7.36 (lH, d,J8.5 Hz, 1-H) and 7.69 (lH, d, J2.5 Hz, 
4-H); 8c (50 MHz) 16.0 (13P-Me), 21.0 (3-0C(O)CH3), 21.5 (17p-OC(O)CH3), 27.2 
(C-7), 28.0 (C-11), 29.1 (C-15), 30.3 (C-12), 31.5 (C-172), 32.3 (C-16), 36.5 (C-1?1), 36.6 
(C-8), 36.9 (C-9), 44.7 (C-14), 47.0 (C-13), 89.6 (C-17), 119.4 (C-2), 127.2 (C-4), 130.8 
(C-1), 132.4 (C-10), 145.8 (C-5), 149.2 (C-3), 169.4 (17-0C(O)CH3), 170.7 (3-0C(O)CH3) 
and 197.4 (C-6). 
14-Ethyl-l 7-oxo-14P-estra-1,3,5(10)-trien-3-yl acetate 86 
A solution of 14-ethyl-3-methoxy-14P-estra-1,3,5(10)-trien-17-one 85 136 (628 mg, 
2 mmol) in acetonitrile (15 cm3) was added to a mixture of chlorotrimethylsilane (0.5 cm3, 
4 mmol) and sodium iodide (600 mg, 4 mmol) in acetonitrile (20 cm3) and the mixture was 
refluxed for 96h. Water was added and the resulting mixture was extracted into 
chloroform. The combined organic phase was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a residue (700 mg) which was dissolved in a 
mixture of THF (8 cm3) and acetic anhydride (5 cm3). Toluene-p-sulfonic acid (200 mg) 
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was added and the mixture was stirred for 18h at 25°C. Saturated aqueous sodium 
hydrogen carbonate was added and once effervescence ceased the mixture was extracted 
into ethyl acetate. The combined organic phase was washed (water), dried (MgS04) and 
evaporated under reduced pressure to give a residue (1 g) which was adsorbed onto silica 
gel (50 g) and eluted with ethyl acetate-toluene (1: 19) to give starting material 85 
(26 mg, 4%) followed by the 3-acetate 86 (475 mg, 70%), m.p. 132-135°C (from 
chloroform-methanol); [a.]o +62° (c 0.3) (Found: C, 77.3; H, 8.3%; M\ 340. C22H2s03 
requires C, 77.6; H, 8.3%; M, 340); Ymaxlcm·1 1725 (C=O); 8H (200 MHz) 0.85 (3H, t, J 2 x 
7.5 Hz, 142-H3), 1.06 (3H, s, 13p-Me), 2.27 (3H, s, 3-0Ac), 6.82 (lH, d, J 2.6 Hz, 4-H), 
6.86 (lH, dd, J 8.7 and 2.6 Hz, 2-H) and 7.30 (lH, d, J 8.7 Hz, 1-H); 8c (50 MHz) 10.0 
(C-142), 15.5 (13P-Me), 21.1 (3-0C(O)CH3), 23.4 (C-7), 25.3 (C-11), 25.5 (C-15), 30.2 
(C-141), 30.5 (C-6), 33.0 (C-12), 33.7 (C-16), 38.2 (C-9), 41.1 (C-8), 46.4 (C-13), 52.5 
(C-14), 118.7 (C-2), 121.3 (C-4), 126.5 (C-1), 138.0 (C-5), 138.1 (C-10), 148.5 (C-3), 
169.7 (3-0C(O)CH3) and 222.6 (C-17). 
3-Methoxy-15P-phenylthioestra-1,3,5(10)-trien-17-one 88 
A solution of 3-methoxyestra-1,3,5(10),15-tetraen-17-one 87 141 (644 mg, 2.3 mmol) and 
ethyldiisopropylamine (0.5 cm3, 2.9 mmol) in thiophenol (5 cm3, 47.5 mmol) was stirred 
for 3h in a stoppered flask. The mixture was adsorbed onto silica gel (55 g) and eluted 
with ethyl acetate-toluene (1 :99) to give thiophenol, followed by the 15P-phenylthio 
17-ketone 88 (832 mg, 93%), m.p. l 12-115°C (from diisopropyl ether); [a.]o +83° (c 0.4) 
(Found: C, 76.2; H, 7.2; S, 8.0%; M\ 392. C25H2802S requires C, 76.5; H, 7.2; S, 8.2%; 
M, 392); Ymaxlcm·1 1734 (C=O); 8H (400 MHz, C6D6) 1.12 (3H, s, 13P-Me), 1.42 (IH, dd,J 
11.2 and 7.0, 14a.-H), 1.76 (IH, qd, J 3 x 11.2 and 2.4 Hz, 8P-H), 2.36 (IH, dd, J 19.6 and 
8.0 Hz, 16P-H), 2.66 (lH, dd, J 19.6 and 1.6 Hz, 16a.-H), 3.42 (3H, s, 3-0Me), 3.49 (lH, 
ddd, J 8.0, 7.0 and 1.6 Hz, 15a.-H), 6.70 (lH, d, J2.1 Hz, 4-H), 6.81 (lH, dd, J 8.6 and 2.1 
Hz, 2-H), 7.10 (lH, d, J8.6 Hz, 1-H) and 6.94-7.20 (5H, m, 15P-SC~5); 8c (100 MHz) 
17.0 (13p-Me), 25.5 (C-11), 26.6 (C-7), 29.4 (C-6), 33.1 (C-12), 36.5 (C-8), 43.7 (C-15), 
44.4 (C-9), 46.6 (C-16), 47.8 (C-13), 53.7 (C-14), 55.2 (3-0Me), 111.5 (C-2), 113.9 (C-4), 
126.1 (C-4'), 126.7 (C-1), 129.2 (C-2' and C-6'), 130.3 (C-3' and C-5'), 131.9 (C-10), 136.8 
(C-5), 137.8 (C-1'), 157.7 (C-3) and 218.5 (C-17). 
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17a-Allyl-3-methoxy-15 p-phenylthioestra-1,3,5(1 O)-trien-17P-ol 89 
A solution of the 15P-phenylthio 17-ketone 88 (400 mg, 1.0 mmol) in THF (5 cm3) was 
added to a solution of allylmagnesium chloride [prepared from allyl chloride (0.5 cm\ 
magnesium (150 mg) and catalytic iodine] in THF (5 cm3) and the mixture was stirred 
for 3h. Saturated aqueous ammonium chloride was added and the mixture was extracted 
into ethyl acetate. The combined organic phase was washed (water, brine), dried (MgS04) 
and evaporated under reduced pressure to give a crude product (433 mg) which was 
recrystallised from methanol to give the 17a-allyl 17P-alcohol 89 (341 mg, 77%). The 
mother liquor was adsorbed onto silica gel (4 g) and eluted with ethyl acetate-hexane (1 :9) 
to give further product 89 (26 mg, 6%), m.p. 68-70°C (from methanol); [a]o +12° (c 0.3) 
(Found: C, 77.2; H, 8.1; S, 7.1%; M\ 434. C2sH3402S requires C, 77.4; H, 7.9; S, 7.4%; 
M, 434); Vmaxlcm·1 3607 (OH); DH (400 MHz) 1.23 (3H, s, 13p-Me), 1.62 (lH, s, D20 
exch., 17p-OH), 3.60-3.70 (IH, m, 15a-H), 3.79 (3H, s, 3-0Me), 5.20 (2H, m, 1?3-H2), 
5.88-6.20 (lH, m, 1 ?2-H), 6.66 (lH, d, J2.I Hz, 4-H), 6.74 (lH, dd, J 8.6 and 2.1 Hz, 2-H) 
and 7.18-7.40 (6H, m, 1-H and 15P-SCJ!s); De (100 MHz) 17.0 (13P-Me), 25.7 (C-11), 
27.9 (C-7), 29.5 (C-6), 32.5 (C-12), 37.2 (C-8), 41.0 (C-1?1), 44.2 (C-9), 45.1 (C-15), 46.6 
(C-13), 47.5 (C-16), 52.7 (C-14), 55.2 (3-0Me), 82.5 (C-17), 111.4 (C-2), 113.9 (C-4), 
119.4 (C-173), 126.0 (C-4'), 126.l (C-1), 128.9 (C-2' and C-6'), 129.8 (C-3' and C-5'), 
132.4 (C-10), 134.4 (C-172). 138.0 (C-5), 138.l (C-1') and 157.6 (C-3). 
Attempted cyclisation of 17a-allyl lSP-phenylthio 17P-alcohol 89 
a) To a solution of the 17a-allyl 15P-phenylthio 17P-alcohol 89 (97 mg, 0.2 mmol) and 
AIBN (10 mg) in dry, deoxygenated toluene (IO cm3) was added tributylstannane (1 cm3) 
and the mixture was refluxed for 3 h. The solvent was removed under reduced pressure 
and the residue (1.3 g) was chromatographed on silica gel (30 g) with ethyl acetate-toluene 
(I: 19) as eluent to give starting material 89 (19 mg, 20%) followed by an inseparable 
mixture of 17a-allyl-3-methoxyestra-1,3,5(1 O)-trien-l 7p-ol 90 and 17a-allyl-
3-methoxyestra-1,3,5(10), 14-tetraen-17P-ol 91 (37 mg), mlz 324 and 326, DH (200 MHz) 
(90, ca. 70%) 0.93 (3H, s, 3-0Me), 3.78 (3H, s, 3-0Me), 5.20 (2H, m, 1?3-H2), 5.85-6.15 
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(lH, m, 1 ?2-H), 6.64-6.74 (2H, m, 2- and 4-H) and 7.24 (lH, br. d, J 9 Hz, 1-H); DH (200 
MHz) (91, ca. 30%) 0.96 (3H, s, 13p-Me), 3.78 (3H, s, 3-0Me), 5.20 (2H, m, li-H2), 5.68 
(lH, dd, J 6.0 and 3.2 Hz, 15-H), 5.85-6.15 (IH, m, 1 i-H), 6.64-6.74 (2H, m, 2- and 4-H) 
and 7.24 (IH, br. d, J9 Hz, 1-H). 
b) A solution of the 17a-allyl 15P-phenylthio 17J3-alcohol 89 (54 mg, 0.1 mmol) in THF 
(10 cm3) was added to a solution of sodium (150 mg, 6.5 mmol) in freshly distilled 
ammonia (10 cm3) at -33°C and the mixture was stirred at -33°C for 2h. The ammonia was 
allowed to evaporate, water was added and the resulting mixture was extracted into ethyl 
acetate. The combined organic phase was washed (water), dried (MgS04) and evaporated 
under reduced pressure to give a residue (18 mg) which was chromatographed on silica gel 
(3 g) with ethyl acetate-hexane (1 :9) as eluent to give 17a-allyl-3-methoxyestra-1,3,5(1 O)-
trien-17P-ol 90 (11 mg, 28%), m.p. 90-91 °C (from diethyl ether-hexane); [a]o +62° (c 0.2) 
(lit., 146 91-91.5°C, [a]o +57.4°) (Found: M+, 326. C22H3002 requires M, 326); DH (200 
MHz) 0.93 (3H, s, 13P-Me), 2.84 (2H, m, 6-H2), 3.78 (3H, s, 3-0Me), 5.20 (2H, m, 
1 i-H2), 5.90-6.15 (IH, m, 1 ?2-H), 6.64 (IH, d, J2.7 Hz, 4-H), 6.72 (lH, dd, J 8.6 and 2.7 
Hz, 2-H) and 7.22 (lH, d, J8.6 Hz, 1-H). 
17a-Allyl-3-methoxyestra-1,3,5(10),15-tetraen-17P-ol 92 
A solution of 3-methoxyestra-1,3,5(10),15-tetraen-17-one 87 (2.0 g, 7.1 mmol) in THF 
( 40 cm3) was added to a solution of allylmagnesium bromide [prepared from allyl bromide 
(6 cm3, 69.3 mmol), magnesium (1.6 g, 66.7 mmol) and catalytic iodine] in diethyl ether 
(20 cm3). The resulting solution was refluxed for 90 min. Saturated aqueous ammonium 
chloride was added to the cooled reaction mixture, and once effervescence had ceased the 
mixture was extracted into ethyl acetate. The combined organic extracts were washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to afford the product 
92 (2.24 g), a portion of which was chromatographed and recrystallised for characterisation 
purposes: m.p. 112-113°C (from methanol); [a]o -76° (c 0.7) [lit., 157 I06-108°C (from 
acetone-hexane); [a]o -76.8°] (Found: C, 81.5; H, 8.7%; M\ 324. C22H280 2 requires 
C, 81.4; H, 8.7%; M, 324); Vmaxlcm· 1 3607 (OH); DH (200 MHz) 0.95 (3H, s, 13J3-Me), 1.85 
(I H, s, D20 exch., 17J3-0H), 2.90 (2H, m, 6-H2), 3. 79 (3H, s, 3-0Me), 5.20 (2H, m, Wv, 18 
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Hz, 1 i-H2), 5.67 (IH, dd, J 6.0 and 3.2 Hz, 15-H), 5.82-6.00 (lH, m, 172-H), 5.99 (lH, 
dd, J 6.0 and 1.6 Hz, 16-H), 6.65 (IH, d, J 2.7 Hz, 4-H), 6.73 (IH, dd, J 8.5 and 2.7 Hz, 
2-H) and 7.21 (IH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 15.0 (13P-Me), 26.0 (C-11), 27.8 (C-7), 
29.6 (C-6), 30.6 (C-12), 36.7 (C-li), 37.9 (C-8), 44.5 (C-9), 51.4 (C-13), 55.2 (3-0Me), 
56.3 (C-14), 86.0 (C-17), 111.4 (C-2), 113.9 (C-4), 118.6 (C-173), 126.0 (C-1), 130.8 
(C-15), 132.5 (C-10), 134.9 (C-16), 137.6 (C-172), 137.8 (C-5) and 157.5 (C-3). 
15a-Allyl-3-methoxyestra-1,3,5(10)-trien-17-one 93 
A solution of the l 7a-allyl l 7p-alcohol 92 (2.2 g, 6.9 mmol) in dry 1,4-dioxan (25 cm3) 
was added to a suspension of potassium hydride [ 4g of 35% suspension in mineral oil, 
35 mmol; pre-washed with hexane (3 x 10 cm3) and treated with a solution of iodine 
(440 mg, 3.5' mmol) 190 in dry 1,4-dioxan (2 cm3)] and 18-crown-6 (50 mg, 0.2 mmol) in 
dry 1,4-dioxan (15 cm3) and the resulting mixture was refluxed for 1 h. To the cooled (0°C) 
suspension was added saturated aqueous ammonium chloride. After the effervescence 
ceased, the mixture was extracted with ethyl acetate. The combined organic phase was 
washed (satd. aq. Na2S203, water, brine), dried (MgS04) and evaporated under reduced 
pressure to give a residue (2.63 g) which was flash chromatographed on silica gel (180 g) 
with toluene affording the 15a-allyl 17-ketone 93 (1.93 g, 86%) followed by a mixture of 
products (320 mg) which was rechromatographed on silica gel (30 g) with ethyl acetate-
hexane (1 :4) as eluent affording further 15a-allyl 17-ketone 93 (171 mg, 8%), m.p. 91-
930C (from ethanol); [a]o +251 ° (c 0.5) [lit., 157 79-80°C (from acetone-hexane); [a]o 
+211.4°] (Found: C, 81.4; H, 8.7%; M\ 324. C22H2s02 requires C, 81.4; H, 8.7%; 
M, 324); Vmaxfcm·1 1728 (C=O); DH (400 MHz) 0.97 (3H, s, I3P-Me), 1.33 (IH, t, J 2 x 
10.8 Hz, 14a-H), 1.65 (lH, dd, J 19.4 and 7.8 Hz, 16P-H), 1.80 (IH, qd, J 10.8 and 2.7 Hz, 
8f3-H), 2.02 (IH, td, J 11.0 and 4.2 Hz, 15 1-H1), 2.71 (IH, dd, J 19.4 and 8.7 Hz, 16a-H), 
2.88 (2H, m, 6-H2), 3.77 (3H, s, 3-0Me), 4.95 (2H, m Wy, 26 Hz, 15
3-H2), 5.52-5.63 (lH, 
m, 152-H), 6.62 (IH, d, J2.7 Hz, 4-H), 6.72 (IH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.20 (IH, 
d, J 8.5 Hz, 1-H); 8c (100 MHz) 15.7 (13f3-Me), 26.5 (C-11), 27.9 (C-7), 30.0 (C-6), 31.6 
(C-12), 35.5 (C-15), 39.7 (C-8), 40.4 (C-15 1), 42.6 (C-16), 44.2 (C-9), 50.4 (C-13), 54.1 
(C-14), 55.2 (3-0Me), 111.8 (C-2), 113.6 (C-4), 116.6 (C-153), 126.8 (C-1), 131.8 (C-10), 
136.3 (C-152), 137.3 (C-5), 157.6 (C-3) and 219.5 (C-17). 
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17a.-Methallyl-3-methoxyestra-1,3,5(10),15-tetraen-17P-ol 94 
A solution of 3-methoxyestra-1,3,5(10),15-tetraen-17-one 87 (100 mg, 0.4 mmol) in THF 
(5 cm3) was added to a solution of methallylmagnesium chloride [prepared from methallyl 
chloride (0.4 cm3, 3.5 rnmol), magnesium (85 mg, 3.5 rnmol) and catalytic iodine] in 
diethyl ether (2 cm3) and the resulting mixture was stirred for 30 min at 25°C. Saturated 
aqueous ammonium chloride was added to the cooled reaction mixture, and the resulting 
mixture was extracted into ethyl acetate. The combined organic extracts were washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a crude 
residue (103 mg) which was adsorbed onto silica gel (10 g) and eluted with ethyl acetate-
hexane (1 :9) affording the l 7a.-methallyl l 7P-alcohol 94 (85 mg, 72%), m.p. 70-73 °C 
(from methanol); [a.]o-68° (c 0.3) (Found: C, 81.6; H, 9.1%; M\ 338. C23H300 2 requires 
C, 81.6; H, 8.9%; M, 338); Vmru/cm·1 3605 (OH); 8H (200 MHz) 0.95 (3H, s, BP-Me), 1.83 
(3H, s, 172-Me), 2.10 (lH, s, D20 exch., 17p-OH), 2.95 (2H, m, 6-H2), 3.79 (3H, s, 
3-0Me), 4.90 (lH, br. s, 1 i-H), 4.96 (lH, br. s, 1 i-H), 5.66 (lH, dd, J 6.0 and 3.1 Hz, 
15-H), 5.95 (lH, dd, J 6.0 and 1.6 Hz, 16-H), 6.62 (lH, d, J 2.7 Hz, 4-H), 6.71 (lH, dd, J 
8.5 and 2.7 Hz, 2-H) and 7.20 (lH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 15.0 (13P-Me), 25.0 
(Ii-Me), 26.0 (C-11), 27.8 (C-7), 29.6 (C-6), 30.4 (C-12), 36.7 (C-171), 40.9 (C-8), 44.4 
(C-9), 52.0 (C-13), 55.2 (3-0Me), 56.0 (C-14), 85.6 (C-17), 111.4 (C-2), 113.9 (C-4), 
114.8 (C-173), 126.0 (C-1), 130.1 (C-15), 132.6 (C-10), 137.8 (C-5), 138.0 (C-16), 143.7 
(C-li) and 157.5 (C-3). 
15a.-Methallyl-3-methoxyestra-1,3,5(1 O)-trien-17-one 95 
The 17a.-methallyl l 7p-alcohol 94 (78 mg, 0.2 mmol) in dry 1,4-dioxan (5 cm3) was added 
to a suspension of potassium hydride [300 mg of 35% suspension in mineral oil, 2.5 mmol; 
washed with hexane (3 x 1 cm3) and treated with iodine (64 mg, 0.25 mmol in dry 
1,4-dioxan (1 cm3)] and 18-crown-6 (10 mg, 0.1 mmol) in dry 1,4-dioxan (5 cm3) and the 
mixture was refluxed for 30 min. To the cooled (0°C) suspension was added saturated 
aqueous ammonium chloride and once effervescence ceased, the mixture was extracted 
with ethyl acetate. The combined organic phase was washed (satd. aq. Na2S203, water, 
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brine), dried (MgS04) and evaporated under reduced pressure to give a residue (112 mg) 
which was chromatographed on silica gel (5 g) with ethyl acetate-toluene (1 :99) to give the 
15a-methallyl 17-ketone 95 (58 mg, 75%), m.p. 129-130°C (from chloroform-methanol); 
[a]o+191° (c 0.2) (Found: C, 81.2; H, 9.1%; M+, 338. C23H3002 requires C, 81.6; H, 
8.9%; M, 338); Yma,/cm·1 1727 (C=O); DH (200 MHz) 0.99 (3H, s, 13P-Me), 1.30 (lH, t, J 
2 x 10.6 Hz, 14a-H), 1.74 (3H, s, 152-Me), 2.88 (2H, m, 6-H2), 3.78 (3H, s, 3-0Me), 4.69 
(IH, hr. s, 153-H), 4.75 (lH, br. s, 153-H), 6.62 (lH, d, J2.8 Hz, 4-H), 6.72 (IH, dd, J 8.6 
and 2.8 Hz, 2-H) and 7.21 (lH, d, J 8.6 Hz, 1-H); 8c (50 MHz) 15.8 (13P-Me), 22.5 
(C-152Me), 26.6 (C-11), 27.9 (C-7), 30.0 (C-6), 31.6 (C-12), 33.7 (C-15), 39.7 (C-8), 42.8 
(C-15 1), 44.3 (C-9), 45.5 (C-16), 50.5 (C-13), 55.2 (3-0Me), 55.4 (C-14), 111.6 (C-153), 
111.8 (C-2), 113.5 (C-4), 126.8 (C-1), 131.8 (C-10), 137.3 (C-5), 144.1 (C-152), 157.6 
(C-3) and 219.7 (C-17). 
lSP-Allyl-3-methoxyestra-1,3,5(10)-trien-17-one 96 
a) To a vigorously stirred solution of 3-methoxyestra-1,3,5(10), 15-tetraen-17-one 87 (50 
mg, 0.2 mmol) in dry dichloromethane (2 cm3) at -78°C was added titanium tetrachloride 
(0.1 cm3, 0.9 mmol) to give a brick-red solution which was stirred for 5 min. 
Allyltrimethylsilane (0.2 cm3, 1.0 mmol) in dry dichloromethane (I cm3) was added over 
15 min and the resultant purple solution was stirred for lh at -78°C. Ice-water was added 
and the mixture was extracted into ethyl acetate. The combined organic phase was washed 
(water, brine), dried (MgS04) and evaporated under reduced pressure to give a residue (51 
mg) which was adsorbed onto silica gel (5 g) and eluted with ethyl acetate-hexane (I :9) to 
give 15P-allyl-3-methoxyestra-l,3,5(10)-trien-17-one 96 (19 mg, 32%), m.p. 122-123 °C 
(from diisopropyl ether); [a]o +77° (c 0.9) [lit., 157 103-104°C (from hexane); [a]0 +81 °] 
(Found: C, 81.1; H, 8.8%; M\ 324. C22H2s02 requires C, 81.4; H, 8.7%; M, 324); 
Ymaxlcm·1 1725 (C=O); 8H (200 MHz) 1.05 (3H, s, 13P-Me), 2.90-3.00 (2H, m, 6-H2), 3.79 
(3H, s, 3-0Me), 5.04 (2H, m, 153-H2), 5.65-5.85 (IH, m, 15
2-H), 6.66 (IH, d, J 2.7 Hz, 
4-H), 6.73 (IH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.20 (lH, d, J 8.5 Hz, 1-H). 
b) Ethylaluminium dichloride (1.8 mo! dm·3 in toluene, 0.5 cm3, 0.9 mmol) was added to a 
solution of the ~ 15 17-ketone 87 (50 mg, 0.2 mmol) in dichloromethane (2 cm3) at -78°C 
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and the mixture was allowed to stir for 5 min. A solution of allyltrimethylsilane (0.2 cm3, 
1.0 mmol) in dichloromethane (I cm3) was added dropwise over 15 min and the resultant 
solution was stirred for 3h at -78°C and 1 hat 0°C. Work-up as in (a) afforded a residue 
(63 mg) which was adsorbed onto silica gel (5 g) and eluted with ethyl acetate-hexane (1 :9) 
to give the 15P-allyl 17-ketone 96 (32 mg, 55%), identical to that described previously. 
c) Tin tetrachloride (I mol dm"3 in dichloromethane, 0.9 cm3, 0.9 mmol) was added to a 
solution of the Li 15 17-ketone 87 (50 mg, 0.2 mmol) in dichloromethane (1 cm3) at -78°C 
and the mixture was allowed to stir for 5 min. A solution of allyltrimethylsilane (0.2 cm3, 
1.0 mmol) in dichloromethane (1 cm3) was added dropwise over 15 min and the resultant 
solution was stirred for 8h at -78°C and 25°C for 18h. Work-up as in (a) afforded a residue 
(85 mg) which was adsorbed onto silica gel (5 g) and eluted with ethyl acetate-hexane (I :9) 
to give the l 5P-allyl 17-ketone 96 (33 mg, 55%), identical to that described previously. 
d) Copper(!) iodide (200 mg, 1.05 mmol) and dry lithium chloride ( 450 mg, 1.05 mmol) 
were placed in a 25 cm3 flask which was evacuated and purged with nitrogen. This process 
was repeated three times, then THF(3 cm3) was added and the mixture was stirred for 5 
min to give a homogenous yellow solution which was cooled to -78°C. A solution of allyl 
lithium [prepared from allyltributyltin (0.3 cm3, I mmol) and methyl lithium (1.5 mol dm"3 
in diethyl ether, 0. 7 cm3, I mmol) in THF (I cm3) stirred at -78°C for 15 min] was then 
added in one portion to give a tan solution. To this solution was added 
chlorotrimethylsilane (0.1 cm3, 1.2 mmol) followed by the Li15 17-ketone 87 (50 mg, 0.2 
mmol) in THF (2 cm3) and the mixture was stirred for 4h at -78°C. Saturated aqueous 
ammonium chloride (10 cm3) was added and the mixture was extracted into ethyl acetate. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give a residue (80 mg) which was adsorbed onto silica gel (15 g) 
and eluted with ethyl acetate-hexane (I :9) to give tin residues followed by 3-methoxyestra-
1,3,5(10),14-tetraen-17-one 97 (11 mg, 22%), m.p. 100-103 °C (from methanol) (lit., 141 
I03-104°C); 8H (200 MHz) 1.16 (3H, s, 13p-Me), 3.79 (3H, s, 3-0Me), 5.61 (IH, m, 
15-H), 6.66 (lH, d, 12.7 Hz, 4-H), 6.73 (IH, dd, 18.5 and 2.7 Hz, 2-H) and 7.20 (IH, d, 1 
8.5 Hz, 1-H). Further elution with the same solvent afforded starting material 87 (13 mg, 
26%). 
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e) Copper(!) cyanide (90 mg, 1 mmol) was dried under vacuwn and then suspended in 
THF (0.9 cm3) and cooled to -78°C. Methyl lithiwn (1.5 mol dm"3 in diethyl ether, 1 cm3, 
1.5 mmol) was added and the mixture allowed to warm to 0°C, during which time the 
suspension dissolved to give a pale yellow solution. Allyltributyltin (0.6 cm3, 1.8 mmol) 
was added and the mixture was stirred at 0°C for 30 min and then cooled to -78°C. To the 
resulting orange-yellow solution was added the Li 15 17-ketone 87 (50 mg, 0.2 mmol) in 
THF (2 cm3) and the initially formed deep orange colour rapidly faded to the original 
orange-yellow colour. The mixture was stirred for a further 30 min at -78°C, then a 
mixture of saturated aqueous ammoniwn chloride and aqueous ammonia (10%) (1: 1) was 
added and the mixture allowed to warm up to 25°C. The resultant solution was extracted 
into diethyl ether, the combined organic phase was washed (water, brine), dried (MgS04) 
and evaporated under reduced pressure to give a residue (100 mg) which was combined 
with a similar residue from an identical experiment and the mixture was adsorbed onto 
silica gel (20 g) and eluted with ethyl acetate-toluene (1 :99) to give tin residues followed 
by an inseparable mixture of 15a-allyl-17-ketone 93 and 15P-allyl-17-ketone 96 (40 mg, 
33%) (ca. 1 :3). The composition of the mixture was estimated from the 1H NMR spectrum 
using the signals for the I3P-Me: 93, DH (200 MHz) 0.97 (3H, s, I3P-Me) and 96, 8H (200 
MHz) 1.05 (3H, s, 13P-Me). Further elution with the same solvent afforded the 17a-allyl 
17P-alcohol 92 (79 mg, 67%), m.p. 108-111 °C (from methanol). 
f) Copper(!) cyanide (90 mg, 1 mmol) was dried under vacuwn and then suspended in 
THF (0.9 cm3) and cooled to -78°C. Methyl lithiwn (1.5 mol dm·3 in diethyl ether, 1 cm3, 
1.5 mmol) was added and the mixture allowed to warm to 0°C, during which time the 
suspension dissolved to give a pale yellow solution. A solution of allyltriphenyltin (366 
mg, 1.8 mmol) in THF (1.5 cm3) was added and the mixture was stirred at 0°C for 30 min 
and then cooled to -78°C. To the resulting orange-yellow solution was added the 
Li15 17-ketone 87 (50 mg, 0.2 mmol) in THF (2 cm3) and the initially formed deep orange 
colour rapidly faded to the original orange-yellow colour. The mixture was stirred for a 
further 30 min at -78°C, then a mixture of saturated aqueous ammonium chloride and 
aqueous ammonia (10%) (1:1) was added and the mixture allowed to warm up to 25°C. 
The resultant solution was extracted into diethyl ether, the combined organic phase was 
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washed (water, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue (241 mg) which was adsorbed onto silica gel (10 g) and eluted with ethyl acetate-
hexane (1:9) to give 3-methoxy-15p-phenylestra-l,3,5(I0)-trien-17-one 98 (50 mg, 77%), 
m.p. 123-124°C (from diisopropyl ether); [a]o +21 ° (c 0.4) (Found: C 83.2; H, 8.0%; 
M+, 360. C25H2802 requires C, 83.3; H, 7.8%; M, 360); Vmaxlcm·
1 1726 (C=O); OH (200 
MHz) 0.88 (3H, s, 13P-Me), 3.78 (3H, s, 3-0Me), 3.90 (lH, m, 15a-H), 6.66 (lH, d, J2.7 
Hz, 4-H), 6.73 (lH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.17-7.38 (6H, m, 1-H and 15P-CJ!5); 
oc (50 MHz) 17.6 (13P-Me), 25.6 (C-11), 27.7 (C-7), 29.4 (C-6), 34.2 (C-12), 37.l (C-8), 
38.6 (C-15), 44.9 (C-9), 45.0 (C-16), 47.3 (C-13), 55.0 (C-14), 55.2 (3-0Me), 111.5 (C-2), 
113.8 (C-4), 126.0 (C-4'), 126.1 (C-1), 128.3 (C-2' and C-6'), 128.4 (C-3' and C-5'), 132.3 
(C-10), 137.7 (C-5), 142.8 (C-1'), 157.7 (C-3) and 221.0 (C-17). 
15a-Acetonyl-3-methoxyestra-1,3,5(10)-trien-17-one 99 
A suspension of palladium(II) chloride (6 mg, 0.03 mmol) and copper(!) chloride (31 mg, 
0.3 mmol) in a mixture of dimethylformamide (DMF) (2 cm3) and water (0.2 cm3) was 
stirred at 25°C under an oxygen atmosphere for 3h. To this suspension was added 
15a-allyl-3-methoxyestra-l,3,5(10)-trien-17-one 93 (100 mg, 0.3 mmol) in a mixture of 
DMF (5 cm3) and water (0.5 cm3) and the mixture was stirred at 25°C under an oxygen 
atmosphere for 24h, poured into cold hydrochloric acid (3 mol dm·3, 20 cm3) and the 
resulting mixture was extracted into ethyl acetate. The combined organic phase was 
washed (satd. aq. NaHC03, water, brine), dried (MgS04) and evaporated under reduced 
pressure to give a residue (97 mg) which was adsorbed onto silica gel (10 g) and eluted 
with ethyl acetate-toluene (1: 19) to give starting material 93 (5 mg, 4%) followed by the 
diketone 99 (91 mg, 87%), m.p. 144-147°C (from chloroform-methanol); [a]0 +221 ° 
(c 0.3) (Found: C, 77.3; H, 8.3%; M\ 340. C22H2s03 requires C, 77.6; H, 8.3%; M, 340); 
Vma:/cm·1 1728 (C=O); OH (200 MHz) 0.99 (3H, s, 13P-Me), 1.33 (lH, t, J 2 x 10.7 Hz, 
14a-H), 2.17 (3H, s, 153-Me), 3.77 (3H, s, 3-0Me), 6.62 (lH, d, J2.7 Hz, 4-H), 6.72 (lH, 
dd, J 8.7 and 2.7 Hz, 2-H) and 7.20 (lH\ d, J 8.5 Hz, 1-H); oc (50 MHz) 15.5 (13P-Me), 
26.5 (C-11), 27.8 (C-7), 29.8 (C-6), 30.4 (C-153), 31.0 (C-151), 31.5 (C-12), 39.5 (C-8), 
43.9 (C-16), 44.1 (C-9), 49.8 (C-13), 50.9 (C-15), 54.l (C-14), 55.2 (3-0Me), 111.8 (C-2), 
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113.5 (C-4), 126.7 (C-1), 131.5 (C-10), 137.0 (C-5), 157.6 (C-3), 207.2 (C-152) and 
219.0 (C-17). 
Attempted aldol closure of the diketone 99 
a) n-Butyllithium (1.6 mol dm-3 in hexanes, 0.15 cm3; 0.2 mmol) was added to a cooled 
(-I0°C, acetone-dry ice) solution of hexamethyldisilazane (0.2 cm3, 0.9 mmol) in THF 
(0.5 cm3) and the mixture was stirred for 45 min at -I0°C and then cooled to -78°C. To 
this solution was added the diketone 99 (44 mg, 0.1 mmol) in THF (1 cm3) and the mixture 
was stirred for 3h at -78°C. Saturated aqueous ammonium chloride was then added and the 
mixture was extracted into ethyl acetate. The combined organic phase was washed (water, 
brine), dried (MgS04) and evaporated under reduced pressure to give starting material 99 
(43 mg, 98%). 
b) n-Butyllithium (1.6 mol dm-3 in hexanes, 0.15 cm3; 0.2 mmol) was added to a cooled 
(-I0°C, acetone-dry ice) solution of diisopropylamine (0.2 cm3, 2.7 mmol) in THF (3 cm3) 
and the mixture was stirred for 45 min at -I0°C and then cooled to -78°C. To this solution 
was added the diketone 99 (66 mg, 0.2 mmol) in THF (2 cm3) and the mixture was stirred 
for lh at -78°C. Work-up, as in (a) afforded starting material 99 (44 mg). 
c) A solution of the diketone 99 (15 mg, 0.05 mmol) in 1,4-dioxane (1 cm3) was added to 
a suspension of sodium hydride [IO mg of a 50% suspension in mineral oil, 0.2 mmol; 
washed with hexane (3 x 2 cm3)] in 1,4-dioxane (1 cm3) at 25°C and the mixture was 
stirred for Sh at 25°C. Work-up as in (a) afforded starting material 99 (12 mg). 
d) The diketone 99 (14 mg, 0.05 mmol) was refluxed in a solution of sodium methoxide 
(0.2 mol dm-3, 5 cm3) for 6h. The cooled solution was subjected to a work-up as in (a) to 
give starting material 99 (12 mg). 
e) The diketone 99 (5 mg, 0.01 mmol) was stirred in a methanolic potassium hydroxide 
solution (1 %; 1 cm3) for 48h. Work-up as in (a) afforded starting material 99 (3 mg) 
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Attempted intramolecular reductive coupling of the diketone 99 
A solution of the diketone 99 (10 mg, 0.1 mmol) in THF (1 cm3) was added to a solution of 
samarium(II) iodide [prepared from samarium (100 mg) and diiodoethane (180 mg)] in 
THF (2 cm\ and the mixture was refluxed for 3h. Saturated aqueous ammonium chloride 
was added and the mixture was extracted into ethyl acetate. The combined organic phase 
was washed (satd. aq. Na2S203, brine), dried (MgS04) and evaporated under reduced 
pressure to give a residue, identified as a complex mixture of 152,17-diols 100 (8 mg) 
(Vmaxlcm-1 3602, 3400 br.; mlz 344) which was suspended in dichloromethane (2 cm3). 
Dess-Martin periodinane 72 (100 mg) was added and the resulting mixture was stirred for 
lh. Diethyl ether (5 cm3) was added, and the mixture was poured into saturated aqueous 
sodium hydrogen carbonate solution (5 cm3) containing sodium thiosulfate (500 mg). The 
resulting mixture was extracted into diethyl ether. The combined organic phase was 
washed (water, brine), dried (MgS04) and evaporated under reduced pressure to give the 
diketone 99 (5 mg, 50%), m.p. 142-145°C (from chloroform-methanol). 
15a-Allyl-3-methoxyestra-1,3,5(1 O)-trien-17P-ol 103 
LAH (250 mg, 6.6 mmol) was added to a solution of 15a-allyl-3-methoxyestra-1,3,5(10)-
trien-17-one 93 ( 442 mg, 1.4 mmol) in THF (10 cm3) and the solution was stirred for 15 
min at 25°C. Ethyl acetate (10 cm3) was added and once effervescence ceased the mixture 
was poured into saturated aqueous sodium hydrogen carbonate (10 cm3) and the resulting 
mixture was extracted into ethyl acetate. The combined organic phase was washed (water, 
brine), dried (MgS04) and evaporated under reduced pressure to give the 17P-alcohol 103 
(445 mg, 99%) m.p. 112-113°C (from methanol); [a]o + 153° (c 0.8) (Found: C, 80.6; H, 
9.4%; M\ 326. C22H3002 requires C, 80.9; H, 9.3%; M, 326); Vmaxlcm-1 3607 (OH); 8H 
(200 MHz) 0.82 (3H, s, 13p-Me), 1.02 (IH, t, J 2 x 8.8 Hz, 14a-H), 1.61 (IH, s, D20 
exch., l 7p-OH), 2.85 (2H, m, 6-H2), 3.68 (IH, t, J2 x 9 Hz, l 7a-H), 3.78 (3H, s, 3-0Me), 
5.05 (2H, m Wy, 17 Hz, 153-H2), 5.71-5.84 (IH, m, 15
2-H), 6.61 (lH, d, J 2.7 Hz, 4-H), 
6.71 (IH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.20 (IH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 12.1 
(13P-Me), 26.9 (C-11), 28.0 (C-7), 30.1 (C-6), 36.0 (C-12), 36.6 (C-15), 37.8 (C-15 1), 39.6 
(C-8), 41.5 (C-16), 44.3 (C-9), 45.1 (C-13), 54.5 (C-14), 55.2 (3-0Me), 80.0 (C-17), 111.7 
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(C-2), 113.5 (C-4), 115.6 (C-153), 126.7 (C-1), 132.4 (C-10), 137.5 (C-152), 137.6 (C-5) 
and 157.4 (C-3). 
15a-(3-Hydroxypropyl)-3-methoxyestra-1,3,5{1 O)-trien-17P-ol 101 
a) Borane-dimethyl sulfide (10 mol dm·3, 0.5 cm3, 5 rnmol) was added to a solution of 
15a-allyl-3-methoxyestra-l ,3,5(1 O)-trien-17-one 93 (170 mg, 0.5 rnmol) in THF (5 cm3) 
and the mixture was stirred for 3h. The mixture was then cooled to 0°C, hydrogen 
peroxide (100 vol, 10 cm3) and aqueous sodium hydroxide (4 mol dm·3, 5 cm3) were added 
and the mixture was stirred for 18h. Water (IO cm3) was added and the mixture was 
extracted into ethyl acetate. The combined organic phase was washed (water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (161 mg) which was 
flash chromatographed on silica gel (20 g) with ethyl acetate-toluene (1 :9) to give an 
unidentified product (17 mg). Further elution with ethyl acetate-toluene (3 :2) afforded an 
inseparable mixture of the 15a-hydroxypropyl 17P-alcohol 101 and the 15a-hydroxypropyl 
17a-alcohol 102 (70 mg, 39%) in approximately a 1: 1 ratio (from 1H NMR). The presence 
of the 15a-hydroxypropyl 17a-alcohol 102 was evident from the duplication of certain 
signals in the 1H NMR spectrum, viz. 8tt 0.75 (3H, s, 13P-Me) and 7.21 (IH, d, 
J 8.8 Hz, 1-H). 
b) Borane-dimethyl sulfide (10 mol dm·3, 0.9 cm3, 9 rnmol) was added to a cooled (0°C) 
solution of cyclohexene (0.3 cm3, 3.1 mmol) in dry diethyl ether (10 cm3) and the mixture 
was stirred at 0°C for 3h, during which, white dicyclohexylborane precipitated out of 
solution. To this suspension was added the 15a-allyl 17-ketone 93 (90 mg, 0.3 mmol) in 
THF (3 cm3) and the mixture was stirred at 25°C for 18h. Water (6 cm3) and sodium 
perborate tetrahydrate (1 g) were added and the mixture was stirred vigorously for 3h and 
then was extracted into ethyl acetate. The combined organic phase was washed (water, 
brine), dried (MgS04) and evaporated under reduced pressure to give a residue (200 mg) 
which was flash chromatographed on silica gel (20 g) with ethyl acetate-toluene ( 4: 1) to 
give the 15a-hydroxypropyl 17P-alcohol 101 (56 mg, 59%), m.p. 168-171 °C (from ethyl 
acetate); [a]o +152° (c 0.6 in THF) (Found: C, 76.6; H, 9.5%; M\ 344. C22H320 3 requires 
C, 76.7; H, 9.4%; M, 344); Vmaxlcm·1 3465 br. (OH); 8H (200 MHz) 0.81 (3H, s, 13P-Me), 
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1.52-1.56 (2H, m, D20 exch., 15
3
- and 17P-OH), 2.80-2.90 (2H, m, 6-H2), 3.61-3.70 (3H, 
m, 153-H2 and l 7a-H), 3.77 (3H, s, 3-0Me), 6.61 (lH, d, J 2.5 Hz, 4-H), 6.71 (lH, dd, J 
8.8 and 2.5 Hz, 2-H) and 7.20 (lH, d, J8.8 Hz, 1-H). 
c) Reaction conditions identical to those described in (a) were applied to the 15a-allyl 
17P-alcohol 103 (170 mg, 0.5 mmol). Flash chromatography on silica gel (50 g) with ethyl 
acetate-toluene (1 :4) afforded an unidentified product (5 mg). Further elution with ethyl 
acetate-toluene (2:3) afforded the 15a-hydroxypropyl 17P-alcohol 101 (101 mg, 57%), 
identical to that described previously. 
15a-Formylethyl-3-methoxyestra-1,3,5(1 O)-trien-17-one 104 
To a stirred suspension of the 15a-hydroxypropyl 17P-alcohol 101 (101 mg, 0.3 mmol) in 
dry chloroform (5 cm3) was added Dess-Martin periodinane 72 (600 mg, 2.3 mmol) and the 
mixture was stirred for 2h. Diethyl ether was added and the mixture was poured into 
saturated aqueous sodium hydrogen carbonate solution (20 cm3) with sodium thiosulfate 
(2 g) dissolved in it. The mixture was stirred for 5 min and extracted with diethyl ether. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give the formylethyl ketone 104 (97 mg, 98%), as an oil, 
Vmaxlcm-1 1727 (C=O); mlz 340; OH (200 MHz) 0.95 (3H, s, 13P-Me), 2.80-2.90 (2H, m, 
6-H2), 3.76 (3H, s, 3-0Me), 6.61 (IH, d, J 2.8 Hz, 4-H), 6.71 (IH, dd, J 8.8 and 2.8 Hz, 
2-H), 7.20 (lH, d, J8.8 Hz, 1-H) and 9.79 (lH, br. s, 153-H). 
Attempted intramolecular reductive coupling of the 15a-formylethyl 17-ketone 104 
a) A solution of the formylethyl ketone 104 (139 mg, 0.4 mmol) in THF (5 cm3) was 
added to a solution of samarium(II) iodide [prepared from samarium (700 mg, 4. 7 mmol) 
and diiodoethane (1.3 g, 4.8 mmol)] in THF (10 cm3) at 0°C and the mixture was stirred 
for 30 min at 0°C and for 4h at 25°C. Saturated aqueous ammonium chloride was added 
and the mixture was extracted into ethyl acetate. The combined organic phase was washed 
(satd. aq. Na2S203, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue (116 mg) which was adsorbed onto silica gel (14 g) and eluted with ethyl acetate-
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toluene (7:3) to give a complex mixture of products (31 mg), followed by the 
l 5a-hydroxypropyl l 7P-alcohol 101 (35 mg, 25%) identical to that described previously. 
b) A solution of the formylethyl ketone 104 (97 mg, 0.3 mmol) in THF ( 4 cm3) was added 
to a solution of samarium(II) iodide [prepared from samarium (350 mg, 2.3 mmol) and 
diiodoethane (660 mg, 2.3 mmol)] in THF (5 cm3) and the mixture was stirred for 72 hat 
25°C, and then at reflux for 4h. Work-up as in (a) gave a residue (69 mg) which was 
adsorbed onto silica gel (5 g) and eluted with ethyl acetate-toluene (2:3) to give a complex 
mixture of products (35 mg), followed by 15a-(3-hydroxypropyl)-3-methoxyestra-
l,3,5(10)-trien-17-one 105 (5 mg, 5%), as an oil, (Found: M\ 342. C22H3003 requires 
M, 342); Vmaxlcm·1 3615 (OH) and 1727 (C=O); DH (400 MHz) 0.96 (3H, s, I3P-Me), 1.58 
(IH, m, D20 exch., 15
3-0H), 1.78 (IH, dd, J 19.1 and 8.0 Hz, I6P-H), 2.79 (IH, dd, J 19.1 
and 8.7 Hz, 16a-H), 2.85 (2H, m, 6-H2), 3.64 (2H, t, J 2 x 6.3 Hz, 15
3-H2), 3.77 (3H, s, 
3-0Me), 6.61 (IH, d, J2.8 Hz, 4-H), 6.71 (IH, dd, J 8.7 and 2.8 Hz, 2-H) and 7.20 (IH, d, 
J8.7 Hz, 1-H). 
Attempted ketyl-olefin coupling of the 15a-allyl-17-ketone 93 
A solution of 15a-allyl-3-methoxyestra-1,3,5(10)-trien-I7-one 93 (100 mg, 0.3 mmol) in 
THF (2 cm3) was added to a solution of samarium(II) iodide [prepared from samarium (350 
mg, 2.3 mmol) and diiodoethane (660 mg, 2.3 mmol)] in THF (5 cm3) and the mixture was 
stirred for lh at 25°C. t-Butyl alcohol (80 mg, 1.1 mmol) in THF (1 cm3) was added and 
the mixture was refluxed for 40h (further t-butyl alcohol was added after 6 and 24h). 
Saturated aqueous ammonium chloride was added and the mixture was extracted into ethyl 
acetate. The combined organic phase was washed (satd. aq. Na2S203, water, brine), dried 
(MgS04) and evaporated under reduced pressure to give a residue (99 mg) which was 
adsorbed onto silica gel (12 g) and eluted with ethyl acetate-toluene (1: 19) to give starting 
material 93 (15 mg, 15%) followed by 15a-allyl-3-methoxyestra-1,3,5(10)-trien-17a-ol 
107 (27 mg, 26%), as an oil; 8H (200 MHz) 0.75 (3H, s, I3p-Me), 2.85 (2H, m, 6-H2), 3.70 
(IH, d, J 5.3 Hz, 17P-H), 3.77 (3H, s, 3-0Me), 5.02 (2H, m Wv. 15 Hz, I53-H2), 5.75-5.96 
(IH, m, 152-H), 6.61 (IH, d, J2.8 Hz, 4-H), 6.70 (IH, dd, J8.5 and 2.8 Hz, 2-H) and 7.22 
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(I H, d, J 8.5 Hz, 1-H). Further elution with ethyl acetate-toluene (I: 19) afforded the 
17P-alcohol 103 (47 mg, 47%) identical to material prepared previously. 
15P-(But-3-enyl)-3-methoxyestra-1,3,5(1 O)-trien-17-one 108 
HMPA (7 cm3, 43 mmol) and copper(!) iodide-dimethylsulfide complex (2.2 g, 9.1 mmol) 
were added to a cooled (0°C) solution of but-1-en-4-ylmagnesium bromide [prepared from 
4-bromobut-1-ene (2 cm3; 20 mmol), magnesium (500 mg, 20 mmol) and catalytic iodine] 
in THF (IO cm3) and the mixture was allowed to stir for 5 min at 0°C. To the resulting 
solution was added a solution of 3-methoxyestra-1,3,5(10),15-tetraen-17-one 87 (500 mg, 
1.8 mmol) and chlorotrimethylsilane (6 cm3, 43 mmol) in THF (15 cm3) over 15 min at 
0°C and the mixture was allowed to stir for lh at 0°C. Saturated aqueous ammonium 
chloride was ·added, followed by aqueous ammonia and the resulting mixture was extracted 
into ethyl acetate. The combined organic phase was washed [aq. NH3 (25%), aq. HCI (I 
mol dm·3), water, brine), dried (MgS04) and evaporated under reduced pressure to give a 
residue (594 mg) which was adsorbed onto silica gel (50 g) and eluted with ethyl acetate-
hexane (1:9) to give the 15P-butenyl 17-ketone 108 (474 mg, 80%), m.p. 126-128°C (from 
diisopropyl ether); [a]o + 108° (c 0.1) (Found: C, 81.6; H, 9.1 %; ~, 338. C23H3o02 
requires C, 81.6; H, 8.9%; M, 338); Ymro/cm·' 1725 (C=O); 8tt (200 MHz) 1.02 (3H, s, 
13P-Me), 3.78 (3H, s, 3-0Me), 4.95-5.10 (2H, m, 154-H2), 5.70-5.92 (lH, m, 153-H), 6.66 
(IH, d, J 2.7 Hz, 4-H), 6.72 (lH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.18 (lH, d, J 8.5 Hz, 
1-H); 8c (50 MHz) 17.7 (13P-Me), 25.5 (C-11), 26.8 (C-7), 29.5 (C-6), 30.4 (C-15 1), 33.6 
(C-12 and C-152), 33.9 (C-15), 36.0 (C-8), 42.7 (C-16), 44.5 (C-9), 47.2 (C-13), 52.8 
(C-14), 55.2 (3-0Me), 111.4 (C-2), 113.9 (C-4), 115.3 (C-154), 126.0 (C-1), 132.4 (C-10), 
137.7 (C-5), 138.1 (C-153), 157.7 (C-3) and 221.1 (C-17). 
15P-Formylethyl-3-methoxyestra-1,3,5(1 O)-trien-17-one 109 
Osmium tetroxide (200 mg, 0.8 mmol) was stirred with the 15P-butenyl 17-ketone 108 
(200 mg, 0.6 mmol) in pyridine (3 cm3) for 72h at 25°C. Sodium metabisulfite (2 g) in 
water (5 cm3) was added and the mixture was stirred for 2h and then was extracted with 
chloroform. The combined organic phase was washed [aq. HCI (3 mol dm·3), water], dried 
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(MgS04) and evaporated under reduced pressure to give a foam (197 mg) which was 
adsorbed onto silica gel (17 g) and eluted with methanol-chloroform (1: 19) to give an 
inseparable mixture (ca. I :1, 1H NMR estimate from the signals for 13P-Me) of 15P-(3R,4-
dihydroxybutyl)-3-methoxyestra-l,3,5( 10)-triene-1 7-one and 15P-(3S,4-dihydroxybutyl)-3-
methoxyestra-1,3,5(10)-triene-17-one (170 mg, 76%), as a foam, m/z 372; Vmaxlcm-1 3615 
(OH), 1725 (C=O), OH (200 MHz) 1.03 and 1.04 (3H, s, 13P-Me), 1.61 (2H, s, D20 exch., 
153- and 154-0H), 3.4-3.5 (lH, m, 153-H), 3.6-3.75 (2H, m, 154-H2), 3.78 (3H, s, 3-0Me), 
6.62 (lH, d, J2.7 Hz, 4-H), 6.72 (lH, dd, J 8.7 and 2.7 Hz, 2-H) and 7.20 (lH, d, J 8.5 Hz, 
1-H). A portion of this mixture, (153 mg, 0.4 mmol) was dissolved in ethanol (5 cm3) and 
was added to an aqueous solution of sodium periodate (0.5 mol dm-3, 10 cm3, 5 mmol) and 
the mixture was stirred for 16 hat 25°C. Water was added and the resulting mixture was 
extracted into chloroform. The combined organic phase was washed (water), dried 
(MgS04) and evaporated under reduced pressure to give the formylethyl ketone 109 (132 
mg, 95%); Vmaxlcm-1 1725 (C=O); mlz 340; OH (200 MHz) 1.03 (3H, s, 13P-Me), 3.4-3.7 
(2H, m, 152-H2), 3.76 (3H, s, 3-0Me), 6.62 (lH, d, J2.7 Hz, 4-H), 6.72 (lH, dd, J 8.7 and 
2.7 Hz, 2-H), 7.20 (lH, d, J8.5 Hz, 1-H) and 9.80 (lH, s, 153-H). 
Attempted intramolecular reductive coupling of the formylethyl ketone 109 
A mixture of titanium trichloride bis(dimethoxyethane) [TiCh(DME)2] 159 (800 mg, 2.4 
mmol) and a zinc-copper couple (500 mg, 7.7 mmol) in dimethoxyethane (4 cm3) was 
refluxed for 2h. The mixture was then cooled to 0°C and a solution of the formylethyl 
ketone 109 (130 mg, 0.4 mmol) in DME (4 cm3) was added over a period of 10 min. The 
resulting solution was stirred at this temperature for 30 min, then allowed to warm to 25°C, 
stirred at this temperature for 18h and then refluxed for 4h. Water was added to the cooled 
solution and the resulting mixture was extracted into ethyl acetate. The combined organic 
phase was washed (water, brine), dried (MgS04) and evaporated under reduced pressure to 
give a residue (58 mg) which TLC indicated was a complex mixture. Chromatography on 
silica gel (5 g) with ethyl acetate-toluene (2:3) failed to elute any steroidal products. 
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lSP-Iodomethyl-3-methoxyestra-1,3,5(10)-trien-17-one 111 
To a suspension of sodium hydride (80 mg, 2 mmol) in dry DMF (4 cm3) was added 
trimethylsulfoxonium iodide ( 400 mg, 2 mmol) in small portions over a 10 minute period. 
The resulting suspension was stirred for a further 30 min and then the 3-methoxyestra-
1,3,5(10),15-tetraen-17-one 87 (130 mg, 0.5 mmol) in DMF (8 cm3) was added, the 
mixture was stirred for 2h and then was poured into cold (0°C) hydrochloric acid (3 mol 
dm-3, 10 cm3). The resulting mixture was extracted into ethyl acetate. The combined 
organic phase was washed (water), dried (MgS04) and evaporated under reduced pressure 
to give 15P,16P-methylene-3-methoxyestra-1,3,5(10)-trien-17-one 110 (130 mg, 100%), 
m.p. 172-174°C (from dichloromethane-methanol); [a]o + 14° (c 0.6) (lit., 168 171-172°C; 
[a]o + 10°) (Found: C, 80.7; H, 8.3%; M\ 296. C20H2402 requires C, 81.0; H, 8.2%; M, 
296); Vmaxlcnf1 1709 (C=O); 8tt (200 MHz) 0.99 (3H, s, BP-Me), 2.90-3.00 (2H, m, 6-H2), 
3.78 (3H, s, 3-0Me), 6.65 (lH, d, 12.7 Hz, 4-H), 6.71 (lH, dd, J 8.5 and 2.7 Hz, 2-H) and 
7.18 (lH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 17.3 (BP-Me), 20.3 (C-161), 22.0 (C-15), 25.6 
(C-11), 25.8 (C-16), 26.6 (C-7), 29.4 (C-6), 35.4 (C-12), 37.1 (C-8), 42.5 (C-13), 44.7 
(C-9), 51.4 (C-14), 55.1 (3-0Me), 111.4 (C-2), 113.9 (C-4), 125.8 (C-1), 132.2 (C-10), 
137.6 (C-5), 157.6 (C-3) and 216.4 (C-17). 
Chlorotrimethylsilane (0.2 cm3, 1.2 mmol) was added to a mixture of sodium iodide (200 
mg, 1.3 mmol) and the 15p,16p-methylene 17-ketone 110 (130 mg, 0.4 mmol) in 
acetonitrile (10 cm3) and the mixture was allowed to stir at 25°C for lh. Water was added 
and the mixture was extracted with ethyl acetate. The combined organic phase was washed 
(water), dried (MgS04) and evaporated under reduced pressure to give a solid residue 
(162 mg) which was adsorbed onto silica gel (18 g) and eluted with ethyl acetate-toluene 
(1:9) to give the 15P-iodomethyl 17-ketone 111 (111 mg, 60%), m.p. 192-194°C (from 
chloroform-methanol); [a]o +84° (c 1.3) (Found: C 56.4; H, 6.0%; M+, 424. C20H25I02 
requires C, 56.6; H, 5.9%; M, 424); Vmaxlcm-1 1731 (C=O); 8tt (200 MHz) 1.05 (3H, s, 
BP-Me), 2.90-3.00 (2H, m, 6-H2), 3.24 (lH, dd, J 12.8 and 9.7 Hz, 15 1-Hpro-R), 3.50 (lH, 
dd, J 12.8 and 2.9 Hz, 15 1-Hpro-s), 3.78 (3H, s, 3-0Me), 6.65 (lH, d, J2.7 Hz, 4-H), 6.71 
(lH, dd, J 8.5 and 2.7 Hz, 2-H) and 7.18 (lH, d, J 8.5 Hz, 1-H); 8c (50 MHz) 8.8 (C-151), 
18.2 (13P-Me), 25.3 (C-11), 27.1 (C-7), 29.3 (C-6), 33.8 (C-12), 35.8 (C-8), 39.2 (C-15), 
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43.7 (C-16), 44.4 (C-9), 47.2 (C-13), 53.4 (C-14), 55.2 (3-0Me), 111.5 (C-2), 113.9 (C-4), 
125.9 (C-1), 131.8 (C-10), 137.4 (C-5), 157.8 (C-3) and 218.2 (C-17). 
Attempted intramolecular Barbier reaction of the 15P-iodomethyl 17-ketone 111 
A solution of tris-(dibenzoylmethido)iron(III) [Fe(DBM)3] 
167 (7 mg, 0.01 mmol) in THF 
(2 cm
3
) was added to a solution of samarium(II) iodide [prepared from samarium (50 mg, 
0.3 mmol) and 1,2-diiodoethane (85 mg, 0.3 mmol)] in THF (2 cm3) and the mixture was 
stirred for 5 min at 25°C. To this solution was added the 15/3-iodomethyl 17-ketone 111 
(77 mg, 0.2 mmol) in THF (3 cm3) and the mixture was refluxed for 2h. Saturated aqueous 
ammonium chloride was added and the resulting mixture was extracted into ethyl acetate. 
The combined organic phase was washed (water, brine), dried (MgS04) and evaporated 
under reduced pressure to give a residue (45 mg) which was adsorbed onto silica gel (5 g) 
and eluted with ethyl acetate-hexane (1 :9) to give an unidentified non-steroidal product 
(9 mg) followed by 3-methoxy-15P-methylestra-1,3,5(10)-trien-17-one 112 (20 mg, 38%), 
m.p. 122-125°C (from acetone-methanol) [lit., 191 122.5-124°C (from acetone-methanol)]; 
Yma:./cm·1 1726 (C=O); Dtt (200 MHz) 1.07 (3H, s, BP-Me), 1.16 (3H, d, J7.3 Hz, 15P-
Me), 2.91 (2H, m, 6-H2), 3.79 (3H, s, 3-0Me), 6.66 (lH, d, J2.7 Hz, 4-H), 6.73 (IH, dd, J 
8.5 and 2.7 Hz, 2-H) and 7.20 (lH, d, J 8.5 Hz, 1-H). 
3-Methoxy-14,17a.-propanoestra-1,3,5(10)-trien-l 7p-yl Acetate 115 
A solution of 3-methoxy-14,17a.-propanoestra-l,3,5(10)-trien-17P-ol 34 (23 mg, 0.07 
mmol) and toluene-p-sulfonic acid (IO mg) in THF (1 cm3) and acetic anhydride (I cm3) 
was stirred for 18h at 25°C. Water and solid sodium hydrogen carbonate were added, and 
once effervescence ceased the mixture was extracted into ethyl acetate. The combined 
organic phase was washed (water, brine), dried (MgS04) and evaporated under reduced 
pressure to give a solid residue (30 mg) which was chromatographed on silica gel (10 g) 
with ethyl acetate-toluene (I: 19) as eluent to give the product 115 (20 mg, 78%), m.p. 
143-145 C (from isopropanol); [a.] 0 +29° (c 0.2) (Found: C, 77.8; H 8.7%; M+ 368. 
C24H3203 requires C, 78.2; H 8.8%; M 368) and Vmaxlcm·
1 1723. 




C29H320 5S, M 492.61; orthorhombic, space group P212121, a= 8.376(4), b = 11.979(2), c = 
24.376(4) A, V = 2445.9(12) A3, Z = 4, De = 1.338 g cm·3 , µ = 0.171 mm·1, F(OOO) = 
1048. A colourless crystal of dimensions 0.35 x 0.35 x 0.50 mm was used for data 
collection. 
Data collection and processing 
A single crystal of diffraction quality was mounted in a Lindemann capillary. X-ray 
intensity data were collected at 298K on an Enraf-Nonius CAD4 diffractometer, using 
graphite-monochromated Mo-Ka radiation ().=0.7107A) and the ro-28 mode; 2465 
reflections measured (2 ~ 28 ~ 50; 0 ~ h ~ 9, 0 ~ k ~ 14, 0 ~ l ~ 28); 2465 independent 
reflections with I > 2crl (R = 0.0436). The unit cell was refined using the setting angles of 
24 reflections in the 8 range 16-17°. Three reference reflections were monitored 
periodically for intensity and orientation control. A Lorentz-polarisation correction was 
applied to the data. 
Structure analysis and refinement 
All non-hydrogen atoms were found by direct methods using SHELXS-86. 192 The 
structure was refined by full-matrix least-squares on F2 using SHELXL-93. 193 The S and 
0 atoms were treated anisotropically, as well as C19, C20, C21 and the carbon atoms in the 
phenyl group (C22-C27). All hydrogen atoms were placed in geometrically calculated 
positions and linked to a common temperature factor for chemically equivalent groups. 
Analysis and refinement details are : number of parameters = 230; max/min residual 
electron density 0.326/-0.358 e A·3; R1 = 0.0436; wR2 = 0.1081; Goodness-of-fit on F2 = 







































Atomic co-ordinates ( x 104) and equivalent isotropic displacement 
parameters (A 2 x 103). Uequiv is defined as one third of the trace of the 
orthogonalized Uij tensor. 
xla ylb zlc Ueguiv 
14988(5) 3701(3) 11461(2) 36(1) 
15943(5) 3019(3) 11773(2) 39(1) 
15355(5) 2005(4) 11956(2) 38(1) 
13823(5) 1678(4) 11818(2) 39(1) 
12863(5) 2357(3) 11489(2) 35(1) 
11230(5) 1956(4) 11325(2) 39(1) 
10548(6) 2591(3) 10834(2) 37(1) 
10677(5) 3850(3) 10953(2) 30(1) 
12438(5) 4209(3) 10981(2) 30(1) 
13432(5) 3397(3) 11316(2) 30(1) 
13214(5) 4424(4) 10414(2) 36(1) 
12263(5) 5214(3) 10050(2) 33(1) 
10558(5) 4777(3) 9976(2) 31(1) 
9755(5) 4589(3) 10554(2) 29(1) 
8065(5) 4320(3) 10374(2) 35(1) 
7755(5) 4909(3) 9921(2) 36(1) 
9230(5) 5594(3) 9798(2) 33(1) 
9291(5) 6533(3) 10228(1) 32(1) 
9654(5) 5853(3) 10750(2) 30(1) 
10621(6) 3759(4) 9595(2) 39(1) 
15781(7) 452(4) 12552(2) 61(2) 
8428(6) 6685(4) 9019(2) 42(1) 
8865(7) 6997(5) 8450(2) 59(1) 
8208(6) 8376(3) 11332(2) 42(1) 
8775(5) 7414(3) 11568(2) 31(1) 
8606(7) 9389(4) 11561(2) 55(1) 
9700(7) 7455(4) 12034(2) 49(1) 
9512(7) 9438(4) 12022(2) 56(1) 
10057(7) 8485(4) 12261(2) 57(1) 
8226(1) 6104(1) 11291(1) 34(1) 
16405(4) 1392(3) 12273(1) 52(1) 
9467(4) 5953(2) 9237(1) 39(1) 
7275(5) 7031(3) 9256(1) 65(1) 
6649(3) 6225(3) 11067(1) 47(1) 
8470(5) 5279(2) 11714(1) 52(1) 
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3-Methoxy-14,17a.-ethanoestra-1,3,5(10)-trien-17p-yl acetate 113 
Crystal data 
C23H3003, M354.49; orthorhombic, space group P212121, a= 18.669(4), b = 8.1387(6), c = 
25.277(4) A, V = 3841(1) A3, Z = 8, De= 1.23 g cm·3 , µ = 0.74 mm·1, F(OOO) = 1536. A 
colourless crystal of dimensions 0.35 x 0.35 x 0.40 mm was used for data collection. 
Data collection and processing 
Intensity X-ray data were collected at 298K on an Enraf-Nonius CAD4 diffractometer, 
using graphite-monochromated Mo-Ka. radiation (A.=0.7107A) and the co-28 mode; 5211 
reflections measured (2 :S; 28 :S; 56; 0 :S; h :S; 24, 0 :S; k :S; 10, 0 :S; I :S; 33); 2437 independent 
reflections with I> 2crl (R = 0.053). The unit cell was refined using the setting angles of 
24 reflections in the e range 16-17°. Three reference reflections were monitored 
periodically for intensity and orientation control. A Lorentz-polarisation correction was 
applied to the data. 
Structure analysis and refinement 
All non-hydrogen atoms were· found by direct methods using SHELXS-86. 192 The 
structure was refined by full-matrix least-squares using SHELX76. 194 All non-hydrogen 
atoms were refined anisotropically, and all hydrogen atoms were placed in geometrically 
calculated positions and linked to a common temperature factor. Analysis and refinement 
details are : number of parameters = 489; max/min residual electron density 0.21/-0.25 
e A·3; R = 0.053; Rw = 0.045. There are two crystallographically independent molecules in 
the asymmetric unit, distinguished by the labels A and B. The refined atom co-ordinates 






























Atomic co-ordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103). Uequiv is defined as one third of the trace of the 
orthogonalized Uu tensor. 
x/a y/b z/c Ueguiv 
2336(3) 10691(7) 3019(2) 57(2) 
2325(3) 11365(7) 3513(2) 60(2) 
2175(3) 10388(7) 3951(2) 49(2) 
2001(3) 8756(7) 3880(2) 41(2) 
1993(2) 8087(6) 3373(2) 39(2) 
1794(3) 6287(6) 3318(2) 45(2) 
1740(3) 5661(7) 2755(2) 47(2) 
2316(3) 6430(6) 2408(2) 37(2) 
2193(3) 8299(6) 2379(2) 41(2) 
2173(3) 9035(6) 2933(2) 40(2) 
2733(3) 9147(6) 2006(2) 54(2) 
2786(3) 8338(6) 1456(2) 47(2) 
2944(3) 6510(6) 1509(2) 40(2) 
2376(3) 5679(6) 1863(2) 40(2) 
2606(3) 3836(6) 1841 (2) 51(2) 
2881(3) 3642(7) 1261(2) 58(2) 
2777(3) 5388(6) 1034(2) 42(2) 
1979(3) 5665(7) 938(2) 53(2) 
1685(3) 5787(7) 1514(2) 50(2) 
3728(3) 6287(8) 1690(2) 52(2) 
2205(2) 11159(5) 4436(1) 67(1) 
2105(4) 10181(8) 4894(2) 68(3) 
3233(2) 5808(4) 590(1) 49(1) 
3198(4) 4922(8) 146(3) 59(3) 
2801(3) 3785(6) 78(2) 86(2) 
3714(3) 5549(9) -261(2) 67(3) 
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Table 6.2: (cont.) Atomic co-ordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103). Uequiv is defined as one third of the trace of the 
orthogonalized Uu tensor. 
Atom x/a y/b zlc Ueguiv 
C1B -126(3) 3684(7) 1262(2) 48(2) 
C2B -25(3) 3211(7) 1788(2) 54(2) 
C3B 416(3) 1904(8) 1896(2) 64(3) 
C4B 715(3) 1037(8) 1487(3) 68(3) 
C5B 607(3) 1483(8) 966(2) 60(2) 
C6B 977(4) 472(8) 544(2) 81(3) 
C7B 749(3) 921(7) -17(2) 64(3) 
C8B 706(3) 2769(6) -81(2) 47(2) 
C9B 103(3) 3450(6) 276(2) 43(2) 
C10B 201(3) 2869(7) 842(2) 45(2) 
Cl1B 47(3) 5339(7) 231(2) 49(2) 
C12B -12(3) 5929(7) -346(2) 51(2) 
C13B 612(3) 5284(6) -673(2) 41(2) 
C14B 640(3) 3380(7) -643(2) 49(2) 
C15B 1267(3) 2972(8) -1016(2) 63(3) 
C16B 1177(3) 4284(8) -1471(2) 65(2) 
C17B 526(3) 5285(8) -1284(2) 50(2) 
C173 -141(3) 4233(8) -1379(2) 67(3) 
C174 -55(3) 2882(8) -948(2) 63(2) 
C18B 1301(3) 6213(8) -512(9) 57(2) 
019B 576(3) 1382(6) 2398(2) 90(2) 
C20B 347(4) 2355(9) 2829(3) 85(3) 
021B 491(2) 6961(5) -1465(1) 60(2) 
C22B 579(3) 7329(9) -1981(3) 63(3) 
023B 610(3) 6324(7) -2318(2) 100(2) 
C24B 620(4) 9146(8) -2051(2) 75(3) 
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3-Methoxy-14,17a-propanoestra-1,3,5(1 O)-trien-17P-yl acetate 115 
Crystal data 
C24H320 3, M 368.52; orthorhombic, space group P21, a = 7.303(2), b = 27.726(4), c = 
10.498(3) A, p = 107.43(2)0 , V = 2028.1(9) A3, Z = 4, De= 1.21 g cm·3 , µ = 0.73 mm·', 
F(OOO) = 800. A colourless crystal of dimensions 0.25 x 0.13 x 0.13 mm was used for data 
collection. 
Data collection and processing 
Intensity X-ray data were collected at 298K on an Enraf-Nonius CAD4 diffractometer, 
using graphite-monochromated Mo-Ka radiation (A.=0.7107A) and the ro-28 mode; 4051 
reflections measured (2 ~ 28 ~ 50; -8 ~ h ~ 8, 0 ~ k ~ 33, 0 ~ 1 ~ 12); 1336 independent 
reflections with I> 2crl (R = 0.071). The unit cell was refined using the setting angles of 
24 reflections in the 8 range 16-17°. Three reference reflections were monitored 
periodically for intensity and orientation control. A Lorentz-polarisation correction was 
applied to the data. 
Structure analysis and refinement 
All non-hydrogen atoms were found by direct methods using SHELXS-86. 192 The 
structure was refined by blocked full-matrix least-squares using SHELX76. 194 All non-
hydrogen atoms were refined anisotropically, and all hydrogen atoms were placed in 
geometrically calculated positions and linked to a common temperature factor. Analysis 
and refinement details are : number of parameters = 254; max/min residual electron density 
0.29/-0.26 e A·3; R = 0.071; Rw = 0.056. There are two crystallographically independent 
molecules in the asymmetric unit, distinguished by the labels A and B. The refined atom 































Atomic co-ordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103). Uequiv is defined as one third of the trace of the 
orthogonalized Uij tensor. 
x/a ylb zlc Ue9uiv 
3940(22) 8866(5) 8862(14) 60(7) 
3658(21) 9367(6) 8634(14) 72(8) 
1751(27) 9535(7) 8352(16) 78(9) 
263(22) 9210(6) 8294(13) 59(7) 
638(20) 8717(5) 8510(11) 44(6) 
-1092(18) 8387(6) 8426(14) 64(7) 
-631(17) 7869(6) 8364(13) 62(7) 
1321(17) 7734(4) 9371(12) 37(6) 
2933(17) 7997(5) 8966(12) 42(7) 
2513(21) 8528(5) 8772(12) 44(7) 
4894(15) 7887(4) 9926(14) 44(6) 
5271(17) 7348(5) 10269(13) 64(7) 
3626(16) 7111(5) 10666(12) 40(6) 
1685(16) 7207(5) 9609(12) 46(6) 
293(17) 6910(5) 10113(14) 57(6) 
1559(17) 6485(4) 10937(12) 51(7) 
3576(22) 6563(5) 10889(15) 56(7) 
3774(20) 6299(6) 9664(16) 83(8) 
2207(25) 6401(6) 8418(16) 87(9) 
1729(19) 6937(5) 8259(13) 73(8) 
3727(16) 7355(4) 12039(12) 50(5) 
5188(16) 6434(0) 12000(12) 77(6) 
5450(37) 6055(8) 12555(12) 116(14) 
4139(19) 5702(5) 12185(15) 128(8) 
7197(23) 5951(6) 13607(19) 124(11) 
1534(17) 9998(4) 8231(11) 91(7) 
-366(27) 10202(7) 8054(20) 110(11) 
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Table 6.3: (cont.) Atomic co-ordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103). Uequiv is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom xla ylb zlc Uequiv 
C1B 4711(18) 7473(6) 5935(12) 54(7) 
C2B 5238(19) 7012(5) 6091(14) 64(7) 
C3B 3873(24) 6671(6) 5529(14) 63(8) 
C4B 1979(22) 6790(6) 4900(13) 61(8) 
C5B 1492(17) 7270(6) 4781(13) 51(7) 
C6B -559(19) 7386(6) 3990(14) 66(8) 
C7B -1093(17) 7905(5) 4010(15) 72(7) 
C8B 519(17) 8232(5) 3823(12) 44(6) 
C9B 2252(17) 8165(4) 5058(12) 37(6) 
C10B 2812(19) 7652(6) 5292(13) 51(7) 
C11B 3963(17) 8497(5) 5130(12) 57(6) 
C12B 3402(18) 9025(5) 4684(13) 61(7) 
Cl3B 1752(16) 9060(5) 3429(12) 40(6) 
C14B 15(18) 8756(5) 3525(11) 41(6) 
C15B -1525(17) 8868(5) 2207(12) 54(6) 
C16B -998(16) 9379(5) 1791(12) 46(6) 
C17B 768(19) 9519(5) 2918(13) 48(6) 
C174 241(21) 9819(5) 4080(13) 70(7) 
C175 -1257(22) 9514(6) 4451(15) 88(9) 
C176 -732(18) 8994(5) 4661(13) 58(6) 
C18B 2487(18) 8833(5) 2293(13) 68(8) 
019B 2203(13) 9826(4) 2517(9) 64(4) 
C20B 1669(30) 10211(5) 1787(20) 77(10) 
021B 50(17) 10364(4) 1406(12) 105(7) 
C22B 3283(26) 10463(6) 1486(18) 112(11) 
023B 4507(14) 6197(4) 5773(9) 79(5) 
C24B 3184(22) 5832(5) 5220(15) 83(8) 
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Analysis 
The crystal structure of the 14a,17a-ethano compound 113 indicated two 
crystallographically independent molecules in the unit cell. The major differences between 
these two molecules lie in the flexible ring B region, as well as in the conformation of the 
protecting groups. This is clearly indicated in Figure 6.1, where the two molecules have 
been superimposed. A complete summary of the observed bond lengths, bond angles and 
endocyclic torsion angles is contained in Figure 6.2 and Table 6.4. No abnormal bond 
lengths, angles or torsion angles were observed in the determination. 
Figure 6.1: Superimposition of the two observed structures of 3-methoxy-14,17a-
ethanoestra-1,3,5(10)-trien-17P-yl acetate 113. Conformation A is displayed in green and 























Figure 6.2: Bond distances (A), bond angles (0 ) and endocyclic torsion angles (0 ) for the 
two crystallographically observed forms of 14a,17a-ethano compound 113. A torsion 
angle a-P-y-'6 is positive if, when viewed down the P-y bond, the a-p bond will eclipse the 
y-'6 bond when rotated less then 180° in a clockwise direction. 
A similar pattern was observed in the case of the 14a,17a-propano compound 115, the two 
crystallographically independent conformations once again mainly differed m the 
conformation of ring B. Interestingly, in this case, unlike as was observed for the 
14a,17a-ethano compound 113 the protecting groups adopted very similar conformations. 
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The two conformations have been superimposed in Figure 6.3. The observed bond lengths, 
bond angles and torsion angles are summarised in Figure 6.4 and Table 6.4, some slightly 
long bonds (1.6 A for C-C single bonds) were observed. 
Figure 6.3: Superimposition of the two observed structures of 3-methoxy-14,17a-
propanoestra-1,3,5(1 O)-trien-17~-yl acetate 115. Conformation A is displayed in green and 
conformation B in purple. 
Table 6.4: Additional bond angles observed in the X-ray crystal structures of the 
14,17-bridged estradiol analogues 113, 115 and 117. 
Compound 
Angle 60 60 115 115 117 117 117 117 
8-14-17213 115.5 116.5 110.8 111.1 108.9 110.3 111. I 1 I 0.5 
13-14-17213 102.4 101.9 107.3 107.1 108.9 108.7 108.1 108.7 
13-17-1?1 103 .5 103.9 109.5 111.6 111.5 111 .5 111.2 111.1 
14-17213 -17 112 103.6 104.4 114.8 114.8 111.0 112.4 113.2 112.8 
15-14-17213 105.1 105.9 104.3 105.6 108.8 109.4 108.7 109.1 
16-17-1 ?1 108.5 107.4 107.5 112.4 111.4 110.1 109.8 109.9 
17-1?1-172 101.7 101.6 114.2 105.0 109.9 111.1 111.3 112.4 
1?1-17-0 114.5 116.4 107.7 105.3 109.7 105.7 110.3 106.1 
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Figure 6.4: Bond distances (A), bond angles (0 ) and endocyclic torsion angles (0 ) for the 
two crystallographically observed forms of 14a,17a-propano compound 115. A torsion 
angle a-P-y-8 is positive if, when viewed down the P-y bond, the a-p bond will eclipse the 
y-8 bond when rotated less then 180° in a clockwise direction. 
Four crystallographically independent conformations were observed in the unit cell of the 
14P, 17P-propano compound 117. 37 These structures differed in the conformation of ring 
B, and in the orientation of the 3-methoxy group. This deviation is apparent from the 
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superimpositions of the various observed conformations depicted in Figure 6.5. The bond 




Figure 6.5: Superimposition of the four crystallographically observed conformations of 
3-methoxy-14,l 7B-propano-14B-estra- l ,3,5(10)-trien-17B-ol ll 7. (a) A and B, (b) A and 
C, (c) A and D, (d) B and C, (e) B and D and (t) C and D. In all cases the former 
conformer is displayed in green and the latter in purple. 
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Figure 6.4: Bond distances CA), bond angles C0 ) and endocyclic torsion angles C0 ) for the 
two crystallographically observed forms of I4P,17P-propano compound 117. A torsion 
angle a.-P-y-8 is positive if, when viewed down the P-y bond, the a.-P bond will eclipse the 
y-8 bond when rotated less then 180° in a clockwise direction. 
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Appendix 1 
Binding Affinity Determination 
The affinities of the estradiol analogues described in this thesis were determined by the 
method of competitive protein binding. 24 In this technique, radioactively labelled 
reference hormone and the test compound are incubated with the receptor. As the test 
material competes for receptor site occupancy, the amount of reference material bound by 
the protein decreases. This competition depends on the concentration of the test material 
and upon it's binding affinity towards the receptor. The affinity is measured in terms of a 
'competition factor' (CF), defined as the ratio of the concentration of the test sample (Ctest) 
and that of the reference (cref) required for 50% competition: 
CF= (CtestlCref) at 50% competition. 
In this case, estradiol was taken as the reference material, and thus has a CF of 1. A 
binding assay of CF $ 1 indicates that the hormone analogue is biologically active, and is 
able to compete successfully with estradiol for receptor site occupancy. A compound with 
a CF of much greater than unity is considered inactive. 
Appendix 2 
Puckering Parameters 
For a six-membered ring, three parameters of pucker in the form of polar coordinates (Q, e, 
~) are obtained from the calculation ( as described by Cremer and Pople ). 178 These 
coordinates map out the conformation of the ring upon the surface of a sphere, radius Q, 
and with poles at e = 0, 180°. 179 Figure A2.1 depicts the surface of this sphere in a two-
dimensional polar projection. 179 
In the case of a 'perfect' chair conformation, Q = 0.63A (assuming all bonds are 1.54A), 
and both e and ~ are 0°. As the ring distorts away from ideality, all of these parameters 
change. As can be seen from Figure A2.1, while e remains at or near 0°C, any deviations 
of~ have little effect on the conformation of the ring, however, as e increases, changes in~ 
have a greater effect on the ring conformation. Thus, the puckering parameters provide an 
excellent method of determining the conformation of a six-membered ring. 
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Figure A2.1: Two dimensional polar projection of a spherical surface to distinguish 


























List of Abbreviations Used 
Proton nuclear magnetic resonance spectroscopy 
Carbon-13 nuclear magnetic resonance spectroscopy 
a,a' -Azobis(isobutyronitrile) 
Cerium(IV) ammonium nitrate 








Frontier molecular orbital 




Lithium aluminium hydride 
Nuclear Overhauser effect 
Phenyl vinyl sulfone 
Triethylamine 
Tetrahydrofuran 
Thin layer chromatography 
meta-Chloroperbenzoic acid 
Appendix 4 
Tables of 13C NMR Data 
Tables of 13C NMR data for selected compounds are presented. All assignments were 
made by a combination of 2D techniques and by analogy with previously reported values 
for related compounds. 66• 195 (All o values are in ppm relative to TMS) 
13a-Series (Section 2.1) 
Carbon 0 0 
~ ~ H 
3 4 
1 126.8 128.0 
2 111.7 112.3 
3 157.5 157.4 
4 113.5 113.3 
5 138.0 137.2 
6 30.3 29.9 
7 28.3 28.2 
8 41.5 41.2 
9 41.4 38.4 
10 131.9 132.8 
11 28.2 27.0 
12 32.0 29.2 
13 50.1 46.5 
14 49.3 56.7 
15 21.0 164.0 
16 33.4 131.3 
17 210.0 214.2 
13a-Me 25.1 24.2 
3-0Me 55.1 55.2 
Sa-series (Section 2.2) 
Carbon OAc OAc OAc OAc OAc 
~' ~-· ~j vf?~ . < ~ . OAc S0,Ph . . 
17 18 31 33 37 
1 130.4 130.4 130.4 130.4 130.2 
2 112.4 112.3 112.3 112.3 112.3 
3 157.6 157.6 157.6 157.6 157.6 
4 113.2 113.2 113.2 113.3 113.1 
5 137.6 136.9 137.1 136.9 136.8 
6 31.3 30.5 30.6 30.8 30.4 
7 27.2 20.1 20.1 21.6 19.8 
8 34.6 37.8 38.0 36.1 37.5 
9 35.4 38.2 38.6 37.4 37.8 
10 132.7 133.4 133.5 133.2 132.9 
11 22.6 28.2 28.1 27.4 27.7 
12 28.1 29.2 30.9 30.4 30.2 
13 60.3 54.4 59.3 87.4 59.7 
14 61.1 61.2 54.4 64.8 54.8 
15 132.5 28.9 28.3 152.8 42.3 
16 135.5 67.2 55.2 146.8 79.0 
17 92.4 95.1 95.5 98.7 97.7 
13p-Me 16.9 16.5 16.4 18.6 17.7 
3-0Me 55.2 55.2 55.2 55.2 55.1 
1?1 31.1 129.2 129.8 140.0 130.6 
Ii 66.3 136.3 140.2 143.5 139.5 
17P-0Ac 21.3 and 170.4 20.9 and 168.9 21.3 and 171.2 21.4 and 170.7 21.3 and 169.2 
misc. 128.1, 129.2, 128.5, 129.1, 201.9 51.3 and 164.7 20.9 and 169.0 
133.3 and 133.3 and (16a-CHO) (16-C02Me) (16a-0Ac) 
141.3 140.9 117.1 
( 1 i-PhS02) (l6a-PhS02) ~16~-CN) 





































































































Ring B unsaturated 14a,17a-ethano derivatives (Section 2.3) 
Carbon OAc OH OH 
~ ~ ~ AcO Meo Meo 
80 81 82 
I 128.4 128.2 128.3 
2 123.8 121.0 111.0 
3 148.2 157.2 157.3 
4 118.9 106.6 113.3 
5 133.6 134.4 137.6 
6 134.5 133.6 37.4 
7 124.7 124.1 25.6 
8 148.2 146.5 167.0 
9 125.1 125.2 156.1 
10 129.5 126.9 124.0 
11 200.0 200.7 200.3 
12 45.6 45.2 44.0 
13 46.0 49.9 48.8 
14 51.0 47.9 49.9 
15 32.3 • 35.8 • 34.l • 
16 39.9 • 39.3 • 35.5 • 
17 88.8 83.9 83.6 
Ii 31.7 • 34.6 • 29.7 • 
Ii 31.2 • 31.3 • 28.0 • 
misc. 21.2 and 170. 7 55.2 55.3 
3-0C(O)CH3 3-0Me 3-0Me 
21.4 and 169.4 
17p-OC(O)CH3 
• Data are interchangeable 
ISP 17-0xo series (Chapter 3) 
Carbon 0 0 0 0 0 
~"" ~ ~ ~ k_, 
88 98 108 110 111 
1 126.7 126.l 126.0 125.8 125.9 
2 111.5 111.5 111.4 111.4 111.5 
3 157.7 157.7 157.7 157.6 157.8 
4 113.9 113.8 113.9 113.9 113.9 
5 136.8 137.7 137.7 137.6 137.4 
6 29.4 29.4 29.5 29.4 29.3 
7 26.6 27.7 26.8 26.6 27.l 
8 36.5 37.l 36.0 37.l 35.8 
9 44.4 44.9 44.5 44.7 44.4 
10 131.9 132.3 132.4 132.2 131.8 
11 25.5 25.6 25.5 25.6 25.3 
12 33.1 34.2 33.6 35.4 33.8 
13 47.8 47.3 47.2 42.5 47.2 
14 53.7 55.0 52.8 51.4 53.4 
15 43.7 38.6 33.9 22.0 39.2 
16 46.6 45.0 42.7 25.8 43.7 
17 218.5 221.0 221.1 216.4 218.2 
13P-Me 17.0 17.6 17.7 17.3 18.2 
3-0Me 55.2 55.2 55.2 55.l 55.2 
misc. 126.1, 129.2, 126.0, 128.3, 30.4, 33.6 20.3 8.8 
130.3 and 128.4 and (C-15 1 and (C-16 1) (C-15 1) 
137.8 142.8 C-152) 




15a 17-0xo series (Chapter 3) 
Carbon 0 0 0 
~ ~~ ~o ~ \ 
93 95 99 
1 126.8 126.8 126.7 
2 111.8 111.8 111.8 
3 157.6 157.6 157.6 
4 113.6 113.5 113.5 
5 137.3 137.3 137.0 
6 30.0 30.0 29.8 
7 27.9 27.9 27.8 
8 39.7 39.7 39.5 
9 44.2 44.3 44.1 
10 131.8 131.8 131.5 
11 26.5 26.6 26.5 
12 31.6 31.6 31.5 
13 50.4 50.5 49.8 
14 54.1 55.4 54.1 
15 35.5 33.7 50.9* 
16 42.6 45.5 43.9 
17 219.5 219.7 219.0 
13P-Me 15.7 15.8 15.5 
3-0Me 55.2 55.2 55.2 
misc. 40.4 22.5 31.0· 
(C-15 1) (C-152-Me) (C-15 1) 
136.3 42.8 207.2 
(C-152) (C-15 1) (C-152) 
116.6 144.1 30.4 
(C-15 3) (C-152) (C-153) 
111.6 
(C-153) 
.• Data are interchangeable 
Appendix 5 
X-Ray Crystal Structure of Estradiol 
For comparison purposes, the relevant details of the X-ray crystal structure of estradiol 184 











Figure AS.l: Bond distances CA), bond angles C0 ) and endocyclic torsion angles C0 ) for the 
two crystallographically observed forms of estradiol. A torsion angle a-P-y-8 is positive if, 
when viewed down the P-y bond, the a.-P bond will eclipse the y-8 bond when rotated less 
then 180° in a clockwise direction. 
